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I. Introduction 
Transition-metal catalyzed cross-couplings belong to the modern repertoire of organic synthesis. 
The agrochemical and pharmaceutical industries extensively use this powerful method for 
forming new carbon-carbon bonds. Palladium complexes are certainly the most frequently used 
catalysts and a vast range of air-stable and convenient palladium complexes are commercially 
available. A broad reaction scope and a large amount of literature ensure an excellent 
applicability of this methodology for complex and new targets.1 
 
1. Recent Advances in Cobalt-Catalyzed Cross-Couplings 
 
Most of these palladium catalysts require expensive phosphines and the palladium salts 
themselves are expensive and toxic, thus the search for alternative transition-metal catalysts 
has been extensively investigated. 2 Although nickel salts have a closely related chemical 
behavior and are quite inexpensive, toxicity issues as well as a more limited scope and a high 
ligand dependence on catalytic activity have hampered broad usage of this metal.1a,2b,c 
Alternatively, iron salts and complexes have successfully been used in several cases, 
nevertheless, the relative insensibility of this metal towards the addition of specific ligands and a 
limited reaction scope has limited their synthetic applications.3 Cobalt salts show a similar 
reactivity compared to iron salts, but display in many cases a higher catalytic activity and a 
lower tendency to produce homo-coupling byproducts. Therefore, they have led to numerous 
synthetic applications and to a broad number of publications over the years.4 Recent work from 
our laboratory led to the discovery of specific ligands such as N-heterocycles5,6 or carboxylate 
                                                
1 a) Metal-Catalyzed Cross-Coupling Reactions, 2nd ed., (Eds.: A. de Meijere, F. Diederich), Wiley-VCH, 
Weinheim, 2004. b) Organotransition Metal Chemistry (Ed.: J. F. Hartwig), University Science Books, 
Sausalito, CA, 2010. 
2 a) world markt prices: Pd ca. 8000 $/lb, ca. Co 10 $/lb; http://www.infomine.com/; retrieved December 
2016. b) Handbook on the Toxicology of Metals (Eds.: L. Friberg, G. F. Nordberg, V. B. Vouk), Elsevier, 
Amsterdam, 1986. c) M. N. Hughes, in Comprehensive Coordination Chemistry (Eds.: G. Wilkinson, R. D. 
Gillard, J. A. McCleverty), Pergamon Press, Oxford, 1987. 
3 a) I. Bauer, H.-J. Knölker, Chem. Rev. 2015, 115, 3170. b) T. L. Mako, J. A. Byers, Inorg. Chem. Front. 
2016, 3, 766.  
4 a) H. Yorimitsu, K. Oshima, Pure Appl. Chem. 2006, 78, 441. b) C. Gosmini, J.-M. Bégouin, A. 
Moncomble, A. Chem. Commun. 2008, 3221. c) G. Cahiez, A. Moyeux, Chem. Rev. 2010, 110, 1435. d) 
C. Gosmini, A. Moncomble, Isr. J. Chem. 2010, 50, 568. e) A. Rudolph, M. Lautens, Angew. Chem. Int. 
Ed. 2009, 48, 2656. 
5 a) T. Thaler, L.-N. Guo, P. Mayer, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 2174. b) O. M. Kuzmina, 
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2 
ligands6 allowing boosting the catalyst activity and more importantly to expand the reaction 
scope of cobalt-catalyzed cross-couplings. In the following sections, an overview on recent work 
involving cobalt-catalyzed coupling reactions and some recent advances from our laboratories 
will be given.7 
 
1.1 Cobalt-Catalyzed Csp2-Csp2 Cross-Couplings 
 
Csp2-Csp2 cross-couplings are difficult to realize in the absence of transition-metal catalysts. By 
using an N-heterocyclic carbene ligand such as 1, it was possible to perform a cobalt-catalyzed 
cross-coupling between aryl and heteroaryl chlorides and arylmagnesium reagents. The 
reaction requires only a few mol% of the Co catalyst and proceeds between 50-60 °C. 
Nakamura showed that cobalt(II) fluoride in combination with 1 gave the best results       
(Scheme 1).8 A detailed mechanistic and theoretical study is given for the corresponding Ni, Fe 
and Co-catalyzed reactions. 
  
 
Scheme 1. Cross-couplings using CoFe2.4H2O and a NHC-ligand. 
 
The fluoride ion proved to be the key for the catalytic activity of cobalt. Gosmini reported a 
cobalt-catalyzed cross-coupling between in situ prepared arylzinc halides and                             
2-chloropyrimidine (2) or 2-chloropyrazine. Using CoBr2 (10 mol%) in the presence of allyl 
                                                                                                                                                       
A. K. Steib, S. Fernandez, W. Boudot, J. T. Markiewicz, P. Knochel, Chem. Eur. J. 2015, 21, 8242. 
6 D. Haas, J. M. Hammann, F. H. Lutter, P. Knochel, Angew. Chem. Int. Ed. 2016, 55, 3809. 
7 J. M. Hammann, F. H. Lutter, D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2017, 129, 1102. 
8 T. Hatakeyama, S. Hashimoto, K. Ishizuka, M. Nakamura, J. Am. Chem. Soc. 2009, 131, 11949.	
MgBr
OMe
F Cl
F
[Co] (5 mol%)
80 °C, 12 h
S Cl
[Co] (2 mol%)
50 °C, 15 h
OMe
S
95%
OMe
F
F
NN
iPr
iPriPr
iPr
Cl CoF2.4H2O[Co] = +
1 (2 equiv.)
(1 equiv.)
97% (1.2 equiv)
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3 
chloride (0.4 equiv) and zinc powder (2.5 equiv) allowed an in situ generation of an intermediate 
arylzinc reagent in acetonitrile (in the presence of traces of trifluoroacetic acid) leading to cross-
coupling products such as 3 within 4 h reaction time at 50 °C (Scheme 2).9 
 
 
Scheme 2. Cross-coupling of 2-chloropyrimidine (2). 
 
Alternatively, Gosmini showed that the use of manganese metal as a reducing agent allows an 
efficient cross-coupling between chloro- and bromo-styrenes and various aryl bromides 
(Scheme 3). 
 
 
Scheme 3. Stereoselective cobalt-catalyzed alkenylation. 
 
Remarkably, this selective cross-coupling, which proceeds rapidly in acetonitrile in a few 
minutes, leads to the expected stilbenes with full retention of the double bond configuration. 
Thus, the reductive manganation of ethyl 4-bromobenzoate (4) followed by the addition of                   
Z-2-bromostyrene furnishes only the Z-stilbene 5 (Scheme 3).10 
Instead of performing such cross-couplings in MeCN, the use of isoquinoline or quinoline          
(7 mol%) as a ligand, allows an efficient cross-coupling between various N-heteroaryl halides 
and arylmagnesium reagents. Thus, the cross-coupling between 
3-N,N-dimethylaminophenylmagnesium bromide (6) and methyl 2-chloronicotinate (7) produces 
                                                
9 J.-M. Begouin, C. Gosmini, J. Org. Chem. 2009, 74, 3221. 
10 A. Moncomble, P. Le Floch, A. Lledos, C. Gosmini, J. Org. Chem. 2012, 77, 5056. 
Cl +  CoBr2 +  Zn
1) MeCN, CF3CO2H (traces)
2)
Br
F
+
N
N
Cl
2 (2.0 equiv)
, 50 °C, 4 h
F
N
N
3: 90%
(40 mol%) (10 mol%) (2.5 equiv)
(1.0 equiv)
Br
CN
2 equiv.
CoBr2 (10 mol%)
PPh3 (10 mol%)
Mn (2 equiv)
MeCN, 50 °C, 3 h
Ph
Br
(1 equiv)
Ph
CN
82%
EtO2C Br
CoBr2 (10 mol%)
PPh3 (10 mol%)
Mn (2 equiv)
MeCN, 50 °C, 3 h
(1 equiv)
Ph Br
EtO2C
Ph4 (2 equiv) 5: 72%
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4 
in the presence of CoCl2 (3 mol%) at 25 °C within 10 minutes the desired cross-coupling product 
8 in only 10% yield. The extension of the reaction time did not increase the product formation. 
However, performing the reaction in the presence of isoquinoline (10 mol%) provides, at 25 °C 
and 10 minutes reaction time, the expected cross-coupling product in 71% isolated yield 
(Scheme 4).5 
 
 
Scheme 4. Cobalt-catalyzed arylation of 2-chloropyridine 7. 
 
Besides displaying a superior scope and reactivity, the use of a cobalt catalyst enhances the 
chemoselectivity of these cross-couplings. Thus, the bromopyridine 9 bearing an alkynyl 
substituent at position 4, which is susceptible to undergo carbomagnesiation reactions, reacts 
only in modest yield in the presence of FeBr3 (3 mol%). However, by using CoCl2 (3 mol%) 
under the same reaction conditions, a yield of 62 % of the disubstituted pyridine 10 is obtained 
(Scheme 5).5  
 
 
Scheme 5. Chemoselective cobalt-catalyzed cross-coupling of 4-alkynyl-2-bromopyridine (9). 
 
Highly chemoselective cobalt-catalyzed biaryl couplings have been reported by Jacobi von 
Wangelin between chloro-substituted styrenes and arylmagnesium reagents. Thus, a cross-
coupling between 4-chloro-styrene (11) and various arylmagnesium reagents such as 12 leads, 
N
CO2Me
Cl
Me2N MgBr
6 (2 equiv)
CoCl2 (3 mol%)
isoquinoline (10 mol%)
tBuOMe/THF
25 °C, 10 min
7
NMe2
CO2Me
N
8: 71%
(10% yield in the absence 
of isoquinoline)
N Br
SiMe3
MgBr
OMe
+
CoCl2 (3 mol%)
or 
FeBr3 (3 mol%)
isoquinoline (10 mol%)
tBuOMe/THF
25 °C, 30 min
N
SiMe3
OMe9
10: 38% using a Fe-catalyst
      62% using a Co-catalyst
(1.5 equiv)
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5 
in the presence of only 1 mol% Co(acac)3 in THF/NMP at 30 °C to the desired cross-coupling 
product 13 in 93% yield (Scheme 6).11 
 
Scheme 6. Cobalt-catalyzed cross-coupling between chlorostyrenes and Grignard reagents. 
 
A careful mechanistic study has been performed showing that the non-innocent vinyl substituent 
of the chlorostyrene 11 facilitates the activation of the C-Cl bond by coordination to the cobalt-
catalyst. The performance of kinetic studies supports a mechanism in which a reduced cobalt-
catalyst [Co(I)] first undergoes a transmetalation with the Grignard reagent (Ar1MgX) providing 
an aryl cobalt-species which in the rate-determining step undergoes an oxidative addition to the 
aryl chloride (Ar2-Cl) leading to a cobalt(III)-species which after reductive elimination produces 
the cross-coupling product (Ar1-Ar2) and regenerates the Co(I)-catalyst (Scheme 7).11  
 
 
Scheme 7. Catalytic pathway for a Co-catalyzed aryl-aryl cross-coupling. 
                                                
11 S. Guelak, O. Stepanek, J. Malberg, B. R. Rad, M. Kotora, R. Wolf, A. Jacobi von Wangelin, Chem. Sci. 
2013, 4, 776. 
	
MgBr
OTHP
+
Co(acac)3 (1 mol%)
THF/NMP, 30 °C
11
13: 93%
Cl
12 (1.1 equiv) OTHP
[Co(I)]
Co(II) precatalyst
Ar1MgX
Ar1-[Co(I)] MgX
Ar2-Cl
[Co(III)]
Ar1
Ar2
Ar1-Ar2
rate-determining step
14
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6 
The oxidative addition step is facilitated both by the formation of a cobaltate(I) species of type 
14 and by the coordination of this ate-species to the olefinic part of the styrene moiety. A similar 
activation may be proposed in the case of the quinoline-catalyzed cobalt cross-coupling. Thus, 
in the case of the electron-deficient chloropyridine 15 the use of an electron-rich substituted 
quinoline (N,N-dimethylquinoline-8-amine, 16) is required in order to achieve a cross-coupling 
reaction with PhMgCl. Both quinoline and isoquinoline provide the product 17 in only modest 
yields (Scheme 8).5b 
 
Scheme 8. Ligand influence on cobalt-catalyzed cross-couplings. 
 
Cobalt catalysis allows also the cross-coupling of arylsulfonic acid salts with Grignard reagents. 
Thus, the treatment of the sodium salts of arylsulfonic acids with arylmagnesium reagents in the 
presence of CoCl2(PCy3)2 (1 mol%) at 25 °C provides the desired biphenyls in excellent yields.12 
In the case of naphthylsulfonic acid salts the reaction may need to be performed at 60 °C for    
24 h (Scheme 9).  
 
 
Scheme 9. Cobalt-catalyzed cross-couplings between a naphthylsulfonic acid salt and a 
sterically hindered Grignard reagent. 
 
Cobalt catalysis also allows the synthesis of functionalized azepenes and piperidines using a 
reductive cross-coupling procedure. Thus, the cross-coupling between the heterocylic bromide 
18 and the dibromonaphthoquinone (19) in the presence of CoBr2 (10 mol%) and PPh3                  
                                                
12 C. A. Malapit, M. D. Visco, J. T. Reeves, C. A. Busacca, A. R. Howell, C. H. Senanayake, Adv. Synth. 
Catal. 2015, 357, 2199. 
N
F3C
Cl N
F3C
Ph
PhMgCl (2 equiv)
CoCl2 (3 mol%)
additive (10 mol%)
tBuOMe/THF
25 °C, 15 min
15 17: 17-79%
       without additive: 17%
       with quinoline: 51%
       with isoquinoline: 18%
with 16: 79%
N
NMe2
16
SO3Na
Me
MgCl
Me Me
+
CoCl2(PCy3)2 (1 mol%)
THF, 60 °C, 24 h
Me
Me
Me
68%
(3.0 equiv)
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7 
(20 mol%), using manganese powder (5 equiv) as reducing agent in MeCN at 25 °C, provides 
the interesting cross-coupling product 20 in 37% yield (Scheme 10).13  
 
 
Scheme 10. Selective reductive cross-coupling of a 2-bromoenamine with a 
dibromonaphthoquinone in acetonitrile. 
 
 
1.2 Cobalt-Catalyzed Csp2-Csp3 Cross-Couplings 
 
Yorimitsu and Oshima reported the cross-coupling between aryl bromides and alkylmagnesium 
reagents in diethyl ether at 25 °C using CoCl2 (5 mol%), 1.5 equiv TMPDA (N,N,N’,N’-
tetramethyl-1,3-propanediamine) and 6 mol% of an NHC-ligand (IMes.HCl, 21). Under these 
conditions, octylmagnesium chloride reacts with the bromide 22 within 1 h at 25 °C producing 
the desired cross-coupling product 23 in 89% yield (Scheme 11).14  
 
 
Scheme 11. CoCl2-catalyzed cross-coupling between an alkylmagnesium chloride and aryl 
bromide (22). 
 
Cahiez reported a related cross-coupling using the reaction of functionalized alkyl bromides and 
arylmagnesium bromides at 0 °C in THF. Thus, the bromoketone 24 reacts with 
                                                
13 T. K. Beng, K. Sincavage, A. W. V. Silaire, A. Alwali, D. P. Bassler, L. E. Spence, O. Beale, Org. 
Biomol. Chem. 2015, 13, 5349. 
14 H. Hamaguchi, M. Uemura, H. Yasui, H. Yorimitsu, K. Oshima, Chem. Lett. 2008, 37, 117. 
N
Boc
Br
O
O
Br
Br
+
CoBr2 (10 mol%)
PPh3 (20 mol%)
Mn (5 equiv.)
MeCN, 25 °C
O
O
N
Boc
Br
18 19 (2.0 equiv) 20: 37%
O O
Me
Br
+  OctMgCl
CoCl2 (5 mol%)
21 (6 mol%)
(1.5 equiv)
Et2O, 25 °C, 1 h
O O
Me
Oct
22 23: 89%
N N MesMes
Cl
21: IMes.HCl(1.5 equiv) Me2N NMe2
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8 
anisylmagnesium bromide (25) in the presence of 5 mol% TMEDA providing the expected 
cross-coupling product 26 in 90% yield (Scheme 12).15 
 
 
Scheme 12. Cobalt-catalyzed cross-coupling between an arylmagnesium halide and a 
bromoketone. 
 
Interestingly, Jacobi von Wangelin reported a direct cobalt-catalyzed cross-coupling between 
aryl and alkyl halides. Thus, the reaction between ortho-bromoanisole with cyclohexyl bromide 
in the presence of magnesium powder (1.2 equiv) and Me4-DACH (10 mol%, N,N,N’,N’-
tetramethyl-1,2-diaminocyclohexane, 27) produces the corresponding cross-coupling product 28 
in 76% yield within 6 h at 0 °C (Scheme 13).16 
 
 
Scheme 13. Direct cobalt-catalyzed cross-coupling. 
 
 
Scheme 14. Cobalt-catalyzed cross-couplings between heterocyclic iodides and arylmagnesium 
reagents. 
                                                
15 G. Cahiez, C. Chaboche, C. Duplais, A.  Moyeux, Org. Lett. 2009, 11, 277. 
16 W. M. Czaplik, M. Mayer, A. J. von Wangelin, Synlett 2009, 2931.	
CoCl2 (5 mol%)
Br
O
Me
Me
MgBr
OMe
+
TMEDA (5 mol%)
THF, 0 °C, 40 min MeO
O
Me
Me
24 25 (1.5 equiv) 26: 90%
OMe
Br
+
Mg (1.2 equiv)
CoCl2 (5 mol%)
27 (10 mol%)
THF, 0 °C, 6 h
OMe
Br
NMe2
NMe2
27: Me4-DACH
28: 76%(1.2 equiv)
N
Boc I
+   PhMgCl
CoCl2(PPh3)2 (5 mol%)
TMEDA (5 mol%)
THF, 25 °C, 2 h
N
Boc Ph
29 30: 84%
N
Boc
I
+
N
MgBr CoCl2 (5 mol%)
27 (6 mol%)
THF, 25 °C, 2 h
N
Boc
N
31 32: 90%
(1.3 equiv)
(1.3 equiv)
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Such cross-couplings have been applied to the synthesis of enantiopure pyrrolidine derivatives.  
Thus, the reaction of the chiral iodide 29 with phenylmagnesium chloride in THF in the presence 
of CoCl2(PPh3)2 (5 mol%) and TMEDA (5 mol%) furnishes the corresponding pyrrolidine 30 in 
84% yield (Scheme 14).17 
 
Cossy reported a straightforward cross-coupling between various iodo-azetidines, -pyrrolidines 
and -piperidines and a range of aryl and heteroaryl iodides.18 Thus, the cross-coupling of the 
iodoazetidine (31) with 3-pyridylmagnesium bromide in the presence of CoCl2 (5 mol%) and of 
ligand 27 (6 mol%) provides the coupling product 32 in 90% yield. It is worth noting that this 
cross-coupling can be performed with the same yield using FeCl2 (10 mol%) as catalyst 
(Scheme 14). Such cross-couplings have been extended by Cossy and Reymond toward the 
diastereoselective synthesis of C-aryl glycosides. Thus, the treatment of the bromoglycoside 33 
with the anisylmagnesium bromide (34) in the presence of 5 mol% Co(acac)3 and 5 mol% 
TMEDA produces the α-isomer with high diastereoselectivity (35) in 82% yield (Scheme 15).19 
 
 
Scheme 15. Cobalt-catalyzed cross-coupling between arylzinc and aryl magnesium reagents 
and functionalized bromides. 
 
                                                
17 S.-F. Hsu, C.-W. Ko, Y.-T. Wu, Adv. Synth. Catal. 2011, 353, 1756. 
18 B. Barre, L. Gonnard, R. Campagne, S. Reymond, J. Marin, P. Ciapetti, M. Brellier, A. Guerinot, J. 
Cossy, Org. Lett. 2014, 16, 6160. 
19 a) L. Nicolas, P. Angibaud, I. Stansfield, P. Bonnet, L. Meerpoel, S. Reymond, J. Cossy, Angew. Chem. 
Int. Ed. 2012, 51, 11101. b) L. Nicolas, E. Izquierdo, P. Angibaud, I. Stansfield, L. Meerpoel, S. Reymond, 
J. Cossy, J. Org. Chem. 2013, 78, 11807. c) L. Gonnard, A. Guerinot, J. Cossy, Chem. Eur. J. 2015, 21, 
12797.	
O Br
OAc
OAc
AcO
AcO
+
MgBr
OMe
Co(acac)3 (5 mol%)
TMEDA (5 mol%)
THF, 0 °C
O
OAc
OAc
AcO
AcO OMe
33 34 (1.5 equiv) 35: 82%; α:β>9:1
I
CO2Me
1) iPrMgCl
    THF, -20 °C
2) ZnCl2, TMEDA
ZnCl.TMEDA
CO2Me
Br CO2Et
F F
36
CoCl2 (5 mol%)
27 (6 mol%)
THF, 25 °C CO2Me
F
F CO2Et
51%(2.0 equiv)
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An efficient cross-coupling of various arylzinc reagents with ethyl bromodifluoroacetate (36), 
catalyzed by cobalt(II) chloride, has been reported by Inoue.20 The method requires only 6 mol% 
of the ligand 27 and proceeds at 25 °C (Scheme 15). Linclau21 has recently reported a total 
synthesis of (±)-paroxetine (37) using a stereoconvergent cobalt-catalyzed arylation reaction. 
Thus, the bromopiperidine 38 was converted in a stereoconvergent manner to the arylated 
cross-coupling product 39 by a treatment with 4-fluorophenylmagnesium bromide in the 
presence of 10 mol% Co(acac)3, 50 mol% TMEDA and 50 mol% HMTA 
(hexamethylenetetramine) in methyltetrahydrofuran (25 °C, 6 h) with a diastereoselectivity of 
88:12 in 76% yield. Deprotection provides the desired pharmaceutical 37 (Scheme 16). 
 
  
 
Scheme 16. Stereoconvergent cobalt-catalyzed cross-coupling leading to (±)-paroxetine. 
 
 
An asymmetric Kumada cross-coupling of racemic α-bromo esters with arylmagnesium 
reagents can be realized using chiral bisoxazoline ligands. Thus, the reaction of the 
arylmagnesium reagent 40 with the racemic bromo ester 41 in the presence of 12 mol% of 
ligand 42 and 10 mol% CoI2 in THF at -80 °C leads to the optically enriched arylated ester 43 in 
87% yield and 93% ee. Palladium-catalyzed reductive deprotection provides the pharmaceutical 
(S)-fenoprofen (44) in 92% ee (Scheme 17).22 
 
                                                
20 K. Araki, M. Inoue, Tetrahedron 2013, 69, 3913. 
21 C. F. Despiau, A. P. Dominey, D. C. Harrowven, B. Linclau, Eur. J. Org. Chem. 2014, 4335.	
22 J. Mao, F. Liu, M. Wang, L. Wu, B. Zheng, S. Liu, J. Zhong, Q. Bian, P. J. Walsh, J. Am. Chem. Soc. 
2014, 136, 17662.	
N
Boc
Br
O O
O F MgBr
Co(acac)3 (10 mol%)
TMEDA (50 mol%)
HMTA (50 mol%)
MeTHF, 0 °C
N
Boc
O O
O
F
38
39: 76%; dr = 88:12
N
H
O O
O
F
37: (±)-paroxetine
1) separation of diasteromers
2) deprotection
(2.0 equiv)
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Scheme 17. Enantioselective synthesis of (S)-fenoprofen using an enantioselective cobalt-
catalyzed arylation. 
 
Often, cheap and structurally simple ligands can be used for cobalt-catalyzed cross-couplings. 
Recently, Casar has found that the naturally occurring ligand sarcosine (45) could be used. This 
ligand allows the performance of smooth cross-couplings between the functionalized allylic 
bromide 46 and various arylmagnesium reagents. The cross-coupling proceeds at -20 °C within 
1 h and provides the desired cross-coupling product 47 in quantitative yield (Scheme 18).23 
 
 
Scheme 18. Cobalt-catalyzed allylation using sarcosine as a ligand. 
  
Benzylic organozinc reagents display a higher reactivity than aryl- or alkyl-zinc reagents. The 
use of isoquinoline as ligand in an ethereal solvent mixture (2:1 = THF : tBuOMe) allowed the 
performance of cross-couplings between various functionalized benzylic zinc chlorides and aryl 
bromides at 50 °C. In a typical example, the ester-substituted benzylic zinc reagent 48 reacts 
with 4-bromo benzonitrile 49 in the presence of 5 mol% CoCl2 and 10 mol% isoquinoline 
furnishing after 18 h at 50 °C the expected cross-coupling product 50 in 62% yield           
(Scheme 19).24 
 
                                                
23 R. Frlan, M. Sova, S. Gobec, G. Stavber, Z. Casar, J. Org. Chem. 2015, 80, 7803. 
24 A. Benischke, I. Knoll, A. Rérat, C. Gosmini, P. Knochel, Chem. Commun. 2016, 52, 3171.	
CO2BnMe
Br
+
MgBr
OPh
CoI2 (10 mol%)
59 (12 mol%)
THF, -80 °C OPh
Me CO2Bn
rac-41 40 (1.4 equiv)
43: 87%; 93% ee
H2, Pd/C
MeOH, 25 °C OPh
Me CO2H
44: (S)-fenoprofen
      81%; 92% ee
O
N N
O
Me Me
Bn Bn
42
Br CO2Me
46
+
F
F
MgBr
F
CoBr2 (5 mol%)
45 (10 mol%)
THF, -20 °C, 1 h
F
F F
CO2Me
47: 97%
Me
H
N CO2H
45: sarcosine
(1.4 equiv)
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Scheme 19. Cobalt-catalyzed cross-coupling of benzylic zinc reagents. 
 
In summary, cobalt salts are catalytically active, require only simple ligands for full activity and 
have already a broad application scope. It can be anticipated that future progress will be made 
in this attractive research field, triggered by the relative simple and practical reaction conditions, 
the low price of cobalt salts and the possibility of showing that cobalt-catalyzed cross-couplings 
can in a number of cases replace palladium catalysis.  
 
CO2Et
ZnCl
+
Br
CN
CoCl2 (5 mol%)
isoquinoline (10 mol%)
THF:tBuOMe 2:1
50 °C, 2 h CO2Et
CN
48 (1.3-1.5 equiv) 49 50: 62%
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II. Objectives 
Transition-metal-catalyzed cross-coupling reactions are valuable tools for C-C bond-forming 
reactions and have found many applications for the syntheses of biologically active molecules.  
As previously mentioned, Pd- or Ni-catalyzed cross-coupling reactions dominate this field, but 
have several drawbacks, for example, the toxicity2b and the high price2a of these metals, as well 
as the requirement of sophisticated ligands to achieve a broad reaction scope. Thus, this thesis 
deals with the replacement of expensive and/or toxic Pd- and Ni-catalysts by environmentally 
more benign cobalt catalysts for such cross-coupling reactions.4 
Recently, there has been much progress in Co-catalyzed cross-coupling reactions.  However, 
despite the spectacular advances and insights into the role of cobalt in coupling reactions, only 
a few diastereoselective transformations have been described. Thus, the aim of the first part of 
this thesis was to develop a general method for the cobalt-catalyzed diastereoselective 
cross-coupling of cyclic TBS-protected halohydrins with various aryl or heteroaryl magnesium 
reagents (Scheme 20).  
 
Scheme 20. Diastereoselective cross-coupling reactions between cyclic protected halohydrins 
and arylmagnesium reagents. 
 
Additionally, we wanted to establish a diastereoselective cross-coupling of variously substituted 
cycloalkyl halides with alkynyl Grignard reagents under cobalt catalysis (Scheme 21). 
 
 
Scheme 21. Diastereoselective cross-couplings of cycloalkyl iodides with alkynyl Grignard 
reagents. 
OTBS
R
cat.
X
OTBS
ZnX
+ ArHal
TBSOZnX
OTBS
Hal
+ArMgX
Co cat.
MgX
RR
Hal R
R
Co cat.
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Often however, magnesium or lithium organometallics are not the best choice for performing   
C-C bond formations, since homo-couplings are often observed side reactions. In comparison 
organomangenese reagents are considerably more stable and allow for the presence of 
sensitive functional groups in cross-coupling reactions even at high temperatures. Thereby, 
cobalt-catalyzed cross-couplings between alkyl halides and diarylmanganese reagents should 
be investigated (Scheme 22).25 
 
Scheme 22. Cross-coupling reactions of diarylmanganese reagents with alkyl halides. 
Pd- or Ni-catalyzed cross-coupling reactions between unsaturated halides and organometallics 
have found broad application. Cross-coupling reactions using boronic acids or esters, known as 
Suzuki cross-coupling reactions, have been extensively used due to the broad availability and 
relative air- and moisture-stability of unsaturated boronic derivatives. Nevertheless, the fast 
transmetalation of organozinc reagents to palladium compared to boronic acids often allows to 
achieve Negishi cross-couplings between a broad range of unsaturated halides and zinc 
organometallics under very mild conditions. The replacement of Pd- and Ni-catalysts employed 
in this reaction by environmentally benign metals, such as cobalt, is therefore highly desirable.  
Thus, a general method for the cobalt-catalyzed cross-coupling of organozinc reagents 
prepared via directed metalation with various alkyl halides should be investigated (Scheme 23). 
Special attention should be drawn to the coupling of secondary alkyl halides without 
rearrangement from branched to unbranched.26 
 
 
                                                
25 This project was developed in cooperation with Maximilian S. Hofmayer, see: M. S. Hofmayer, J. M. 
Hammann, D. Haas, P. Knochel, Org. Lett. 2016, 18, 6456 and Maximilian S. Hofmayer, PhD 
Dissertation, LMU Munich. 
26 This project was developed in cooperation with Diana Haas, see: J. M. Hammann, D. Haas, and P. 
Knochel, Angew. Chem. Int. Ed. 2015, 54, 4478 and Diana Haas, PhD Dissertation, LMU Munich. 
Co cat.
Alk Hal
Mn
2R Alk
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Scheme 23. Cross-coupling of organometallic reagents prepared via direct metalation with alkyl 
halides. 
Due to the broad and constantly increasing availability of zinc organometallics Negishi cross-
coupling reactions of (hetero)aryl halides with arylzinc reagents under cobalt-catalysis should 
also be investigated (Scheme 24).27 
 
Scheme 24. Cross-coupling of (hetero)aryl halides and arylzinc reagents. 
Boron organometallics have extensively been used for coupling reactions in medicinal 
chemistry, allowing for late-stage functionalizations of biologically active molecules. However, 
some of these boron derivatives are sensitive or difficult to prepare in high yields and in general 
require an additional base to achieve satisfactory cross-couplings. Hence, a robust and broadly 
applicable Co-catalyzed cross-coupling between functionalized air-stable aryl and heteroarylzinc 
reagents and various aryl or heteroaryl halides should be developed (Scheme 25).28 
 
Scheme 25. Cross-coupling of (hetero)aryl halides with bench-stable arylzinc pivalates. 
 
                                                
27 This project was developed in cooperation with Diana Haas, see: D. Haas, J. M. Hammann, F. H. 
Lutter, P. Knochel, Angew. Chem. Int. Ed. 2016, 55, 3809 and Diana Haas, PhD Dissertation, LMU 
Munich. 
28 This project was developed in cooperation with Ferdinand H. Lutter, see: J. M. Hammann, F. H. Lutter, 
D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 1082 and Ferdinand H Lutter, PhD Dissertation, 
LMU Munich. 
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Co cat.
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DG
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III. Results and Discussion 
1. Cobalt-Mediated Diastereoselective Cross-Coupling Reactions 
between Cyclic Halohydrins and Arylmagnesium Reagents 
1.1 Introduction 
Transition metal-catalyzed cross-coupling reactions are indispensable tools for the construction 
of C-C bonds in organic synthesis.1 Recently, there has been much progress in Co-catalyzed 
coupling methods. However, despite the spectacular advances and insights into the role of Co in 
coupling reactions,5 only a few diastereoselective Co-mediated or catalyzed transformations of 
this type have been described.19,2930 Previously, we have reported a diastereoselective Fe-
mediated cross-coupling of cyclic iodohydrins with aryl Grignard reagents leading to products of 
type 51 (Scheme 26).31  Although very effective with electron-poor Grignard reagents, this 
method displays a limited reaction scope, and electron-rich arylmagnesium bromides gave 
unsatisfactory results. Additionally, cyclic bromohydrins did not react.  
                                                
29  For selected cobalt-catalyzed cross-couplings and related reactions, see: a) M. Lautens, C. M. 
Crudden, Organometallics 1989, 8, 2733. b) M. Lautens, W. Tam, C. Sood, J. Org. Chem. 1993, 58, 
4513. c) G. Cahiez, H. Avedissian, Tetrahedron Lett. 1998, 39, 6159. d) K. Wakabayashi, H. Yorimitsu, K. 
Oshima, J. Am. Chem. Soc. 2001, 123, 5374. e) T. Tsuji, H. Yorimitsu, K. Oshima, Angew. Chem. Int. 
Ed. 2002, 41, 4137. f) H. Shinokubo, K. Oshima, Eur. J. Org. Chem. 2004, 2081. g) H. Ohmiya, T. Tsuji, 
H. Yorimitsu, K. Oshima, Chem. Eur. J. 2004, 10, 5640. h) H. Ohmiya, H. Yorimitsu, K. Oshima, Org. Lett. 
2006, 8, 3093. i) W. Affo, H. Ohmiya,
 
T. Fujioka,
 
Y. Ikeda,
 
T. Nakamura,
 
H. Yorimitsu, K. Oshima, Y. 
Imamura,
 
T. Mizuta,
 
K. Miyoshi, J. Am. Chem. Soc. 2006, 128, 8068. j) H. Someya, H. Ohmiya, H. 
Yorimitsu, K. Oshima, Org. Lett. 2007, 9, 1565. k) H. Someya, H. Ohmiya, H. Yorimitsu, K. Oshima, 
Tetrahedron 2007, 63, 8609. l) C. Gosmini, J.-M. Bégouin, A. Moncomble, Chem. Commun. 2008, 28, 
3221. m) K. Murakami, H. Yorimitsu, K. Oshima, Org. Lett. 2009, 11, 2373. n) D. L. Usanov, H. 
Yamamoto, Angew. Chem. Int. Ed. 2010, 49, 8169. o) X. Qian, A. Auffrant, A. Felouat, C. Gosmini, 
Angew. Chem. Int. Ed. 2011, 50, 10402. p) K. Gao, N. Yoshikai, Acc. Chem. Res. 2014, 47, 1208. q) L. 
Gonnard, A. Guérinot, J. Cossy, Chem. - Eur. J. 2015, 21, 12797. r) N. Sauermann, M. J. Gonzalez, L. 
Ackermann, Org. Lett. 2015, 17, 5316. s) J. Li, L. Ackermann, Angew. Chem. Int. Ed. 2015, 54, 8551. t) 
M. Moselage, N. Sauermann, S. C. Richter, L. Ackermann, Angew. Chem. Int. Ed. 2015, 54, 6352. u) J. 
Wu, N. Yoshikai, Angew. Chem. Int. Ed. 2015, 55, 336. v) M. Moselagea, N. Sauermanna, J. Koellera, J. 
Liua, D. Gelmanb, L.  Ackermann, Synlett 2015, 26, 1596. w) T. Yamakawa, Y. W. Seto, N. Yoshikai, 
Synlett 2015, 26, 340. x) J. Li, M. Tang, L. Zang, X. Zhang, Z. Zhang, L. Ackermann, Org. Lett. 2016, 18, 
2742. y)	J. M. Neely, M. J. Bezdek, P J. Chirik ACS Cent. Sci. 2016, 2, 935.  
30  For selected diastereoselective cobalt-catalyzed cross-coupling reactions, see: a) H. Ohmiya, K. 
Wakabayashi, H. Yorimitsu, K. Oshima, Tetrahedron 2006, 62, 2207. b) H. Ohmiya, H. Yorimitsu, K. 
Oshima, J. Am. Chem. Soc. 2006, 128, 1886.  
31 a) A. K. Steib, T. Thaler, K. Komeyama, P. Mayer, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 3303. 
b) L. R. Jefferies, S. P. Cook, Org. Lett. 2014, 16, 2026. c) L. R. Jefferies, S. R. Weber, S. P. Cook, 
Synlett 2015, 26, 331. 
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Scheme 26. Diastereoselective α-arylation of alcohol derivatives. 
 
1.2 Cobalt-Mediated Aryl-Alkyl Cross-Coupling Reactions 
Herein, we report a new broadly applicable cobalt-mediated α-arylation of TBS-protected  cyclic 
bromo- and iodohydrins.32 In optimization studies, we have examined the arylation of 52a         
(dr 75:25, cis/trans) with 4-anisylmagnesium bromide (25a) in the presence of various transition 
metal salts (Table 1). As mentioned above, the use of FeCl2·2LiCl proved to be unsatisfactory, 
and the coupling of 52a with 25a furnished the expected product 51a in only 18% yield (entry 1). 
Changing the iron salt or the ligand was not satisfactory (entries 2-3).33 Therefore, we examined 
other metallic salts. MnCl2·2LiCl34 and CrCl235 gave poor results (entries 4-5), in contrast to 
cobalt salts. Thus, CoCl2·2LiCl (0.85 equiv)36  and 4-fluorostyrene (0.5 equiv) used as an 
additive37 led to the product 51a with a dr = 99:1, but with only 44% yield (entry 6). In the 
absence of 4-fluorostyrene, the yield improved to 62%. Finally, adding TMEDA as a ligand gave 
the best results (71% isolated yield, dr 95:5; entry 8).38 
 
                                                
32 For selected examples of α-arylations to oxygen, see: a) M. Palucki, S. L. Buchwald, J. Am. Chem. 
Soc. 1997, 119, 11108. b) J. M. Fox, X. Huang, A. Chieffi, S. L. Buchwald, J. Am. Chem. Soc. 2000, 122, 
1360. c) A. Ehrentraut, A. Zapf, M. Beller, Adv. Synth. Catal. 2002, 344, 209. d) J. Cossy, A. de Filippis, 
D. G. Pardo, Org. Lett. 2003, 5, 3037. e) O. Navarro, N. Marion, Y. Onishi, R. A. Kelly, S. P. Nolan, J. 
Org. Chem. 2006, 71, 685. f) W. Su, S. Raders, J. G. Verkade, X. Liao, J. F. Hartwig, Angew. Chem. Int. 
Ed. 2006, 45, 5852. g) X. Dai, N. A. Strotman, G. C. Fu, J. Am. Chem Soc. 2008, 130, 3302. h) P. M. 
Lundin, J. Esquivias, G. C. Fu, Angew. Chem. Int. Ed. 2009, 48, 154. i) S. Lou, G. C. Fu, J. Am. Chem. 
Soc. 2010, 132, 1264. 
33 G. Cahiez, V. Habiak, C. Duplais, A. Moyeux, Angew. Chem. Int. Ed. 2007, 46, 4364. 
34 a) M. Alami, P. Ramiandrasoa, G. Cahiez, Synlett 1998, 325. b) G. Cahiez, O. Gager, F. Lecomte, Org. 
Lett. 2008, 10, 5255. c) T. C. Atack, S. P. Cook J. Am. Chem. Soc. 2016, 138, 6139. 
35 A. K. Steib, O. M. Kuzmina, S. Fernandez, D. Flubacher, P. Knochel, J. Am. Chem. Soc. 2013, 135, 
15346. 
36 G. Cahiez, C. Chaboche, C. Duplais, A. Giulliani, A. Moyeux, Adv. Synth. Catal. 2008, 350, 1484. 
37 A. E. Jensen, P. Knochel, J. Org. Chem. 2002, 67, 79. 
38  a) The use of triisopropylsilyl-protected (TIPS-protected) 2-iodocyclohexanol led to a similar 
diastereoselectivity (dr 93:7), whereas protection with the bulky tert-butyldiphenylsilyl (TBDPS) group 
resulted in a decreased diastereoselectivity (dr 91:9). b) The role of N,N,N’,N’-tetramethylethane-1,2-
diamine (TMEDA) is to coordinate the low-valent cobalt intermediate.	
OTBS
Hal
OTBS
Ar
51
ArMgX
Co cat.
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Table 1. Optimization of the diastereoselective cross-coupling of (52a) with (25a). 
 
a Determined by capillary GC analysis. Undecane (C11H24) was used as internal standard.            
b Isolated yield.  
 
Thus, the dropwise addition of various Grignard reagents to a mixture of the protected 
iodohydrin 52a (1.0 equiv), CoCl2·2LiCl (0.85 equiv, 1 M in THF)39 and TMEDA (0.3 equiv) in 
THF at -50 °C led to the trans-coupling products (51a-k) in 55-91% yield and excellent 
diastereoselectivity (dr >95:5, Table 2).40 Both electron-poor or electron-rich arylmagnesium 
halides were used successfully. Furthermore, heterocylic Grignard reagents obtained either by a 
directed magnesiation41 or magnesium insertion42 led to the desired cross-coupling product in 
very high diastereoselectivity (up to >99:1 dr). Thus, the magnesiation of the uracil derivative 53 
with TMPMgCl·LiCl (1.1 equiv, THF, 0 °C, 0.5 h) led to the heterocyclic Grignard reagent 25b 
(>90% yield). Its coupling with 52a under the standard conditions furnished the pyrimidine 51b 
in 55% yield (dr >99:1). Also, N-methyl-5-bromoindole 54 reacted with Mg, LiCl (25 °C, 1 h) to 
                                                
39 The use of catalytic amounts of CoCl2·2LiCl (0.40 equiv) did not lead to a satisfactory conversion of the 
starting material (54% yield). 
40 Treatment of a mixture of CoCl2·2LiCl (0.85 equiv), TMEDA (0.3 equiv), ArMgCl (1.7 equiv) with the 
protected iodohydrin (1 equiv) in THF at -50 °C did not lead to the formation of the desired product. 
41 M. Mosrin, P. Knochel, Org. Lett. 2008, 10, 2497. 
42 a) F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 
6802. b) F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. - Eur. J. 
2009, 15, 7192.	
metal mediator, additive
THF, -50 °C to rt, 10 h
OTBS
I
OTBS
52a 51a
OMeMeO MgBr
entry drametal mediator 
(equiv)
yielda 
(%)
1 FeCl2.2LiCl (0.85) 18 94:6
additive
(equiv)
4-fluorostyrene (0.50)
3 91:924TMEDA (0.30)
FeCl2.2LiCl (0.85)2 88:1253TMEDA (0.30)
CoCl2.2LiCl (0.85)6 99:1444-fluorostyrene (0.50)
Fe(acac)3 (0.85)
4 n.d.0TMEDA (0.30)MnCl2.2LiCl (0.85)
5 99:15TMEDA (0.30)CrCl2 (0.20)
CoCl2.2LiCl (0.85)8 95:579 (71)bTMEDA (0.30)
CoCl2.2LiCl (0.85)7 99:162_
25a (1.7 equiv)
	
	
RESULTS AND DISCUSSION 
_____________________________________________________________________________________________ 
 
 
19 
produce the corresponding Grignard reagent 25c in >90% yield. Coupling with 52a under our 
standard conditions produced the indole 51c (60% yield, dr 98:2, Scheme 27).  
Table 2. Products obtained by the diastereoselective cross-coupling of (52a) with various 
Grignard reagents. 
 
a Isolated yield. b Determined by capillary GC and 1H NMR analysis. 
 
 
entry product yield (%)
a
drb
5 67%98:2
OTBS
1 65%
>99:1
OTBS
entry product yield (%)
a
drb
6 70%98:2
OTBS
2 71%
95:5
OTBS
7 91%>99:1
OTBS
3 73%
97:3
OTBS
8 63%99:1
OTBS
4 71%
>99:1
OTBS
Cl
OMe
OMe
O
O
Me
Cl
SF5
O
O
NMe2
CoCl2.2LiCl (85 mol%)
TMEDA (30 mol%)
ArMgX (1.7 equiv)
THF, -50 °C to rt, 10 h
OTBS
I
OTBS
Ar
51d–k
51d
51e
51f
51g
51h
51i
51j
51k
CF3
52a
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Scheme 27. Preparation of heterocyclic Grignard reagents and their diastereoselective cross-
coupling with (52a). 
 
Extension of this coupling to the 5-membered iodohydrin 52b (X = I, dr 1:99, cis/trans) led to the 
expected α-arylated or -heteroarylated cyclopentanol silyl ethers 55a-j in 52-80% yield             
(dr >97:3; Table 3). The mild conditions required for this cross-coupling allowed the presence of 
sensitive functional groups in the Grignard reagent. Thus, the treatment of the bromobenzonitrile 
56 with iPrMgCl·LiCl (1.1 equiv, THF, -20 °C, 0.5 h)43 provides the corresponding Grignard 
reagent 25d (>90%), which smoothly undergoes a Co-mediated cross-coupling, providing the 
cyclopentanol derivative 55a in 67% yield (dr >99:1). Similarly, the arylmagnesium reagent 25e 
(>90%) prepared from the iodobenzoate 57 by I/Mg-exchange furnished, after cross-coupling 
with 52b, the cyclopentanol derivative 55b in 52% yield (dr 97:3, Scheme 28). 
 
 
 
 
 
 
                                                
43 a) A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333. b) A. Krasovskiy, B. F. Straub, P. 
Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. 
51b
55%, dr >99:1
OTBS
N
NMeO
OMe
N
NMeO
OMe
TMPMgCl.LiCl
THF,  0 °C
0.5 h
N
NMeO
OMe
ClMg
CoCl2·2LiCl
TMEDA, 52a
THF, -50 °C to rt
10 h
53 25b: >90%
N
Me
Br
Mg, LiCl
THF,  rt
1 h
N
Me
BrMg CoCl2·2LiCl
TMEDA, 52a
THF, -50 °C to rt
10 h
N
Me
OTBS
51c 
60%, dr 98:2
54 25c: >90%
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Table 3. Products obtained by the diastereoselective cross-coupling of (52b) with various 
Grignard reagents. 
 
a Isolated yield. b Determined by capillary GC and 1H NMR analysis. c Reaction performed on a   
4 mmol scale. 
 
The use of CoCl2·2LiCl allows further expansion of the reaction scope of this coupling, and the 
iodohydrins 52a-b can be replaced advantageously by the corresponding bromohydrin (52c, X = 
Br, dr 1:99, cis/trans). Using the same reaction conditions, the cross-coupling products 58a-d 
were obtained with high diastereoselectivities (dr >97:3, Scheme 29). 
 
entry product yield (%)
a
drb
5 58%98:2
OTBS
1 73%
>99:1
OTBS
entry product yield (%)
a
drb
6 78%>99:1
OTBS
2 79%
>99:1
OTBS
7 80%
c
>99:1
OTBS
8 65%99:1
OTBS
4 61%99:1
OTBS
3 74%
99:1
OTBS
OMe
N
Me
OMe
OMe
O
O
S
SF5
CoCl2.2LiCl (85 mol%)
TMEDA (30 mol%)
ArMgX (1.7 equiv)
THF, -50 °C to rt, 10 h
OTBS
I
OTBS
Ar
52b 5c–j
55c
55d
55e
55g
55h
55i
55j55f
N
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Scheme 28. Preparation of various Grignard reagents and their cross-coupling reaction. 
Remarkably, this cross-coupling can also be performed with heterocyclic iodohydrins such as 
59a (dr 1:99, cis/trans) or 59b (dr 1:99, cis/trans), leading to trans-3,4-disubstituted 
tetrahydrofurans (60) and pyrrolidines (61) as single diastereomers (71-74%, Scheme 30). The 
up-scaling of this cross-coupling is readily performed as indicated in Table 3 (entry 7) as well as 
in the synthesis of 60, which has been performed on a 4 mmol scale (gram scale). 
 
Scheme 29. Products of type 58 obtained by the diastereoselective cross-coupling of 
bromohydrin 52c with arylmagnesium reagents. 
 
OTBS
OTBS
CN
F
CN
F
Br
I
THF, _20 °C
0.5 h
THF, _20 °C
0.5 h
CN
F
ClMg
ClMg
CoCl2·2LiCl
TMEDA, 52b
THF, -50 °C to rt
10 h
CoCl2·2LiCl
TMEDA, 52b
THF, -50 °C to rt
10 h
55a
67%, dr >99:1
56 25d: >90%
55b
52%, dr 97:3
57 25e: >90%
iPrMgCl.LiCl
iPrMgCl.LiCl
CO2Et CO2Et
CO2Et
OTBS
58d
57%, dr 98:2
58b
50%, dr 98:2
58a
53%, dr 97:3
OTBS
58c
59%, dr 98:2
OMe
F
OTBS OTBS
Me Me
Me
CoCl2.2LiCl (85 mol%)
TMEDA (30 mol%)
ArMgX (1.7 equiv)
THF, -50 °C to rt, 10 h
OTBS
Br
OTBS
Ar
58a–d52c
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Scheme 30. Diastereoselective cross-coupling of the heterocyclic halohydrins such as 59. 
 
Preliminary mechanistic studies have shown that ArMgX and CoCl2 readily react with each 
other, leading to the homo-coupling products quantitatively. However, under the reaction 
conditions (slow addition of ArMgX to a mixture of the respective halohydrin, CoCl2·2LiCl and 
TMEDA) the desired cross-coupling is much faster. The stereoconvergence of the reaction may 
be the result of a radical generated at the α-position to oxygen. Further extension of this method 
as well as mechanistic studies, are currently underway. 
 
 
 
 
 
 
 
 
 
TBSO TBSO
O
N
Ts
60
74%, dr >99:1
61
71%, dr >99:1
OMe
OMe
CoCl2.2LiCl
TMEDA, 25a
THF, -50 °C to rt
10 h
CoCl2.2LiCl
TMEDA, 25a
THF, -50 °C to rt 
10 h
TBSO
X
I
X = O (59a), TsN (59b)
gram scale
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2. Diastereoselective Cobalt-Mediated Cross-Couplings of Cycloalkyl 
Iodides with Alkynyl or (Hetero)Aryl Grignard Reagents 
2.1. Introduction 
The formation of Csp2-Csp3 bonds is of great importance for the pharmaceutical industry.1 Thus, 
there is a need for cheaper transition metal catalysts for such couplings, and cobalt salts have 
proven to be a powerful alternative.5 Despite the diversity of various Co-catalyzed15,18,29 cross-
couplings,19,30  only a few stereoselective transformations have been described. In the previous 
section, we reported a Co-mediated diastereoselective cross-coupling of substituted cyclic 
iodohydrins with (hetero)aryl Grignard reagents.44 This method, however, gave unsatisfactory 
results with alkynylmagnesium reagents. Thus, the development of a novel method for the 
stereoselective C-C coupling is of great interest.  
 
2.2. Cobalt-Mediated Alkyl-Alkynyl and Alkyl-Aryl Cross-Coupling Reactions 
Herein, we report a new broadly applicable stereoconvergent cobalt-mediated cross-coupling of 
alkynyl or (hetero)aryl magnesium halides and variously substituted cycloalkyl iodides. 
In optimization studies, we examined the alkynylation of menthyl iodide 62a (dr 1:99, cis/trans) 
with ((triisopropylsilyl)ethynyl)magnesium bromide (1.5 equiv, 63a) at -40 °C, in the presence of 
various transition metal salts (Table 4). The use of CrCl2,35 MnCl2·2LiCl,34 or FeCl2·2LiCl31 
proved to be unsatisfactory, and the coupling of 62a with 63a furnished the expected product 
64a in only 27% yield at best when using 20 mol% of FeCl2·2LiCl (entries 1-3). 
 
 
 
 
 
                                                
44 J. M. Hammann, A. K. Steib, P. Knochel, Org. Lett. 2014, 16, 6500. 
	
	
RESULTS AND DISCUSSION 
_____________________________________________________________________________________________ 
 
 
25 
Table 4. Optimization of the diastereoconvergent cross-coupling of 62a with 63a. 
 
a Determined by capillary GC and 1H NMR analysis. Undecane was used as internal standard.   
b Isolated yield. 
A general and more broad screening of reaction conditions using cobalt salts showed that 
Co(acac)345 or cobalt halides46 gave much better results (entries 4−6). Also, the THF-soluble 
CoCl2·2LiCl7 afforded the coupling product 64a in 42% yield (dr 99:1, entry 7). Switching to more 
polar cosolvents such as DMPU47 or NMP48 leads to the formation of the desired product (64a) 
in up to 48% yield and a diastereoselectivity of up to 91:9 dr (entries 8 and 9). The use of 4-
fluorostyrene10 resulted in a yield of 44% and an excellent diastereoselectivity of 99:1 (entry 10). 
The addition of N,N,N′,N′-tetramethylethylenediamine (TMEDA)7 leads to a deterioration of the 
diastereoselectivity (dr 90:10, entry 11). Changing the additive to neocuproine (20 mol%)5 gave 
the best result, leading to product 64a in 63% yield and high dr (dr = 93:7, entry 12).  
                                                
45 T. J. Korn, M. A. Schade, S. Wirth, P. Knochel, Org. Lett. 2006, 8, 725. 
46 O. M. Kuzmina, A. K. Steib, J. T. Markiewicz, D. Flubacher, P. Knochel, Angew. Chem. Int. Ed. 2013, 
52, 4945. 
47 T. J. Korn, P. Knochel, Angew. Chem. Int. Ed. 2005, 44, 2947. 
48 A. Fuerstner, A. Leitner, M. Méndez, H. Krause, J. Am. Chem. Soc. 2002, 124, 13856. 
metal mediator, additive
THF, -40 °C, 8 h
MgBr
88(83)b 99:1
FeCl2.2LiCl (0.20) 99:119-
CoCl2.2LiCl (0.20) 99:1444-fluorostyrene (0.20)
93:763
neocuproine (0.20)CoCl2.2LiCl (0.50)
63a (1.5 equiv)I
n.d.0MnCl2.2LiCl (0.20)
n.d.tracesCrCl2 (0.20)
62a 64a
86:1436-CoCl2 (0.20)
CoBr2 (0.20) - 22 85:15
Co(acac)3 (0.20) - 28 83:17
CoCl2.2LiCl (0.20) - 42 88:12
CoCl2.2LiCl (0.20)
CoCl2.2LiCl (0.20)
DMPU (0.20)
NMP (0.20)
48 90:10
41 91:9
entry d.r.a
metal mediator 
(equiv)
yielda 
(%)
7
additive
(equiv)
12
6
4
5
13
8
9
10
3
2
1
neocuproine (0.20)CoCl2.2LiCl (0.20)
11 90:1034TMEDA (0.20)CoCl2.2LiCl (0.20)
(iPr)3Si Si(iPr)3
N N
MeMe neocuproine
-
-
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Significant improvements were achieved by using substoichiometric amounts (50 mol%) of the 
complex CoCl2·2LiCl, this complex leads exclusively to the thermodynamically more stable 
trans-isomer 64a in 83% isolated yield and 99:1 dr (entry 13).  
 
Scheme 31. Diastereoselective cross-coupling of 62a and 62b with the alkynyl Grignard reagent 
63b. 
 
With these optimized reaction conditions in hand, we performed a range of coupling reactions 
using various alkynylmagnesium halides. Alkynyl Grignard reagents obtained by magnesiation 
using TMPMgCl·LiCl (1.1 equiv, THF, 0 °C, 3 h) led to the desired trans-cross-coupling products 
in very high diastereoselectivities. Thus, the coupling of ((4-methoxyphenyl)ethynyl)magnesium 
chloride (63b) with 62a (dr 99:1, cis/trans) or 62b (dr 1:99, cis/trans) using standard conditions 
furnished the coupling products 64b-c in 69-74% yield (dr 99:1, Scheme 31). 
 
 
 
 
 
 
OMe
74%, dr 99:1
69%, dr 99:1
OTBS OMeOTBS
I
I
62b 64c
64b62a
CoCl2.2LiCl (50 mol%)
neocuproine (20 mol%)
THF, -40 °C, 8 h
CoCl2.2LiCl (50 mol%)
neocuproine (20 mol%)
THF, -40 °C, 8 h
MeO MgCl
(63b, 1.5 equiv)
(63b, 1.5 equiv)
MeO MgCl
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Table 5. Coupling of 1,2-substituted cycloalkyl iodides with various alkynyl Grignard reagents. 
 
a Isolated yield. b Determined by capillary GC and 1H NMR analysis. 
 
We have further extended this Co-mediated coupling reaction to various alkynyl Grignard 
reagents (see Table 5).  
 
 
 
 
OTBS Si(iPr)3
OTBS
Si(i-Pr)3
Si(CH3)2t-Bu OTBS
CN
entry product yield (%)
a
drb
1
entry product yield (%)
a
drb
2
3
4
5
6
7
8
68%
99:1
55%
99:1
68%
99:1
69%
97:3
77%
99:1
gram scale
64d
64e
64f
64g
64h
64i
64j
64k
I
CoCl2.2LiCl (50 mol%)
neocuproine (20 mol%)
THF, -40 °C, 8 h
R2 MgClR1 R1 R2
nn
n = 0,1
OTBS
68%
99:1
64d-k
(1.5 equiv)
SiMe2t-Bu
78%
99:1
59%
99:1
SiMe3
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Table 6. Products obtained by the diastereoselective cross-coupling with various substituted 
Grignard reagents. 
 
a Isolated yield. b Determined by capillary GC and 1H NMR analysis. 
 
Thus, alkynylmagnesium reagents bearing silyl (entries 1-4 and 8), aliphatic (entries 5 and 6), 
and aromatic substituents (entry 7) were successfully coupled, leading to the desired products 
64d-k in up to 78% yield and a dr up to 99:1 even on a gram scale (entry 8). To underline its 
synthetic utility, we extended this reaction to the cross-coupling of cycloalkyl iodides such as 
CN
OTBS
entry product yield (%)
a
drb
1
75%
96:4
entry product
yield (%)a
drb
2
3
61%
99:1
4
73%
99:1
gram scale
62%
99:1
5
OPiv
SF5
6
7
75%
99:1
8
68%
99:1
62%
91:9
9
NMe2
10
CF3 CO2NEt2
71%
99:1
75%
99:1
N
Me
Piv
70%
99:1
65a
65b
65c
65d
65e 65j
65i
65h
65g
65f
Ar(Het)Ar-MgX (1.5 equiv)
65a-j
CoCl2.2LiCl (50 mol%)
neocuproine (20 mol%)
THF, 0 °C, 8 h62a
I
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62a with heterocyclic and aryl magnesium reagents. Thus, the dropwise addition of various 
Grignard reagents (1.5 equiv) to a mixture of the cycloalkyl iodide 66a (1.0 equiv), CoCl2·2LiCl 
(50 mol%, 1 M in THF), and neocuproine (20 mol%) in THF at 0 °C led to the desired trans-
coupling products (65a-j) in 61-75% yield and a dr >91:9 (Table 6).  
Both, electron-poor or electron-rich arylmagnesium halides were employed successfully, and a 
range of functional groups such as CF3, Piv, CN, OPiv, NMe2, CO2NEt2, SF5, and OTBS were 
tolerated in the Grignard reagents (entries 1-9). Additionally, a heterocyclic magnesium halide 
was coupled successfully, leading to the indole derivative 65j in high diastereoselectivity with 
75% isolated yield and dr 99:1 (entry 10). 
Additionally, we have applied this Co-mediated cross-coupling to various substituted cycloalkyl 
iodides such as 62c (dr 99:1, cis/trans) or 62d (dr 99:1, cis/trans). To our delight, the trans-
coupling products 66a-b (Scheme 32A) and 67a-b (Scheme 32B) were obtained in a dr up to 
99:1. Thus, the reaction of (3-((tert-butyldimethylsilyl)oxy)-phenyl)magnesium bromide, (4-
(trifluoromethyl)phenyl)- magnesium bromide, or (4-methoxyphenyl)magnesium bromide with 
the cycloalkyl iodides 62c or 62d, using CoCl2·2LiCl (50 mol%) and neocuproine (20 mol%), 
furnished the arylated derivatives 66a-b and 67a-b in up to 81% yield and with a dr of 99:1. 
 
Scheme 32. Diastereoselective cross-coupling of cyclic 1,2-substituted alkyl iodides with 
various magnesium halides. 
OMe
O
O
CF3
O
O
I
CoCl2.2LiCl 
(50 mol%)
neocuproine  
(20 mol%)
m-TBSO-C6H4-MgBr   
(1.5 equiv)
THF, 0 °C, 8 h
CoCl2.2LiCl 
(50 mol%)
neocuproine  
(20 mol%)
p-CF3-C6H4-MgBr   
(1.5 equiv)
THF, 0 °C, 8 h
CF3
67b: 61%, 99:167a: 77%, dr 99:1
OTBS
CoCl2.2LiCl 
(50 mol%)
neocuproine  
(20 mol%)
p-MeO-C6H4-MgBr   
(1.5 equiv)
THF, 0 °C, 8 h
CoCl2.2LiCl 
(50 mol%)
neocuproine  
(20 mol%)
p-CF3C6H4-MgBr 
(1.5 equiv)
THF, 0 °C, 8 h 66b: 77%, dr 99:166a: 81%, dr 99:1
I
O
O
62c
62d
A)
B)
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Scheme 33. Diastereoselective cross-coupling of 62d with p-MeOC6H4MgBr. 
Table 7. Coupling of various 1,2-substituted heterocyclic alkyl iodides with aryl Grignard 
reagents. 
 
a Isolated yield. b Determined by capillary GC and 1H NMR analysis. 
 
The diastereoselective cross-coupling products of type 67 are synthetically useful and can easily 
be converted to the corresponding ketones. Thus, the coupling of 62d with p- MeOC6H4MgBr 
I
OMe
67c: 85%, dr 99:162d
O3
CH2Cl2, -78 °C,
 10 min
OMeO
68: 61%, dr 99:1
CoCl2.2LiCl 
(50 mol%)
neocuproine  
(20 mol%)
p-MeO-C6H4-MgBr  
(1.5 equiv)
THF, 0 °C, 8 h
entry product yield (%)
a
drb
entry product
yield (%)a
drb
5
1
2
6
64%
99:1
O
CO2Et
4
3
71%
97:3
O
CF3
N
Ts
N
Ts
66%
99:1
88%
99:1
OTBS
O
OMe
O
CF3
57%
99:1
54%
99:1
Ar-MgX (1.5 equiv)
62e
n = 0,1
X = O, NTs
69a-j
CoCl2.2LiCl (50 mol%)
neocuproine (20 mol%)
THF, 0 °C, 8 h
X X
R I R Ar
69a
69b
69c
69d
69e
69f
OMe
	
	
RESULTS AND DISCUSSION 
_____________________________________________________________________________________________ 
 
 
31 
gave the desired product 67c in 99:1 dr and 85% yield. The alkene moiety in 67c was 
transformed via ozonolysis to ketone 68, without loss of the stereoselectivity and in 61% isolated 
yield (Scheme 33). 
Remarkably, this cross-coupling can also be performed with heterocyclic alkyl iodides of type 
62e, leading to trans-3,4-disubstituted tetrahydrofurans (69a-d, entries 1-4) and pyrrolidines 
(69e-f, entries 5 and 6) as single diastereomers (Table 7). 
Although the mechanism of this cross-coupling was not studied in detail, experiments have 
shown that when R1MgX and CoCl2 readily react with each other, leading to the homocoupling 
products quantitatively. However, when R1MgX is slowly added to the reaction mixture, the 
desired cross-coupling is faster than the biaryl (R1-R1) formation. The stereoconvergence of the 
reaction may be the result of a radical reaction pathway, as proposed by Oshima for similar 
reactions. Mechanistic studies, are currently underway. 
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3. Cobalt-Catalyzed Csp2-Csp3 Cross-Coupling Reactions of 
Diarylmanganese Reagents with Secondary Alkyl Iodides 
3.1. Introduction 
Palladium-catalyzed cross-couplings have widely been used.1 However, toxicity2 and cost3 
considerations led to the search of alternative transition metal catalysts for cross coupling 
reactions. Especially cobalt-catalyzed transformations have shown their synthetic utility.5 
Pioneering work of several research groups demonstrated the broad field of applications of 
cobalt salt catalysis for forming new carbon carbon bonds.  
In the previous chapters, we have shown that cobalt halides are excellent catalysts for the 
cross-couplings of magnesium organometallics.6b,35,49 However, these organometallic reagents 
are not always the best choice for performing C-C bond formations, since homo-couplings are 
often observed side reactions. 
3.2. Cobalt-Catalyzed Aryl-Alkyl Cross-Coupling Reactions 
Herein, we report a new cobalt-catalyzed cross-coupling between secondary alkyl iodides and 
diarylmanganese reagents catalyzed by CoCl2·2LiCl and performed in the absence of any 
additional ligand.  
 
Scheme 34. Cobalt-catalyzed cross-coupling reactions of various organometallic reagents with 
alkyl iodide 70a. 
 
                                                
49 a) T. J. Korn, G. Cahiez, P. Knochel, Synlett 2003, 1892. b) T. J. Korn, M. A. Schade, M. N. Cheemala, 
S. Wirth, S. A. Guevara, G. Cahiez, P. Knochel, Synthesis 2006, 3547.  
I
Me
Cl
OMe
Me
Cl
CoCl2·2LiCl (20 mol%)
THF, -20 °C to rt, 8 h
70a 71a: 40% (using 25a)
75% (using 72a)
MeO
MgBr Mn
2
MeO
25a 72a
or
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Table 8. Reaction conditions optimization of the cross-coupling of alkyl iodide 70a with the 
manganese reagent 72a. 
 
a Using 40% of the ligand. b Calibrated GC yield using undecane as internal standard. c Isolated 
yield.  dUsing 10% CoCl2·2LiCl. 
Thus, preliminary experiments have shown that the cross-coupling between the secondary alkyl 
iodide 70a and p-anisylmagnesium bromide (25a) proceeds in the presence of 20 mol% 
CoCl2·2LiCl in THF at -20 to 25 °C (8 h) to produce the substitution product 71a in only 40% 
yield due to extensive homo-coupling side reactions. However, we found that by replacing 25a 
with the corresponding dianisylmanganese reagent (72a) prepared by the transmetallation of 
25a with MnCl2·2LiCl50 (0.5 equiv), the same cross-coupling now produces 71a in 75% isolated 
                                                
50 Butyl Manganese Chloride and Related Reagents in Encyclopedia of Reagents for Organic Synthesis, 
(Eds.: G. Cahiez, L. Paquette), Wiley-VCH, Chichester, 1995.  
catalyst (20 mol%)
(p-MeO-C6H4)2Mn
(72a; 0.7 equiv)I
Me
Cl
OMe
Me
Cl
THF, -20 °C to rt, 8 h
entry catalyst liganda yield (%)b
14
5
13
1
2
Co(acac)2
CoCl2·2LiCl
Co(acac)3
26
83 (75)c
7
54
82
-
-
-
-
-FeCl2
NiCl2
3
11
12
4 CoCl2
73
3
3-
-
-CoBr2
CuCl2
CrCl2
10
79
2-
-
PdCl2
7
8 CoCl2·2LiCl
32
32
L1CoCl2·2LiCl
L2
L1
Me2N
NMe2
F
L2
9 11L3CoCl2·2LiCl
N N
Me MeL3
70a 71a
6 CoCl2·2LiCld 64-
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34 
yield (Scheme 34). Remarkably, we did not observe rearrangement products (branched to 
unbranched) during these couplings.51 
This encouraging result led us to examine the scope of this cross-coupling more extensively 
(Table 8). CoCl2·2LiCl was the preferred catalyst since Co(acac)2, Co(acac)3, CoBr2 and CoCl2 
gave inferior yields (entries 1-4). The use of 10 mol% CoCl2·2LiCl instead of 20 mol%, reduced 
the yield of 71a to 64% (compare entries 5 and 6). Attempts to improve the reaction by adding 
ligands such as TMEDA (L1),30b 4-fluorostyrene (L2),31 or neocuproine (L3)5a did not improve 
the reaction yield (entries 7-9). Also alternative transition metal salts such as PdCl2, CuCl2, 
CrCl2, NiCl2 or FeCl2 were inefficient (entries 10-14). A solvent screening showed that THF was 
the best solvent when compared to NMP, DMPU, DME, 1,4-dioxane and t-BuOMe. 
 
Table 9. Cobalt-catalyzed cross-coupling reactions between various secondary alkyl iodides of 
type 70 and the diarylmanganese reagent 72a. 
 
                                                
51 a) K. Tamao, Y. Kiso, K. Sumitani, M. Kumada, J. Am. Chem. Soc. 1972, 94, 9268. b) T. Hayashi, M. 
Konishi, Y. Kobori, M. Kumada, T. Higuchi, K. Hirotsu, J. Am. Chem. Soc. 1984, 106, 158. c) A. Joshi-
Pangu, M. Ganesh, M. R. Biscoe, Org. Lett. 2011, 13, 1218. d) J. T. Binder, C. J. Cordier, G. C. Fu. J. 
Am. Chem. Soc. 2012, 134, 17003. 
entry electrophile yield (%)dr
CoCl2·2LiCl (20 mol%)
72a (0.7 equiv)
THF, -20 °C to rt, 8 hI
MeO
product
I
I
Me
CF3
Me
OTBS
Me
CF3
Me
OTBS
MeO
MeO
77%
73% (63%)a
2
1
70b 71b
70c 71c
70 71
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a CoCl2 (20 mol%) was used instead of CoCl2·2LiCl. b dr ca. 70:30 cis/trans. 
 
These cobalt-catalyzed alkylations proved to be general and the cross-coupling between the 
dianisylmanganese reagent (72a) and various secondary alkyl iodides has been successfully 
performed (Table 9). 52  Thus, various secondary alkyl iodides bearing a range of various 
functional groups (OTBS, CF3, OAc; 70b-d) reacted with the dianisylmanganese reagent (72a) 
providing the expected products 71b-d in 73-77% yield (entries 1-3). Also, various cyclohexyl 
iodides underwent the cross-coupling with 72a yielding the desired arylated products 71e-g in 
75-84% yield. Additionally, this cross-coupling can be performed with cyclopentyl iodides 70h-i, 
leading to the expected products 71h and 71i in 59-70% yield (entries 7-8). When a TBSO 
                                                
52 Using primary or tertiary alkyl halides did not lead to a good conversion. 
I
I
I
OTBS
I
TBSO
Me
I
OAc
N
I
TBSO
Ts
OTBS
TBSO
Me
OAc
N
TBSO
Ts
MeO
MeO
MeO
MeO
MeO
MeO
84% (81%)a
70%
75%b
83%
99:1
75%
59%
95:5
5
3
6
8
7
4
70e 71e
70h 71h
70d 71d
70i (dr 99:1) 71i
70g (dr 75:25) 71g
70f (dr 99:1) 71f
Table 9 continued
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substituent was present in position 2 to the carbon-iodide bond, excellent diastereoselectivities 
were observed (dr up to 99:1, see entries 6 and 8).53 
Table 10. Cobalt-catalyzed cross-couplings of diaryl manganese reagents of type 72 with 
secondary alkyl iodides of type 70. 
 
                                                
53 The use of TIPS-protected 2-iodocyclohexanol led to a similar diastereoselectivity (dr 95:5) whereas 
protection with the bulky TBDPS-group resulted in a decreased diastereoselectivity (dr 90:10).	
entry manganesereagent
I Ar
substrate
3
2
1
Me
MOMO
MOMO
NBoc
CF3
F3C
Me
Cl
product / yield (%) / dr
MOMO
72b
Mn
2
Me
CF3I
NBoc
I
F3C
Mn
2 Me
Cl
I
72b
72c 70a
70j
70c 71j: 76%
71k: 75%
71l: 81%
MOMO
Mn
2
4
Me
OMeF3C
Me
OMe
I
72c 70k 71m: 87%
F3C
Mn
2
6
7
NTs
OTBS
I
TBSO
TBSO
Mn
2
TBSO
NTs
OTBS
I
72e
72e 70i (dr 99:1)
70h 71o: 74%
71p: 92%, dr 99:1
Mn
2
TBSO
5
Mn
2
BocO
I
BocO
72d 70h 71n: 76%
CoCl2·2LiCl (20 mol%)
72 (0.7 equiv)
THF, -20 °C to rt, 8 h
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a CoCl2 (20 mol%) was used instead of CoCl2·2LiCl. 
 
Furthermore, a range of functionalized diarylmanganese reagents could also be readily used in 
this reaction (Table 10). (p-MOMO-C6H4)2Mn (72b) reacted smoothly with the alkyl iodides 70c 
and 70j, leading to the arylated products 71j-k in 75-76% yield (entries 1-2). The coupling of the 
electron poor manganese reagent 72c with 70a or 70k afforded the cross-coupling products 71l-
m in 81-87% yield (entries 3-4). Interestingly, the manganese reagents bearing an OBoc- (72d) 
or an OTBS-group (72e) were well tolerated and the cross-coupling with 70h and 70i (dr = 99:1) 
led to the desired products 71n-p in 74-92% yield (entries 5-7). Moreover, the electron rich 
13
12
72h
72h 70i (dr 99:1)
70h 71u: 63%
71v: 82%, dr 99:1
MeO
Me
I
Mn
2
Me
Me
MeO
Me
NTs
OTBS
Me
MeO
NTs
OTBS
I
Me
9
8
72f
72f 70b
70e 71q: 80% (48%)a
71r: 60% (19%)a
MeO
MeO
I
Mn
2
MeO
OMe
MeO
OMe
I
Me
OTBS
Me
OTBS
MeO
MeO
OMe
10
11
72g
72g 70m
70l 71s: 66%
71t: 70%
Mn
2
O
O
Me
OBnO
O
I
Me
OBn
O
I
O
O
O
Mn
2
Me
Me
MeO
Mn
2
MeO
OMe
MeO
Mn
2
O
O
Table 10 continued
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diarylmanganese reagent 72f was readily coupled with the cyclic alkyl iodides 70e and 70b to 
provide the corresponding arylated products 71q-r in 60-80% yield. The cross-coupling of 70l or 
70m with the di(1,3-benzodioxol-5-yl)manganese reagent (72g) afforded the arylated 
compounds 71s-t in 66-70% yield (entries 10-11). Also, the di(4-methoxy-3,5- 
dimethylphenyl)manganese reagent (72h) was successfully coupled with 70h and 70i                
(dr = 99:1), leading to the desired products 71u-v in 63-82% yield (entries 12-13). For the 
diarylmanganese reagents 72e and 72h using the protected heterocyclic iodohydrine 70i          
(dr = 99:1) we also observed excellent diastereoselectivities (dr = 99:1, see entries 7 and 13).  
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4. Cobalt-Catalyzed Negishi Cross-Coupling Reactions of 
(Hetero)Arylzinc Reagents with Primary and Secondary Alkyl 
Bromides and Iodides 
4.1. Introduction 
Transition metal-catalyzed cross-coupling reactions are valuable tools for the syntheses of 
biologically active molecules. Recently, cross-coupling reactions with cobalt catalysts were 
found to be a valuable alternative, when compared to Pd or Ni catalysts.1 However, despite the 
advances of cobalt-catalyzed cross-couplings between Csp2 and Csp3 centers by using 
magnesium reagents,15,19,29 no Co-catalyzed Negishi-type coupling reactions using arylzinc 
reagents have been described. 
 
Scheme 35. Metalation reaction using TMP2Zn (73) and cobalt-catalyzed cross-coupling of the 
diarylzinc species. (MgCl2 and LiCl are omitted for the sake of clarity) 
 
Knochel and co-workers have reported a range of synthetic methods for the preparation of 
polyfunctional unsaturated zinc reagents. 54  In particular, the directed metalation 55  of 
polyfunctional heterocycles and aromatic substrates has a broad reaction scope, and sterically 
                                                
54 a) P. Knochel, W. Dohle, N. Gommermann, F. F. Kneisel, F. Kopp, T. Korn, I. Sapountzis, V. A. Vu, 
Angew. Chem. Int. Ed. 2003, 42, 4302. b) T. Klatt, J. T. Markiewicz, C. Saemann, P. Knochel, J. Org. 
Chem. 2014, 79, 4253. 
55 a) P. Beak, R. A. Brown, J. Org. Chem. 1982, 47, 34. b) P. Beak, A. Tse, J. Hawkins, C. W. Chen, S. 
Mills, Tetrahedron 1983, 39, 1983. c) Y. Zhao, V. Snieckus, J. Am. Chem. Soc. 2014, 136, 11224. d) K. 
Groom, S. M. S. Hussain, J. Morin, C. Nilewski, T. Rantanen, V. Snieckus, Org. Lett. 2014, 16, 2378. 
Zn Alk Hal
R
)2 +
Co cat
Alk
R
N MgCl.LiCl
ZnCl2
(0.5 equiv)
N Zn·2MgCl2.2LiCl
73: 95%; 0.44 M in THF
b)
a)
20 to 25 °C, 3 h
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hindered bases,56 such as TMP2Zn·2MgCl2·2LiCl (73), have given a straightforward entry to a 
range of unsaturated and highly reactive diorganozinc compounds. In order to establish a 
cobalt-catalyzed Negishi cross-coupling it has been envisioned that diarylzinc reagents 
prepared by a directed C-H zincation using TMP2Zn·2MgCl2·2LiCl (73) can be employed in a 
cross-coupling reaction with various primary and secondary alkyl halides (Scheme 35). 
 
4.2. Cobalt-Catalyzed Aryl-Alkyl Cross-Coupling Reactions 
Table 11. Optimization of the reaction conditions for the Co-catalyzed cross-coupling. 
 
a MgCl2 and LiCl are omitted for the sake of clarity. b Determined by GC using undecane as an 
internal standard. c Yield of isolated product. L4 = trans-N,N,N',N'-tetramethylcyclohexane-1,2-
diamine. 
                                                
56 a) D. R. Armstrong, W. Clegg, S. H. Dale, E. Hevia, L. M. Hogg, G. W. Honeyman, R. E. Mulvey, 
Angew. Chem. Int. Ed. 2006, 45, 3775. b) A. J. Martinez-Martinez, A. R. Kennedy, R. E. Mulvey, C. T. 
O'Hara, Science 2014, 346, 834. 
EtO2C
F
EtO2C
F
Zn
75a 74a
THF, rt, 8 h
TMP2Zna
(0.6 equiv)
CoCl2.2LiCl
(20 mol%)
additive
(30 mol%)
EtO2C
F
76a
I
(0.7 equiv)
0 °C, 6 h
2
entry
5
1
4
10
7
2
3
6
8
9
metal mediator 
(mol%)
CoCl2 (20)
CoCl2.2LiCl (10)
Co(acac)2 (20)
FeCl2 (20)
CoCl2.2LiCl (20)
Co(acac)2 (20)
FeCl2 (20)
CoCl2 (20)
CoCl2.2LiCl (20)
CoCl2.2LiCl (20)
additive
(mol%)
4-fluorostyrene (50)
4-fluorostyrene (50)
TMEDA (30)
TMEDA (30)
TMEDA (30)
TMEDA (30)
4-fluorostyrene (50)
TMEDA (30)
4-fluorostyrene (30)
L4 (30)
yield (%)b
42
0
18
33
94 (87)c
13
0
84
38
40
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In preliminary experiments, we have examined the cross-coupling of the diarylzinc reagent (74a) 
which was generated by a directed metalation of ethyl 3-fluorobenzoate (75a) 57  using 
TMP2Zn·2MgCl2·2LiCl (73, 0.6 equiv) with c-Hex-I in the presence of various metal catalysts 
(Table 11).  
The addition of the zinc species to c-Hex-I in the presence of Co(acac)2 or FeCl218 resulted in 
the exclusive formation of the protonated zinc species when using 4-fluorostyrene                    
(50 mol%) as an additive (Table 11, entries 1 and 3).63a Moderate yields of 76a (13-18%) were 
obtained using TMEDA (30 mol%) as a ligand (entries 2 and 4). Switching to CoCl2 (20 mol%) 
and 4-fluorostyrene (50 mol%) or TMEDA (30 mol%) in THF at 0 °C furnished the desired cross-
coupling product 76a in 42% and 84% yield, respectively (entries 5 and 6). Significant 
improvements were achieved by using the THF-soluble salt CoCl2·2LiCl (20 mol%)36 and 
TMEDA (30 mol%), which afforded the desired coupling product 76a in 94% yield (entry 7). 
Further variation of the ligand30b or lowering the amount of the catalyst loading from 20 mol% to 
10 mol% led only to a decrease in the yield (entries 7-10). 
With these optimized reaction conditions in hand, we have performed a range of alkylations 
using various primary and secondary alkyl halides to afford alkylated benzoates of type 76 
(Scheme 36). 
 
Scheme 36. Zincation of ethyl 3-fluorobenzoate (75a) and cobalt-catalyzed cross-coupling with 
alkyl halides. 
                                                
57 As a consequence of its electron-acceptor properties, the fluoro-substituent facilitates the zincation, as 
well as the cobalt-catalyzed cross-coupling reaction and therefore ethyl 3-fluorobenzoate was chosen as 
the model substrate. 
EtO2C
F
EtO2C
F
Zn
75a 74a
THF, r.t., 8 h
TMP2Zn.2MgCl2.2LiCl
(73, 0.6 equiv) )2
CoCl2·2LiCl (20 mol%)
TMEDA (30 mol%)
EtO2C
F
76b-h
R
Alk-X (0.7 equiv)
0 °C, 6 h
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Table 12. Scope of various primary and secondary alkyl iodides or bromides. 
 
entry Alk-X
EtO2C
F
EtO2C
F
EtO2C
F
CN
OTBS
76f: 79%, dr 50:50
76d: 71% (X = I)
      51% (X = Br)
76g: 79%
1
2
3
4
5
product /  yield (%)a
EtO2C
F
76h: 68%, dr 99:1
EtO2C
F
CO2Et
76c: 58% (X = I) 
      38% (X = Br)
EtO2C
F
Me
76b: 63%
NBoc
Me
76e: 70%, dr 50:50
F
EtO2C Me
Me
OTBS
6
7
8
EtO2C
F
OTBS
76a: 61% (X = Br)
        2% (X = Cl)b
Me
Me
I
CO2EtX
CNX
X
I
Me
OTBS
Me
OTBSI
NBoc
I
OTBS
I
dr 75:25
dr 75:25
dr 99:1
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 a Isolated yield of analytically pure product. b The yield was determined by GC using C11H24 as 
an internal standard.  
The reaction of the zincated species 74a with primary alkyl iodides led to the polyfunctional 
alkylated benzoates (76a-c) in 58-77% yield (Table 12, entries 1-3). Remarkably, the 
ortho,ortho’ substituents present in the diarylzinc species (74a) did not disturb the cross-
coupling and most of the reactions were complete within 6 h at 0 °C. Primary alkyl bromides 
have also been successfully coupled, but with somewhat lower yields (entries 2-4), whereas 
cyclohexyl chloride only gave trace amounts of the desired product 76a (compare entry 4). 
Functional groups, such as an ester or a nitrile, are well-tolerated in these cross-coupling 
reactions and products such as 76c-d were isolated. Interestingly, also secondary alkyl iodides 
reacted smoothly to provide the alkylation products 76a,e-j in 55-79% yield (entries 4-10). To 
our delight, no rearrangement products were observed (branched to unbranched; see entry 5 
and Table 13).51 When an oxygen substituent was present in α-position of the carbon-iodine 
bond, excellent diastereoselectivities were observed (dr up to 99:1, see entries 8-10) and the 
products 76h-j were isolated in 55-69% yield. Additionally, this cross-coupling can also be 
performed with heterocyclic alkyl iodides, thereby leading to the expected products 76g and 76j 
in 79% and 55% yield, respectively (see entries 7 and 10). 
EtO2C
F
OTBS
76i: 69%, d.r. 99:1
EtO2C
F
O
OTBS
76j: 55 %, d.r. 99:1
9
10
OTBS
I
O
OTBS
I
dr 99:1
dr 99:1
Table 12 continued
	
	
RESULTS AND DISCUSSION 
_____________________________________________________________________________________________ 
 
 
44 
Table 13. Cobalt-catayzed cross-coupling of various diaryl- and diheteroarylzinc reagents with 
alkyl iodides. 
 
 a Isolated yield of analytically pure product. b The starting material was 99:1 syn/anti, the product 
was ca. 50:50 syn/anti. 
entry product /  yield (%)a
77h: 72%
77k: 76%
77m: 88%b
1
2
3
4
5
entry product /  yield (%)a
77l: 66%
77b: 84%
77c: 63%b
77d: 52%
77n: 51%
8
9
10
11
12
77e: 71%
77j: 61%
6
7
77i: 69%
77f: 61%
13
O O
CN
O O
O O
Me OTBS
S
F
CN
F
CN
Me OTBS
Me
F
CN
CF3
S
O
Me
Me
N
N
OMe
OMe
N
N
OMe
OMe
Me
Me
O
O Me
Me Me
77g: 63%
O
Me
77a: 81%
F
CN
Me
Me
14
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The reaction scope of this Co-catalyzed alkylation is quite broad and a range of diarylzinc 
reagents prepared by a directed deprotonation using TMP2Zn·2MgCl2·2LiCl (73, 0.6 equiv) 
provided the isolated alkylated products 77a-n in 51–88% yield (Table 13). Thus, this sequential 
one-pot metalation/cross-coupling procedure could be extended to other 1,3-disubstituted 
aromatic compounds: the zincation of 2-fluorobenzonitrile or 3-fluorobenzonitrile using 73 
(0.6 equiv) proceeds within 12 h at 25 °C, and the subsequent coupling reactions with 
secondary alkyl iodides provides the desired products 77a-d in 52-84% yield (entries 1-4). 
Remarkably, diheteroarylzinc reagents generated by directed zincation using 73 also undergo 
the alkylation reactions in good yields to afford the expected products 77e-n (51-88% yield, 
entries 5-14). Thus, zincated benzofurans or benzothiophenes reacted with secondary alkyl 
iodides such as c-Hex-I, i-Pr-I, or n-Bu-I to furnish the corresponding cross-coupling products 
77e-h in 61-76% yield (entries 5-8).  
The metalation of benzofuran with TMP2Zn·2MgCl2·2LiCl (73, 0.6 equiv) was complete within 
12 h at 25 °C, thereby providing the corresponding zinc reagent. This species undergoes the 
Co-catalyzed cross-coupling with n-Bu-I to afford the substituted benzofuran 77g in 63% yield 
(entry 7). This alkylated benzofuran (77g) is a key intermediate for the synthesis of amiodarone, 
an active antiarrhythmic agent.58  Similarly, 3,6-dimethoxypyridazine was zincated using 73        
(0.6 equiv, 4 h, 25 °C), and the cross-coupling with 2-iodopropane or c-Hex-I afforded the 
desired polyfunctional hetereocycles 77i-j in 69% and 61% yield, respectively (entries 9-10). 
Coumarin is also an excellent substrate and its zincation is complete within 1 h at 25 °C. After 
alkylation with various primary and secondary alkyl iodides, the substituted coumarins 77k-n 
were obtained in up to 88% yield (entries 11-13). Similarly, the regioselective zincation of 
thiochromone (-40 °C, 1 h) at the α-position to sulfur followed by a Co-catalyzed alkylation with 
2-iodobutane led to the desired product 77n in 51% yield (entry 14).  
 
 
 
                                                
58 a) H. R. Ha, B. Stieger, G. Grassi, H. R. Altorfer, F. Follath, Eur. J. Clin. Pharmacol. 2000, 55, 807. b) 
M. Witczak, H. Kwiecien, Synth. Commun. 2005, 35, 2223. c) K. M. Zareba, Drugs Today 2006, 42, 75. 
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5. Mild Cobalt-Catalyzed Negishi Cross-Couplings of (Hetero)Arylzinc 
Reagents with (Hetero)Aryl Halides 
 
5.1. Introduction 
To date, the Negishi cross-coupling has attracted a lot of attention since a wide range of 
polyfunctional zinc reagents are available59 and transmetalations with transition metal catalysts 
are fast and efficient. Mostly, Pd- and Ni-catalysts have been used to perform such Csp2-Csp2 
cross-couplings, however, toxicity3 and price2 issues have led to the search of alternative metal 
catalysts, such as cobalt5 and iron.60 Bedford has demonstrated that iron(I)-complexes allow to 
achieve Negishi cross-couplings with great efficiency. 61  Gosmini has shown in one-pot 
procedures that organozinc reagents can be in situ generated and cross-coupled with heteroaryl 
halides.9 Interestingly, Yoshikai has reported impressive organometallic cascade reactions, 
where arylzincs are generated via Co-catalysis, followed by cross-coupling with aryl iodides in 
the presence of a Pd-catalyst.62 Also, Hayashi and Nishimura have reported novel cobalt-
catalyzed asymmetric Csp2-Csp-couplings.63 
 
In the previous section, we have shown that Csp2-Csp3 couplings between arylzinc reagents 
that are prepared via directed metalation, undergo smooth cross-couplings with primary and 
secondary alkyl bromides and iodides.64 Although, this method proceeds under mild conditions, 
a limited scope concerning the nature of the arylzinc reagent was observed and extension to 
Csp2-Csp2 couplings under the reported reaction conditions was difficult. 
 
                                                
59  For a general overview on the generation of organometallics reagents, see: a) Handbook of 
Functionalized Organometallics: Applications in Synthesis (Ed.: P. Knochel), Wiley-VCH, Weinheim, 
2004. For representative examples, see: b) N. Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. 
Knochel, J. Am. Chem. Soc. 2007, 129, 12358. c) A. Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 
10, 1107. 
60 For selected reviews on iron-catalyzed reactions, see: a) C. Bolm, Nature Chem. 2009, 1, 420. b) A. 
Fürstner, Angew. Chem. Int. Ed. 2009, 48, 1364. c) W. M. Czaplik, M. Mayer, J. Cvengroš, A. Jacobi von 
Wangelin, ChemSusChem 2009, 2, 396. d) E. Nakamura, N.  Yoshikai, J. Org. Chem. 2010, 75, 6061. 
61 For representative examples, see a) C.J. Adams, R. B. Bedford, E. Carter, N. J. Gower, M. F. Haddow, 
J. N. Harvey, M.Huwe, M. Ángeles Cartes, S. M. Mansell, C. Mendoza, D. M. Murphy, E. Neeve, J. Nunn, 
J. Am. Chem. Soc. 2012, 134, 10333. b) R. B. Bedford, E. Carter, P. M. Cogswell, N. J. Gower, M. F. 
Haddow, J. N. Harvey, D. M. Murphy, E. C. Neeve, J. Nunn, Angew. Chem. Int. Ed. 2013, 52, 1285. 
62 B.-H. Tan, J. Dong, N. Yoshikai, Angew. Chem. Int. Ed. 2012, 51, 9610. 
63 a) T. Sawano, K. Ou, T. Nishimura, T. Hayashi, Chem. Commun. 2012, 48, 6106. b) T. Sawano, K. Ou, 
T. Nishimura, T. Hayashi, J. Org. Chem. 2013, 78, 8986. 
64 J. M. Hammann, D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2015, 54, 4478. 
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5.2. Cobalt-Catlyzed Aryl-Aryl Cross-Coupling Reactions 
 
Herein, we report a new set of reaction conditions allowing for the smooth cross-coupling of 
various arylzinc reagents with aryl and heteroaryl chlorides or bromides within a few hours at 
room temperature. Thus, in a preliminary experiment, we have treated 2-bromoquinoline (78a) 
with p-anisylzinc chloride (79a, 1.2 equiv) in the presence of 5 mol% CoCl2.2LiCl and observed 
a complete conversion to the desired cross-coupling product (80a) in 65% yield. However, the 
cross-coupling was too slow and side-reactions, such as homocouplings are observed. To 
improve the reaction outcome, our attention was attracted by the recent work of Miller, who 
showed that the addition of potassium formate played the role of a mild reducing agent in Suzuki 
reactions.65 We anticipated that this salt could generate reduced cobalt species to which we 
attribute high catalytic activity. To our delight, the addition of HCO2Na (50 mol%) led to an 
improved isolated yield of 88% (Scheme 37).  
 
 
Scheme 37. Cobalt-catalyzed cross-coupling of 2-bromoquinoline (78a) and p-anisylzinc 
chloride (80a) with and without sodium formate. 
 
 
 
 
 
 
 
 
 
                                                
65 W. D. Miller, A. H. Fray, J. T. Quatroche, C. D. Sturgill, Org. Process Res. Dev. 2007, 11, 356. 
N Br
MeO ZnCl
(79a, 1.2 equiv)
CoCl2.2LiCl (5 mol%)
HCO2Na (50 mol%)
THF, 25 °C, 8 h
N
OMe
80a: 65% (without HCO2Na)
        88% (with HCO2Na)
78a
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Table 14. Optimization of the reaction conditions for the Co-catalyzed Csp2-Csp2 cross-coupling 
of 2-bromopyridine (78b). 
 
a MgCl2 and LiCl are omitted for sake of clarity. b Undecane was used as an internal standard. c 
99.99% purity. d Isolated yield. 
 
Preliminary mechanistic studies showed that the main effect of HCO2Na is to considerably 
reduce the occurrence of side reactions, thus, as anticipated, leading to more selective cross-
couplings and higher reaction yields. 66  This effect proved to be general, and a broader 
screening of reaction conditions using 2-bromopyridine (78b) showed that cobalt halides, such 
as CoCl2 or CoBr2, as well as Co(acac)2, and Co(acac)3 gave good results (Table 14, entries    
1-5). In particular, CoCl2·2LiCl, which is conveniently soluble in THF, afforded product 80b in 
excellent yield in the presence of HCO2Na (entry 6-7). Interestingly, when sodium pivalate         
(t-BuCO2Na = PivONa) was used as an additive, the reaction was equally efficient, showing that 
                                                
66 Premixing of CoCl2·2LiCl and HCO2Na in THF using the same stoichiometry as in the standard reaction 
led to the same reaction outcome as the one-pot procedure (also, compare table 9, entry 7).  
entry additive
(50 mol%)
1 -CoCl2
3 -CoBr2
2 -CoCl2c
catalyst
(5 mol%)
5 -Co(acac)3
4 -Co(acac)2
7 HCO2NaCoCl2.2LiCl
6 -CoCl2.2LiCl
8 PivONaCoCl2.2LiCl
9 DMPUCoCl2.2LiCl
N Br
MeO ZnCl
(79a, 1.2 equiv)a
catalyst, additive
THF, 25 °C, 8 h
N
OMe
yield (%)b
78b 80b
10 TMEDACoCl2.2LiCl
11 HCO2NaCo(acac)3
12 HCO2Na-
13 -CrCl2
14 -FeCl2
82
78
76
80
72
94 (87)d
81
96
84
51
89
0
traces
17
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HCO2Na does not act as a reducing agent, but rather as a ligand (entry 8). 67  Control 
experiments using ultrapure CoCl2 (99.99%) confirmed that the Co salts are the active catalysts 
and that metal impurities do not play a role (compare with entry 2). Polar solvents, such as N,N’-
dimethylpropylene urea (DMPU), or the use of a typical additive, such as TMEDA, did not 
improve the reaction outcome (entries 9-10). The use of Co(acac)3 instead of CoCl2·2LiCl was 
not advantageous (entry 11). Furthermore, we confirmed that HCO2Na alone did not catalyze 
this coupling by additional metal impurities (entry 12). Additional control experiments indicated 
that Cr35 and Fe68  salts are not good catalysts for this reaction (entries 13-14). 
 
 
Table 15. Co-catalyzed cross-coupling reactions between 2-chlorinated aromatic ketones and 
arylzinc reagents. 
 
                                                
67 We propose that the halide ligands in CoCl2·2LiCl are replaced by carboxylate ligands (HCO2-), which 
provides a more selective cobalt catalyst. In fact, halide ligands mostly lead to tetrahedral coordination 
(see, for example: N. S. Gill, F.  B. Taylor, Inorg. Synth. 1967, 9,136), whereas carboxylate ligands lead to 
an octahedral coordination (see, for example: a) A. Kaufmann, C. Afshar, M. Rossi, D. E. Zacharias, J. P. 
Glusker, Struct. Chem. 1993, 4, 191; b) G. Aromí, A. S. Batsanov, P. Christian, M. Helliwell, A. Parkin, S. 
Parsons, A. A. Smith, G. A. Timco, R. E. P. Winpenny, Chem. Eur. J. 2003, 9, 5142). Furthermore, 
whereas CoCl2·2LiCl in THF is a blue solution, the addition of HCO2Na leads to a pink solution, which is 
typical for a coordination change. 
68 a) O. M. Kuzmina, A. K. Steib, D. Flubacher, P. Knochel, Org. Lett. 2012, 14, 4818. b) T. C. Atack, R. 
M. Lecker, S. P. Cook J. Am. Chem. Soc. 2014, 136, 9521. c) T. Agrawal, S. P. Cook Org. Lett. 2014, 16, 
5080.	
entry electrophile zinc reagent product /  yield (%)a
1
2
Me
O
X
78c (X = Cl)
78d (X = Br)
MeO
Me
Me
ZnCl Me
O
Me
Me
OMe
81a: 65% (X = Cl)
81b: 74% (X = Br)
79b
Me
O
Cl
78c 79c
Ph
F ZnCl Me
O
Ph
F
81c: 67%
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3 Ph
O
Cl
78e 79d
Me2N
ZnCl Ph
O
NMe2
81d: 73%
4 Ph
O
Cl
78e 79e
NC
ZnCl
Ph
O
CN
81e: 98%
F
F
5 c-Pent
O
Cl
78f 79a
MeO
ZnCl c-Pent
O
OMe
81f: 76%
6 c-Pent
O
Cl
78g 79f
ZnCl c-Pent
O
81g: 68%
F
F
TBSO
OTBS
7 Ph
O
Cl
78h 79g
ZnCl Ph
O
81h: 89%
Cl
ClF3C
CF3
8 Ph
O
Cl
78h 79h
ZnCl Ph
O
81i: 61%
Cl
ClN
NMe
Me
Table 15 continued
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a Yield of isolated product. 
 
 
The reaction scope of this cross-coupling proved to be quite broad. Thus, 2-halogenated 
functionalized aceto- and benzophenones (78c-j) undergo the cobalt-catalyzed cross-coupling 
with a range of aryl- and heteroarylzinc reagents (79a-h), yielding the corresponding 
polyfunctionalized ketones (81a-k) in 61-98% yield (Table 15). 2-Chloro- or 
2-bromoacetophenone (78c-d) react with zinc reagents bearing various functional groups, such 
as F or MeO, providing the expected products (81a-c) in 65-74% yield (entries 1−2). 
Interestingly, a dimethylamino substituent or a cyano group were well tolerated in the zinc 
reagents (79d-e), as they reacted with 2-chlorobenzophenone (78e) to give the products 81d 
and 81e in 73−98% yield (entries 3-4). Remarkably, various other 2-chlorinated aromatic 
ketones (78f-j) undergo the cross-coupling with both, electron-rich and -poor substituted arylzinc 
reagents, leading to the desired products 81f-81k in 61-89% yield (entries 5-10). Also, 
heterocyclic zinc reagents, such as 79h, provided the new ketones 81i and 81k in 61-62% yield 
(entries 8 and 10). 
 
 
 
 
 
9 p-F(C6H4)
O
Cl
78i 79g
ZnCl p-F(C6H4)
O
81j: 73%
F3C
CF3
10 p-F(C6H4)
O
Cl
78i 79h
ZnCl p-F(C6H4)
O
81k: 62%
N
NMe
Me
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Table 16. Co-catalyzed cross-coupling reactions between 2-chloropyridines and arylzinc 
reagents. 
 
entry electrophile zinc reagent product /  yield (%)a
1
N
CO2Et
Cl
78k
MeO
ZnCl
N
CO2Et
80c: 70%79a
OMe
2
N
CO2Me
Cl
78l
ZnCl
N
CO2Me
80d: 71%79i
OBn
OBn
3
N
CO2Me
Cl
78l
Me2N
ZnCl
N
CO2Me
80e: 91%79d
NMe2
4
N
CO2Me
Cl
1m
MOMO
ZnCl
N
CO2Me
80f: 60%79j
OMOM
5
N Cl
78n
MeO
ZnCl
N
80g: 89%79a
OMe
EtO2C
EtO2C
6
N Cl
78n
Ph
ZnCl
N
80h: 88%79c
Ph
EtO2C
EtO2C
F
F
7
N Cl
78o
MeO
ZnCl
N
80i: 86%
OMe
F3C
F3C
Me
Me
Me
79b
Me
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a Yield of isolated product. 
 
Additionally, a range of 2,3-disubstituted-N-heterocyclic chlorides can be readily employed in 
this protocol (Table 16, entries 1-4). p-MeOC6H4ZnCl (79a) undergoes a smooth cross-coupling 
with ethyl 2-chloronicotinate (78k), leading to the 2,3-disubstituted pyridine 80c in 70% yield 
(entry 1). Also, the coupling of electron-rich arylzinc reagents 79i and 79d with methyl 2-
chloronicotinate (78l) afforded the pyridines 80d−e in 71-91% yield (entries 2-3). Similarly, the 
cross-coupling of 2-chloronicotinonitrile (1m) and a zinc organometallic bearing a OMOM-group 
(79j), led to the desired pyridine 80f in 60% yield (entry 4). Furthermore, 2,5-disubstituted-N-
heterocyclic chlorides were also good substrates producing the diarylated pyridines 80g-l       
(73-89%; entries 5-10). 
 
 
 
 
 
 
 
 
8
N Cl
78o
ZnCl
N
80j: 73%
F3C
F3C
OMe
79k
MeO
9
N Cl
78p
ZnCl
N
80k: 84%
NC
NC
OTBS
79f
TBSO
10
N Cl
78p
ZnCl
N
80l: 84%
NC
NC
79a
MeO
OMe
Table 16 continued
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Table 17. Co-catalyzed cross-coupling reactions between N-hetereocyclic halides and arylzinc 
reagents. 
 
entry electrophile zinc reagent product /  yield (%)a
1
N
CN
Cl
78q
ZnCl
N
CN
80m: 92%79f
TBSO
OTBS
2
N Cl
78r
ZnCl
N
80n: 65%79a
CO2Et
MeO
CO2Et
OMe
3
N
N
Br
78s
ZnCl
N
N
80o: 92%79f
TBSO
OTBS
4 N
N
Br
78t
ZnCl
N
N
80p: 86%79l
MeO
OMe
OMe
OMe
Cl
Cl
5
N
N
Br
78u
ZnCl
N
N
80q: 76%79c
F
F
Me
Me Ph
Ph
6
N
N
Cl
78v
ZnCl
N
N
80r: 65%79l
MeO
OMe
Me
Me
Me
Me
OMe
OMe
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a Yield of isolated product. 
 
Moreover, halogenated quinolines, pyrimidines and triazines also proved to be good substrates 
for this cross-coupling (Table 17). Substituted quinolines, such as 2-bromoquinoline-3-
carbonitrile (78q) and ethyl 2-bromoquinoline-4-carboxylate (78r), rapidly couple with the zinc 
organometallics 79a,f to provide the arylated quinolines in 65-92% yield (80m-n; entries 1-2). 
Pyrimidines, which are common scaffolds found in pharmaceuticals,69 are readily obtained by 
the coupling of 2-chloro- or 2-bromopyrimidines (78s-v) in 65-92% yield (entries 3–6). Also, 
triazines are of great importance as building blocks for materials and agrochemicals.70 The 
cross-coupling of 2-chloro-4,6-diphenyl-1,3,5-triazine (78w) with the arylzinc reagent 79f leads 
to the desired product 80s in 61% yield (entry 7). 4,6-Dichloropyrimidine (82) also underwent a 
coupling reaction with p-MeOC6H4ZnCl (2.4 equiv, 79a), affording the arylated compound 83 in 
73% isolated yield (Scheme 38). 
 
Scheme 38. Co-catalyzed cross-coupling reaction between 4,6-dichloropyrimidine (82) and 
p-MeOC6H4ZnCl (79a). 
 
The synthesis of heteroaryl–heteroaryl cross-coupling products is a challenge. When using Pd 
or Ni as catalysts, deactivation of the catalyst is often observed owing to chelation of the 
                                                
69 M. E Welsch, S. A Snyder, B. R Stockwell, Curr. Op. Chem. Bio. 2010, 14, 347. 
70 a) H. Zhong, H. Lai, Q. Fang, J. Phys. Chem. 2011, 115, 2423. b) R. V. Patel, Y.-S. Keum, S. W. Park, 
Mini-Rev. Med. Chem. 2014, 14, 768. 
7 N
N
N
Cl
78w
ZnCl N
N
N
80s: 61%79m
BocO
OBoc
Ph
Ph
Ph
Ph
Table 17 continued
(79a, 2.4 equiv)
CoCl2.2LiCl (5 mol%)
HCO2Na (50 mol%)
THF, r.t., 8 h
ZnClMeO
N
N
N
NCl
Cl
OMe
OMe
83: 73%
gram scale
82
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reagents with the catalyst.71 However, the THF-soluble CoCl2.2LiCl-catalyzed reaction (5 mol%) 
promoted by sodium formate (50 mol%) allows smooth cross-coupling of 2-bromopyrimidine 
(78s) with (1-methyl-1H-indol-5-yl)zinc chloride (79h) or thiophen-3-ylzinc chloride (79n) to 
afford the heteroaryl compounds 84a-b in 61-66% isolated yield (Scheme 39).  
 
 
Scheme 39. Heteroaryl–heteroaryl cross-coupling reactions between 2-bromopyrimidine (78s) 
and hetereoarylzinc organometallics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
71 a) G. S. Hanan, U. S. Schubert, D. Volkmer, E. Rivière, J.-M. Lehn, N. Kyritsakas, J. Fischer, Can. J. 
Chem. 1997, 75, 169. b) C. Kaes, A. Katz, M.W. Hosseini, Chem. Rev. 2000, 100, 3553. c) S. Bedel, G. 
Ulrich, C. Picard, P. Tisnès, Synthesis 2002, 1564; d) Comprehensive Coordination Chemistry II, Vol. 1 
(Eds.: J. A. McCleverty, T. J. Meyer), Elsevier, Oxford, 2004. 
(79n, 1.2 equiv)
CoCl2.2LiCl (5 mol%)
HCO2Na (50 mol%)
THF, r.t., 8 h
N
N
Br
N
Me
ClZn
(79h, 1.2 equiv)
CoCl2.2LiCl (5 mol%)
HCO2Na (50 mol%)
THF, r.t., 8 h
S
ZnCl
N
N
N
Me
N
N
S
84b: 61%84a: 72%
gram scale
78s
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6. A Robust and Broadly Applicable Cobalt-Catalyzed Cross-Coupling 
of Functionalized Bench-Stable Organozinc Pivalates with 
Unsaturated Halides 
 
6.1. Introduction 
To date, boron organometallics have extensively been used for cross-coupling reactions in 
medicinal chemistry,72 allowing late-stage functionalizations of biologically active molecules.73 
Their air and water stability has made boronic esters, 74  boronic acids, 75  as well as 
trifluoroboronates,76 highly attractive for the pharmaceutical industry. However, some of these 
boron derivatives are sensitive or difficult to prepare in high yields and in general require an 
additional base to achieve satisfactory cross-couplings.77 In comparison, organozinc reagents 
display an excellent functional group compatibility and a better reactivity in coupling reactions.78 
No additional base is required and the transmetalation from Zn to Pd or other transition metals is 
very fast. Nevertheless, standard organozinc reagents (RZnX, X = Hal), are highly air and 
moisture sensitive, thus limiting their synthetic applications. Recently, we demonstrated that 
organozinc pivalates (RZnOPiv)79 afford, after solvent evaporation, solid organozinc compounds 
with greatly improved air and moisture stability, allowing them to be weighed out on the 
benchtop. 
                                                
72 a) P. A. Wender, M. K. Hilinski, A. V.W. Mayweg, Org. Lett. 2005, 7, 79. b) M. G. Campbell, T. Ritter, 
Org. Process Res. Dev. 2014, 18, 474. 
73 a) H.-X. Dai, A. F. Stepan, M. S. Plummer, Y.-H. Zhang, J.-Q. Yu, J. Am. Chem. Soc. 2011, 133, 7222. 
b) J. Wencel-Delord, F. Glorius, Nat. Chem. 2013, 5, 369. c) D. A. DiRocco, K. Dykstra, S. Krska, P. 
Vachal, D. V. Conway, M. Tudge, Angew. Chem. Int. Ed. 2014, 53, 4802. d) T. Cernak, K. D. Dykstra, S. 
Tyagarajan, P. Vachal, S. W. Krska, Chem. Soc. Rev. 2016, 45, 546. 
74 a) H. Noguchi, K. Hojo, M. Suginome, J. Am. Chem. Soc. 2007, 129, 758. b) S. J. Lee, K. C. Gray, J. S. 
Paek, M. D. Burke, J. Am. Chem. Soc. 2008, 130, 466. c) D. M. Knapp, E. P. Gillis, M. D. Burke, J. Am. 
Chem. Soc. 2009, 131, 6961.  
75 a) N. Miyaura, K. Yamada, H. Suginome, A. Suzuki, J. Am. Chem. Soc. 1985, 107, 972. b) A. Suzuki, 
Pure Appl. Chem. 1985, 57, 1749. c) N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457. 
76 a) G. A. Molander, B. Biolatto, J. Org. Chem. 2003, 68, 4302. b) G. A. Molander, B. Canturk, Angew. 
Chem. Int. Ed. 2009, 48, 9240. 
77 a) N. Kudo,M. Perseghini, G. C. Fu, Angew. Chem. Int. Ed. 2006, 45, 1282. b) A. J. J. Lennox,G. C. 
Lloyd-Jones, Isr. J. Chem. 2010, 50, 664. 
78 D. Haas, J. M. Hammann, R. Greiner, P. Knochel ACS Catal. 2016, 6, 1540. 
79 NMR experiments and crystallographic data showed that the structure of these zinc reagents is 
RZnX·Mg(OPiv)2·LiCl. However, for the sake of clarity, we have named these reagents RZnOPiv, see: A. 
Hernán-Gómez, E. Herd, E. Hevia, A. R. Kennedy, P. Knochel, K. Koszinowski, S. M. Manolikakes, R. E. 
Mulvey, C. Schnegelsberg, Angew. Chem. Int. Ed. 2014, 53, 2706. 
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These organozinc pivalates readily undergo Pd-catalyzed cross-couplings.80 However, since 
palladium81 and nickel,82 the favored transition metal catalysts for couplings, are toxic3 and/or 
expensive,2 we envisioned the performance of cross-couplings with organozinc pivalates using 
industry-friendly transition metal catalysts. Cobalt-catalyzed couplings are of special interest 
since cobalt salts are much less toxic than palladium salts and additionally are ca. 800 times 
cheaper. Although several Co-catalyzed Csp2-Csp2 cross-couplings have been reported, all 
these methods lack generality and a broad reaction scope is essential for an extensive use in 
industrial and academic research.5,18 Also, many Co-catalyzed cross-couplings are limited to 
electron-deficient N-heterocyclic halides and ortho-activated electron-poor aromatic halides.17 
Herein, we report a practical, robust and broadly applicable Co-catalyzed Csp2-Csp2 cross-
coupling between various aryl or heteroarylzinc pivalates and electron-poor aryl or heteroaryl 
iodides, bromides and chlorides. In the previous chapter, we have noticed that sodium formate 
was an excellent promoter for cross-couplings between ortho-activated heterocyclic halides and 
arylzinc chlorides.83 These results encouraged us to examine the use of arylzinc pivalates as 
nucleophilic cross-coupling partners. The pivalate anion10 like sodium formate may accelerate 
the coupling reaction. To our delight, this hypothesis was confirmed. 
 
 
 
 
                                                
80 a) S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9205. b) C. I. 
Stathakis, S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9428. c) J. R. Colombe, S. 
Bernhardt, C. Stathakis, S. L. Buchwald, P. Knochel, Org. Lett. 2013, 15, 5754. d) C. I. Stathakis, S. M. 
Manolikakes, P. Knochel, Org. Lett. 2013, 15, 1302. e) S. M. Manolikakes, M. Ellwart, C. I. Stathakis, P. 
Knochel, Chem. - Eur. J. 2014, 20, 12289. 
81 a) S. D. Walker, T. E. Barder, J. R. Martinelli, S. L. Buchwald, Angew. Chem. Int. Ed. 2004, 43, 1871. b) 
J. E. Milne, S. L. Buchwald, J. Am. Chem. Soc. 2004, 126, 13028. c) T. E. Barder, S. D. Walker, J. R. 
Martinelli, S. L. Buchwald, J. Am. Chem. Soc. 2005, 127, 4685. d) K. L. Billingsley, K. W. Anderson, S. L. 
Buchwald, Angew. Chem. Int. Ed. 2006, 45, 3484. e) Y. Yang, N. J. Oldenhuis, S. L. Buchwald, Angew. 
Chem. Int. Ed. 2013, 52, 615. f) Y. Yang, K. Niedermann, C. Han, S. L. Buchwald, Org. Lett. 2014, 16, 
4638. 
82 a) M. Kranenburg, Y. E. M. van der Burgt, P. C. J. Kamer, P. W. N. M. van Leeuwen, K. Goubitz, J. 
Fraanje, Organometallics 1995, 14, 3081. b) L. Melzig, T. Dennenwaldt, A. Gavryushin, P. Knochel, J. 
Org. Chem. 2011, 76, 8891. 
83 Although sodium formate proved to be and excellent catalyst for the cross-coupling of activated 
heteroaryl halides, the scope of this method was limited to activated substrates, see (6). For other 
realated reactions using PivOR, see: a) D. S. Roman and A. B. Charette Org. Lett. 2013, 15, 4394. b) P. 
Cyr, S. Régnier, W. S. Bechara, A. B. Charette Org. Lett. 2015, 17, 3386. c) C. L. Ladd, A. V. Belouin, A. 
B. Charette J. Org. Chem. 2016, 81, 256. 
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6.2. Cobalt-Catalyzed Aryl-Aryl Cross-Coupling Reactions 
Preliminary experiments showed, the treatment of the bromobenzonitrile (85a) with p-anisylzinc 
chloride 79a in the presence of CoCl2 (5 mol%)84 in THF (40 °C,85 16 h) gave the desired 
product 86a in 41% yield (Scheme 40).  
 
 
Scheme 40. Cobalt-catalyzed cross-coupling of 4-bromo-2-fluorobenzonitrile (85a). 
 
During this reaction, extensive homo-coupling as well as hydrolysis of the organometallic 
species was observed explaining the low yield. However, using p-anisylzinc pivalate (87a) 
prepared from 4-bromoanisole (88) by Mg-insertion in the presence of LiCl42 followed by a 
transmetalation with Zn(OPiv)2 (>95% yield), we observed a very clean cross-coupling affording 
the biphenyl (86a) in 80% yield showing the clear superiority of ArZnOPiv over ArZnCl. 
Remarkably, although ortho-fluoro electron-deficient aromatics are known to readily undergo 
Co-catalyzed cross-couplings with Grignard reagents, using 4-bromo-2-fluorobenzonitrile (85a) 
only a regio- and chemoselective coupling of bromide occurs. With these results in hand, we 
have further optimized the reaction conditions and showed that MnCl2,34 CrCl235 or FeCl268 were 
unsuitable catalysts (Table 18, entries 2-4).   
 
 
 
 
 
 
                                                
84	See experimental part for more details (page 186).	
85 See experimental part for more details (page 185).	
OMe
CoCl2 (5 mol%)
THF, 40 °C, 16 h
NC
F
Br
NC
F
85a
86a: 41% (Met = ZnCl)
        80% (Met = ZnOPiv)
(1.5 equiv)
MeO Met
79a (Met = ZnCl)
87a (Met = ZnOPiv)
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Table 18. Reaction conditions optimization for the cobalt-catalyzed cross-coupling of 4-bromo-
2-fluorobenzonitrile (85a). 
 
a GC yield. Undecane was used as an internal standard. b Isolated yield. c 99.99% purity.             
d Technical grade THF was used as a solvent. 
 
We found that CoCl2 is superior to other cobalt salts, such as Co(acac)2, Co(acac)3, CoBr2 and 
CoCl2.2LiCl36 (entries 5-9). At this point, we have verified that no other metal contaminant is 
responsible for this catalysis by using 5% CoCl2 (99.99% purity) which produced 86a in 71% 
yield (entry 10). Solvent screening showed that THF was the best solvent compared to NMP, 
DMPU, DME, 1,4-dioxane, tBuOMe, EtOAc.86 Remarkably, the improved water and air stability 
of arylzinc pivalates allows performing these couplings in technical (undistilled) THF providing 
86a in 78% yield (compare entries 11 and 9). Additionally, whereas previous cobalt-catalyzed 
cross-couplings were often limited to aryl halides bearing an ortho-electron-withdrawing 
substituent, the reaction scope was found to be quite broad. Thus, not only 2-iodobenzonitrile 
(85b) underwent the described cross-coupling with 87a, but 3-iodo and 4-iodobenzonitrile    
                                                
86 See experimental part for more details (page 186). 
	
entry yield (%)a
1 tracesnone
3 6CrCl2
2 tracesMnCl2
catalyst
(mol%)
5 72Co(acac)2
4 7FeCl2
7 81CoBr2
6 74Co(acac)3
8 77CoCl2.2LiCl
9 85 (80)bCoCl2
10 71cCoCl2
11 78dCoCl2
NC
catalyst (5 mol%)
Br
THF, 40 °C, 16 h
85a (1.0 equiv)
OMe
Br 1) Mg (1.1 equiv)
    LiCl (1.1 equiv)
    THF, 0 °C, 3 h
2) Zn(OPiv)2 (1.0 equiv)
    THF, 0 °C, 1 h OMe
ZnOPiv
F
OMe
CN
F
87a: >95%
86a
88 (1.5 equiv)
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(85c-d) reacted smoothly, leading to the expected products (86b-d) in 71-75% yield (Table 19, 
entry 1). 
 
Table 19. Cobalt-catalyzed cross-couplings between aryl halides and arylzinc pivalates. 
 
entry electrophile zinc reagent product /  yield (%)a
I
MeO
ZnOPiv
MeO1
85b (ortho)
85c (meta)
85d (para)
86b 71% (ortho)
86c 72% (meta)
86d 75% (para)
CN CN
2
CN
I
ZnOPivO
O
CN
O
O
85d
87a
87b 86e: 72%
3 CN
Br
F ZnOPiv
N
Me
85a 87c 86f: 65%
CN
F
N
Me
CN
Br
F
85a
5
ZnOPiv
O
O
CN
F
87e 86h: 75%
O
O
CN
Br
CF3
85e
6
MeO
ZnOPiv CN
CF3
87f 86i: 72%
MeO
MeO
OMe
MeO
OMe
CN
Br
F
85a
4
ROOC
ZnOPiv CN
F
87d 86g: 75%ROOC
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CO2Et
Br
F
85f
7
Me
ZnOPiv
CO2Et
F
87a 86j: 71%
Me
Me
Me
Me
Me
CO2Et
I
85g
8
MeO
ZnOPiv
CO2Et
87a 86k: 61%
MeO
CO2Et
I
85g
9
ROOC
ZnOPiv
CO2Et
87d 86l: 65%
ROOC
85h
10
MeO
ZnOPiv
87h 86m: 65%
OEtO2C Br
OEtO2C
Me
Me Me
OMe
Me
O
FCl
ZnOPiv
F3C O
CF3
F
85i
11
87i 86n: 80%
O
Br
O
O
O
ZnOPivO
O
85j
12
87b 86o: 81%
N
Br
N
OMe
MeO
ZnOPiv
85k
13
87a 86p: 74%
Table 19 continued
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a Yield of isolated product. R = ZnOPiv 
 
Similarly, 4-iodobenzonitrile (85d) reacts with the organozinc pivalate 87b to give 86e in 72% 
yield (entry 2). Also, (1-methyl-1H-indol-5-yl)zinc pivalate 87c as well as the bis-zinc pivalate 
(87d) and the functionalized arylzinc reagents (87e-f) undergo a regioselective cross-coupling 
providing the biphenyls (86f-i) in 65-75% yield (entries 3-6). Also, the ethyl benzoate (85f) 
bearing a 4-bromo and 2-fluoro substituent react regio- and chemo-selectively with the sterically 
demanding mesitylzinc pivalate (87g) furnishing the substituted benzoate (86j) in 71% yield 
(entry 7). Similarly, the reaction of 4-iodobenzoate (85g) with 87a and 87d provided the coupling 
products (86k-l) in 61-65% yield (entries 8-9). The bromofuran derivative (85h) is coupled with 
87h affording the disubstitued furan (86m) in 65% yield (entry 10). 2-Chloro and 4-
bromobenzophenones (85i-j) are readily cross-coupled with 87i and 87b leading to the desired 
products (86n-o) in 80-81% yield (entries 11-12). Electron-deficient bromides and chlorides 
such as the 3-bromo- or 4-chloroquinoline (85k-l) undergo a smooth cross-coupling with 3a 
leading to the quinolines (86p-q) in 72-74% yield (entries 13-14). Finally, 2-chloropyridazine 
(85m) which is notoriously difficult to cross-couple, 85m reacts with 3-thioanisylzinc pivalate 
(87j) giving the arylated pyridazine (86r) in 89% yield showing that thioethers do not inhibit this 
cobalt catalysis (entry 15). 
 
MeO
ZnOPiv
N
Cl
CF3
N CF3
OMe
85l
14
87a 86q: 74%
N
N
Cl
ZnOPivMeS
N
N
SMe
85m
15
87j 86r: 85%
Table 19 continued
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Scheme 41. Cobalt-catalyzed heteroaryl–heteroaryl cross-coupling reactions. 
 
Cross-couplings between heterocyclic moieties is a synthetic challenge in pharmaceutical and 
agrochemical research87 and this new cobalt-catalyzed cross-coupling procedure allows the 
linkage between 5-indolylzinc pivalate (87c) and 2-bromopyrimidine (78u) as well as 
2-chloropyrazine (85m) leading to the complex heterocycles (88a-b in 81-85% yield, Scheme 
41).  
 
Additionally, this cobalt-catalyzed cross-coupling was extended to the performance of aryl-
alkenyl cross-couplings (Table 20). Thus, the (Z)-3-iodo- and (Z)-3-bromo-acrylates (89a-b), E/Z 
= 1:99) undergo a stereoselective reaction with arylzinc pivalate (87h) under our standard 
conditions providing (Z)-ethyl cinnamate (90a) in 94-98% yield with complete rentention of the 
double bond geometry (E/Z = 1:99, entry 1).  
 
 
 
   
 
 
 
                                                
87 a) C. Kaes, A. Katz, M. W. Hosseini, Chem. Rev. 2000, 100, 3553. b) Comprehensive Coordination 
Chemistry II, Vol. 1 (Eds.: J. A. McCleverty, T. J. Meyer), Elsevier, Oxford, 2004. b) For additional cross-
coupling reactions using heteroarylzinc pivalates, see experimental part (page 186). 
	
CoCl2 (5 mol%)
THF, 40 °C, 16 h
N
N
Me Br
(87c, 1.5 equiv)
N
N
Cl
88a: 81%
CoCl2 (5 mol%)
THF, 40 °C, 16 h
(87c, 1.5 equiv)
N
Me
PivOZn
N
Me
PivOZn
N
N
Me
N
N
N
N
Me
Me
88b: 85%
78u
85m
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Table 20. Co-catalyzed cross-coupling reactions between alkenyl halides of type 89 and 
arylzinc pivalates of type 87. 
 
a Yield of isolated product. 
 
Similarly, the arylzinc pivalate (87i) reacts with 89a providing the corresponding Z-ester (90b) in 
80% yield (E/Z = 3:97, entry 2). The E-styryl bromide (89c, E/Z = 99:1) cross-couples with the 
arylzinc pivalate (87k) leading to the E-stilbene 90c in 97% yield (E/Z = 99:1, entry 3). Also, 2-
bromo-indene (89d) reacts with pivalate 87f providing the desired cross-coupling product (90d) 
in 70% yield (entry 4).  
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Scheme 42. Cobalt-catalyzed cross-couplings of organozinc pivalates with bromoalkynes. 
 
Finally, this Co-catalyzed cross-coupling can further be extended to Csp2-Csp couplings. Typical 
bromoalkynes88 such as 91a-b react with the arylzinc pivalate (87a) affording the functionalized 
alkynes (92a-b) in 61-71% yield (Scheme 42). Preliminary mechanistic studies show that Co(I)-
complexes are as active as Co(II)-complexes (Scheme 43). Further studies are currently 
underway. 
 
 
Scheme 43. Cobalt-catalyzed cross-couplings of Co(I) and Co(II)-complexes. 
 
 
                                                
88 a) D. Castagnolo, M. Botta, Eur. J. Org. Chem. 2010, 17, 3224. b) M. Corpet, X.-Z. Bai, C. Gosmini 
Adv. Synth. Catal. 2014, 356, 2937. 
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IV. Summary 
The research described in this thesis focused on cobalt-catalyzed/mediated cross-coupling 
reactions. First, we developed a highly diastereoselective cross-coupling of cyclic TBS-protected 
iodohydrins (and bromohydrins) with various aryl and heteroarylmagnesium reagents in the 
presence of THF-soluble CoCl2·2LiCl and TMEDA as a ligand leading to trans-2-
arylcyclohexanol derivatives in good yields and a dr up to 99:1. A range of functional groups 
were tolerated in the Grignard reagent (e.g. COOR, CN, CF3, SF5). The use of heterocyclic 
iodohydrins leads to trans-3,4-disubstituted pyrrolidines and tetrahydrofurans (Scheme 44). 
 
 
Scheme 44. Cobalt-mediated diastereoselective cross-coupling reactions between cyclic 
halohydrins and arylmagnesium reagents 
 
Moreover, we have discovered a highly diastereoselective cross-coupling of variously 
substituted cycloalkyl iodides with alkynyl and (hetero)aryl Grignard reagents using cobalt(II) 
chloride. With the THF-soluble CoCl2·2LiCl and the inexpensive ortho-phenanthroline derivative 
neocuproine, as a ligand, diastereomeric ratios of up to 99:1 were achieved. A range of 
functional groups were tolerated in the Grignard reagent (e.g., CF3, Piv, CN, OPiv, NMe2, 
CO2NEt2, SF5, OTBS; Scheme 45). 
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Scheme 45. Diastereoselective cobalt-mediated cross-couplings of cycloalkyl iodides with 
alkynyl or (hetero)aryl Grignard reagents. 
We also developed a cobalt-catalyzed cross-coupling of diarylmanganese reagents with 
secondary alkyl iodides using CoCl2·2LiCl, which leads to the cross-coupling products in up to 
92% yield. High diastereoselectivities can be reached in these cross-couplings (dr up to 99:1). 
Remarkably, rearrangement of secondary alkyl iodides to unbranched products was not 
observed in these C-C forming reactions (Scheme 46). 
 
Scheme 46. Cobalt catalyzed Csp2-Csp3 cross-coupling reactions of diarylmanganese reagents 
with secondary alkyl iodides. 
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Furthermore, we have developed a new cobalt-catalyzed cross-coupling of polyfunctional diaryl- 
and diheteroarylzinc reagents prepared via directed zincation using TMP2Zn·2MgCl2·2LiCl with 
primary and secondary alkyl iodides or bromides using the cobalt complex CoCl2·2LiCl. 
Remarkably, no rearrangement of the secondary alkyl group was observed for the alkyl halides 
employed in this procedure. This cross-coupling proceeds under mild conditions and is 
compatible with various functional groups and hetereocyclic scaffolds (Scheme 47). 
 
 
Scheme 47. Cobalt-catalyzed negishi cross-coupling reactions of (hetero)aryl-zinc reagents with 
primary and secondary alkyl bromides and iodides. 
 
Also, we investigated cobalt-catalyzed Negishi cross-couplings of (hetero)arylzinc reagents with 
(hetero)aryl halides. A simple, practical cobalt salt-catalyzed procedure allows for cross-coupling 
reactions of halogenated aryl ketones, as well as N-heterocyclic chlorides and bromides with 
various electron-rich and -poor arylzinc reagents. The addition of sodium formate is essential for 
this cross-coupling (Scheme 48). 
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Scheme 48. Mild cobalt-catalyzed Negishi cross-couplings of (hetero)arylzinc reagents with 
(hetero)aryl halides. 
 
Finally, we discovered a robust and broadly applicable CoCl2-catalyzed cross-coupling between 
functionalized bench-stable aryl and heteroarylzinc reagents and various electron-poor aryl and 
heteroaryl halides (X = Cl, Br, I). Couplings with (E)- or (Z)-bromo- or iodo-alkenes proceed with 
retention of configuration. Also, alkynyl bromides react with arylzinc pivalates providing arylated 
alkynes (Scheme 49). 
 
Scheme 49. Cobalt-catalyzed cross-coupling of functionalized bench-stable organozinc 
pivalates with unsaturated halides. 
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V. Experimental Part 
1. General Considerations 
All reactions were carried out with magnetic stirring and in flame-dried glassware under argon 
atmosphere using Schlenk technique. Syringes used to transfer reagents and solvents were 
purged with argon prior to use.  
1.1 Solvents and Reagents 
CH2Cl2 was predried over CaCl2 and distilled from CaH2. DME was predried over CaCl2 and 
distilled from sodium benzophenone ketyl under argon atmosphere. DMF was refluxed over 
CaH2 (14 h), distilled from CaH2 and stored over 4 Å MS under argon atmosphere. DMPU was 
predried over CaH2 (4 h) and distilled. TEA was dried over KOH and distilled. THF was 
continuously refluxed and distilled from sodium benzophenone ketyl under nitrogen and stored 
over 4 Å MS under argon atmosphere. TMEDA was predried over CaH2 (12 h) and distilled from 
sodium benzophenone ketyl under argon atmosphere. TMPH was distilled from CaH2 under 
argon prior to use. 
Solvents for reaction workups and column chromatography were distilled prior to use. 
 
1.2 Organometallic Reagents 
Commercially available starting materials were used without further purification. 
i-PrMgCl·LiCl was purchased as a solution in THF from Albemarle Corp. as a 14% solution in 
THF and was titrated with I2 prior to use. 
n-BuLi was purchased as a solution in hexane from Albemarle Corp.. 
ZnCl2 solution in THF (1.0 M) was prepared by drying ZnCl2 (40.9 g, 300 mmol) in a Schlenk-
flask under high vacuum at 150 °C for 4 h. After cooling to 25 °C, anhydrous THF was added 
until a total volume of 300 mL was reached. The suspension was left stirring overnight at 25 °C 
and after 12 h the salts had completely dissolved. The stirring was stopped and the solution was 
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left for some hours to become completely clear. The solution was stored over 4 Å MS under 
argon upon use.  
CuCN·2LiCl solution in THF (1.0 M) was prepared by drying LiCl (17.0 g, 400 mmol) and 
CuCN (17.9 g, 200 mmol) in a Schlenk-flask under high vacuum at 150 °C for 4 h. After cooling 
to 25 °C, anhydrous THF was added until a total volume of 200 mL was reached. The 
suspension was left stirring overnight at 25 °C and after 12 h the salts had completely dissolved. 
The stirring was stopped and the solution was left for some more time to become completely 
clear. The solution was stored under argon upon use. 
CoCl2·2LiCl solution in THF (1.0 M) was prepared by drying LiCl (8.5 g, 200 mmol) in a 
Schlenk-flask under high vacuum at 130 °C for 3 h. After cooling to 25 °C, anhydrous CoCl2 
(13.0 g, 100 mmol) was added and the salts were further heated to 130 °C for 5 h under high 
vacuum. After cooling to 25 °C anhydrous THF (100 mL) was added. The mixture was 
vigorously stirred until all solids were dissolved and the reagent was obtained as a dark blue 
solution.  
MnCl2·2LiCl solution in THF (1.0 M) was prepared by drying LiCl (140 mmol, 5.94 g) in a 
Schlenk-flask under high vacuum at 130 °C for 3 h. After cooling to rt under vacuum, anhydrous 
MnCl2 (70.0 mmol, 8.81 g) was added under argon. The Schlenk-flask was further heated to 
130 °C for 3 h under high vacuum, cooled to 25 °C and charged with dry THF (70 mL). The 
mixture was stirred for at least 24 h (covered with aluminum foil) at room temperature and the 
resulting reagent MnCl2·2LiCl (1 M in THF) was obtained as a yellow solution. 
Preparation of Zn(OPiv)2: Pivalic acid (20.4 g, 22.6 mL, 200 mmol) was placed in a dry and 
argon-flushed 500 mL three-necked round-bottom flask, equipped with a magnetic stirring bar, a 
septum and a pressure equalizer, and was dissolved in dry THF (120 mL). The mixture was 
cooled to 0 °C, and a solution of Et2Zn (13.0 g, 10.8 mL, 105 mmol) in dry THF (120 mL) was 
added over a period of 30 min under vigorous stirring. Then, the ice-bath was removed and 
stirring was continued at 25 °C for one additional hour at which point bubbling was ceased (a 
thick slurry was formed). The solvent was removed in vacuo and the solid residue was dried for 
at least 4 h longer. Zn(OPiv)2 was obtained in quantitative yield, as a puffy amorphous white 
solid. 
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Preparation of EtMgBr: A dry and argon-flushed 100mL flask, equipped with a stirring bar and 
a septum, was charged with magnesium turnings (60 mmol, 1.44 g) in THF (50 mL). 
Bromoethane (50 mmol, 5.4 g) was added dropwise at -20 °C and the reaction mixture was 
shortly heated to reflux and again cooled to -20 °C. This procedure was repeated until the 
reaction started. After disappearance of the Mg turnings the dark-grey solution was titrated by 
using a stoichiometric amount of iodine (100 mg) in THF (2 mL) and a concentration of 0.94 M 
was determined. 
Preparation of TMPMgCl·LiCl: A 250 mL Schlenk-flask was charged with i-PrMgCl·LiCl (120 
mmol, 100 mL, 1.2 M in THF). Freshly distilled 2,2,6,6-tetramethylpiperidine (TMPH; 126 mmol, 
23.9 mL) was added dropwise at 25 °C and the mixture was stirred for 48 h.  
Preparation of TMPZnCl·LiCl: A 250 mL Schlenk-flask was charged with freshly distilled 
TMPH (60 mmol, 10 mL) dissolved in THF (60 mL). The solution was cooled to -40 °C and n-
BuLi (60 mmol, 25 mL, 2.4 M in hexane) was added dropwise. The reaction was allowed to 
warm slowly to -10 °C within 1 h. ZnCl2 (66 mmol, 66 mL, 1 M in THF) was added dropwise and 
the resulting solution was stirred for 0.5 h at -10 °C and then 0.5 h at 25 °C. The solvents were 
removed in vacuo to afford a light yellow solid and freshly distilled THF was added under 
vigorous stirring until the salts were completely dissolved.  
The content of organometallic reagent was determined either by the method of Paquette89 using 
i-PrOH and 1,10-phen as indicator (organolithium reagents) or the method of Knochel90 using I2 
in THF (organomagnesium and -zinc reagents). 
TMP-Bases were titrated against benzoic acid using 4-(phenylazo)diphenylamine as indicator in 
THF. 
 
 
 
                                                
89 H. S. Lin, A. Paquette, Synth. Commun. 1994, 24, 2503. 
90 A. Krasovskiy, P. Knochel, Synthesis 2006, 5, 890.	
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1.3 Chromatography 
Flash column chromatography was performed using silica gel 60 (40 – 63 μm 230-400 mesh 
ASTM) from Merck. 
Thin layer chromatography (TLC) was performed using aluminum plates covered with SiO2 
(Merck 60, F-254) and visualized either by UV detection or by staining with KMnO4 solution (1.5 
g KMnO4, 10 g K2CO3, 1.25 mL 10% NaOH solution in 200 mL H2O). 
 
1.4 Analytical Data 
NMR spectra were recorded on Varian VXR 400S, Bruker Avance III HD 400 MHz and Bruker 
AMX 600 instruments. Chemical shifts (d) are reported in parts per million (ppm) relative to the 
residual solvent peak of CHCl3 (dH = 7.26, dC = 77.0). For the characterization of the observed 
signal multiplicities the following abbreviations were used: s (singlet), d (doublet), t (triplet), q 
(quartet), quint (quintet), sept (septet), m (multiplet), br (broad). 
 
Mass spectra and high resolution mass spectra (HRMS) were recorded on a Finnigan MAT 
95Q (EI) or a Thermo Finnigan LTQ FT instrument (ESI). Electron impact ionization (EI) was 
conducted with an electron energy of 70 eV. Electrospray ionization (ESI) was conducted with 
an IonMax ion-source equipped with an ESI head. It was performed with a voltage of 4 kV at the 
spray capillary tube, a heating filament temperature of 250 °C and a nitrogen flow of 25 units. 
 
Gas Chromatography (GC) was performed withmachines of the types Hewlett-Packard 6890 
or 5890 Series II (Hewlett Packard, 5% phenylmethylpolysiloxane; column length: 15 m, 
diameter: 0.25 mm; film thickness: 0.25 mm). For the combination of gas chromatography with 
mass spectroscopic detection, a GC-MS from Hewlett Packard of type 6890/MSD 5973 was 
used. 
 
Infrared spectra (IR) were recorded from 4500 cm-1 to 650 cm-1 on a Perkin Elmer Spectrum 
BX-59343 instrument. For detection a Smiths Detection Dura SamplIR II Diamond ATR sensor 
was used. The absorption bands (!) are reported in wave numbers (cm-1). 
 
Melting points (m.p.) were measured using a Büchi B-540 apparatus and are uncorrected. 
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2. Cobalt-Mediated Diastereoselective Cross-Coupling Reactions 
between Cyclic Halohydrines and Arylmagnesium Reagents 
 
2.1 Preparation of Starting Materials 
The following starting materials were prepared according to literature procedures with only little 
deviation. The spectral data of known compounds were in full agreement with the literature 
(Signals of the main diastereomer are given). 
tert-Butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a) 
 
dr: 25:75 (trans/cis).  
1H NMR (300 MHz, CDCl3) δ/ppm: 4.53 - 4.39 (m, 1 H), 3.36 (s br., 1 H), 2.32 - 2.20 (m, 1 H), 
1.96 - 1.84 (m, 1 H), 1.79 - 1.60 (m, 3 H), 1.57 - 1.30 (m, 3 H), 0.95 (s, 9 H), 0.14 (s, 3 H), 0.08 
(s, 3 H). 
 
tert-Butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b) 
 
dr: 99:1 (trans/cis).  
1H NMR (300 MHz, CDCl3) δ/ppm: 4.43 (ddd, J=6.3, 3.6, 3.3 Hz, 1 H), 4.06 - 3.98 (m, 1 H), 
2.41 - 2.28 (m, 1 H), 2.16 - 1.97 (m, 2 H), 1.80 (quin, J=7.39 Hz, 2 H), 1.60 - 1.49 (m, 1 H), 0.89 
(s, 9 H), 0.10 (s, 3 H), 0.07 (s, 3 H). 
 
 
OTBS
I
OTBS
I
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 ((2-Bromocyclohexyl)oxy)(tert-butyl)dimethylsilane (52c) 
 
dr: 99:1 (trans/cis).  
1H NMR (300 MHz, CDCl3) δ/ppm: 3.90 (ddd, J = 9.6, 7.6, 4.1, 1H), 3.73 – 3.63 (m, 1H), 2.36 – 
2.25 (m, 1H), 2.09 – 1.95 (m, 1H), 1.88 – 1.58 (m, 4H), 1.43 – 1.23 (m, 3H), 0.90 (s, 9H), 0.12 
(s, 3H), 0.08 (s, 3H). 
 
tert-Butyl((4-iodotetrahydrofuran-3-yl)oxy)dimethylsilane (59a) 
 
dr: 99:1 (trans/cis).  
1H NMR (300 MHz, CDCl3) δ/ppm: 0.01 - 0.14 (m, 6 H), 0.87 (s, 9 H), 3.66 (dd, J=9.26, 2.07 Hz, 
1 H), 3.97 - 4.10 (m, 2 H), 4.17 - 4.36 (m, 2 H), 4.58 (dt, J=4.42, 2.21 Hz, 1 H). 
 
3-((tert-Butyldimethylsilyl)oxy)-4-iodo-1-tosylpyrrolidine (59b) 
 
dr: 99:1 (trans/cis).  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.08 - 0.02 (m, 6 H), 0.73 (s, 9 H), 2.40 (s, 3 H), 3.17 (dd, 
J=10.23, 1.94 Hz, 1 H), 3.63 - 3.71 (m, 1 H), 3.77 - 3.96 (m, 3 H), 4.34 (dt, J=4.70, 2.35 Hz, 1 
H), 7.30 (m, J=8.57 Hz, 2 H), 7.70 (m, J=8.29 Hz, 2 H). 
 
 
OTBS
Br
O
OTBS
I
TsN
OTBS
I
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2.2 Cobalt-Mediated Cross-Coupling of Various Protected Cycloalcohols with 
(Hetero)Arylmagnesium Reagents 
 
Typical Procedure 1 (TP1): A dry and Ar-flushed 10 mL Schlenk-tube, equipped with a stirring 
bar and a septum, was charged with a solution of CoCl2·2LiCl (1 M in THF) (0.43 mmol, 0.43 
mL, 0.85 equiv) and anhydrous THF (0.5 mL). The respective protected cyclicalcohols (0.5 
mmol, 1 equiv) and TMEDA (0.15 mmol, 22.6 mg, 0.3 equiv) were added via syringe. The 
reaction mixture was cooled to -50 °C and a solution of the appropriate Grignard reagent (0.85 
mmol, 1.7 equiv) was added dropwise over 10 min via syringe. The reaction mixture was 
allowed to warm to rt over 10 h. Saturated aqueus NH4Cl solution (5 mL) and EtOAc (5 mL) was 
added, the phases were separated and the aqueous phase was extracted with EtOAc (4 x 50 
mL). The combined organic layers were dried over Na2SO4. The solvents were evaporated and 
the residue was subjected to column chromatography yielding the respective title compound. 
 
tert-Butyl((trans-2-(4-methoxyphenyl)cyclohexyl)oxy)dimethylsilane (51a) 
 
Following TP1, tert-Butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (4-methoxyphenyl)magnesium bromide (1.7 equiv, 0.94 M) at -50 °C. The solution was 
allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 114 mg (71 %), (colorless oil)  
dr: 95:5.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.50 (s, 3 H), -0.20 (s, 3 H), 0.67 (s, 9 H), 1.27 - 1.57 (m, 4 
H), 1.69 - 1.86 (m, 3 H), 1.92 - 2.02 (m, 1 H), 2.33 - 2.44 (m, 1 H), 3.47 (td, J=9.74, 4.56 Hz, 1 
H), 3.77 (s, 3 H), 6.81 (m, 2 H), 7.09 (m, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.5, -4.8, 17.8, 25.3, 25.7, 26.1, 32.9, 36.7, 52.1, 55.3, 76.0, 
OTBS
OMe
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113.3, 129.0, 137.3, 158.0.  
MS (70 eV, EI) m/z (%): 320 (2), 263 (100), 189 (14), 121 (32), 75 (34).  
IR (ATR) ! (cm-1): 2928, 2855, 1612, 1513, 1471, 1462, 1448, 1361, 1282, 1245, 1177, 1124, 
1091, 1040, 1006, 983, 906, 881, 856, 846, 826, 772, 666.  
HRMS (EI) for C19H32O2Si (320.2172) [M]+: 320.2231. 
 
5-(trans-2-((tert-Butyldimethylsilyl)oxy)cyclohexyl)-4,6-dimethoxypyrimidine (51b) 
 
Following TP1, tert-Butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (4,6-dimethoxypyrimidin-5-yl)magnesium chloride (1.7 equiv, 0.75 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 9:1  
yield: 97 mg (55 %), (colorless oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.41 (s, 3 H), -0.13 (s, 3 H), 0.61 (s, 9 H), 1.20 - 1.36 (m, 3 
H), 1.52 (dt, J=13.14, 2.50 Hz, 1 H), 1.62 - 1.76 (m, 2 H), 1.87 - 2.00 (m, 2 H), 2.98 (ddd, 
J=12.72, 9.91, 3.74 Hz, 1 H), 3.92 (s, 6 H), 3.97 - 4.07 (m, 1 H), 8.27 (s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -5.7, -4.3, 17.6, 25.0, 25.4, 25.9, 28.2, 36.7, 41.7, 53.8, 71.3, 
107.4, 154.0, 168.4.  
MS (70 eV, EI) m/z (%): 296 (19), 295 (100), 263 (25), 153 (7).  
IR (ATR) ! (cm-1): 2952, 2928, 2856, 1572, 1461, 1415, 1384, 1373, 1294, 1282, 1249, 1232, 
1184, 1157, 1136, 1128, 1089, 1022, 1006, 984, 882, 864, 833, 816, 805, 793, 771, 750, 662. 
HRMS (EI) for C18H32N2O3Si (352.2182) [M]+: 352.2236. 
 
 
 
OTBS
N
NMeO
OMe
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5-(trans-2-((tert-butyldimethylsilyl)oxy)cyclohexyl)-1-methyl-1H-indole (51c) 
 
Following TP1, tert-Butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (1-methyl-1H-indol-5-yl)magnesium bromide (1.7 equiv, 0.94 M) at -50 °C. The solution was 
allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 111 mg (65 %), (colorless oil)  
dr: 99:1.  
1H NMR (600 MHz, CDCl3) δ/ppm: 7.41 (d, J=1.8 Hz, 1H), 7.19 (d, J=8.4 Hz, 1H), 7.06 (dd, 
J=8.5, 1.6 Hz, 1H), 6.99 - 6.96 (m, 1H), 6.38 (dd, J=2.9 Hz, 1.4, 1H), 3.75 (d, J=1.6 Hz, 3H), 
3.59 (d, J=4.4 Hz, 1H), 2.61 - 1.30 (m, 10H), 0.63 (d, J=1.7 Hz, 9H), -0.27 (d, J=1.6 Hz, 3H), -
0.65 (d, J=1.5 Hz, 3H).  
13C NMR (150 MHz, CDCl3) δ/ppm: 135.8, 135.7, 128.5, 122.4, 120.1, 108.3, 100.4, 76.3, 52.9, 
36.8, 33.5, 32.8, 26.3, 25.7, 25.4, 17.9, -4.9, -5.5.  
MS (70 eV, EI) m/z (%): 288 (12), 287 (43), 286 (198), 212 (34), 210 (16), 188 (12), 182 (10), 
157 (10), 144 (48), 75 (19), 73 (13), 43 (10).  
IR (ATR) ! (cm-1): 2928, 2856, 1514, 1490, 1471, 1247, 1096, 989, 905, 835, 774, 730.  
HRMS (EI) for C21H33NOSi (343.2331) [M]+: 343.2339.  
 
tert-Butyl((trans-2-(4-chloro-3-(trifluoromethyl)phenyl)cyclohexyl)oxy)dimethylsilane 
(51d) 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (4-chloro-3-(trifluoromethyl)phenyl)magnesium chloride (1.7 equiv, 1.07 M) at -50 °C. The 
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solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 128 mg (65 %), (colorless oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.50 (s, 3 H), -0.15 (s, 3 H), 0.65 (s, 9 H), 1.25 - 1.45 (m, 3 
H), 1.49 - 1.60 (m, 1 H), 1.73 - 1.89 (m, 3 H), 1.94 - 2.06 (m, 1 H), 2.50 (ddd, J=12.72, 9.54, 
3.46 Hz, 1 H), 3.48 (td, J=9.81, 4.42 Hz, 1 H), 7.26 - 7.32 (m, 1 H), 7.36 - 7.43 (m, 1 H), 7.51 (d, 
J=2.21 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.7, -4.5, 17.7, 25.0, 25.5, 25.7, 32.3, 36.5, 52.4, 75.7, 123.0 
(q, J=273.2 Hz), 127.6 (q, J=5.3 Hz), 127.7 (q, J=30.9 Hz), 129.5 (q, J=1.9 Hz), 130.8, 132.4 (q, 
J=1.1 Hz), 144.2.  
MS (70 eV, EI) m/z (%): 337 (35), 336 (21), 335 (100), 267 (9), 241 (8).  
IR (ATR) ! (cm-1): 2930, 2858, 1482, 1473, 1463, 1450, 1424, 1362, 1314, 1276, 1260, 1250, 
1229, 1209, 1196, 1172, 1134, 1108, 1094, 1046, 1035, 1006, 990, 939, 916, 900, 872, 833, 
815, 773, 732, 700, 663.  
HRMS (EI) for C19H28ClF3OSi (392.1550) [M]+: 392.1532. 
 
tert-butyl((trans-2-(3,5-dimethoxyphenyl)cyclohexyl)oxy)dimethylsilane (51e) 
 
Following TP1, tert-Butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (3,5-dimethoxyphenyl)magnesium chloride (1.7 equiv, 1.1 M) at -50 °C. The solution was 
allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 50:1  
yield: 124 mg (71 %), (colorless oil)  
dr: 95:5.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.44 (s, 3 H), -0.16 (s, 3 H), 0.64 - 0.72 (m, 9 H), 1.23 - 1.42 
(m, 3 H), 1.45 - 1.62 (m, 1 H), 1.69 - 1.88 (m, 3 H), 1.92 - 2.03 (m, 1 H), 2.38 (ddd, J=12.51, 
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9.47, 3.46 Hz, 1 H), 3.53 (td, J=9.81, 4.42 Hz, 1 H), 3.76 (s, 6 H), 6.29 (t, J=2.21 Hz, 1 H), 6.37 
(d, J=2.49 Hz, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.5, -4.7, 17.8, 25.2, 25.7, 25.9, 32.7, 36.7, 53.5, 55.2, 75.8, 
98.3, 106.5, 147.5, 160.4.  
MS (70 eV, EI) m/z (%): 294 (21), 293 (100), 219 (5), 151 (8).  
IR (ATR) ! (cm-1): 2928, 2855, 2839, 1606, 1596, 1470, 1462, 1428, 1360, 1342, 1318, 1291, 
1255, 1248, 1204, 1150, 1128, 1093, 1063, 1007, 992, 938, 893, 880, 832, 816, 772, 695, 666. 
HRMS (EI) for C20H34O3Si (350.2277) [M]+: 350.2271.  
 
((trans-2-(4-(1,3-Dioxolan-2-yl)phenyl)cyclohexyl)oxy)(tert-butyl)dimethylsilane (51f) 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (4-(1,3-dioxolan-2-yl)phenyl)magnesium chloride (1.7 equiv, 0.95 M) at -50 °C. The solution 
was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 25:1  
yield: 132 mg (73 %), (colorless oil)  
dr: 97:3.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.53 (s, 3 H), -0.20 (s, 3 H), 0.65 (s, 9 H), 1.27 - 1.43 (m, 3 
H), 1.51 - 1.61 (m, 1 H), 1.69 - 1.85 (m, 3 H), 1.94 - 2.02 (m, 1 H), 2.46 (ddd, J=12.58, 9.58, 
3.46 Hz, 1 H), 3.54 (td, J=9.72, 4.49 Hz, 1 H), 4.00 - 4.11 (m, 4 H), 5.81 (s, 1 H), 7.20 (d, J=8.23 
Hz, 2 H), 7.34 - 7.38 (m, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.6, -4.7, 17.8, 25.2, 25.6, 32.8, 36.6, 52.9, 65.1, 65.3, 75.8, 
103.8, 126.0, 128.3, 135.7, 146.2.  
MS (70 eV, EI) m/z (%): 305 (25), 262 (32), 261 (100), 185 (6), 129 (4), 91 (16). 
IR (ATR) ! (cm-1): 2928, 2884, 2855, 1472, 1462, 1448, 1431, 1388, 1361, 1249, 1219, 1180, 
1125, 1082, 1042, 1028, 1022, 1006, 983, 939, 908, 882, 846, 833, 772, 739, 721, 698, 666. 
HRMS (EI) for C21H34O3Si (362.2277) [M]+: 362.2196. 
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tert-Butyl((trans-2-(4-chloro-2-methylphenyl)cyclohexyl)oxy)dimethylsilane (51g) 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (4-chloro-2-methylphenyl)magnesium chloride (1.7 equiv, 0.91 M) at -50 °C. The solution 
was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
yield: 170 mg (71 %), (colorless oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.51 (s, 3 H), -0.16 (s, 3 H), 0.65 (s, 9 H), 1.29 - 1.49 (m, 4 
H), 1.69 - 1.83 (m, 4 H), 1.95 - 2.02 (m, 1 H), 2.32 (s, 3 H), 2.74 (ddd, J=12.44, 9.54, 3.46 Hz, 1 
H), 3.52 (dt, J=9.74, 4.94 Hz, 1 H), 7.06 - 7.11 (m, 3 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.6, -4.7, 17.7, 20.2, 25.2, 25.5, 25.9, 26.1, 32.7, 36.81, 
46.8, 125.7, 127.2, 129.5, 130.7, 139.1, 142.3.  
MS (70 eV, EI) m/z (%): 283 (35), 281 (100), 141 (8), 139 (23), 115 (6).  
IR (ATR) ! (cm-1): 2929, 2856, 1486, 1472, 1462, 1448, 1360, 1249, 1174, 1133, 1090, 1050, 
1006, 983, 939, 908, 876, 834, 813, 800, 773, 675, 666.  
HRMS (EI) for C19H31ClOSi (338.1833) [M]+: 338.1820. 
 
tert-Butyldimethyl((trans-2-(3-(pentafluoro-λ6-sulfanyl)phenyl)cyclohexyl)oxy)silane  
(51h) 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (3-(pentafluoro-λ6-sulfanyl)phenyl)magnesium chloride (1.7 equiv, 0.91 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
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yield: 139 mg (67 %), (colorless oil)  
dr: 98:2.  
1H NMR (300 MHz, CDCl3) δ/ppm: 7.58 (d, J=1.7 Hz, 2H), 7.37 - 7.30 (m, 2H), 3.54 (d, J=4.5, 
1H), 2.53 (s, 4H), 1.51 (s, 4H), 0.63 (s, 9H), -0.15 (d, 3H), -0.51 (s, 3H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 154.0, 146.5, 131.4, 128.1, 125.6, 123.6, 75.8, 53.2, 36.5, 
32.6, 25.8, 25.4, 25.0, 17.7, -4.6, -5.9.  
MS (70 eV, EI) m/z (%): 359 (9), 251 (134), 157 (108), 142 (6), 129 (179), 115 (6), 88 (5), 81 
(4), 75 (9), 73 (7), 57 (5).  
IR (ATR) ! (cm-1): 2928, 2856, 1472, 1462, 1257, 1094, 989, 872, 831, 816, 805, 788 (s) 771, 
693. 
HRMS (EI) for C18H29F5OSSi (416.1629) [M-H]+: 415.1361. 
 
((trans-2-(Benzo[d][1,3]dioxol-5-yl)cyclohexyl)oxy)(tert-butyl)dimethylsilane (51i) 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with benzo[d][1,3]dioxol-5-ylmagnesium chloride (1.7 equiv, 1.0 M) at -50 °C. The solution was 
allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 117 mg (70 %), (colorless oil)  
dr: 98:2.  
1H NMR (600 MHz, CDCl3) δ/ppm: 6.72 - 6.68 (m, 2H), 6.64 (dd, J=8.0 Hz, 1.8, 1H), 5.88 (d, 
J=2.0 Hz, 2H), 3.44 (td, J=9.8, 4.2 Hz, 1H), 2.36 (ddd, J=12.8, 9.7, 3.5 Hz, 1H), 2.01 - 1.66 (m, 
1H), 1.53 - 1.21 (m, 1H), 0.69 (t, J=1.7 Hz, 8H), -0.16 (d, J=1.9 Hz, 3H), -0.44 (d, J=1.9 Hz, 3H).  
13C NMR (150 MHz, CDCl3) δ/ppm: 147.12 145.6, 139.1, 121.2, 108.7, 107.8, 100.5, 76.0, 52.7, 
36.7, 33.0, 26.0, 25.7, 25.2, 17.8, -4.7, -5.5.  
MS (70 eV, EI) m/z (%): 279 (3), 278 (10), 27 (42), 203 (5), 179 (9), 135 (10), 81 (4), 75 (7), 73 
(4), 75 (7), 73 (4), 57 (2), 42 (5).  
IR (ATR) ! (cm-1): 2929, 2856, 1504, 1484, 1441, 1246, 1093, 1041, 939, 905, 835, 774, 710, 
OTBS
O
O
EXPERIMENTAL PART 
____________________________________________________________________________ 
 84 
HRMS (EI) for C19H30O3Si (334.1964) [M]+: 334.1959. 
tert-Butyldimethyl((trans-2-(naphthalen-1-yl)cyclohexyl)oxy)silane (51j)[6] 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with naphthalen-1-ylmagnesium chloride (1.7 equiv, 0.94 M) at -50 °C. The solution was allowed 
to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
yield: with 52a: 186 mg (51j, 91 %); with 52c: 120 mg (59 %), (colorless oil)  
dr: >99:1.  
1H NMR (400 MHz, CDCl3) δ/ppm: 8.31 (d, J=8.46 Hz, 1H), 7.88 - 7.82 (m, 1H), 7.73 (d, J=7.44 
Hz, 1H), 7.55 - 7.40 (m, 4H), 3.77 (br s., 1 H), 3.49 (t, J=9.49 Hz, 1 H), 2.16 - 2.08 (m, 1 H), 2.00 
- 1.86 (m, 2 H), 1.85 (dd, J=8.59, 2.44 Hz, 1H), 1.81 - 1.72 (m, 1H), 1.65 - 1.46 (m, 3H), 0.49 (s, 
9H), -0.22 (s, 3H), -0.81 (s, 3H).  
13C NMR (101 MHz, CDCl3) δ/ppm: 142.1, 133.7, 133.3, 128.3, 126.2, 125.3, 125.2, 125.0, 
124.5, 123.0, 77.2, 45.9, 37.1, 33.2, 26.4, 25.4, 25.4, 17.5, -4.9, -5.9.  
MS (70 eV, EI) m/z (%): 339 (1), 325 (1), 284 (20), 283 (100), 210 (3), 208 (4), 179 (3), 165 (4), 
141 (8), 75 (11), 73 (3).  
IR (ATR) ! (cm-1): 2928, 2856, 1248, 1096, 1084, 972, 880, 862, 832, 814, 792, 772 (vs), 666, 
HRMS (EI) for C22H31O1Si1 (339.2149) [M-H]+: 339.2136. 
 
4-(trans-2-((tert-Butyldimethylsilyl)oxy)cyclohexyl)-N,N-dimethylaniline (51k) 
 
Following TP1, tert-butyl((2-iodocyclohexyl)oxy)dimethylsilane (52a, 0.5 mmol, 1.0 equiv) reacts 
with (4-(dimethylamino)phenyl)magnesium chloride (1.7 equiv, 1.0 M) at -50 °C. The solution 
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was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:2  
yield:  104 mg (63 %), (colorless oil)  
dr: 99:1.  
1H NMR (400 MHz, CDCl3) δ/ppm: 7.11 - 7.02 (m, 2H), 6.72 - 6.66 (m, 2H), 3.47 (dd, J=4.6 Hz, 
1H), 2.89 (s, 6H), 2.36 (ddd, J=13.0, 9.6, 3.6 Hz, 1H), 1.99 - 1.35 (m, 8H), 0.70 (s, 9H), -0.19 (s, 
3H), -0.47 (s, 3H).  
13C NMR (101 MHz, CDCl3) δ/ppm: 149.5, 133.8, 128.8, 113.1, 76.1, 51.9, 41.2, 36.7, 32.9, 
26.2, 25.8, 25.3, 17.9, -4.8, -5.5.  
MS (70 eV, EI) m/z (%): 333 (4), 277 (6), 276 (25), 203 (3), 202 (17), 200 (4), 178 (2), 160 (3), 
134 (10), 75 (3), 73 (2), 57 (2).   
IR (ATR) ! (cm-1): 2925, 2852, 1613, 1519, 1471, 1446, 1341, 1247, 1128, 1091, 983, 880, 
846, 833, 813, 772,  
HRMS (EI) for C20H35NOSi (333.2488) [M]+: 333.2482. 
 
2-(trans-2-((tert-Butyldimethylsilyl)oxy)cyclopentyl)-5-fluorobenzonitrile (55a) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (2-cyano-4-fluorophenyl)magnesium chloride (1.7 equiv, 0.78 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 107 mg (67 %), (colorless oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.27 (s, 3 H), -0.15 (s, 3 H), 0.76 (s, 9 H), 1.66 - 2.06 (m, 5 
H), 2.12 - 2.24 (m, 1 H), 3.31 (dt, J=10.16, 8.19 Hz, 1 H), 4.10 (q, J=7.46 Hz, 1 H), 7.20 - 7.35 
(m, 4 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.2, -4.9, 17.8, 21.7, 25.6, 30.9, 34.6, 52.1, 81.3, 114.2, 
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114.3, 117.1, 117.2, 119.1, 119.4, 120.2, 120.5, 129.0, 129.1, 144.1, 144.2, 158.7, 162.0. 
MS (70 eV, EI) m/z (%): 304 (2), 262 (100), 188 (27), 75 (64), 69 (12).  
IR (ATR) ! (cm-1): 2955, 2930, 2857, 2231, 1610, 1584, 1498, 1472, 1464, 1415, 1387, 1361, 
1312, 1251, 1191, 1146, 1117, 1090, 1084, 1006, 941, 909, 885, 871, 856, 833, 774, 710, 669. 
HRMS (EI) for C18H26FNOSi (319.1768) [M]+: 319.1754. 
 
Ethyl 3-(trans-2-((tert-butyldimethylsilyl)oxy)cyclopentyl)benzoate (55b) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (3-(ethoxycarbonyl)phenyl)magnesium chloride (1.7 equiv, 0.77 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 50:1  
yield: 90 mg (52 %), (colorless oil)  
dr: 97:3.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.26 (s, 3 H), -0.19 (s, 3 H), 0.77 (s, 9 H), 1.38 (t, J=7.19 
Hz, 3 H), 1.61 - 1.89 (m, 4 H), 1.95 - 2.15 (m, 2 H), 2.87 - 2.98 (m, 1 H), 4.01 (q, J=7.19 Hz, 1 
H), 4.36 (q, J=7.19 Hz, 2 H), 7.29 - 7.44 (m, 2 H), 7.87 (dt, J=7.46, 1.66 Hz, 1 H), 7.89 - 7.94 (m, 
1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.1, -5.0, 14.3, 17.9, 21.7, 25.7, 30.6, 34.7, 54.0, 60.80, 
81.3, 127.3, 128.0, 128.6, 130.3, 132.3, 144.2, 166.8.  
MS (70 eV, EI) m/z (%): 333 (1), 303 (5), 291 (37), 247 (100), 231 (24), 171 (11).  
IR (ATR) ! (cm-1): 2956, 2930, 2857, 1719, 1606, 1587, 1472, 1463, 1443, 1389, 1367, 1284, 
1251, 1201, 1172, 1105, 1086, 1025, 1006, 939, 900, 876, 834, 816, 774, 752, 696, 681, 668. 
HRMS (EI) for C20H32O3Si (348.2121) [M]+: 348.2089. 
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3-(trans-2-((tert-Butyldimethylsilyl)oxy)cyclopentyl)pyridine (55c) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with  pyridin-3-ylmagnesium chloride (1.7 equiv, 0.90 M) at -50 °C. The solution was 
allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 4:1  
yield: 101 mg (73 %), (slightly yellow oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.30 - -0.24 (m, 3 H), -0.18 (s, 3 H), 0.76 (s, 9 H), 1.64 - 
1.91 (m, 4 H), 1.92 - 2.12 (m, 2 H), 2.79 - 2.94 (m, 1 H), 3.98 (q, J=7.00 Hz, 1 H), 7.18 (dd, 
J=7.60, 4.56 Hz, 1 H), 7.50 (ddd, J=8.02, 1.94, 1.66 Hz, 1 H), 8.38 - 8.50 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -5.1, -4.9, 17.9, 21.6, 25.6, 30.8, 34.6, 51.8, 81.3, 123.1, 
134.7, 139.1, 147.6, 149.6.  
MS (70 eV, EI) m/z (%): 262 (3), 221 (14), 220 (100), 146 (34), 75 (22). 
IR (ATR) ! (cm-1): 2955, 2929, 2856, 1576, 1472, 1463, 1426, 1388, 1377, 1361, 1250, 1190, 
1114, 1086, 1025, 1006, 938, 889, 860, 834, 809, 774, 714, 668.  
HRMS (EI) for C16H27NOSi (277.1862) [M]+: 277.1848. 
 
tert-Butyl((trans-2-(3-methoxyphenyl)cyclopentyl)oxy)dimethylsilane (55d) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (3-methoxyphenyl)magnesium chloride (1.7 equiv, 1.14 M) at -50 °C. The solution 
was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 121 mg (79 %), (colorless oil)  
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dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.21 (s, 3 H), -0.17 (s, 3 H), 0.79 (s, 9 H), 1.61 - 1.88 (m, 4 
H), 1.91 - 2.12 (m, 2 H), 2.81 - 2.91 (m, 1 H), 3.79 (s, 3 H), 4.03 (q, J=7.00 Hz, 1 H), 6.70 - 6.86 
(m, 3 H), 7.20 (t, J=7.88 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.0, -5.0, 18.0, 21.9, 25.8, 30.9, 34.8, 54.5, 55.1, 81.51, 
111.3, 113.5, 120.0, 129.1, 145.8, 159.5.  
MS (70 eV, EI) m/z (%): 250 (25), 249 (54), 75 (100), 43 (15). 
IR (ATR) ! (cm-1): 2954, 2929, 2856, 1602, 1584, 1492, 1471, 1464, 1454, 1436, 1377, 1360, 
1287, 1249, 1194, 1156, 1113, 1047, 1006, 939, 902, 870, 833, 814, 772, 697, 668. 
HRMS (EI) for C18H30O2Si (306.2015) [M]+: 306.2007. 
 
tert-Butyl((trans-2-(3,5-dimethoxyphenyl)cyclopentyl)oxy)dimethylsilane (55e) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (3,5-dimethoxyphenyl)magnesium chloride (1.7 equiv, 1.14 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 50:1  
yield: 124 mg (74 %), (colorless oil)  
dr: 99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.18 (s, 3 H), -0.15 (s, 3 H), 0.80 (s, 9 H), 1.59 - 1.85 (m, 4 
H), 1.92 - 2.11 (m, 2 H), 2.78 - 2.88 (m, 1 H), 3.77 (s, 6 H), 4.02 (q, J=6.73 Hz, 1 H), 6.30 (t, 
J=2.35 Hz, 1 H), 6.39 (d, J=2.21 Hz, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.0, -4.9, 18.0, 22.0, 25.8, 30.9, 34.9, 54.7, 55.2, 81.38, 
98.0, 105.8, 146.6, 160.5.  
MS (70 eV, EI) m/z (%): 280 (21), 279 (100), 205 (7), 75 (34).  
IR (ATR) ! (cm-1): 2954, 2930, 2856, 2839, 1595, 1471, 1461, 1428, 1376, 1359, 1339, 1317, 
1294, 1249, 1204, 1151, 1114, 1087, 1060, 1006, 939, 923, 872, 830, 774, 694, 668. 
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HRMS (EI) for C19H32O3Si (336.2121) [M]+: 336.2115. 
 
tert-Butyldimethyl((trans-2-(3-(pentafluoro-λ6-sulfanyl)phenyl)cyclopentyl)oxy)silane 
(55f) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (3-(pentafluoro-λ6-sulfanyl)phenyl)magnesium chloride (1.7 equiv, 1.0 M) at -50 °C. 
The solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
yield: 123 mg (61 %), (colorless oil)  
dr: 99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: 7.64 - 7.54 (m, 2H), 7.41 - 7.33 (m, 2H), 4.00 (dd, J=7.4, 0.7, 
1H), 2.93 (d, J=10.0 Hz, 1H), 2.35 - 1.50 (m, 8H), 0.77 (s, 9H), -0.16 (s, 3H), -0.26 (s, 3H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 154.1, 145.2, 130.7, 128.4, 125.2, 123.7, 81.4, 54.2, 34.6, 
30.5, 25.6, 21.5, 17.9, -5.0, -5.4.  
MS (70 eV, EI) m/z (%): 345 (18), 323 (5), 237 (40), 219 (11), 143 (65), 128 (99), 118 (39), 88 
(48), 78 (22).  
IR (ATR) ! (cm-1): 2955, 2857, 1604, 1471, 1250, 1257, 1110, 905, 828, 788, 773, 693, 
HRMS (EI) for C17H27F5OSSi (402.1472) [M-tBu]+: 345.0784. 
 
((trans-2-(Benzo[b]thiophen-3-yl)cyclopentyl)oxy)(tert-butyl)dimethylsilane (55g) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with benzo[b]thiophen-3-ylmagnesium chloride (1.7 equiv, 0.84 M) at -50 °C. The solution 
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was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 96 mg (58 %), (colorless oil)  
dr: 98:2.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.23 (s, 3 H), -0.16 (s, 3 H), 0.80 (s, 9 H), 1.68 - 2.05 (m, 5 
H), 2.19 - 2.27 (m, 1 H), 3.34 - 3.44 (m, 1 H), 4.25 (q, J=5.99 Hz, 1 H), 7.08 (s, 1 H), 7.29 - 7.40 
(m, 2 H), 7.82 - 7.91 (m, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -4.9, -5.0, 18.0, 22.1, 25.8, 30.0, 34.9, 47.8, 80.2, 119.7, 
122.7, 122.8, 123.6, 124.1, 139.3, 139.3, 140.5.  
MS (70 eV, EI) m/z (%): 277 (8), 276(18), 275 (100), 201 (11), 147 (9), 75 (53). 
IR (ATR) ! (cm-1): 2954, 2928, 2856, 1471, 1461, 1428, 1388, 1360, 1250, 1157, 1115, 1096, 
1081, 1048, 1026, 1005, 938, 903, 883, 863, 833, 813, 773, 759, 730, 715, 667. 
HRMS (EI) for C19H28OSSi (332.1630) [M]+: 332.1613. 
 
((trans-2-(4-(1,3-Dioxolan-2-yl)phenyl)cyclopentyl)oxy)(tert-butyl)dimethylsilane (55h) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (4-(1,3-dioxolan-2-yl)phenyl)magnesium chloride (1.7 equiv, 0.95 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 25:1  
yield: 135 mg (78 %), (colorless oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.23 (s, 3 H), -0.18 (s, 3 H), 0.78 (s, 9 H), 1.66 - 1.89 (m, 4 
H), 1.91 - 2.11 (m, 2 H), 2.84 - 2.96 (m, 1 H), 4.00 - 4.05 (m, 2 H), 4.09 - 4.13 (m, 2 H), 5.80 (s, 
1 H), 7.20 - 7.25 (m, 2 H), 7.35 - 7.39 (m, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -4.9, -5.0, 18.0, 22.0, 25.8, 31.1, 34.9, 54.2, 65.2, 81.4, 
103.8, 126.3, 127.6, 128.3, 129.2, 135.6, 145.3.  
OTBS O
O
EXPERIMENTAL PART 
____________________________________________________________________________ 
 91 
MS (70 eV, EI) m/z (%): 291 (36), 248 (19), 247 (100), 171 (6), 149 (5), 115 (5). 
IR (ATR) ! (cm-1): 2954, 2929, 2884, 2856, 1472, 1463, 1388, 1361, 1274, 1250, 1220, 1180, 
1112, 1079, 1021, 1012, 1006, 968, 941, 911, 890, 861, 833, 774, 707, 668. 
HRMS (EI) for C20H32O3Si (348.2121) [M]+: 348.2110. 
 
tert-Butyldimethyl((trans-2-(naphthalen-1-yl)cyclopentyl)oxy)silane (55i) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (4b, 4 mmol, 1.0 equiv) reacts 
with naphthalen-1-ylmagnesium chloride (1.7 equiv, 1.0 M) at -50 °C. The solution was allowed 
to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
yield: 1.04 g (80 %), (colorless oil)  
dr: >99:1.  
1H NMR (400 MHz, CDCl3) δ/ppm: 8.30 (d, J=8.21 Hz, 1 H), 7.91 - 7.84 (m, 1 H), 7.74 (d, 
J=8.08 Hz, 1 H), 7.57 - 7.38 (m, 4H), 4.34 (q, J=6.11 Hz, 1 H), 3.91 - 3.84 (m, 1 H), 2.37 - 2.29 
(m, 1 H), 2.13 - 1.87 (m, 4 H), 1.84 - 1.76 (m, 1 H), 0.80 (s, 9 H), -0.17 (s, 3 H), -0.28 (s, 3 H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 140.6, 133.8, 132.7, 128.5, 126.4, 125.4, 125.4, 125.3, 
124.4, 122.7, 81.3, 49.0, 35.1, 31.3, 25.7, 22.5, 17.9, -5.0, -5.1.  
MS (70 eV, EI) m/z (%): 326 (1), 270 (22), 269 (100), 195 (8), 193 (18), 191 (9), 165 (12), 141 
(16), 115 (4), 75 (66), 73 (11), 57 (3).  
IR (ATR) ! (cm-1): 2954 (w), 2928 (w), 2856 (w), 1472 (w), 1250, 1114, 1094, 1078, 1062, 1032 
(w), 1006 (w), 890, 864, 834, 810, 794, 772 (vs), 730 (w), 668,  
HRMS (EI) for C21H30O1Si1 (326.2066) [M]+: 326.2053. 
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5-(trans-2-((tert-Butyldimethylsilyl)oxy)cyclopentyl)-1-methyl-1H-indole (55j) 
 
Following TP1, tert-butyl((2-iodocyclopentyl)oxy)dimethylsilane (52b, 0.5 mmol, 1.0 equiv) 
reacts with (1-methyl-1H-indol-5-yl)magnesium bromide (1.7 equiv, 1.0 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:2  
yield: 106 mg (65 %), (colorless oil)  
dr: 99:1.  
1H NMR (600 MHz, CDCl3) δ/ppm: 7.44 (s, 1H), 7.22 (d, J=8.4 Hz, 1H), 7.10 (dt, J=8.6 Hz, 1.7, 
1H), 7.01 - 6.98 (m, 1H), 6.40 (t, J=2.3 HZ, 1H), 4.10 (qd, J=6.6 Hz, 1.8, 1H), 3.76 (d, J=1.9 Hz, 
3H), 2.99 (d, J=7.8 Hz, 1H), 2.20 - 2.07 (m, 1H), 2.00 (d, J=6.6 Hz, 1H), 1.92 - 1.74 (m, 3H), 
1.70 - 1.63 (m, 1H), 0.82 - 0.76 (m, 10H), -0.22 (dd, J=13.0, 2.0 Hz, 6H).  
13C NMR (150 MHz, CDCl3) δ/ppm: 135.6, 134.8, 128.7, 128.5, 121.7, 119.2, 108.7, 100.5, 
81.7, 54.4, 34.9, 32.8, 31.7, 25.8, 22.2, 18.1, -4.8, -5.0.  
MS (70 eV, EI) m/z (%): 329 (3) [M]+, 273 (10), 272 (50), 199 (3), 198 (20), 196 (6), 157 (4), 144 
(6), 75 (10), 73 (5).   
IR (ATR) ! (cm-1): 2954, 2929, 2856, 1491, 1247, 1113, 1079, 906, 879, 835, 775, 731.  
HRMS (EI) for C20H31NOSi (329.2175) [M]+: 329.2180. 
tert-Butyl((trans-2-(3-methoxyphenyl)cyclohexyl)oxy)dimethylsilane (58a) 
 
Following TP1, ((2-bromocyclohexyl)oxy)(tert-butyl)dimethylsilane (52c, 0.5 mmol, 1.0 equiv) 
reacts with (3-methoxyphenyl)magnesium chloride (1.7 equiv, 1.14 M) at -50 °C. The solution 
was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 100:1  
yield: 85 mg (53 %), (colorless oil)  
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dr: 97:3.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.49 (s, 3 H), -0.18 (s, 3 H), 0.67 (s, 9 H), 1.27 - 1.42 (m, 3 
H), 1.51 - 1.61 (m, 1 H), 1.70 - 1.88 (m, 3 H), 1.94 - 2.01 (m, 1 H), 2.42 (ddd, J=12.65, 9.47, 
3.59 Hz, 1 H), 3.53 (td, J=9.81, 4.42 Hz, 1 H), 3.78 (s, 3 H), 6.68 - 6.82 (m, 3 H), 7.16 (t, J=7.88 
Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -5.6, -4.7, 17.8, 25.2, 25.7, 26.0, 32.8, 36.7, 53.1, 55.2, 75.9, 
111.5, 114.2, 120.7, 128.8, 146.7, 159.3.  
MS (70 eV, EI) m/z (%): 264 (35), 263 (100), 189 (7), 121 (19), 75 (87).  
IR (ATR) ! (cm-1): 2928, 2856, 1602, 1585, 1493, 1471, 1463, 1448, 1437, 1361, 1284, 1256, 
1249, 1226, 1218, 1206, 1166, 1157, 1128, 1094, 1048, 1023, 1002, 990, 938, 926, 878, 863, 
833, 815, 771, 752, 743, 698, 666.  
HRMS (EI) for C19H32O2Si (320.2172) [M]+: 320.2162. 
 
tert-Butyl((trans-2-(4-fluorophenyl)cyclohexyl)oxy)dimethylsilane (58b) 
 
Following TP1, ((2-bromocyclohexyl)oxy)(tert-butyl)dimethylsilane (52c, 0.5 mmol, 1.0 equiv) 
reacts with (4-(fluoro)phenyl)magnesium chloride (1.7 equiv, 1.0 M) at -50 °C. The solution was 
allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
yield: 80 mg (52 %), (colorless oil)  
dr: 97:3.  
1H NMR (300 MHz, CDCl3) δ/ppm: 7.18 - 7.08 (m, 1H), 6.95 (d, J=8.8 Hz, 1H), 3.42 - 3.52 (m, 
1H), 2.48 - 2.32 (m, 1H), 2.08 - 1.60 (m, 1H), 1.60 - 1.23 (m, 1H), 0.67 (s, 9), -0.18 (s,3H), -0.50 
(s, 3H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 159.8, 140.7, 129.4, 114.4, 75.9, 52.2, 36.6, 32.8, 26.0, 25.6, 
25.2, 17.8, -4.6, -5.6.  
19F NMR (75 MHz, CDCl3) δ/ppm: -117.94.  
MS (70 eV, EI) m/z (%): 251 (90), 132 (4), 183 (9), 149 (12), 109 (19), 81 (3), 75 (28), 73 (8). 
OTBS
F
EXPERIMENTAL PART 
____________________________________________________________________________ 
 94 
IR (ATR) ! (cm-1): 2927, 2854, 1605, 1509, 1255, 1248, 1226, 1092, 1086, 983, 827, 833, 772, 
666. 
HRMS (EI) for C18H29FOSi (251.1267) [M-tBu]+: 251.1798. 
 
tert-Butyl((trans-2-mesitylcyclohexyl)oxy)dimethylsilane (58d) 
 
Following TP1, ((2-bromocyclohexyl)oxy)(tert-butyl)dimethylsilane (52c, 0.5 mmol, 1.0 equiv) 
reacts with mesitylmagnesium chloride (1.7 equiv, 0.95 M) at -50 °C. The solution was allowed 
to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane  
yield: 98 mg (59 %), (colorless oil)  
dr: 98:2.  
1H NMR (300 MHz, CDCl3) δ/ppm: 6.76 (d, J=10.57 Hz, 2H), 4.11 - 4.03 (m, 1H), 3.07 - 2.98 (m, 
1H), 2.43 (s, 3H), 2.33 (s, 3H), 2.22 (s, 3H), 2.05 - 1.95 (m, 2H), 1.82 - 1.69 (m, 3H), 1.38 - 1.27 
(m, 3H), 0.65 (s, 9H), -0.13 (s, 3H), -0.48 (s, 3H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 138.2, 137.3, 135.4, 134.7, 130.8, 128.9, 72.3, 48.2, 37.6, 
29.8, 26.8, 25.5, 25.3, 22.3, 21.7, 20.6, 17.7, -4.6, -5.7.  
MS (70 eV, EI) m/z (%): 332 (1), 276 (22), 275 (100), 199 (7), 157 (7), 143 (3), 133 (35), 105 
(3), 75 (78), 73 (13).  
IR (ATR) ! (cm-1): 2950, 2928, 2856, 1472, 1248, 1090, 988, 880, 848, 834, 802, 772, 666.  
HRMS (EI) for C21H36O1Si1 (332.2535) [M]+: 332.2510. 
 
tert-Butyl((trans-4-(4-methoxyphenyl)tetrahydrofuran-3-yl)oxy)dimethylsilane (60) 
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Following TP1, tert-butyl((4-iodotetrahydrofuran-3-yl)oxy)dimethylsilane (59a, 4 mmol, 1.0 equiv) 
reacts with (4-methoxyphenyl)magnesium bromide (1.7 equiv, 0.94 M) at -50 °C. The solution 
was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/Et2O = 20:1  
yield: 912 mg (74 %), (colorless oil)  
dr: >99:1.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.05 (s, 6 H), 0.85 (s, 9 H), 3.14 - 3.23 (m, 1 H), 3.68 (dd, 
J=9.12, 3.87 Hz, 1 H), 3.78 (s, 3 H), 3.91 (dd, J=8.85, 5.53 Hz, 1 H), 4.03 (dd, J=9.12, 5.25 Hz, 
1 H), 4.21 - 4.30 (m, 2 H), 6.85 (m, 2 H), 7.16 (m, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: -4.9, -4.7, 18.0, 25.7, 53.9, 55.2, 73.1, 74.8, 80.2, 114.0, 
128.4, 133.0, 158.4.  
MS (70 eV, EI) m/z (%): 251 (6), 134 (17), 121 (100), 117 (4).  
IR (ATR) ! (cm-1): 2953, 2930, 2857, 1613, 1513, 1471, 1464, 1442, 1361, 1304, 1247, 1179, 
1097, 1080, 1057, 1037, 1003, 939, 909, 863, 830, 811, 775, 668.  
HRMS (EI) for C17H28O3Si (308.1808) [M]+: 308.1817. 
 
trans-3-((tert-Butyldimethylsilyl)oxy)-4-(4-methoxyphenyl)-1-tosylpyrrolidine (61) 
 
Following TP1, 3-((tert-butyldimethylsilyl)oxy)-4-iodo-1-tosylpyrrolidine (59b, 0.5 mmol, 1.0 
equiv) reacts with (4-methoxyphenyl)magnesium bromide (1.7 equiv, 0.94 M) at -50 °C. The 
solution was allowed to warm to rt over 10 h and was worked-up as usual. 
column chromatography: SiO2; n-hexane/EtOAc = 9:1  
yield: 164 mg (71 %), (white solid)  
dr: >99:1.  
Melting point: 129.1-131.2 °C.  
1H NMR (300 MHz, CDCl3) δ/ppm: -0.22 (s, 3 H), -0.17 (s, 3 H), 0.70 (s, 9 H), 2.43 (s, 3 H), 2.96 
- 3.09 (m, 2 H), 3.45 - 3.54 (m, 1 H), 3.55 - 3.67 (m, 2 H), 3.76 (s, 3 H), 4.03 (q, J=5.25 Hz, 1 H), 
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6.81 (m, 2 H), 7.07 (m, 2 H), 7.33 (m, J=7.74 Hz, 2 H), 7.74 (m, J = 8.29 Hz, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -5.2, -5.1, 17.8, 21.5, 25.5, 51.3, 51.8, 54.3, 55.2, 77.53, 
114.1, 127.6, 128.4, 129.7, 131.1, 133.8, 143.4, 158.7.  
MS (70 eV, EI) m/z (%): 446 (2), 406 (14), 404 (100), 147 (11), 121 (46), 91 (26). 
IR (ATR) ! (cm-1): 2955, 2926, 2884, 2858, 1612, 1600, 1516, 1498, 1472, 1464, 1441, 1391, 
1362, 1340, 1336, 1317, 1308, 1294, 1284, 1250, 1220, 1205, 1182, 1166, 1152, 1122, 1106, 
1092, 1065, 1053, 1036, 1020, 1009, 941, 922, 861, 834, 818, 802, 778, 744, 726, 708, 664. 
HRMS (EI) for C24H35NO4SSi (461.2056) [M]+: 461.2045. 
 
3. Diastereoselective Cobalt-Mediated Cross-Couplings of Cycloalkyl 
Iodides with Alkynyl or (Hetero)Aryl Grignard Reagents 
3.1 Optimization of the Reaction Conditions: Solvent Screening 
 
aDetermined by capillary GC and 1H NMR analysis. Undecane (C11H24) was used as internal 
standard. 
 
 
a) metal mediator
neocuproine (20 mol%)
b)
solvent, -40 °C, 8 h
MgBr
CoCl2.2LiCl (0.50) 85
CoCl2.2LiCl (0.20) 58DME
(1.5 equiv)
I
63CoCl2.2LiCl (0.20)
88CoCl2.2LiCl (0.50)
62a 64a
8NMPCoCl2.2LiCl (0.20)
CoCl2.2LiCl (0.50) NMP 28
CoCl2.2LiCl (0.20) 59
CoCl2.2LiCl (0.50) DMPU 13
CoCl2.2LiCl (0.20)
CoCl2.2LiCl (0.50)
DMPU
DME
3
86
entry
metal mediator 
(equiv)
GC yielda 
(%)
7
solvent
6
4
5
8
9
10
3
2
1
(iPr)3Si
Si(iPr)3
THF
THF
Et2O
Et2O
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3.2 Synthesis of Starting Materials  
The following starting materials were prepared according to literature procedures with only little 
deviation. The spectral data of known compounds are in full agreement with the literature. 
2-Iodo-1-isopropyl-4-methylcyclohexane (62a)91 
 
dr = 99:1  
1H-NMR (300 MHz, CDCl3, ppm): δ = 4.94 (p, J = 2.8 Hz, 1H), 2.38 (dtd, J = 14.5, 3.3, 2.2 Hz, 
1H), 2.14 (tdd, J = 11.6, 5.7, 3.2 Hz, 1H), 1.92 (ttd, J = 12.7, 3.5, 2.2 Hz, 2H), 1.58 – 1.36 (m, 
3H), 1.15 – 1.01 (m, 10H), 0.00 (ddt, J = 11.9, 9.1, 2.9 Hz, 1H). 
2-(2-Iodocyclohexyl)-5,5-dimethyl-1,3-dioxane (62c)92 
 
dr = 99:1  
1H-NMR (300 MHz, CDCl3, ppm): δ = 4.85 (dq, J = 3.1, 1.7 Hz, 1H), 4.07 (d, J = 7.5 Hz, 1H), 
3.60 (ddd, J = 11.6, 9.3, 2.7 Hz, 2H), 3.43 (dd, J = 11.4, 5.0 Hz, 2H), 2.19 – 2.13 (m, 1H), 1.79 – 
1.62 (m, 4H), 1.55 (s, 1H), 1.40 – 1.22 (m, 2H), 1.17 (s, 3H), 0.77 (ddt, J = 10.6, 7.6, 2.9 Hz, 
1H), 0.72 (s, 3H). 
 
 
 
 
                                                
91 S. D. Lepore, D. Mondal, S. Y. Li, A. K. Bhunia, Angew. Chem. Int. Ed. 2008, 47, 7511. 
92 K. Moriya, P. Knochel, Org. Lett. 2014, 16, 924.	
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2-Iodo-4-methyl-1-(prop-1-en-2-yl)cyclohexane (62d)1 
 
dr = 99:1  
1H-NMR (300 MHz, CDCl3, ppm): δ = 4.86 (ddd, J = 5.8, 3.0, 1.5 Hz, 2H), 4.66 (td, J = 1.7, 0.8 
Hz, 1H), 2.25 (dtd, J = 14.4, 3.2, 2.3 Hz, 1H), 1.99 (tdt, J = 14.8, 6.6, 3.1 Hz, 1H), 1.87 – 1.75 
(m, 1H), 1.74 (dt, J = 1.4, 0.7 Hz, 3H), 1.70 – 1.53 (m, 2H), 1.45 (ddd, J = 14.6, 11.5, 3.3 Hz, 
1H), 1.30 – 1.15 (m, 1H), 1.05 (dtd, J = 13.3, 12.0, 4.8 Hz, 1H), 0.94 (d, J = 6.6 Hz, 3H). 
3-Iodo-4-isopropyltetrahydrofuran 
 
dr = 99:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.21 – 4.12 (m, 1H), 3.81 – 3.67 (m, 2H), 3.43 (t, J = 7.9 
Hz, 1H), 1.94 (d, J = 5.8 Hz, 1H), 1.80 (ddd, J = 10.9, 8.8, 5.5 Hz, 1H), 1.57 (dh, J = 13.5, 6.6 
Hz, 1H), 1.02 (d, J = 6.6 Hz, 3H), 0.89 (d, J = 6.7 Hz, 3H). 
 
3-Iodo-4-(prop-1-en-2-yl)tetrahydrofuran 
 
dr = 99:1 
1H-NMR (300 MHz, CDCl3, ppm): d = 5.03 – 4.91 (m, 1H), 4.62 – 4.60 (m, 1H), 4.57 (td, J = 4.6, 
1.6 Hz, 1H), 4.52 (dd, J = 10.4, 4.4 Hz, 1H), 4.41 (dd, J = 10.4, 1.6 Hz, 1H), 4.03 (s, 1H), 4.01 (d, 
J = 1.8 Hz, 1H), 2.34 – 2.27 (m, 1H), 1.79 (dt, J = 1.6, 0.8 Hz, 3H).  
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3-Iodo-4-isopropyl-1-tosylpyrrolidine 
 
dr = 99:1  
1H-NMR (300 MHz, CDCl3, ppm): δ = 7.74 (d, J = 7.9 Hz, 2H), 7.33 (d, J = 7.9 Hz, 2H), 4.33 (t, 
J = 4.1 Hz, 1H), 4.16 (dd, J = 12.4, 4.3 Hz, 1H), 3.97 (d, J = 12.4 Hz, 1H), 3.56 (dd, J = 11.1, 9.3 
Hz Hz, 1H), 3.01 (dd, J = 11.0, 9.3 Hz, 1H), 2.43 (s, 3H), 1.43 (dp, J = 9.5, 6.6 Hz, 1H), 0.92 (d, 
J = 6.6 Hz, 3H), 0.82 (d, J = 6.5 Hz, 3H), 0.78 – 0.70 (m, 1H). 
 
3.3 Preparation of Orgamometallic Reagents 
Preparation of alkynyl grignard reagents: 
The corresponding alkyne (1 equiv, 1 mmol) and THF (1 mL) were added to a dry and argon-
flushed 10 mL Schlenk-flask, equipped with a stirring bar and a septum. TMPMgCl.LiCl (1.2 
equiv, addition at 0 °C) or EtMgBr (1.2 equiv, addition at -20 °C) were added dropwise and the 
reaction mixture was allowed to warm to room temperature and stirred until a reaction aliquot 
quenched with I2 in THF showed full conversion of the starting material by GC. 
Preparation of aryl magnesium reagents via insertion of magnesium: 
LiCl (1.1 equiv) was dried under high vacuum and allowed to cool to room temperature, then Mg 
turnings (1.2 equiv) and THF (1 M solution relating to the aryl bromide) were added. The 
reaction mixture was cooled to 0 °C and the corresponding aryl bromide (1.0 equiv) was added 
dropwise. The reaction was stirred until iodolysis of a reaction aliquot indicated full consumption 
of the starting material. 
Preparation of aryl magnesium reagents via iodine-magnesium exchange: 
The corresponding aryl bromide (1.0 equiv) was dissolved in THF (1 M solution relating to the 
aryl bromide) and the reaction mixture was cooled to -30 °C. Then i-PrMgCl.LiCl (1.1 equiv) was 
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added dropwise and the reaction was stirred at this temperature until reaction aliquots quenched 
with iodine showed full consumption of the starting material. 
 
3.4 Diastereoselective Cobalt-Mediated Cross-Couplings of Cycloalkyl Iodides 
with Alkynyl or (Hetero)Aryl Grignard Reagents 
Typical procedure 2 (TP2): A dry and argon-flushed 10 mL Schlenk-tube was charged with 
CoCl2·2LiCl (1.0 M in THF) (0.25 mmol, 0.25 mL, 50 mol %) and neocuproine (0.2 mmol, 21 mg, 
20 mol %), in dry THF (1 mL). The respective cycloalkyl iodide (0.5 mmol) was added and the 
mixture was cooled to -40 °C or 0 °C. Then, a solution of the appropriate alkynyl or aryl Grignard 
reagent (0.75 mmol, 1.5 equiv) was added dropwise over 10 min via syringe. The reaction was 
stirred and monitored by GC-analysis (C14H30 was used as an internal standard). Upon 
consumption of the starting material, saturated aq. NH4Cl solution (5 mL) was added, the 
phases were separated and the aqueous phase was extracted with EtOAc (3 x 25 mL). The 
combined organic layers were dried over MgSO4. The solvents were evaporated and the residue 
was subjected to column chromatography on silica yielding the respective title compound. 
 
Triisopropyl(((1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)ethynyl)silane (64a) 
 
Isolated yield: 108 mg, 0.34 mmol, 68%, colorless oil  
dr: 99:1.  
Purification: i-hexane  
1H-NMR (300 MHz, CDCl3, ppm): δ = 2.27 (ddq, J = 9.9, 7.0, 3.5, 2.9 Hz, 1H), 2.11 (td, J = 
11.5, 3.5 Hz, 1H), 1.92 (dq, J = 12.9, 3.4 Hz, 1H), 1.67 – 1.59 (m, 1H), 1.59 – 1.49 (m, 1H), 1.30 
– 1.20 (m, 1H), 1.01 – 0.95 (m, 28H), 0.84 (d, J = 7.1 Hz, 3H), 0.81 (d, J = 6.5 Hz, 3H), 0.71 (d, 
J = 6.9 Hz, 3H).  
13C-NMR (75 MHz, CDCl3, ppm):  δ = 112.6, 80.2, 47.5, 42.6, 34.9, 34.6, 32.5, 28.7, 24.2, 22.3, 
21.3, 18.6, 15.7, 11.3. 
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FT-IR (ATR, cm-1): ! = 2942, 2924, 2891, 2865, 2170, 1647, 1462, 1375, 1259, 1060,996, 908, 
884, 844, 735, 678.  
MS (EI, 70 eV): m/z (%) = 224 (4), 323 (12), 291 (3), 278 (2), 277 (9), 276 (40), 275 (100), 273 
(6). 
HR-MS (EI, 70 eV): [C21H38Si], calcd.: 275.2201; found: 275.2192 [M+-iPr]. 
 
1-(((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)ethynyl)-4-methoxybenzene (64b) 
 
Isolated yield: 100 mg, 0.37 mmol, 74%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 100:2  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.26 (d, J = 8.9 Hz, 2H), 6.73 (d, J = 8.6 Hz, 2H), 3.72 (s, 
3H), 2.31 – 2.21 (m, 2H), 2.03 – 1.95 (m, 1H), 1.70 – 1.62 (m, 1H), 1.60 – 1.54 (m, 1H), 1.37 – 
1.24 (m, 1H), 1.24 – 1.04 (m, 3H), 0.99 – 0.90 (m, 1H), 0.87 (d, J = 7.1 Hz, 3H), 0.83 (d, J = 6.5 
Hz, 3H), 0.75 (d, J = 6.9 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm):  δ = 158.9, 132.9, 116.4, 113.7, 91.9, 81.1, 55.3, 47.5, 42.5, 
34.9, 34.1, 32.5, 28.9, 24.3, 22.3, 21.4, 15.9.  
FT-IR (ATR, cm-1): ! = 2954, 2869, 2253, 1607, 1509, 1288, 1246, 1172, 1035, 906, 831, 731.  
MS (EI, 70 eV): m/z (%) = 270 (15), 255 (100), 213 (14), 147 (35), 145 (9), 120 (20), 114 (2), 42 
(4), 40 (8).  
HR-MS (EI, 70 eV): [C19H26O], calcd.: 270.1984; found: 238.1356. 
 
tert-Butyl(((1R,2S)-2-((4-methoxyphenyl)ethynyl)cyclopentyl)oxy)dimethylsilane (64c) 
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Isolated yield: 114 mg, 0.34 mmol, 69%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 100:2  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.24 – 7.18 (m, 2H), 6.73 – 6.67 (m, 2H), 4.12 (q, J = 5.7 
Hz, 1H), 3.69 (s, 3H), 2.67 – 2.57 (m, 1H), 2.05 – 1.96 (m, 1H), 1.90 – 1.80 (m, 1H), 1.70 – 1.55 
(m, 3H), 1.52 – 1.41 (m, 1H), 0.80 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H).  
13C-NMR (100 MHz, CDCl3, ppm):  δ = 158.9, 132.8, 116.2, 113.8, 91.1, 81.2, 79.9, 55.3, 40.2, 
34.6, 31.0, 25.9, 21.9, 18.2, -4.5, -4.7.  
FT-IR (ATR, cm-1): ! = 2955, 2856, 2359, 1607, 1509, 1287, 1247, 1090, 1038, 906, 832, 776, 
731. 
MS (EI, 70 eV): m/z (%) = 273 (29), 200 (13), 199 (100), 171 (5), 164 (4), 121 (4), 75 (15), 73 
(15). 
HR-MS (EI, 70 eV): [C16H21O2Si], calcd.: 273.1311; found: 273.1326 [M+-tBu]. 
 
tert-Butyl(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)ethynyl)dimethylsilane (64d) 
 
Isolated yield: 79 mg, 0.28 mmol, 61%, colorless oil  
dr: 99:1.  
Purification: i-hexane  
1H-NMR (300 MHz, CDCl3, ppm): δ = 2.29 (pd, J = 7.0, 2.9 Hz, 1H), 2.21 – 2.13 (m, 1H), 1.98 
(dtd, J = 13.0, 3.5, 2.2 Hz, 1H), 1.73 – 1.67 (m, 1H), 1.64 – 1.57 (m, 1H), 1.38 – 1.25 (m, 1H), 
1.23 – 1.03 (m, 2H), 0.97 – 0.90 (m, 14H), 0.88 (d, J = 6.5 Hz, 3H), 0.77 (d, J = 6.9 Hz, 3H), 
0.07 (s, 6H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 111.5, 82.9, 47.5, 42.6, 35.0, 34.7, 32.6, 28.8, 26.7, 26.3, 
26.2, 24.4, 22.4, 21.4, 16.7, 15.9, -4.2, -4.2.  
FT-IR (ATR, cm-1): ! = 2955, 2929, 2857, 2167, 1471, 1249, 908, 908, 837, 824, 810, 775, 735, 
686. 
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MS (EI, 70 eV): m/z (%) =  221 (5), 74 (8), 73 (100), 57 (11).  
HR-MS (EI, 70 eV): [C18H34Si], calcd.: 221.1720; found: 221.1720 [M+-C4H9]. 
 
(((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)ethynyl)trimethylsilane (64e) 
 
Isolated yield: 92 mg, 0.39 mmol, 78%, colorless oil  
dr: 99:1.  
Purification: i-hexane  
1H-NMR (400 MHz, CDCl3, ppm): δ = 2.25 (pd, J = 7.1, 2.8 Hz, 1H), 2.17 (td, J = 11.5, 3.5 Hz, 
1H), 1.98 (dd, J = 12.8, 3.2 Hz, 1H), 1.75 – 1.66 (m, 1H), 1.64 – 1.57 (m, 1H), 1.39 – 1.24 (m, 
1H), 1.24 – 1.10 (m, 2H), 1.01 – 0.94 (m, 2H), 0.93 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.5 Hz, 3H), 
0.78 (d, J = 6.9 Hz, 3H), 0.14 (s, 9H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 110.6, 84.4, 46.8, 42.0, 34.5, 34.1, 32.1, 28.3, 24.0, 
22.0, 21.0, 15.5, 0.0.  
FT-IR (ATR, cm-1): ! = 2956, 1704, 1456, 1407, 1386, 1368, 1248, 1131, 930, 835, 758, 696, 
668. 
MS (EI, 70 eV): m/z (%) =  237 (4), 236 (21), 222 (25), 221 (100), 163 (26), 162 (66), 147 (32), 
140 (15), 109 (13), 73 (55).  
HR-MS (EI, 70 eV): [C15H28Si], calcd.: 236.1960; found: 236.1945. 
 
tert-Butyldimethyl(((1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)ethynyl)silane (64f) 
 
 
Isolated yield: 76 mg, 0.27 mmol, 55%, colorless oil  
dr: 99:1.  
SiMe3
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Purification: i-hexane  
1H-NMR (300 MHz, CDCl3, ppm): δ = 4.75 (q, J = 1.2 Hz, 2H), 2.29 (ddd, J = 11.9, 11.0, 3.5 Hz, 
1H), 2.01 (dtd, J = 13.1, 3.5, 2.0 Hz, 1H), 1.93 (ddd, J = 12.0, 11.0, 3.3 Hz, 1H), 1.70 (m, 3H), 
1.69 – 1.62 (m, 2H), 1.42 – 1.23 (m, 2H), 1.17 – 1.06 (m, 1H), 1.06 – 0.93 (m, 1H), 0.90 (d, J = 
5.7 Hz, 12H), 0.04 (s, 6H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 148.1, 111.2, 110.9, 82.7, 51.3, 41.8, 34.8, 34.7, 32.3, 
32.0, 26.2, 22.4, 19.8, 16.7, 1.2, -4.2, -4.3.  
FT-IR (ATR, cm-1): ! = 2952, 2927, 2865, 2171, 1647, 1456, 1248, 1006, 907, 845, 825, 811, 
774, 734, 685, 650.  
MS (EI, 70 eV): m/z (%) = 276 (2), 221 (16), 220 (69), 219 (100), 217 (13), 178 (11), 177 (65), 
163 (9), 160 (18), 159 (37), 157 (14), 151 (9), 149 (17), 135 (14), 123 (16), 119 (11), 109 (38), 
105 (11), 98 (14), 96 (13), 83 (22), 81 (11), 73 (98), 59 (80), 57 (21), 55 (15), 43 (9), 43 (11), 41 
(24). 
HR-MS (EI, 70 eV): [C18H32Si], calcd.: 276.2273; found: 276.2272. 
 
Triisopropyl(((1S,2S,5S)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)ethynyl)silane (64g) 
 
Isolated yield: 108 mg, 0.34 mmol, 68%, colorless oil  
1H-NMR (300 MHz, CDCl3, ppm): δ  = 4.74 (dt, J = 5.4, 1.8 Hz, 2H), 2.36 – 2.22 (m, 1H), 2.02 
(dtd, J = 13.1, 3.5, 1.9 Hz, 1H), 1.94 (td, J = 11.8, 3.3 Hz, 1H), 1.71 (t, J = 1.1 Hz, 3H), 1.69 – 
1.62 (m, 1H), 1.44 – 1.22 (m, 2H), 1.21 – 0.92 (m, 23H), 0.90 (d, J = 6.5 Hz, 3H).  
13C-NMR (75 MHz, CDCl3, ppm):  δ = 148.1, 112.0, 111.2, 80.0, 78.7, 51.5, 42.0, 34.8, 34.7, 
32.3, 32.1, 22.4, 19.6, 18.8, 18.8, 18.8, 11.4, 11.4.  
FT-IR (ATR, cm-1): ! = 2942, 2924, 2891, 2865, 2170, 1647, 1462, 1375, 1259, 1060, 996, 908, 
884, 844, 735, 678.  
MS (EI, 70 eV): m/z (%) = 323 (23), 307 (3), 277 (10), 276 (40), 275 (100), 273 (6). 
HR-MS (EI, 70 eV): [C21H38Si], calcd.: 275.2195; found: 275.2192 [M+-C3H7]. 
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tert-butyl(((1R,2S)-2-(cyclopentylethynyl)cyclopentyl)oxy)dimethylsilane (64h) 
 
Isolated yield: 85 mg, 0.29 mmol, 58%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 99:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.99 (q, J = 5.7 Hz, 1H), 2.49 (pd, J = 7.5, 2.1 Hz, 1H), 
2.41 (tdd, J = 7.7, 5.5, 2.1 Hz, 1H), 1.98 – 1.87 (m, 1H), 1.87 – 1.75 (m, 3H), 1.67 – 1.54 (m, 
4H), 1.51 – 1.37 (m, 6H), 0.81 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H).  
13C-NMR (100 MHz, CDCl3, ppm):  δ = 85.4, 82.2, 80.1, 39.6, 34.4, 34.1, 31.3, 30.4, 25.9, 24.9, 
21.8, 18.2, -4.6, -4.7.  
FT-IR (ATR, cm-1): ! = 2954, 2931, 2858, 1710, 1472, 1361, 1251, 1085, 1005, 939, 895, 865, 
835, 775, 668.  
MS (EI, 70 eV): m/z (%) = 291 (1), 235 (28), 161 (24), 159 (63), 91 (32), 75 (100), 73 (31), 67 
(12). 
HR-MS (EI, 70 eV): [C18H32OSi], calcd.: 291.2148; found: 291.2144. 
 
tert-butyl(((1R,2S)-2-(cyclohex-1-en-1-ylethynyl)cyclopentyl)oxy)dimethylsilane (64i) 
 
Isolated yield: 104 mg, 0.34 mmol, 68%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 99:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 5.99 (dt, J = 4.0, 2.1 Hz, 1H), 4.13 (q, J = 5.4 Hz, 1H), 
2.67 – 2.57 (m, 1H), 2.11 – 2.03 (m, 5H), 1.91 (ddt, J = 12.6, 8.6, 6.3 Hz, 1H), 1.72 – 1.51 (m, 
8H), 0.89 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 133.2, 121.0, 89.7, 83.2, 79.9, 40.1, 34.51, 31.2, 29.6, 
25.9, 25.6, 22.4, 21.9, 21.6, 18.2, -4.7, -4.8.  
FT-IR (ATR, cm-1): ! = 2950, 2930, 2857, 1715, 1674, 1472, 1462, 1447, 1388, 1360, 1250, 
OTBS
OTBS
EXPERIMENTAL PART 
____________________________________________________________________________ 
 106 
1170, 1087, 1005, 939, 867, 834, 775, 668.  
MS (EI, 70 eV): m/z (%) = 304 (1), 247 (47), 174 (15), 173 (100), 171 (53), 129 (15), 91 (15), 75 
(68), 73 (34).  
HR-MS (EI, 70 eV): [C19H32OSi], calcd.: 304.2222; found: 304.2202. 
 
4-(((1S,2R)-2-((tert-butyldimethylsilyl)oxy)cyclohexyl)ethynyl)benzonitrile (64j) 
 
Isolated yield: 105 mg, 0.31 mmol, 62%, yellow oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 9:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.55 (d, J = 8.3 Hz, 2H), 7.44 (d, J = 8.3 Hz, 2H), 3.69 – 
3.58 (m, 1H), 2.52 (ddd, J = 10.0, 8.1, 3.9 Hz, 1H), 2.09 – 1.99 (m, 1H), 1.95 – 1.86 (m, 1H), 
1.78 – 1.61 (m, 2H), 1.53 – 1.40 (m, 1H), 1.37 – 1.19 (m, 3H), 0.88 (s, 9H), 0.07 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 132.1, 131.9, 129.2, 118.7, 110.8, 98.3, 80.4, 73.1, 38.7, 
34.5, 30.3, 29.7, 25.8, 24.3, 23.5, 18.1, -4.4, -4.6.  
FT-IR (ATR, cm-1): ! = 2929, 2856, 2227, 1605, 1501, 1472, 1462, 1249, 1131, 1100, 1059, 
1039, 1022, 1006, 938, 876, 833, 773, 668.  
MS (EI, 70 eV): m/z (%) = 339 (1), 284 (14), 283 (43), 282 (22), 208 (17), 184 (25), 15 (13), 75 
(100), 44.  
HR-MS (EI, 70 eV): [C21H29NOSi], calcd.: 339.2018; found: 339.1996. 
 
tert-Butyldimethyl((trans-2-((triisopropylsilyl)ethynyl)cyclohexyl)oxy)silane (64k) 
 
Isolated yield: 910 mg, 77 %, colorless oil  
dr: 99:1.  
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Purification: i-hexane:EE = 100:2  
1H-NMR (300 MHz, CDCl3, ppm): δ = 3.71 (td, J = 6.4, 3.1 Hz, 1H), 2.44 (td, J = 6.8, 4.1 Hz, 
1H), 2.03 – 1.85 (m, 1H), 1.73 – 1.58 (m, 2H), 1.52 –1.41 (m, 1H), 1.32 (qt, J = 6.2, 3.4 Hz, 3H), 
1.15 – 0.96 (m, 21H), 0.89 (s, 10H), 0.08 (d, J = 5.6 Hz, 6H).  
13C-NMR (75 MHz, CDCl3, ppm):  δ = 111.7, 81.7, 72.0, 47.8, 37.9, 32.7, 29.3, 26.1, 26.0, 23.4, 
22.3, 18.8, 18.2, 11.5, -4.4, -4.5.  
FT-IR (ATR, cm-1): ! = 2937, 2892, 2863, 2359, 2166, 1463, 1366, 1383, 1252, 1157, 1105, 
1068, 1022, 942, 908, 875, 836, 775, 735, 676.  
MS (EI, 70 eV): m/z (%) = 394 (1), 393 (1), 337 (8), 309 (18), 296 (26), 295 (100), 267 (19), 253 
(4), 225 (8).  
HR-MS (EI, 70 eV): [C23H46OSi2], calcd.: 394.3087; found: 394.3076. 
 
1-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)-4-(trifluoromethyl)benzene (65a) 
 
Isolated yield: 201 mg, 0.36 mmol, 71%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 100:3  
1H-NMR (400 MHz, CDCl3, ppm): d = 7.55 (d, J = 8.5 Hz, 2H), 7.33 - 7.16 (m, 2H), 2.49 (td, J = 
11.6, 3.5 Hz, 1H), 1.84 - 1.66 (m, 2H), 1.56 (s, 1H), 1.53 - 1.41 (m, 2H), 1.36 - 0.95 (m, 4H), 
0.89 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H), 0.65 (d, J = 6.9 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): d = 152.4, 132.2, 128.3, 119.1, 109.5, 48.3, 47.2, 44.8, 35.0, 
33.1, 27.6, 24.36, 22.4, 21.4, 15.3.  
FT-IR (ATR, cm-1): ! = 2957, 2871, 1447, 1324, 1164, 1125, 1073, 906, 799, 732, 703, 665. 
MS (EI, 70 eV): m/z (%) = 284 (56), 199 (74), 173 (51), 172 (94), 159 (100), 112 (42), 69 (53). 
HR-MS (EI, 70 eV): [C17H23F3], calcd.: 284.1752; found: 284.1735. 
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1-(4-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)phenyl)-2,2-dimethylpropan-1-one (65b) 
 
Isolated yield: 221 mg, 0.35 mmol, 70%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.90 (d, J = 8.3 Hz, 2H), 7.19 (d, J = 8.2 Hz, 2H), 2.48 (td, 
J = 11.6, 3.5 Hz, 1H), 1.86 – 1.68 (m, 3H), 1.57 (s, 9H), 1.52 – 1.32 (m, 3H), 1.19 – 0.97 (m, 
3H), 0.88 (d, J =6.5 Hz, 3H), 0.77 (d, J = 7.0 Hz, 3H), 0.65 (d, J = 6.9 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 165.8, 151.7, 129.5, 80.5, 48.1, 47.3, 44.9, 35.2, 33.1, 
28.2, 27.5, 24.5, 22.4, 21.4, 15.3.  
FT-IR (ATR, cm-1): ! = 2954, 2918, 1711, 1608, 1455, 1367, 1290, 1255, 1165, 1116, 1102, 
908, 850, 773, 733, 708.  
MS (EI, 70 eV): m/z (%) = 261 (33), 250 (100), 243 (56), 149 (43), 148 (73), 135 (35), 125 (26), 
91 (23), 69 (37), 57 (87), 40 (32).  
HR-MS (EI, 70 eV): [C21H32O2], calcd.: 316.2402; found: 316.2387. 
 
4-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)benzonitrile (65c) 
 
Isolated yield: 147 mg, 0.31 mmol, 61%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 100:3  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.55 (d, J = 8.5 Hz, 2H), 7.33 - 7.16 (m, 2H), 2.49 (td, J = 
11.6, 3.5 Hz, 1H), 1.84 - 1.66 (m, 2H), 1.56 (s, 1H), 1.53 - 1.41 (m, 2H), 1.36 - 0.95 (m, 5H), 
0.89 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H), 0.65 (d, J = 6.9 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 152.4, 132.2, 128.3, 119.1, 109.5, 48.3, 47.2, 44.8, 35.0, 
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33.1, 27.6, 24.36, 22.4, 21.4, 15.3.  
FT-IR (ATR, cm-1): ! = 1413, 1342, 1322, 1253, 1165, 1125, 1097, 1076, 1045, 895, 796, 702, 
665. 
MS (EI, 70 eV): m/z (%) = 241 (100), 156 (73), 142 (53), 130 (95), 116 (52), 81 (53). 
HR-MS (EI, 70 eV): [C17H23N], calcd.: 241.1830; found: 241.1821. 
4-((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)phenyl pivalate (65d) 
 
Isolated yield: 119 mg, 0.38 mmol, 75%, colorless crystals  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 96:4  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.15 (d, J = 8.0 Hz, 2H), 6.97 (d, J = 8.0 Hz, 2H), 2.43 (td, 
J = 11.7, 3.4 Hz, 1H), 1.88 – 1.67 (m, 3H), 1.52 – 1.37 (m, 3H), 1.35 (s, 9H), 1.20 – 0.94 (m, 
3H), 0.89 (d, J = 6.4 Hz, 3H), 0.78 (d, J = 6.8 Hz, 3H), 0.65 (d, J = 6.6 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 177.3, 148.9, 143.9, 128.2, 121.2, 47.6, 47.4, 45.3, 39.1, 
35.3, 33.2, 27.3, 27.2, 27.1, 24.5, 22.6, 22.5, 21.5, 15.3.  
FT-IR (ATR, cm-1): ! = 2963, 2921, 2872, 2842, 1744, 1730, 1504, 1492, 1480, 1462, 1454, 
1442, 1398, 1384, 1366, 1277, 1231, 1202, 1194, 1165, 1118, 1101, 1068, 1053, 1030, 1014, 
968, 944, 937, 919, 896, 872, 852, 832, 819, 808, 796, 784, 759, 723, 621, 604, 594, 585, 574, 
566, 558.  
MS (EI, 70 eV): m/z (%) = 317 (5), 316 (23), 233 (18), 232 (100), 146 (77), 107 (31), 91 (7), 95 
(8), 57 (42), 41 (11).  
HR-MS (EI, 70 eV): [C21H32O2], calcd.: 316.2402; found: 316.2388. 
 
4-((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)-N,N-dimethylaniline (65e) 
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Isolated yield: 80 mg, 0.31 mmol, 62%, white solid  
dr: 91:9.  
Purification: i-hexane:ethyl acetate = 98:2  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.04 (d, J = 8.1 Hz, 2H), 6.70 (d, J = 8.1 Hz, 2H), 2.92 (s, 
6H), 2.33 (td, J = 11.6, 3.4 Hz, 1H), 1.87 – 1.65 (m, 3H), 1.54 – 1.28 (m, 3H), 1.20 – 0.94 (m, 
3H), 0.88 (d, J = 6.5 Hz, 3H), 0.79 (dd, J = 6.7 Hz, 1.2, 3H), 0.67 (dd, J = 7.0, 1.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 148.8, 134.9, 128.0, 112.8, 47.6, 46.9, 45.7, 40.9, 35.4, 
33.3, 27.3, 24.6, 22.6, 21.6, 15.4.  
FT-IR (ATR, cm-1): ! = 2951, 2913, 2868, 2844, 2798, 1613, 1565, 1519, 1493, 1480, 1461, 
1452, 1444, 1383, 1366, 1344, 1277, 1206, 1191, 1162, 1138, 1097, 1082, 1059, 1038, 999, 
978, 948, 935, 868, 818, 808, 749, 730, 724, 690, 642, 626, 595.  
MS (EI, 70 eV): m/z (%) = 260 (14), 259 (72), 258 (3), 244 (6), 175 (13), 174 (100), 160 (6), 159 
(5), 147 (9), 146 (10), 135 (6), 134 (52).  
HR-MS (EI, 70 eV): [C18H29N], calcd.: 259.2300; found: 259.2297. 
 
N,N-Diethyl-O-(4-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)benzoyl)hydroxylamine 
(65f) 
 
Isolated yield: 248 mg, 0.38 mmol, 75%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 100:3  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.27 – 7.22 (m, 1H), 7.00 – 6.91 (m, 3H), 3.49 – 3.37 (m, 
4H), 2.44 (td, J = 11.6, 3.4 Hz, 1H), 1.84 – 1.70 (m, 3H), 1.55 – 1.43 (m, 3H), 1.30 – 1.10 (m, 
8H), 1.01 (tdd, J = 12.9, 11.5, 3.4 Hz, 1H), 0.89 (d, J = 6.7 Hz, 3H), 0.81 (d, J = 7.1 Hz, 3H), 
0.69 (d, J = 6.9 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 154.2, 151.6, 148.1, 128.9, 118.9, 47.9, 47.3, 45.2, 42.1, 
41.8, 35.3, 33.2, 27.4, 24.5, 22.5, 21.5, 15.4, 14.3, 13.4.  
FT-IR (ATR, cm-1): ! = 2954, 2916, 2871, 1715, 1608, 1472, 1456, 1415, 1272, 1255, 1216, 
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1153, 970, 907, 773, 730, 698.  
MS (EI, 70 eV): m/z (%) = 331 (39), 107 (11), 106 (12), 100 (34), 71 (100), 55 (11), 43 (20), 40 
(13). 
HR-MS (EI, 70 eV): [C21H33NO2], calcd.: 331.2511; found: 331.2500. 
 
Pentafluoro(3-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyl)phenyl)-λ6-sulfane (65g) 
 
Isolated yield: 116 mg, 0.34 mmol, 68%, colorless oil  
dr: 99:1. 
Purification: i-hexane  
1H-NMR (400 MHz, CDCl3, ppm): δ =7.55 (d, J = 8.1 Hz, 1H), 7.53 (s, 1H), 7.36 (t, J = 7.8 Hz, 
1H), 7.30 (d, J = 7.7 Hz, 1H), 2.51 (td, J = 11.7 Hz, 3.4 Hz, 1H), 1.88 – 1.71 (m, 3H), 1.56 – 1.28 
(m, 3H), 1.25 – 0.97 (m, 3H), 0.90 (d, J = 6.7 Hz, 3H), 0.81 (d, J = 6.9 Hz, 3H), 0.67 (d, J = 
6.9 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm):  δ = 154.1, 147.9, 130.6, 128.6, 125.0 (m), 123.4 (p, J = 
4.6 Hz), 48.1, 47.3, 45.1, 35.1, 33.2, 27.5, 24.5, 22.4, 21.4, 15.3. 
FT-IR (ATR, cm-1): ! = 2963, 2921, 2872, 2842, 1744, 1730, 1504, 1492, 1480, 1462, 1454, 
1442, 1398, 1384, 1366, 1277, 1231, 1202, 1194, 1165, 1118, 1101, 1068, 1053, 1030, 1014, 
968, 944, 937, 919, 896, 872, 852, 832, 819, 808, 796, 784, 759, 723, 621, 604, 594, 585, 574, 
566, 558.  
MS (EI, 70 eV): m/z (%) = 343 (16), 342 (100), 257 (27), 230 (74), 217 (71), 130 (68), 129 (52), 
116 (69), 83 (61), 55 (80).  
HR-MS (EI, 70 eV): [C16H23F5S], calcd.: 342.1441; found: 342.1430. 
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tert-Butyl(3-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)phenoxy)dimethylsilane (65h) 
 
Isolated yield: 252 mg, 0.37 mmol, 73%, colorless oil  
dr: 99:1.  
Purification: i-hexane  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.30 - 7.21 (m, 1H), 7.18 - 7.10 (m, 1H), 6.87 (dq, J = 7.7, 
0.9 Hz, 1H), 6.72 - 6.64 (m, 1H), 2.39 (td, J = 11.5, 3.4 Hz, 1H), 1.95 - 1.70 (m, 3H), 1.62 - 1.37 
(m, 3H), 1.27 - 1.08 (m, 3H), 1.02 (dd, J = 1.7, 0.7 Hz, 9H), 0.92 (d, J = 6.6 Hz, 3H), 0.85 - 0.80 
(m, 3H), 0.71 (dd, J = 6.8, 0.7 Hz, 3H), 0.22 (dd, J = 2.7, 0.7 Hz, 6H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 155.6, 148.2, 129.3, 129.1, 121.3, 120.1, 117.5, 47.9, 
47.5, 45.1, 35.3, 33.2, 27.4, 25.8, 25.7, 24.5, 22.5, 21.5, 18.3, 15.4, -4.4, -4.4. 
FT-IR (ATR, cm-1): ! = 2955, 2929, 2859, 1597, 1491, 1484, 1440, 1362, 1252, 1155, 1002, 
971, 908, 867, 835, 779, 730, 801, 665.  
MS (EI, 70 eV): m/z (%) = 346 (71), 290 (31), 289 (98), 193 (30), 179 (91), 165 (37), 75 (8). 
HR-MS (EI, 70 eV): [C22H38OSi], calcd.: 346.2692; found: 346.2687. 
 
1-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)naphthalene (65i) 
 
Isolated yield: 165 mg, 0.31 mmol, 62%, colorless oil  
dr: 99:1.  
Purification: i-hexane  
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.20 - 8.15 (m, 1H), 7.84 (dd, J = 8.0, 1.5 Hz, 1H), 7.67 
(dd, J = 8.2, 1.1 Hz, 1H), 7.53 - 7.42 (m, 3H), 7.38 (dd, J = 7.3, 1.3 Hz, 1H), 3.38 (td, J = 11.5, 
3.4 Hz, 1H), 1.95 - 1.83 (m, 4H), 1.77 (tt, J = 11.5, 3.0 Hz, 1H), 1.38 - 1.23 (m, 2H), 1.13 - 1.04 
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(m, 2H), 0.89 (d, J = 6.6 Hz, 3H), 0.81 (d, J = 7.0 Hz, 3H), 0.61 (d, J = 6.9 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 142.7, 134.0, 131.8, 128.9, 125.7, 125.6, 125.5, 125.1, 
123.2, 122.7, 46.8, 45.8, 40.8, 35.4, 33.5, 27.3, 24.8, 22.4, 21.6, 16.1.  
FT-IR (ATR, cm-1): ! = 3045, 2925, 2867, 1595, 1511, 1455, 1368, 1016, 905, 794, 776, 729. 
MS (EI, 70 eV): m/z (%) = 266 (100), 181 (86), 154 (31), 142 (60), 141 (87), 69 (12).  
HR-MS (EI, 70 eV): [C20H26], calcd.: 266.2035; found: 266.2020. 
 
5-((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)-1-methyl-1H-indole (65j) 
 
Isolated yield: 128 mg, 0.38 mmol, 75%, white solid  
dr: 96:4.  
Purification: i-hexane: ethyl acetate 99:1  
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.44 – 7.38 (m, 1H), 7.28 – 7.23 (m, 1H), 7.07 (dd, J = 
8.4, 1.6 Hz, 1H), 7.02 (d, J = 3.1 Hz, 1H), 6.43 (dd, J = 3.1, 0.9 Hz, 1H), 3.77 (s, 3H), 2.52 (td, J 
= 11.6, 3.4 Hz, 1H), 1.89 – 1.78 (m, 2H), 1.77 (dq, J = 12.4, 3.1 Hz, 1H), 1.57 – 1.43 (m, 3H), 
1.30 – 1.11 (m, 2H), 0.91 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 6.9 Hz, 4H), 0.70 (d, J = 6.8 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm):  δ = 137.6, 135.4, 128.7, 128.6, 121.3, 119.1, 108.9, 100.5, 
48.0, 47.8, 46.2, 35.5, 33.5, 32.9, 27.4, 24.7, 22.6, 21.7, 15.4.  
FT-IR (ATR, cm-1): ! = 2957, 2859, 1600, 1585, 1484, 1471, 1443, 1344, 1278, 1253, 1159, 
1097, 1001, 908, 837, 781, 726, 700, 662.  
MS (EI, 70 eV): m/z (%) = 270 (15),  269 (82), 185 (13), 184 (100), 169 (6), 168 (5), 158 (9), 
157 (11), 145 (25), 144 (52), 131 (7). 
HR-MS (EI, 70 eV): [C19H27N], calcd.: 269.2143; found: 269.2138. 
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2-((1R,2R)-2-(4-Methoxyphenyl)cyclohexyl)-5,5-dimethyl-1,3-dioxane (66a) 
 
Isolated yield: 246 mg, 0.41 mmol, 81%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.10 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.7 Hz, 1H), 3.89 (d, 
J = 2.1 Hz, 2H), 3.80 (s, 3H), 3.50 (dd, J = 10.9, 2.8 Hz, 2H), 3.15 (dd, J = 10.9, 1.0 Hz, 2H), 
2.49 (td, J = 11.9, 3.5 Hz, 1H), 2.07 (ddd, J = 13.4, 3.3, 1.6 Hz, 1H), 1.88 – 1.66 (m, 4H), 1.51 – 
1.26 (m, 4H), 1.13 (s, 3H), 0.60 (s, 3H).  
13C-NMR (100 MHz, CDCl3, ppm):  δ = 157.7, 137.8, 128.4, 113.6, 101.6, 55.1, 47.6, 44.7, 
35.4, 30.1, 26.7, 25.94, 24.3, 22.8, 21.6.  
FT-IR (ATR, cm-1): ! = 2931, 2853, 2248, 1512, 1394, 1247, 114, 968, 904, 828, 727, 648. 
MS (EI, 70 eV): m/z (%) = 304 (10), 200 (30), 196 (43), 17 (10), 120 (28), 114 (100), 69 (52), 45 
(13), 41 (12).  
HR-MS (EI, 70 eV): [C19H28O3], calcd.: 304.2038; found: 304.2030. 
 
5,5-Dimethyl-2-((1R,2R)-2-(4-(trifluoromethyl)phenyl)cyclohexyl)-1,3-dioxane (66b) 
 
Isolated yield: 242 mg, 0.36 mmol, 71%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (600 MHz, CDCl3, ppm): δ = 7.56 – 7.51 (m, 2H), 7.29 (d, J = 8.0 Hz, 2H), 3.84 (d, J = 
2.2 Hz, 1H), 3.49 (ddd, J = 30.7, 10.9, 2.8 Hz, 2H), 3.13 (ddd, J = 67.3, 10.9, 1.0 Hz, 2H), 2.63 
(td, J = 11.9, 3.3 Hz, 1H), 2.10 (ddt, J = 13.1, 4.1, 2.9 Hz, 1H), 1.90 – 1.76 (m, 4H), 1.54 – 1.31 
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(m, 4H), 1.11 (s, 3H), 0.60 (s, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 149.8, 127.9, 126.4, 125.2, 104.3, 101.2, 47.1, 45.5, 
35.1, 30.1, 26.5, 25.8, 24.2, 22.7, 21.5.  
FT-IR (ATR, cm-1): ! = 2933, 2856, 2252, 1618, 1325, 112, 1116, 1069, 903, 834, 723, 649, 
606. 
MS (EI, 70 eV): m/z (%) = 341 (10), 196 (23), 158 (15), 115 (100), 69 (47), 44 (12), 40 (13). 
HR-MS (EI, 70 eV): [C19H25F3O2], calcd.: 342.1807; found: 342.1721. 
 
tert-Butyldimethyl(3-((1R,2R,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)phenoxy)silane 
(67a) 
 
Isolated yield: 264 mg, 0.39 mmol, 77%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.16 - 7.06 (m, 1H), 6.79 - 6.70 (m, 1H), 6.64 (dq, J = 8.8, 
1.3 Hz, 2H), 4.59 - 4.52 (m, 2H), 2.52 (td, J = 11.6, 3.4 Hz, 1H), 2.22 (td, J = 11.6, 3.3 Hz, 1H), 
1.92 - 1.72 (m, 3H), 1.67 - 1.28 (m, 6H), 1.24 - 1.06 (m, 2H), 1.04 - 0.98 (m, 7H), 0.94 (d, J = 6.6 
Hz, 2H), 0.89 (d, J = 6.7 Hz, 2H), 0.20 (d, J = 0.6 Hz, 6H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 155.4, 148.3, 147.7, 128.8, 120.6, 119.4, 117.5, 111.1, 
51.1, 47.9, 44.5, 41.4, 35.1, 33.1, 32.8, 25.7, 22.5, 19.8, 18.2, 11.5, -4.4, -4.4.  
FT-IR (ATR, cm-1): ! = 3072, 2951, 2926, 2857, 1645, 1601, 1483, 1440, 1374, 1270, 1252, 
1156, 1002, 982, 936, 907, 866, 779, 731, 698.  
MS (EI, 70 eV): m/z (%) = 344 (63), 288 (38), 287 (100), 191 (33), 177 (93), 163 (41), 73 (14). 
HR-MS (EI, 70 eV): [C22H36OSi], calcd.: 344.2535; found: 344.2533. 
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1-((1R,2R,5R)-5-Methyl-2-(prop-1-en-2-yl)cyclohexyl)-4-(trifluoromethyl)benzene (67b) 
 
Isolated yield: 169 mg, 0.30 mmol, 60%, colorless oil  
dr: 99:1.  
Purification: i-hexane  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.42 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 4.49 - 
4.41 (m, 2H), 2.57 (td, J = 11.7, 3.4 Hz, 1H), 2.20 (td, J = 11.6, 3.3 Hz, 1H), 1.74 (dq, J = 13.4, 
3.3 Hz, 3H), 1.56 - 1.35 (m, 5H), 1.13 - 0.95 (m, 2H), 0.85 (d, J = 6.5 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 150.2, 147.8, 128.1, 127.8, 127.7, 125.1, 125.1, 125.0, 
111.6, 50.8, 47.8, 44.5, 35.0, 323.0, 32.6, 22.4, 19.7.  
FT-IR (ATR, cm-1): ! = 2927, 2873, 1463, 1381, 1326, 1168, 1131, 1069, 957, 890, 739, 564. 
MS (EI, 70 eV): m/z (%) = 282 (16), 218 (35), 216 (100), 148 (32), 123 (28), 91 (36), 83 (23), 57 
(22). 
HR-MS (EI, 70 eV): [C17H21F3], calcd.: 282.1595; found: 282.1570. 
 
1-Methoxy-4-((1R,2R,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)benzene (67c) 
 
Isolated yield: 104 mg, 0.43 mmol, 85%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 100:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.08 - 7.06 (m, 1H), 7.05 (d, J = 2.2 Hz, 1H), 6.81 (d, J = 
2.2 Hz, 1H), 6.79 (d, J = 2.1 Hz, 1H), 4.61 - 4.46 (m, 2H), 3.78 (s, 2H), 2.52 (td, J = 11.7, 3.4 Hz, 
1H), 2.23 (td, J = 11.6, 3.4 Hz, 1H), 1.80 (dddd, J = 11.3, 9.6, 4.9, 2.4 Hz, 3H), 1.64 - 1.42 (m, 
6H), 1.22 - 1.02 (m, 2H), 0.92 (d, J = 6.5 Hz, 2H), 0.91 - 0.85 (m, 1H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 157.5, 148.6, 138.3, 129.4, 128.2, 113.9, 113.4, 111.0, 
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55.1, 51.1, 47.0, 45.1, 35.1, 33.1, 32.8, 22.4, 19.7.  
FT-IR (ATR, cm-1): ! = 3070, 2948, 2916, 1645, 1610, 1511, 1454, 1373, 1301, 1243, 1177, 
1037, 906, 885, 826, 754, 729, 692.  
MS (EI, 70 eV): m/z (%) = 244 (44), 229 (11), 173 (26), 161 (100), 134 (33), 121 (92), 91 (23), 
55(23). 
HR-MS (EI, 70 eV): [C17H24O], calcd.: 244.1827; found: 244.1823. 
 
1-((1S,2S,4S)-2-(4-methoxyphenyl)-4-methylcyclohexyl)ethan-1-one (68) 
 
Substrate 6c (244 mg, 1 mmol) and was dissolved in dry CH2Cl2 (15 mL) and the solution was 
cooled to -78 °C, at which point a stream of O3 was introduced through a disposable pipet for 3 
min. After 15 min, the reaction was sparged with O2 and then argon. The crude reaction mixture 
was diluted with CH2Cl2 (10 mL) and sat. aq. NaHCO3 (15 mL). The aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers were dried over Na2SO4 and 
filtered. The residue was purified via flash chromatography with hexanes/ethyl acetate 100:1 to 
furnish the ketone 7 as a white solid (150 mg, 0.61 mmol, 61%). 
dr: 99:1.  
m.p.: 102.8 – 104.5 °C  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.01 (d, J = 8.6 Hz, 2H), 6.73 (d, J = 8.7 Hz, 2H), 3.69 (s, 
3H), 2.61 – 2.65 (m, 2H), 1.89 – 1.68 (m, 6H), 1.58 – 1.34 (m, 2H), 1.18 – 0.91 (m, 2H), 0.86 (d, 
J = 6.5 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 212.8, 157.9, 136.7, 128.2, 113.9, 57.3, 55.2, 45.6, 43.3, 
34.1, 32.6, 30.1, 29.5, 22.4.  
FT-IR (ATR, cm-1): ! = 2924, 2253, 1706, 1610, 1512, 1455, 1355, 1245, 1178, 1035, 905, 827, 
726. 
MS (EI, 70 eV): m/z (%) = 246 (77), 161 (100), 121 (84), 97 (28), 71 (28), 69 (34), 57 (54), 55 
(48), 43 (44), 42 (58).  
HR-MS (EI, 70 eV): [C16H22O2], calcd.: 246.1620; found: 246.1621. 
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(3S,4R)-3-Isopropyl-4-(4-(trifluoromethyl)phenyl)tetrahydrofuran (69a) 
 
Isolated yield:  92 mg, 0.36 mmol, 71%, colorless liquid  
dr: 97:3.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (300 MHz, CDCl3, ppm): δ = 7.55 (d, J = 8.1 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 4.18 
(dd, J = 8.7, 7.8 Hz, 1H), 4.11 (ddd, J = 8.9, 7.8, 0.5 Hz, 1H), 3.74 (dd, J = 8.9, 6.7 Hz, 1H), 3.64 
(t, J = 8.5 Hz, 1H), 3.14 (q, J = 7.3 Hz, 1H), 2.16 (p, J = 7.8 Hz, 1H), 1.79 – 1.60 (m, 1H), 0.88 
(d, J = 6.7 Hz, 3H), 0.84 (d, J = 6.7 Hz, 3H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 148.4 (q, J = 1.8, 1.1 Hz), 128.7 (q, J = 32.5 Hz), 127.9, 
125.5 (q, J = 3.8 Hz), 124.0 (q, J = 271.8 Hz), 76.3, 72.6, 50.0, 31.3, 21.6, 20.5. 
FT-IR (ATR, cm-1): ! = 2962, 2874, 1620, 1469, 1423, 1390, 1370, 1323, 1242, 1188, 1163, 
1119, 1110, 1089, 1067, 1018, 950, 927, 836, 761, 716, 670, 647, 637, 605, 576, 566, 556. 
MS (EI, 70 eV): m/z (%) = 258 (4), 228 (6), 213 (9), 186 (7), 185 (23), 173 (10), 172 (100), 165 
(7), 159 (9), 115 (8), 91 (5), 95 (6).  
HR-MS (EI, 70 eV): [C14H17F3O], calcd.: 258.1231; found: 258.1233. 
 
Ethyl 3-((3R,4S)-4-isopropyltetrahydrofuran-3-yl)benzoate (69b) 
  
Isolated yield:  84 mg, 0.32 mmol, 64%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.94 (s, 1H), 7.89 (d, J = 7.8 Hz, 1H), 7.46 (d, J = 7.8 Hz, 
1H), 7.37 (t, J = 7.7 Hz, 1H), 4.38 (q, J = 7.3 Hz, 2H), 4.18 (t, J = 8.4 Hz, 1H), 4.13 (t, J = 8.3 Hz, 
1H), 3.72 (t, J = 8.0 Hz, 1H), 3.66 (t, J = 8.4 Hz, 1H), 3.14 (q, J = 7.7 Hz, 1H), 2.20 (p, J = 7.9 
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Hz, 1H), 1.78 – 1.61 (m, J = 6.8 Hz, 1H), 1.40 (t, J = 7.2 Hz, 3H), 0.88 (d, J = 6.7 Hz, 3H), 0.82 
(d, J = 6.7 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 166.7, 144.1, 132.2, 130.8, 128.7, 128.7, 127.6, 72.6, 
61.1, 55.0, 50.4, 31.3, 21.7, 20.5, 14.4.  
FT-IR (ATR, cm-1): ! = 2961, 1618, 1424, 1323, 1303, 1185, 1158, 1122, 1107, 1094, 1067, 
1048, 1027, 1016, 1004, 840, 814, 740, 709, 665, 653.  
MS (EI, 70 eV): m/z (%) = 262 (17), 253 (14), 216 (28), 177 (22), 176 (100), 164 (21), 148 (27), 
145 (14), 131 (37), 129 (12), 128 (11), 117 (50), 116 (15), 115 (33), 77 (17).    
HR-MS (EI, 70 eV): [C16H22O3], calcd.: 262.1569; found: 262.1562. 
 
(3R,4R)-3-(Prop-1-en-2-yl)-4-(4-(trifluoromethyl)phenyl)tetrahydrofuran (69c) 
 
Isolated yield:  69 mg, 0.27 mmol, 54%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 9:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.49 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 4.75 – 
4.64 (m, 1H), 4.68 (d, J = 0.8 Hz, 1H), 4.18 (t, J = 8.3 Hz, 1H), 4.11 (t, J = 8.3 Hz, 1H), 3.82 – 
3.64 (m, 2H), 3.30 (q, J = 8.3 Hz, 1H), 2.94 (q, J = 8.6 Hz, 1H), 1.66 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 145.6, 142.5, 129.0 (q, J = 32.4 Hz), 127.8, 125.6 (q, J = 
3.7 Hz), 124.2 (q, J = 275.1 Hz), 112.6, 75.2, 72.6, 55.1, 49.5, 20.3.  
FT-IR (ATR, cm-1): ! = 2936, 2863, 1620, 1423, 1323, 1163, 1114, 1067, 1017, 945, 923, 896, 
835. 
MS (EI, 70 eV): m/z (%) = 256 (15), 237 (11), 212 (14), 211 (100), 198 (18), 192 (35), 188 (81), 
177 (16), 172 (43), 159 (19), 157 (32), 142 (31), 141 (11).  
HR-MS (EI, 70 eV): [C14H15F3O], calcd.: 256.1075; found: 256.1068. 
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(3R,4R)-3-(4-Methoxyphenyl)-4-(prop-1-en-2-yl)tetrahydrofuran (69d) 
 
Isolated yield:  62 mg, 0.29 mmol, 57%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.20 – 7.13 (m, 2H), 6.88 – 6.83 (m, 2H), 4.80 – 4.74 (m, 
2H), 4.23 (t, J = 8.2 Hz, 1H), 4.15 (t, J = 8.3 Hz, 1H), 3.79 (s, 3H), 3.78 – 3.73 (m, 2H), 3.28 (q, 
J = 8.8 Hz, 1H), 2.98 (q, J = 8.7 Hz, 1H), 1.72 (s, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 158.3, 143.0, 132.8, 128.4, 114.0, 112.3, 75.6, 72.6, 
55.3, 54.8, 48.9, 20.3. 
FT-IR (ATR, cm-1): ! = 2936, 2863, 1620, 1423, 1323, 1163, 1114, 1067, 1017, 945, 923, 896, 
835. 
MS (EI, 70 eV): m/z (%) = 218 (21), 203 (15), 173 (12), 150 (28), 135 (15), 134 (16), 122 (11), 
121 (100), 43 (10).  
HR-MS (EI, 70 eV): [C14H18O2], calcd.: 218.1307; found: 218.1304. 
 
trans-3-Isopropyl-4-(3-methoxyphenyl)-1-tosylpyrrolidine (69e) 
 
Isolated yield: 246 mg, 0.33 mmol, 66%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (600 MHz, CDCl3, ppm): δ = 7.68 – 7.62 (m, 2H), 7.29 – 7.24 (m, 2H), 7.09 (t, J = 7.9 
Hz, 1H), 6.68 – 6.54 (m, 4H), 3.68 (s, 2H), 3.51 (ddd, J = 39.1, 9.9, 8.0 Hz, 2H), 3.03 (dt, J = 
34.1, 9.6 Hz, 2H), 2.81 (td, J = 9.6, 8.0 Hz, 1H), 2.37 (s, 3H), 2.00 (tdd, J = 9.7, 8.0, 6.1 Hz, 1H), 
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1.52 – 1.39 (m, 1H), 0.69 (d, J = 6.8 Hz, 3H), 0.64 (d, J = 6.8 Hz, 3H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 159.8, 143.5, 142.5, 133.6, 129.7, 127.6, 119.9, 113.7, 
111.8, 55.9, 55.2, 51.7, 50.5, 48.1, 29.2, 21.5, 18.7.  
FT-IR (ATR, cm-1): ! = 2959, 1598, 1487, 1466, 1341, 1287, 1263, 1156, 1094, 1042, 1015, 
909, 814, 781, 730, 662.  
MS (EI, 70 eV): m/z (%) = 222 (100), 219 (15), 190 (17), 146 (16), 134 (23), 121 (16), 110 (16), 
91 (29), 83 (14), 42 (56).  
HR-MS (EI, 70 eV): [C21H27NO3S], calcd.: 373.1712; found: 373.1709. 
 
trans-3-Isopropyl-4-(3-methoxyphenyl)-1-tosylpyrrolidine (69f) 
 
Isolated yield: 416 mg, 0.44 mmol, 88%, colorless oil  
dr: 99:1.  
Purification: i-hexane:ethyl acetate = 95:5  
1H-NMR (600 MHz, CDCl3, ppm): δ  = 7.69 – 7.63 (m, 2H), 7.31 – 7.22 (m, 2H), 7.02 (t, J = 7.8 
Hz, 1H), 6.60 (ddt, J = 8.0, 3.4, 1.3 Hz, 2H), 6.51 (t, J = 2.0 Hz, 1H), 3.52 (ddd, J = 38.5, 9.9, 8.0 
Hz, 2H), 3.02 (dt, J = 28.5, 9.7 Hz, 2H), 2.78 (td, J = 9.7, 7.9 Hz, 1H), 2.37 (s, 3H), 2.04 – 1.89 
(m, 1H), 1.45 (dq, J = 13.4, 6.7 Hz, 1H), 0.89 (s, 9H), 0.69 (d, J = 6.7 Hz, 3H), 0.63 (d, J = 6.8 
Hz, 3H), 0.09 (s, 6H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 155.9, 143.5, 142.4, 133.6, 129.7, 129.6, 127.6, 120.7, 
119.2, 118.7, 55.9, 51.7, 50.6, 47.9, 29.2, 25.7, 21.6, 21.5, 18.8, 18.2, -4.4. 
FT-IR (ATR, cm-1): ! = 2957, 2859, 1600, 1585, 1484, 1471, 1443, 1344, 1278, 1253, 1159, 
1097, 1001, 908, 837, 781, 726, 700, 662.  
MS (EI, 70 eV): m/z (%) = 417 (26), 416 (100), 149 (13), 91 (4), 73 (3), 42 (6). 
HR-MS (EI, 70 eV): [C26H39NO3SSi], calcd.: 473.2420; found: 473.2329.  
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4. Cobalt-Catalyzed Csp2-Csp3 Cross-Coupling Reactions of 
Diarylmanganese Reagents with Secondary Alkyl Iodides 
4.1. Additional Comments 
When the diarylmanganese reagent 72a reacted with iodide 70b the coupling-product 71b was 
obtained in only 63% yield using CoCl2. In contrast, using THF soluble CoCl2·2LiCl gave 71b in 
73% yield (Table 2, entry 1). The reaction of 72a with cyclohexyl iodide (70e) gave 71e in 81% 
yield using CoCl2 compared to 84% yield when using CoCl2·2LiCl in THF (Table 2, entry 4). 
Interestingly, the yields decreased dramatically when the organomanganese reagent 72f 
reacted with iodide 70e (CoCl2: 48%; CoCl2·2LiCl: 80%; Table 3, entry 8) and iodide 70b (CoCl2: 
19%; CoCl2·2LiCl: 60%; Table 3, entry 9) to afford the arylated products 71r. 
 
4.2. Preparation of Organometallic Reagents 
Typical procedure 3 (TP3): Preparation of diarylmanganese reagents by 
magnesium-insertion and transmetallation 
LiCl (1.1 equiv) was dried under high vacuum and allowed to cool to room temperature, then Mg 
turnings (1.2 equiv) and THF (1 M solution relating to the aryl bromide) were added. The 
reaction mixture was cooled to 0 °C and the corresponding aryl bromide (1.0 equiv) was added 
dropwise. The reaction was stirred until iodolysis of a reaction aliquot indicated full consumption 
of the starting material. Then a solution of MnCl2·2LiCl (0.55 equiv, 1 M in THF) was added 
dropwise and the solution was stirred for 1 h to afford the corresponding diarylmanganese 
reagent (ca. 0.5 M in THF). 
Typical procedure 4 (TP4): Preparation of diarylmanganese reagents b 
bromine-magnesium exchange and transmetallation 
The corresponding aryl bromide (1.0 equiv) was dissolved in THF (1 M solution relating to the 
aryl bromide) and the reaction mixture was cooled to -30 °C. Then i-PrMgCl·LiCl (1.1 equiv) was 
added dropwise and the reaction was stirred at this temperature until reaction aliquots quenched 
with iodine showed full consumption of the starting material. Then a solution of MnCl2·2LiCl 
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(0.55 equiv, 1 M in THF) was added dropwise and the solution was stirred for 1 h before use to 
afford the corresponding diarylmanganese reagent (ca. 0.5 M in THF). 
 
4.2. Synthesis of Starting Materials 
The following starting materials were prepared according to literature procedures with only little 
deviation.93 The spectral data of known compounds were in full agreement with the literature. 
1-Chloro-4-(2-iodopropyl)benzene (70a) 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.31 – 7.27 (m, 2H), 7.14 – 7.10 (m, 2H), 4.29 (dp, J = 
7.6, 6.8 Hz, 1H), 3.22 (dd, J = 14.2, 7.6 Hz, 1H), 3.04 (dd, J = 14.2, 7.0 Hz, 1H), 1.90 (d, J = 6.8 
Hz, 3H). 
 
tert-Butyl(3-iodobutoxy)dimethylsilane (70b)94  
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.35 (dqd, J = 9.5, 6.9, 4.4 Hz, 1H), 3.76 (ddd, J = 10.3, 
5.7, 4.6 Hz, 1H), 3.65 (ddd, J = 10.3, 8.1, 4.8 Hz, 1H), 2.04 – 1.94 (m, 4H), 1.78 (dddd, J = 14.6, 
8.1, 5.7, 4.4 Hz, 1H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
 
1-(2-Iodopropyl)-3-(trifluoromethyl)benzene (70c) 
 
                                                
93 C. W. Cheung, P. Ren, X. Hu, Org. Lett. 2014, 16, 2566. 
94 R. Yefidoff, A. Albeck, Tetrahedron 2004, 60, 8093.	
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1H-NMR (400 MHz, CDCl3, ppm): δ =7.57 – 7.52 (m, 1H), 7.48 – 7.41 (m, 2H), 7.41 – 7.36 (m, 
1H), 4.32 (dp, J = 7.7, 6.8 Hz, 1H), 3.30 (dd, J = 14.3, 7.7 Hz, 1H), 3.13 (dd, J = 14.2, 6.9 Hz, 
1H), 1.93 (d, J = 6.8 Hz, 3H). 
 
4-(3-Iodobutyl)phenyl acetate (70d) 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.23 – 7.19 (m, 2H), 7.03 – 6.98 (m, 2H), 4.10 (dqd, J = 
9.2, 6.8, 4.4 Hz, 1H), 2.84 (ddd, J = 14.0, 9.0, 5.1 Hz, 1H), 2.69 (ddd, J = 13.9, 9.0, 7.0 Hz, 1H), 
2.29 (s, 3H), 2.19 – 2.08 (m, 1H), 1.94 (d, J = 6.8 Hz, 3H), 1.86 (dddd, J = 14.6, 9.0, 7.0, 4.4 Hz, 
1H). 
 
tert-Butyl((4-iodocyclohexyl)oxy)dimethylsilane (70f)4 
 
dr = 99:1 (cis:trans) 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.44 – 4.32 (m, 1H), 3.96 – 3.82 (m, 1H), 2.30 (dtd, J = 
13.1, 9.0, 3.8 Hz, 2H), 1.97 – 1.87 (m, 2H), 1.72 – 1.62 (m, 2H), 1.63 – 1.52 (m, 2H), 0.90 (s, 
9H), 0.04 (s, 6H). 
 
2-Iodo-2,3-dihydro-1H-indene (70h)95  
 
                                                
95 Y. Dai, F. Wu, Z.  Zang, H. You, H. Gong, Chem. - Eur. J. 2012, 18, 808. 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 7.28 – 7.23 (m, 2H), 7.23 – 7.18 (m, 2H), 4.71 (tt, J = 6.5, 
5.0 Hz, 1H), 3.48 (dd, J = 16.8, 6.5 Hz, 2H), 3.39 (dd, J = 16.8, 5.0 Hz, 2H). 
 
1-(3-Iodobutyl)-4-methoxybenzene (70k) 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.15 – 7.10 (m, 2H), 6.87 – 6.81 (m, 2H), 4.11 (dqd, J = 
9.1, 6.8, 4.5 Hz, 1H), 3.79 (s, 3H), 2.79 (ddd, J = 13.9, 8.8, 5.2 Hz, 1H), 2.64 (ddd, J = 13.8, 8.8, 
7.0 Hz, 1H), 2.13 (dtd, J = 14.2, 8.9, 5.2 Hz, 1H), 1.95 (d, J = 6.8 Hz, 3H), 1.84 (dddd, J = 14.6, 
8.8, 7.1, 4.5 Hz, 1H). 
 
 
((3-Iodobutoxy)methyl)benzene (70m) 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.39 – 7.27 (m, 5H), 4.64 – 4.44 (m, 2H), 4.39 (dqd, 
J=9.5, 6.9, 4.6, 1H), 3.67 – 3.61 (m, 1H), 3.55 (ddd, J=9.6, 8.0, 5.0, 1H), 2.15 – 2.03 (m, 1H), 
2.00 – 1.86 (m, 4H). 
 
4-Iodotetrahydro-2H-pyran (70n) 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.45 (tt, J = 7.7, 5.5 Hz, 1H), 3.87 – 3.76 (m, 2H), 3.57 – 
3.48 (m, 2H), 2.18 – 2.12 (m, 4H). 
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tert-Butyl 3-iodopiperidine-1-carboxylate (70o) 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.29 – 3.92 (m, 2H), 3.78 (d, J = 13.0 Hz, 1H), 3.53 – 
3.24 (m, 1H), 3.09 (s, 1H), 2.26 (s, 1H), 2.10 – 1.95 (m, 1H), 1.72 (d, J = 13.5 Hz, 1H), 1.57 (s, 
1H), 1.46 (s, 9H). 
 
4.3. Cobalt-Catalyzed Cross-Coupling of Diarylmanganese Reagents with 
Secondary Alkyl Halides 
Typical Procedure 5 (TP5): A dry and argon-flushed 10 mL Schlenk-tube, equipped with a 
stirring bar and a septum, was charged with CoCl2·2LiCl (1 M in THF, 0.1 mL, 0.10 mmol, 
20 mol%). The secondary alkyl halide (0.50 mmol, 1.0 equiv) and THF (1 mL) were added and 
the mixture was cooled to -20 °C. The diarylmanganese reagent (0.35 mmol, 0.7 equiv) was 
added dropwise and the mixture was allowed to warm to room temperature overnight. A sat. aq. 
solution of NH4Cl (5 mL) and EtOAc (5 mL) were added and the aqueous phase was extracted 
with EtOAc (3 x 20 mL). The combined organic phases were washed with brine, dried over 
Na2SO4 and the solvents were evaporated. The residue was subjected to column 
chromatography purification (SiO2; i-hexane/EtOAc) yielding the corresponding title compound. 
 
1-Chloro-4-(2-(4-methoxyphenyl)propyl)benzene (71a) 
 
Following TP5 1-Chloro-4-(2-iodopropyl)benzene (70a, 140 mg, 0.5 mmol, 1 equiv, in 1 mL 
THF) reacts with the di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) prepared 
according to TP3, at -20 °C. The solution was allowed to warm to room temperature under 
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stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:1.5) as an eluent to afford 71a as a 
colorless solid (75%, 98 mg, 0.38 mmol). 
Mp.: 62.2 – 63.5 °C  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.21 – 7.16 (m, 2H), 7.08 – 7.03 (m, 2H), 6.98 – 6.93 (m, 
2H), 6.85 – 6.79 (m, 2H), 3.79 (s, 3H), 2.92 (h, J = 6.9 Hz, 1H), 2.84 (dd, J = 13.3, 7.0 Hz, 1H), 
2.74 (dd, J = 13.2, 7.6 Hz, 1H), 1.22 (d, J = 6.8 Hz, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 158.0, 139.4, 138.6, 131.7, 130.6, 128.3, 128.0, 113.8, 
55.4, 44.7, 41.1, 21.6. 
FT-IR (ATR, cm-1): 2956, 2925, 2852, 1513, 1490, 1455, 1440, 1259, 1241, 1177, 1088, 1031, 
1008, 829, 814, 806, 798, 698, 656.  
MS (EI, 70 eV): m/z (%) = 260 (2), 136 (8), 135 (100), 125 (4), 105 (5), 103 (4), 91 (5), 77 (3). 
HR-MS (EI, 70 eV): [C16H17ClO], calcd.: 260.0968; found: 260.0952. 
 
tert-Butyl(3-(4-methoxyphenyl)butoxy)dimethylsilane (71b) 
 
Following TP5 tert-butyl(3-iodobutoxy)dimethylsilane (70b, 157 mg, 0.5 mmol, 1 equiv, in 1 mL 
THF) reacts with the di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) prepared 
according to TP3, at -20 °C. The solution was allowed to warm to room temperature under 
stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:2) as an eluent to afford 71b as a 
yellowish oil (73%, 108 mg, 0.37 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.14 – 7.08 (m, 2H), 6.86 – 6.81 (m, 2H), 3.79 (s, 3H), 
3.57 – 3.43 (m, 2H), 2.84 (h, J = 7.1 Hz, 1H), 1.80 – 1.73 (m, 2H), 1.22 (d, J = 7.0 Hz, 3H), 0.88 
(s, 9H), 0.00 (d, J = 0.8 Hz, 6H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 157.9, 139.5, 128.0, 113.8, 61.4, 55.4, 41.5, 35.4, 26.1, 
22.7, 18.4, -5.1.  
FT-IR (ATR, cm-1): 2953, 2927, 2856, 2834, 1612, 1512, 1462, 1245, 1176, 1095, 1037, 899, 
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827, 773.  
MS (EI, 70 eV): m/z (%) = 237 (100), 165 (20), 135 (22), 97 (20), 89 (56), 85 (42), 84 (31), 
83 (29), 71 (49), 69 (32), 57 (89), 55 (29), 44 (25), 43 (46), 41 (28).  
HR-MS (EI, 70 eV): [C13H21O2Si], calcd.: 237.1305; found: 237.1314 [M+-tBu]. 
 
1-(2-(4-Methoxyphenyl)propyl)-3-(trifluoromethyl)benzene (71c) 
 
Following TP5 1-(2-Iodopropyl)-3-(trifluoromethyl)benzene (70c, 157 mg, 0.5 mmol, 1 equiv, in 
1 mL THF) reacts with the di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) prepared 
according to TP3, at -20 °C. The solution was allowed to warm to room temperature under 
stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:5) as an eluent to afford 71c as a 
colorless oil (77%, 114 mg, 0.39 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.44 – 7.39 (m, 1H), 7.35 – 7.27 (m, 2H), 7.21 – 7.17 (m, 
1H), 7.09 – 7.03 (m, 2H), 6.85 – 6.80 (m, 2H), 3.79 (s, 3H), 3.02 – 2.89 (m, 2H), 2.88 – 2.79 (m, 
1H), 1.24 (d, J = 6.8 Hz, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 158.2, 141.8, 138.3, 132.7, 130.5 (q, J = 31.9 Hz), 128.5, 
128.0, 126.0 (q, J = 3.9 Hz), 124.4 (q, J = 272.2 Hz), 122.8 (q, J = 3.9 Hz), 113.9, 55.4, 45.2, 
41.0, 21.4.  
FT-IR (ATR, cm-1): 2959, 2929, 2836, 2360, 1611, 1512, 1449, 1326, 1245, 1176, 1159, 1118, 
1072, 1037, 904, 827, 796, 702, 661.  
MS (EI, 70 eV): m/z (%) = 158 (4), 136 (8), 135 (100), 105 (5), 103 (4), 91 (6), 79 (3), 77 (4), 
42 (3). 
HR-MS (EI, 70 eV): [C17H17F3O], calcd.: 294.1231; found: 294.1232. 
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4-(3-(4-Methoxyphenyl)butyl)phenyl acetate (71d) 
 
Following TP5 4-(3-Iodobutyl)phenyl acetate (70d, 159 mg, 0.5 mmol, 1 equiv, in 1 mL THF) 
reacts with the di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) prepared according 
to TP3, at -20 °C. The solution was allowed to warm to room temperature under stirring for 8 h 
and was worked-up as usual. The crude product was purified by column chromatography on 
silica using i-hexane:ethyl acetate (100:5) as an eluent to afford 71d as a colorless oil (75%, 
112 mg, 0.37 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.16 – 7.09 (m, 4H), 7.00 – 6.94 (m, 2H), 6.90 – 6.84 (m, 
2H), 3.81 (s, 3H), 2.68 (h, J=7.1, 1H), 2.49 (td, J=7.9, 1.8, 2H), 2.29 (s, 3H), 1.93 – 1.82 (m, 
2H), 1.25 (d, J=6.9, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 169.8, 158.0, 148.7, 140.3, 139.4, 129.4, 128.0, 121.3, 
113.9, 55.4, 40.2, 38.8, 33.4, 22.9, 21.3.  
FT-IR (ATR, cm-1): 3032, 2995, 2955, 2928, 2866, 2835, 1758, 1610, 1510, 1507, 1368, 1244, 
1213, 1189, 1164, 1031, 1017, 1010, 910, 828, 808.  
MS (EI, 70 eV): m/z (%) = 299 (4), 298 (22), 256 (14), 148 (5), 136 (10), 135 (100), 121 (8), 
107 (12), 105 (4), 91 (5), 77 (5), 43 (8).  
HR-MS (EI, 70 eV): [C19H22O3], calcd.: 298.1569; found: 298.1565. 
 
1-Cyclohexyl-4-methoxybenzene (71e)96  
 
Following TP5 iodocyclohexane (70e, 105 mg, 0.5 mmol, 1 equiv, in 1 mL THF) reacts with the 
di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) prepared according to TP3, 
at -20 °C. The solution was allowed to warm to room temperature under stirring for 8 h and was 
                                                
96 M. Nakamura, K. Matsuo, S. Ito, E. Nakamura, J. Am. Chem. Soc. 2004, 126, 3686. 
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worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (100:2) as an eluent to afford 71e as a colorless solid (84%, 80 mg, 
0.42 mmol). 
Mp.: 58.1-58.7 °C  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.17 – 7.11 (m, 2H), 6.87 – 6.82 (m, 2H), 3.79 (s, 3H), 
2.46 (ddq, J=11.7, 8.7, 3.3, 1H), 1.91 – 1.81 (m, 4H), 1.79 – 1.71 (m, 1H), 1.47 – 1.32 (m, 4H), 
1.31 – 1.20 (m, 1H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 157.8, 140.5, 127.8, 113.8, 55.4, 43.8, 34.9, 27.1, 26.3. 
MS (EI, 70 eV): m/z (%) = 190 (56), 147 (97), 121 (34), 111 (36), 97 (59), 95 (47), 85 (51), 
84 (93), 83 (45), 71 (65), 69 (68), 57 (100), 55 (74), 43 (71), 42 (62), 39 (72).  
HR-MS (EI, 70 eV): [C13H18O], calcd.: 190.1358; found: 190.1349. 
tert-Butyl((4-(4-methoxyphenyl)cyclohexyl)oxy)dimethylsilane (71f) 
 
Following TP5 tert-Butyl((4-iodocyclohexyl)oxy)dimethylsilane (70f, 170 mg, 0.5 mmol, 1 equiv, 
in 1 mL THF) reacts with the di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) 
prepared according to TP3, at -20 °C. The solution was allowed to warm to room temperature 
under stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:2) as an eluent to afford 71f as a 
colorless oil (75%, 120 mg, 0.37 mmol). 
Signals of both diasteriomers are given (dr = 70:30). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.18 – 7.09 (m, 2H), 6.89 – 6.79 (m, 2H), 3.79 (d, J=1.9, 
3H), 4.09 – 3.58 (m, 1H), 2.51 – 2.38 (m, 1H), 2.03 – 1.72 (m, 4H), 1.64 – 1.37 (m, 4H), 0.92 (s, 
9H), 0.07 (s, 6H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 157.9, 157.8, 140.4, 139.2, 127.8, 127.7, 113.8, 113.8, 
71.6, 66.0, 55.4, 43.3, 42.8, 36.5, 34.0, 33.1, 28.3, 26.1, 26.0, 18.4, 18.3, -4.4, -4.7. 
FT-IR (ATR, cm-1): 2927, 2855, 1612, 1582, 1512, 1471, 1462, 1450, 1441, 1420, 1387, 1375, 
1360, 1304, 1281, 1245, 1177, 1117, 1091, 1040, 1019, 1005, 988, 938, 891, 859, 833, 824, 
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805, 793, 772, 749, 668.  
MS (EI, 70 eV): m/z (%) = 263 (18), 189 (8), 188 (50), 187 (100), 173 (5), 134 (15), 121 (17), 
75 (39), 73 (8).  
HR-MS (EI, 70 eV): [C19H32O2Si], calcd.: 320,2172; found: 320.2168.  
 
tert-Butyl((2-(4-methoxyphenyl)cyclohexyl)oxy)dimethylsilane (71g) 
 
Following TP5 tert-Butyl((cis-2-iodocyclohexyl)oxy)dimethylsilane (70g, 170 mg, 
0.5 mmol, 1 equiv, in 1 mL THF) reacts with the di(p-anisyl)manganese reagent (72a, 
0.35 mmol, 0.7 equiv) prepared according to TP3, at -20 °C. The was allowed to warm to room 
temperature under stirring for 8 h and was worked-up as usual. The crude product was purified 
by column chromatography on silica using i-hexane:ethyl acetate (100:2) as an eluent to afford 
71g as a colorless oil (83%, 133 mg, 0.41 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.13 – 7.07 (m, 2H), 6.84 – 6.78 (m, 2H), 3.78 (s, 3H), 
3.47 (td, J=9.8, 4.5, 1H), 2.39 (ddd, J=13.1, 9.6, 3.6, 1H), 2.03 – 1.93 (m, 1H), 1.87 – 1.76 (m, 
2H), 1.76 – 1.70 (m, 1H), 1.53 (qd, J=13.0, 3.6, 1H), 1.44 – 1.24 (m, 3H), 0.68 (s, 9H), -0.19 (s, 
3H), -0.50 (s, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 158.1, 137.5, 129.3, 113.5, 76.2, 55.5, 52.2, 36.9, 33.1, 
26.3, 25.9, 25.4, 18.0, -4.6, -5.4.  
FT-IR (ATR, cm-1): 2926, 2854, 2360, 2341, 1512, 1360, 1244, 1176, 1124, 1090, 1039, 983, 
881, 857, 846, 831, 813, 772, 753, 666.  
MS (EI, 70 eV): m/z (%) = 305 (1), 265 (6), 264 (22), 263 (100), 189 (12), 187 (7), 165 (7), 
121 (33), 75 (33), 73 (12).  
HR-MS (EI, 70 eV): [C18H29O2Si], calcd.: 305.1931; found: 305.1936 [M+-CH3].  
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2-(4-Methoxyphenyl)-2,3-dihydro-1H-indene (71h) 
 
Following TP5 2-Iodo-2,3-dihydro-1H-indene (70h, 122 mg, 0.5 mmol, 1 equiv, in 1 mL THF) 
reacts with the di(p-anisyl)manganese reagent (72a, 0.35 mmol, 0.7 equiv) prepared according 
to TP3, at -20 °C. The solution was allowed to warm to room temperature under stirring for 8 h 
and was worked-up as usual. The crude product was purified by column chromatography on 
silica using i-hexane:ethyl acetate (100:2) as an eluent to afford 71h as a colorless oil (70%, 
78 mg, 0.35 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.29 – 7.19 (m, 4H), 7.22 – 7.17 (m, 2H), 6.90 – 6.84 (m, 
2H), 3.81 (s, 3H), 3.66 (p, J=8.6, 1H), 3.33 (dd, J=15.4, 8.0, 2H), 3.06 (dd, J=15.5, 9.0, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 158.1, 143.2, 137.7, 128.1, 126.5, 124.4, 114.0, 55.4, 
45.0, 41.2.  
FT-IR (ATR, cm-1): 3066, 3019, 2932, 2903, 2833, 1611, 1511, 1482, 1458, 1441, 1243, 1220, 
1177, 1034, 825, 741. 
MS (EI, 70 eV): m/z (%) = 225 (19), 224 (100), 209 (34), 116 (36), 115 (30), 82 (18), 57 (23), 
55 (21), 43 (47), 42 (14).  
HR-MS (EI, 70 eV): [C16H16O], calcd.: 224.1201; found: 224.1193. 
 
3-((tert-Butyldimethylsilyl)oxy)-4-(4-methoxyphenyl)-1-tosylpyrrolidine (71i) 
 
Following TP5 3-((tert-Butyldimethylsilyl)oxy)4-iodo-1-tosylpyrrolidine (70i, 241 mg, 
0.5 mmol, 1 equiv, in 1 mL THF) reacts with the di(p-anisyl)manganese reagent (72a, 
0.35 mmol, 0.7 equiv) prepared according to TP3, at -20 °C. The solution was allowed to warm 
to room temperature under stirring for 8 h and was worked-up as usual. The crude product was 
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purified by column chromatography on silica using i-hexane:ethyl acetate (9:1) as an eluent to 
afford 71i as a colorless solid (59%, 136 mg, 0.29 mmol). 
Signals of the main diastereomer are given (dr = 95:5). 
Mp.: 124.3-126.1 °C  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.78 – 7.74 (m, 2H), 7.37 – 7.32 (m, 2H), 7.15 – 7.05 (m, 
2H), 6.86 – 6.80 (m, 2H), 4.04 (q, J=5.3, 1H), 3.78 (s, 3H), 3.67 – 3.58 (m, 2H), 3.51 (dd, J=9.8, 
6.2, 1H), 3.10 – 2.97 (m, 2H), 2.45 (s, 3H), 0.71 (s, 9H), -0.16 (s, 3H), -0.21 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 158.9, 143.6, 134.0, 131.2, 129.8, 128.6, 127.7, 114.2, 
77.7, 55.4, 54.4, 51.9, 51.5, 25.7, 21.7, 17.9, -4.9, -5.0.  
FT-IR (ATR, cm-1): 2953, 2929, 2885, 2856, 1515, 1346, 1250, 1161, 1093, 1034, 834, 778, 
666. 
MS (EI, 70 eV): m/z (%) = 406 (10), 405 (24), 400 (100), 270 (3), 174 (3), 149 (4), 147 (5), 
134 (5), 125 (6), 121 (17), 91 (8), 72 (8), 42 (7).  
HR-MS (EI, 70 eV): [C23H32NO4SSi], calcd.: 446.1816; found: 446.1805 [M+-CH3]. 
 
1-(2-(4-(Methoxymethoxy)phenyl)propyl)-3-(trifluoromethyl)benzene (71j) 
 
Following TP5 1-(2-Iodopropyl)-3-(trifluoromethyl)benzene (70c, 314 mg, 1 mmol, 1 equiv, in 
2 mL THF) reacts with the di(4-(methoxymethoxy)benzene)manganese reagent (72b, 0.7 mmol, 
0.7 equiv) prepared according to TP3, at -20 °C. The was allowed to warm to room temperature 
under stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:2) as an eluent to afford 71j as a 
colorless oil (76%, 246 mg, 0.76 mmol). 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.42 (d, J=7.7, 1H), 7.33 (t, J=7.7, 1H), 7.27 (s, 1H), 7.22 
(d, J=7.6, 1H), 7.08 – 7.03 (m, 2H), 6.98 – 6.93 (m, 2H), 5.15 (s, 2H), 3.48 (s, 3H), 3.02 – 2.88 
(m, 2H), 2.87 – 2.79 (m, 1H), 1.24 (d, J=6.7, 3H).  
13C-NMR (151 MHz, CDCl3, ppm): δ = 155.8, 141.8, 139.7, 132.7 (d, J = 1.2 Hz), 130.5 (q, J = 
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31.9 Hz), 128.6, 128.1, 126.0 (q, J = 3.8 Hz), 124.4 (q, J = 272.3 Hz), 122.9 (q, J = 3.8 Hz), 
116.3, 94.7, 56.1, 45.1, 41.1, 21.4.  
FT-IR (ATR, cm-1): 2961, 2930, 2899, 1511, 1328, 1314, 1234, 1200, 1152, 1120, 1073, 1019, 
999, 921, 831, 796, 702, 661. 
MS (EI, 70 eV): m/z (%) = 324 (2), 293 (2), 166 (9), 165 (100), 159 (10), 136 (4), 135 (42), 91 
(6), 77 (2), 45 (80).  
HR-MS (EI, 70 eV): [C18H19F3O2], calcd.: 324.1337; found: 324.1334. 
tert-Butyl 4-(4-(methoxymethoxy)phenyl)piperidine-1-carboxylate (71k) 
 
Following TP5 tert-butyl 4-iodopiperidine-1-carboxylate (70j, 156 mg, 0.5 mmol, 1 equiv, in 1 mL 
THF) reacts with the di(4-(methoxymethoxy)benzene)manganese reagent (72b, 0.35 mmol, 
0.7 equiv) prepared according to TP3, at -20 °C. The solution was allowed to warm to room 
temperature under stirring for 8 h and was worked-up as usual. The crude product was purified 
by column chromatography on silica using i-hexane:ethyl acetate (10:1) as an eluent to afford 
71k as a colorless solid (75%, 121 mg, 0.38 mmol). 
Mp.: 84.8 – 86.6 °C  
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.14 – 7.09 (m, 2H), 7.00 – 6.97 (m, 2H), 5.15 (s, 2H), 
4.23 (s, 2H), 3.47 (s, 3H), 2.85 – 2.73 (m, 2H), 2.59 (tt, J = 12.2, 3.6 Hz, 1H), 1.79 (d, J = 12.6 
Hz, 2H), 1.63 – 1.54 (m, 2H), 1.48 (s, 9H).  
13C-NMR (151 MHz, CDCl3, ppm): δ = 155.8, 155.0, 139.4, 127.8, 116.4, 94.7, 79.5, 56.1, 44.7, 
42.1, 33.5, 28.6.  
FT-IR (ATR, cm-1): 2974, 2932, 2850, 1687, 1511, 1422, 1365, 1279, 1228, 1198, 1151, 1123, 
1106, 1077, 1001, 985, 922, 831, 762.  
MS (EI, 70 eV): m/z (%) = 321 (7), 265 (22), 248 (14), 221 (22), 220 (15), 203 (17), 189 (6), 176 
(14), 82 (13), 57 (89), 56 (15), 45 (100), 41 (17).  
HR-MS (EI, 70 eV): [C18H27NO4], calcd.: 321.1940; found: 321.1931. 
 
MOMO
NBoc
EXPERIMENTAL PART 
____________________________________________________________________________ 
 135 
1-Chloro-4-(2-(4-(trifluoromethyl)phenyl)propyl)benzene (71l) 
 
Following TP5 tert-butyl 4-iodopiperidine-1-carboxylate (70a, 140 mg, 0.5 mmol, 1 equiv, in 
1 mL THF) reacts with the di(4-(trifluoromethyl)benzene)manganese reagent (72c, 0.35 mmol, 
0.7 equiv) prepared according to TP4, at -20 °C. The solution was allowed to warm to room 
temperature under stirring for 8 h and was worked-up as usual. The crude product was purified 
by column chromatography on silica using i-hexane as an eluent to afford 71l as a colorless oil 
(81%, 106 mg, 0.41 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.52 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 8.2 Hz, 2H), 7.22 – 
7.17 (m, 2H), 7.00 – 6.93 (m, 2H), 3.04 (h, J = 7.1 Hz, 1H), 2.92 – 2.77 (m, 2H), 1.27 (d, J = 6.9 
Hz, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 150.5 (d, J = 1.5 Hz), 138.6, 132.0, 130.5, 128.7 (q, J = 
30.7 Hz), 128.5, 127.5, 125.4 (q, J = 4.0 Hz), 124.4 (q, J = 272.0 Hz), 44.2, 41.9, 21.2. 
FT-IR (ATR, cm-1): 2964, 2928, 2874, 2856, 1618, 1491, 1322, 1161, 1114, 1105, 1093, 1068, 
1014, 834, 801.  
MS (EI, 70 eV): m/z (%) = 298 (10), 174 (35), 173 (35), 153 (11), 133 (14), 127 (36), 126 (18), 
125 (100), 103 (4), 90 (4), 89 (9), 44 (5), 43 (7).  
HR-MS (EI, 70 eV): [C16H14ClF3], calcd.: 298.0736; found: 298.0736. 
 
1-Methoxy-4-(3-(4-(trifluoromethyl)phenyl)butyl)benzene (71m) 
 
Following TP5 1-(3-iodobutyl)-4-methoxybenzene (70k, 145 mg, 0.5 mmol, 1 equiv, in 1 mL 
THF) reacts with the di(4-(trifluoromethyl)benzene)manganese reagent (72c, 0.35 mmol, 
0.7 equiv) prepared according to TP4, at -20 °C. The solution was allowed to warm to room 
temperature under stirring for 8 h and was worked-up as usual. The crude product was purified 
F3C
Me
Cl
Me
OMeF3C
EXPERIMENTAL PART 
____________________________________________________________________________ 
 136 
by column chromatography on silica using i-hexane:ethyl acetate (100:2)  as an eluent to afford 
72m as a colorless oil (87%, 134 mg, 0.43 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.57 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 7.06 – 
7.01 (m, 2H), 6.84 – 6.80 (m, 2H), 3.79 (s, 3H), 2.78 (h, J = 7.1 Hz, 1H), 2.52 – 2.41 (m, 2H), 
1.98 – 1.85 (m, 2H), 1.28 (d, J = 6.9 Hz, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 157.9, 151.6 (d, J = 1.5 Hz), 134.2, 129.3, 128.4 (q, J = 
32.2 Hz), 127.6, 125.5 (q, J = 4.0 Hz), 124.5 (q, J = 272.0 Hz), 113.9, 55.4, 40.0, 39.5, 33.0, 
22.4. 
FT-IR (ATR, cm-1): 2958, 2931, 2835, 2360, 2332, 1511, 1323, 1243, 1161, 1115, 1066, 1036, 
1016, 837, 820.  
MS (EI, 70 eV): m/z (%) = 309 (5), 308 (23), 135 (17), 134 (12), 122 (16), 121 (100), 108 (6), 
91 (10), 78 (7), 77 (8), 57 (6).  
HR-MS (EI, 70 eV): [C18H19F3O], calcd.: 308.1388; found: 308.1383. 
 
tert-Butyl (3-(2,3-dihydro-1H-inden-2-yl)phenyl) carbonate (71n) 
 
Following TP5 2-iodo-2,3-dihydro-1H-indene (70h, 122 mg, 0.5 mmol, 1 equiv, in 1 mL THF) 
reacts with the di(3-(BocO)benzene-1-yl)manganese reagent (72d, 0.35 mmol, 0.7 equiv) 
prepared according to TP3, at -20 °C. The solution was allowed to warm to room temperature 
under stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:2) as an eluent to afford 71n as a 
colorless oil (76%, 118 mg, 0.38 mmol). 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.30 (t, J = 7.9 Hz, 1H), 7.27 – 7.22 (m, 2H), 7.21 – 7.14 
(m, 3H), 7.12 – 7.10 (m, 1H), 7.03 (ddd, J = 8.1, 2.4, 1.0 Hz, 1H), 3.70 (p, J = 8.6 Hz, 1H), 3.36 
(dd, J = 15.5, 8.2 Hz, 2H), 3.08 (dd, J = 15.5, 8.9 Hz, 2H), 1.56 (s, 9H).  
13C-NMR (151 MHz, CDCl3, ppm): δ = 152.1, 151.3, 147.4, 142.8, 129.4, 126.6, 124.5, 124.5, 
120.1, 119.2, 83.6, 45.4, 40.9, 27.9.  
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FT-IR (ATR, cm-1): 2980, 2934, 2907, 2844, 2361, 2332, 1753, 1586, 1369, 1269, 1253, 1232, 
1138, 1002, 780, 742, 692.  
MS (EI, 70 eV): m/z (%) = 211 (11), 210 (84), 195 (15), 178 (8), 165 (11), 117 (9), 116 (27), 
115 (11), 57 (100), 40 (11).  
HR-MS (EI, 70 eV): [C20H22O3], calcd.: 310.1569; found: 310.1556. 
 
tert-Butyl(3-(2,3-dihydro-1H-inden-2-yl)phenoxy)dimethylsilane (71o) 
 
Following TP5 2-iodo-2,3-dihydro-1H-indene (70h, 122 mg, 0.5 mmol, 1 equiv, in 1 mL THF) 
reacts with the di(3-(TBSO)benzene-1-yl)manganese reagent (72e, 0.35 mmol, 0.7 equiv) 
prepared according to TP3, at -20 °C. The solution was allowed to warm to room temperature 
under stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane as eluent to afford 71o as a colorless oil (74%, 
120 mg, 0.37 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.29 – 7.21 (m, 2H), 7.21 – 7.14 (m, 3H), 6.92 – 6.88 (m, 
1H), 6.79 (t, J = 2.2 Hz, 1H), 6.70 (ddd, J = 8.1, 2.4, 1.0 Hz, 1H), 3.65 (p, J = 8.5 Hz, 1H), 3.34 
(dd, J = 15.5, 8.1 Hz, 2H), 3.07 (dd, J = 15.5, 8.8 Hz, 2H), 0.98 (s, 9H), 0.18 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 155.8, 147.2, 143.1, 129.4, 126.6, 124.4, 120.2, 118.8, 
117.9, 45.5, 41.0, 25.9, 18.4, -4.2.  
FT-IR (ATR, cm-1): 3069, 3023, 2954, 2930, 2857, 1602, 1584, 1483, 1472, 1278, 1252, 1158, 
899, 836, 808, 779, 740, 695. 
MS (EI, 70 eV): m/z (%) = 325 (5), 324 (20), 269 (6), 268 (21), 267 (100), 134 (4), 117 (32), 115 
(9), 91 (4).  
HR-MS (EI, 70 eV): [C21H28OSi], calcd.: 324.1909; found: 324.1904. 
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3-((tert-Butyldimethylsilyl)oxy)-4-(3-((tert-butyldimethylsilyl)oxy)phenyl)-1tosylpyrrolidine 
(71p) 
 
Following TP5 3-((tert-Butyldimethylsilyl)oxy)4-iodo-1-tosylpyrrolidine (70i, 241 mg, 
0.5 mmol, 1 equiv, in 1 mL THF) reacts with the di(3-(TBSO)benzene-1-yl)manganese reagent 
(72e, 0.35 mmol, 0.7 equiv) prepared according to TP3, at -20 °C. The solution was allowed to 
warm to room temperature under stirring for 8 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (100:5) 
as eluent to afford 71p as a colorless solid (92%, 257 mg, 0.46 mmol). 
Mp.: 96.6-97.2 °C  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.79 – 7.73 (m, 2H), 7.37 – 7.32 (m, 2H), 7.13 (t, J = 7.8 
Hz, 1H), 6.77 – 6.67 (m, 3H), 4.07 (dt, J = 5.6 Hz, 1H), 3.67 – 3.59 (m, 2H), 3.50 (dd, J = 10.0, 
6.6 Hz, 1H), 3.05 (dd, J = 10.2, 5.2 Hz, 1H), 2.99 (dt, J = 7.8, 6.2 Hz, 1H), 2.45 (s, 3H), 0.98 (s, 
9H), 0.72 (s, 9H), 0.18 (s, 6H), -0.16 (s, 3H), -0.21 (s, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 156.1, 143.6, 140.7, 133.9, 129.8, 129.8, 127.7, 120.5, 
119.3, 119.0, 77.6, 54.5, 52.6, 51.4, 25.8, 25.7, 21.7, 18.4, 17.9, -4.2, -4.9, -5.0. 
FT-IR (ATR, cm-1): 2954, 2929, 2886, 2857, 1602, 1585, 1485, 1472, 1463, 1347, 1280, 1252, 
1160, 1143, 1093, 1003, 905, 861, 834, 813, 778, 732, 699, 663, 608, 589.  
MS (EI, 70 eV): m/z (%) = 507 (4), 506 (19), 505 (33), 504 (100), 224 (8), 149 (3), 91 (3), 73 (4). 
HR-MS (EI, 70 eV): [C28H44NO4SSi2], calcd.: 546.2524; found: 546.2526 [M+ -CH3] 
 
5-Cyclohexyl-1,2,3-trimethoxybenzene (70q) 
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Following TP5 iodocyclohexane (70e, 105 mg, 0.5 mmol, 1 equiv, in 1 mL THF) reacts with the 
di(3,4,5-(trimethoxy)benzene)manganese reagent (72f, 0.35 mmol, 0.7 equiv) prepared 
according to TP3, at -20 °C. The solution was allowed to warm to room temperature under 
stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:5) as eluent to afford 71q as a 
colorless oil (80%, 101 mg, 0.40 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 6.43 (s, 2H), 3.86 (s, 6H), 3.83 (s, 3H), 2.50 – 2.38 (m, 
1H), 1.94 – 1.80 (m, 4H), 1.79 – 1.70 (m, 1H), 1.47 – 1.34 (m, 4H), 1.31 – 1.19 (m, 1H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 153.2, 144.1, 136.2, 103.9, 61.0, 56.2, 45.2, 34.8, 27.0, 
26.3. 
FT-IR (ATR, cm-1): 2923, 2850, 2363, 2341, 1587, 1508, 1449, 1418, 1330, 1238, 1184, 1133, 
1121, 1103, 1009,956, 822, 775, 689.  
MS (EI, 70 eV): m/z (%) = 251 (25), 250 (100), 236 (9), 235 (51), 207 (13), 181 (16), 176 (10), 
153 (22), 151 (15), 57 (8).  
HR-MS (EI, 70 eV): [C15H22O3], calcd.: 250.1569; found: 250.1562. 
 
tert-Butyldimethyl(3-(3,4,5-trimethoxyphenyl)butoxy)silane (71r) 
 
Following TP5 tert-butyl(3-iodobutoxy)dimethylsilane (70b, 157 mg, 0.5 mmol, 1 equiv, in 1 mL 
THF) reacts with the di(3,4,5-(trimethoxy)benzene)manganese reagent (72f, 0.35 mmol, 
0.7 equiv) prepared according to TP3, at -20 °C. The solution was allowed to warm to room 
temperature under stirring for 8 h and was worked-up as usual. The crude product was purified 
by column chromatography on silica using i-hexane:ethyl acetate (100:8) as eluent to afford 71r 
as a colorless oil (60%, 157 mg, 0.30 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 6.40 (s, 2H), 3.85 (s, 6H), 3.83 (s, 3H), 3.60 – 3.44 (m, 
2H), 2.82 (h, J = 7.1 Hz, 1H), 1.77 (q, J = 6.8 Hz, 2H), 1.24 (d, J = 7.0 Hz, 3H), 0.89 (s, 9H), 
0.01 (d, J = 2.0 Hz, 6H).  
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13C-NMR (101 MHz, CDCl3, ppm): δ = 153.2, 143.3, 136.3, 104.1, 61.3, 61.0, 56.2, 41.4, 36.7, 
26.1, 22.5, 18.4, -5.1.  
FT-IR (ATR, cm-1): 2954, 2929, 2856, 1588, 1510, 1459, 1420, 1322, 1236, 1128, 1100, 1010, 
982, 899, 832, 811, 773, 664. 
MS (EI, 70 eV): m/z (%) = 354 (8), 299 (7), 298 (20), 297 (100), 282 (12), 252 (13), 196 (11), 
195 (10), 191 (8), 89 (14), 73 (5).  
HR-MS (EI, 70 eV): [C19H34O4Si], calcd.: 354.2226; found: 354.2226. 
 
5-(4-(Benzyloxy)butan-2-yl)benzo[d][1,3]dioxole (71s) 
 
Following TP5 ((3-iodobutoxy)methyl)benzene (70l, 145 mg, 0.5 mmol, 1 equiv, in 1 mL THF) 
reacts with the di(1,3-benzodioxol-5-yl)manganese reagent (72g, 0.35 mmol, 0.7 equiv) 
prepared according to TP3, at -20 °C. The solution was allowed to warm to room temperature 
under stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (100:1) as eluent to afford 71s as a 
colorless oil (66%, 93 mg, 0.33 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.38 – 7.26 (m, 5H), 6.75 – 6.68 (m, 2H), 6.63 (dd, J = 
7.9, 1.7 Hz, 1H), 5.92 (s, 2H), 4.44 (d, J = 2.2 Hz, 2H), 3.45 – 3.29 (m, 2H), 2.86 (dp, J = 9.0, 
6.9 Hz, 1H), 1.95 – 1.75 (m, 2H), 1.22 (d, J = 7.0 Hz, 3H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 147.7, 145.7, 141.1, 138.7, 128.5, 127.8, 127.6, 120.1, 
108.2, 107.4, 100.9, 73.1, 68.6, 38.4, 36.5, 22.7.  
FT-IR (ATR, cm-1): 3030, 2958, 2926, 2868, 1503, 1486, 1453, 1439, 1363, 1241, 1204, 1189, 
1093, 1075, 1060, 1038, 937, 912, 860, 808, 734, 697.  
MS (EI, 70 eV): m/z (%) = 285 (11), 284 (65), 192 (52), 176 (21), 163 (30), 150 (30), 149 (100), 
135 (27), 119 (19), 91 (88), 65 (18), 43 (20).  
HR-MS (EI, 70 eV): [C18H20O3], calcd.: 284.1412; found: 284.1406. 
Me
OBnO
O
EXPERIMENTAL PART 
____________________________________________________________________________ 
 141 
5-(Tetrahydro-2H-pyran-4-yl)benzo[d][1,3]dioxole (71t) 
 
Following TP5 4-iodotetrahydro-2H-pyran (70m, 106 mg, 0.5 mmol, 1 equiv, in 1 mL THF) 
reacts with the di(1,3-benzodioxol-5-yl)manganese reagent (72g, 0.35 mmol, 0.7 equiv) 
prepared according to TP3, at -20 °C. The solution was allowed to warm to room temperature 
under stirring for 8 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using i-hexane:ethyl acetate (9:1) as eluent to afford 71t as a colorless 
solid (70%, 72 mg, 0.35 mmol). 
Mp.: 73.4-74.2 °C  
1H-NMR (400 MHz, CDCl3, ppm): δ = 6.76 (d, J = 8.0 Hz, 1H), 6.73 (d, J = 1.8 Hz, 1H), 6.67 
(ddd, J = 8.0, 1.8, 0.6 Hz, 1H), 5.93 (s, 2H), 4.08 (td, J = 3.0, 0.9 Hz, 1H), 4.06 – 4.03 (m, 1H), 
3.54 – 3.46 (m, 2H), 2.68 (tt, J = 10.6, 5.3 Hz, 1H), 1.84 – 1.69 (m, 4H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 147.8, 146.0, 140.2, 119.6, 108.4, 107.4, 101.0, 68.5, 
41.5, 34.4.  
FT-IR (ATR, cm-1): 2935, 2915, 2841, 1503, 1487, 1440, 1385, 1262, 1247, 1227, 1189, 1129, 
1085, 1037, 1020, 980, 930, 911, 875, 806, 776.  
MS (EI, 70 eV): m/z (%) = 207 (13), 206 (100), 162 (39), 161 (24), 149 (13), 148 (45), 146 (27), 
135 (26), 132 (12), 119 (13), 91 (13), 89 (12).  
HR-MS (EI, 70 eV): [C12H14O3], calcd.: 206.0943; found: 206.0934. 
 
5. Cobalt-Catalyzed Negishi Cross-Coupling Reactions of 
(Hetero)Arylzinc Reagents with Primary and Secondary Alkyl 
Bromides and Iodides 
5.1 Synthesis of Starting Materials  
The following starting materials were prepared according to literature procedures with only little 
deviation. The spectral data of known compounds were in full agreement with the literature 
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(Signals of the main diastereomer are given). 
tert-butyl 4-iodopiperidine-1-carboxylate 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.38 (quin, J = 5.9 Hz, 1 H) 3.43 - 3.60 (m, 2 H) 3.14 - 
3.29 (m, 2 H) 1.96 (q, J = 5.6 Hz, 4 H) 1.39 (s, 9 H). 
 
tert-butyl((4-iodopentan-2-yl)oxy)dimethylsilane 
 
d.r.: 99:1 (syn/anti)  
1H-NMR (300 MHz, CDCl3, ppm): δ = 4.17 (ddq, J = 7.9, 6.85, 6.84 Hz, 1H), 3.92 (qt, J = 6.11, 
6.10 Hz, 1H), 2.19 (ddd, J = 14.4, 8.0. 6.6 Hz, 1H), 1.93 (d, J = 6.8 Hz, 3H), 1.70 (dt, J = 14.1, 
6.5 Hz, 1H), 1.12 (d, J = 6.0 Hz, 3H), 0.89 (s, 9H), 0.074 (s, 3H), 0.068 (s, 3H).  
tert-butyl((3-iodocyclohexyl)oxy)dimethylsilane 
 
d.r.: 22:78 (syn/anti).  
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.66 (tt, J = 8.4, 4.2 Hz, 1 H) 3.93 - 4.03 (m, 1 H) 1.89 - 
2.21 (m, 3 H) 1.57 (m, 3 H) 0.90 (s, 9 H) 0.06 (d, 6 H). 
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5.2 Cobalt-Catalyzed Cross-Coupling of (Hetero)Arylzinc Reagents with Alkyl 
Iodides and Bromides 
 
Typical procedure 6 (TP6): Metalation using TMP2Zn·2MgCl2·2LiCl: 
A dry and argon-flushed 10 mL Schlenk-tube, equipped with a stirring bar and a septum, was 
charged with a solution of the corresponding (hetero)arene (1.4 mmol, 1.0 equiv) in dry THF (1 
mL). TMP2Zn·2MgCl2·2LiCl (1, 0.84 mmol, 0.44 M, 1.91 mL, 0.6 equiv) was added dropwise at 
the given temperature and the reaction mixture was stirred at this temperature. The completion 
of the metalation was checked by GC-analysis of reaction aliquots quenched with a solution of I2 
in dry THF. 
Typical procedure 7 (TP7): Cobalt-catalyzed cross-coupling of organozinc reagents: 
A dry and argon-flushed 10 mL Schlenk-tube, equipped with a stirring bar and a septum, was 
charged with a solution of CoCl2·2LiCl (1 M in THF) (0.2 mmol, 0.2 mL, 20 mol%) and dry THF 
(1.0 mL). The respective alkyl iodide or bromide (1.0 mmol, 1.0 equiv) and TMEDA (0.3 mmol, 
45 mg, 30 mol%) were added via syringe. The reaction mixture was cooled to 0 °C and a 
solution of the appropriate zinc reagent (1.4 mmol, 1.4 equiv) was added dropwise over 5 min 
via syringe. The reaction was allowed to warm to 25 °C and was monitored by GC-analysis 
(undecane C11H24 was used as an internal standard). Upon consumption of the starting material, 
saturated aqueous NH4Cl solution (5 mL) and ethyl acetate (5 mL) were added, the phases 
were separated and the aqueous phase was extracted with ethyl acetate (3 x 50 mL). The 
combined organic layers were dried over Na2SO4. The solvents were evaporated and the 
residue was subjected to column chromatography yielding the respective title compound. 
 
Ethyl 2-cyclohexyl-3-fluorobenzoate (76a)97 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
                                                
97 S. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 9717. 
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to warm to 25 °C, stirred for 8 h and was then added dropwise according to TP7 to 
iodocyclohexane (210 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was 
evaporated in vacuo. The crude product was purified by column chromatography on silica using 
hexane:ethyl acetate (99:1) as an eluent to afford 76a as a colorless oil (87%, 218 mg, 
0.87 mmol). 
1H-NMR 300 MHz, CDCl3, ppm): δ = 7.35 (ddd, J = 7.6, 1.5, 0.4 Hz, 1 H), 7.04-7.20 (m, 2 H), 
4.36 (q, J = 7.1 Hz, 2 H), 3.01-3.13 (m, 1 H), 1.68-1.93 (m, 7 H), 1.39 (t, J = 7.1 Hz, 3 H), 1.26-
1.37 (m, 3 H). 
 
Ethyl 3-fluoro-2-isopentylbenzoate (76b) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to 1-iodo-3-
methylbutane (198 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was 
evaporated in vacuo. The crude product was purified by column chromatography on silica using 
hexane:ethyl acetate (9:1) as an eluent to afford 76b as a colorless oil (63%, 150 mg, 
0.63 mmol). 
1H-NMR (300 MHz, CDCl3, ppm): δ = 7.62 – 7.58 (m, 1H), 7.23 – 7.11 (m, 2H), 4.36 (q, J = 7.1 
Hz, 0.4, 2H), 3.03 – 2.89 (m, 2H), 1.71 – 1.59 (m, 1H), 1.51 – 1.43 (m, 2H), 1.39 (t, J = 7.1 Hz, 
3H), 1.08 – 0.88 (d, J = 6.4 Hz, 6 H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 167.0, 161.2 (d, J = 246.1 Hz), 132.3 (d, J = 4.6 Hz), 
131.8 (d, J = 17.3 Hz), 126.5 (d, J = 9.3 Hz), 125.9 (d, J = 3.5 Hz), 118.4 (d, J = 23.9 Hz), 61.1, 
39.7, 28.5, 24.1, 22.4, 14.2.  
FT-IR (ATR, cm-1): ! = 2956, 2871, 1456, 1366, 1257, 1172, 1257, 1099, 1025, 907, 755. 
MS (EI, 70 eV): m/z (%) = 238 (20), 195 (20), 193 (18), 183 (10), 182 (86), 167 (52), 163 (17), 
154 (20), 153 (41), 149 (59), 08 (12). 
HR-MS (EI, 70 eV): [C14H19FO2], calcd.: 238.1369; found: 238.1356. 
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Ethyl 2-(4-ethoxy-4-oxobutyl)-3-fluorobenzoate (76c) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to either ethyl 4-
iodobutanoate (X = I, 242 mg, 1.0 mmol) or 4-ethyl bromobutanoate (X = Br, 195 mg, 1.0 mmol) 
in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on silica using hexane:ethyl acetate (92:8) as 
an eluent to afford 76c as a colorless oil (X = I: 58%, 164 mg, 0.58 mmol; X = Br: 38%, 107 mg, 
0.38 mmol). 
1H-NMR (300 MHz, CDCl3, ppm): δ = 7.67 – 7.60 (m, 1H), 7.25 – 7.11 (m, 2H), 4.34 (q, J = 7.1 
Hz, 0.4, 2H), 4.17 – 4.04 (m, 2H), 3.00 (q, J = 7.3 Hz, 2H), 2.35 (t, J = 7.7 Hz, 2H), 1.99 – 1.86 
(m, 2H), 1.37 (t, J = 7.1 Hz, 3H), 1.23 (t, J = 7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 173.3, 166.6 (d, J = 3.5 Hz), 161.3 (d, J = 244.6 Hz), 
132.2 (d, J = 4.2 Hz), 130.4 (d, J = 17.6 Hz), 127.0 (d, J = 9.0 Hz), 126.2 (d, J = 3.4 Hz), 118.6 
(d, J = 24.0 Hz), 61.1, 60.2, 34.1, 25.6, 25.1, 14.2.  
FT-IR (ATR, cm-1): ! = 2981, 1720, 1456, 1367, 1258, 1174, 1129, 1059, 1024, 934, 757, 732. 
MS (EI, 70 eV): m/z (%) = 237 (45), 236 (55), 208 (15), 194 (21), 191 (15), 190 (18), 163 (31), 
162 (12), 153 (16), 149 (32), 135 (16), 133 (11).  
HR-MS (EI, 70 eV): [C15H19FO4], calcd.: 282.1267; found: 282.1271. 
 
Ethyl 2-(3-cyanopropyl)-3-fluorobenzoate (76d) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to either 4-
iodobutanenitrile (X = I, 195 mg, 1.0 mmol) or 4-bromobutanenitrile (X = Br, 148 mg, 1.0 mmol) 
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in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on silica using hexane:ethyl acetate (97:3) as 
an eluent to afford 76d as a colorless oil (X = I: 71%, 167 mg, 0.71 mmol; X = Br: 51%, 120 mg, 
0.51 mmol). 
1H-NMR (300 MHz, CDCl3, ppm): δ  = 8.04 - 7.96 (m, 1H), 7.05 – 6.90 (m, 2H), 4.36 (q, J = 7.2 
Hz, 2H), 3.18 – 3.03 (m, 2H), 2.41 (t, J = 7.2 Hz, 2H), 2.06 – 1.88 (m, 2H), 1.40 (t, J = 7.2 Hz, 
3H). 
13C-NMR (75 MHz, CDCl3, ppm): δ = 166.1, 165.2 (d, J = 254.1 Hz), 154.5 (d, J = 8.4 Hz), 
133.8 (d, J = 9.3 Hz), 125.6 (d, J = 2.8 Hz), 119.4, 117.8 (d, J = 21.6 Hz), 113.7 (d, J = 21.0 Hz), 
61.1, 33.5, 26.7, 16.9, 14.3.  
FT-IR (ATR, cm-1): !  = 2254, 1715, 1458, 1261, 1139, 1056, 1020, 905, 760, 725. 
MS (EI, 70 eV): m/z (%) = 235 (2), 217 (4), 190 (16), 189 (25), 188 (5), 167 (45), 109 (5). 
HR-MS (EI, 70 eV): [C13H14FNO2], calcd.: 235.1009; found: 235.1006. 
 
 
Ethyl 2-(4-((tert-butyldimethylsilyl)oxy)pentan-2-yl)-3-fluorobenzoate (76e) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to tert-butyl((4-
iodopentan-2-yl)oxy)dimethylsilane (328 mg, 1.0 mmol) in THF (1.0 mL). After standard work-
up, the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography on silica using hexane:ethyl acetate (95:5) as an eluent to afford 76e as a 
colorless oil (70%, 258 mg, 0.70 mmol, d.r. 52:48). 
Signals of both diastereomers are given: 
1H-NMR (300 MHz, CDCl3, ppm): δ = 7.38 (dddd, J = 13.3, 7.6, 1.5, 0.6 Hz, 2H), 7.25 – 7.02 
(m, 4H), 4.34 (qdd, J = 7.1, 4.1, 2.1 Hz, 4H), 3.85 – 3.64 (m, 2H), 3.56 – 3.43 (m, 2H), 2.07 – 
1.70 (m, 5H), 1.47 – 1.30 (m, 13H), 1.10 (dd, J = 6.1, 1.7 Hz, 6H), 0.92 – 0.81 (m, 18H), 0.04 – -
F
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0.07 (m, 12H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 167.9 (d, J = 3.8 Hz), 167.9 (d, J = 3.9 Hz), 162.4 (d, J = 
248.3 Hz), 162.1 (d, J = 247.1 Hz), 134.5 (d, J = 14.9 Hz), 134.0 (d, J = 6.5 Hz), 133.8 (d, J = 
14.8 Hz), 133.5 (d, J = 6.6 Hz), 127.0 (d, J = 9.4 Hz), 126.8 (d, J = 9.4 Hz), 125.1 (d, J = 3.5 
Hz), 124.8 (d, J = 3.5 Hz), 118.9 (d, J = 24.0 Hz), 118.6 (d, J = 23.8 Hz), 67.9, 66.7, 61.3 45.5, 
45.1, 31.0, 30.5, 25.9, 25.8, 23.8, 23.7, 20.3, 19.4, 18.0, 18.0, 14.2, -4.4, -4.5, -4.8, -4.9. 
FT-IR (ATR, cm-1): ! = 2959, 2930, 2857, 1723, 1451, 1367, 1278, 1255, 1178, 1142, 1037, 
909, 834, 808, 773, 733.  
MS (EI, 70 eV): m/z (%) = 311 (73), 265 (27), 223 (19), 163 (24), 159 (6), 149 (19), 121 (4), 103 
(10), 75 (24), 73 (16).  
HR-MS (EI, 70 eV): [C16H24FO3Si], calcd.: 311.1479; found: 311.1488. 
 
Ethyl 2-(3-((tert-butyldimethylsilyl)oxy)cyclohexyl)-3-fluorobenzoate (76f) 
 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to tert-butyl((3-
iodocyclohexyl)oxy)dimethylsilane (340 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, 
the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography on silica using hexane:ethyl acetate (98:2) as an eluent to afford 76f as a 
colorless oil (79%, 301 mg, 0.79 mmol, d.r. 51:49). 
Signals of both diastereomers are given: 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.41 (d, J = 7.3 Hz, 1 H), 7.32 (d, J = 7.6 Hz, 1 H), 7.16 - 
7.25 (m, 2 H), 7.05 - 7.15 (m, 2 H), 4.24 - 4.48 (m, 4 H), 4.15 (br., 1 H), 3.54 - 3.68 (m, 2 H), 
3.13 - 3.24 (m, 1 H), 2.05 - 2.16 (m, 1 H), 1.64 - 2.01 (m, 12 H), 1.44 - 1.61 (m, 2 H), 1.40 (t, J = 
7.1 Hz, 3 H), 1.40 (t, J = 7.1 Hz, 3 H), 1.33 - 1.37 (m, 1 H), 0.91 (s, 9 H), 0.89 (s, 9 H), 0.08 (s, 3 
H), 0.06 (s, 3 H), 0.04 (s, 3 H), 0.02 (s, 3 H).  
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13C-NMR (100 MHz, CDCl3, ppm): δ = 168.5 (d, J = 3.7 Hz), 168.2 (d, J = 3.7 Hz), 162.6 (d, J = 
248.0 Hz), 162.3 (d, J = 248.0 Hz), 134.8 (d, J = 6.6 Hz), 133.6 (d, J = 6.6 Hz), 132.9 (d, J = 
14.7 Hz), 132.4 (d, J = 14.7 Hz), 127.2 (d, J = 8.8 Hz), 127.0 (d, J = 9.5 Hz), 125.1 (d, J = 3.7 
Hz), 124.5 (d, J = 3.70 Hz), 119.1 (d, J = 24.2 Hz), 118.6 (d, J = 24.2 Hz), 71.7, 67.0, 61.4, 40.1 
(d, J = 4.4 Hz), 37.8 (d, J = 1.5 Hz), 37.7, 37.6, 35.7, 33.1 (d, J = 1.5 Hz), 32.9, 30.7 (d, J = 
2.9 Hz), 29.8 (d, J = 4.4 Hz), 25.9, 25.8, 24.8, 20.4, 18.2, 18.1, 14.3, 14.3, -4.6, -4.9. 
FT-IR (ATR, cm-1): ! = 2930, 2857, 1724, 1453, 1367, 1280, 1269, 1251, 1230, 1174, 1140, 
1120, 1091, 1057, 1038, 1026, 981, 856, 834, 805, 773, 758.  
MS (EI, 70 eV): m/z (%) = 365 (2), 335 (8), 325 (7), 324 (24), 323 (100), 305 (5), 278 (9), 277 
(43), 260 (5), 259 (25), 249 (19), 235 (9), 227 (10), 221 (10), 203 (19)m 202 (8), 185 (29), 183 
(22), 175 (12), 165 (15), 147 (19), 133 (13).  
HR-MS (EI, 70 eV): [C21H33FO328Si], calc.: 365.1948; found: 365.1939 [M+-CH3]. 
 
tert-Butyl 4-(2-(ethoxycarbonyl)-6-fluorophenyl)piperidine-1-carboxylate (76g) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to tert-butyl 4-
iodopiperidine-1-carboxylate (311 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the 
solvent was evaporated in vacuo. The crude product was purified by column chromatography on 
silica using hexane:ethyl acetate (9:1) as an eluent to afford 76g as a colorless oil (79%, 
277 mg, 0.79 mmol). 
1H-NMR (300 MHz, CDCl3, ppm): δ = 7.41 (d, J = 1.4 Hz, 1H), 7.27 – 7.06 (m, 2H), 4.36 (q, J = 
7.1, 2H), 4.21 (d, J = 13.2 Hz, 2H), 3.40 – 3.25 (m, 1H), 2.82 – 2.65 (m, 2H), 2.17 – 1.95 (m, 
2H), 1.72 (d, J = 1.7 Hz, 2H), 1.47 (s, 9H), 1.38 (t, J = 7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 167.8, 162.1 (d, J = 249.1 Hz), 154.9, 133.6 (d, J = 6.9 
Hz), 131.9 (d, J = 14.3 Hz), 127.5 (d, J = 8.9 Hz), 125.3 (d, J = 3.8 Hz), 119.2 (d, J = 23.9 Hz), 
79.3, 61.4, 44.7, 37.9, 29.9, 28.5, 14.2.  
FT-IR (ATR, cm-1): ! = 2978, 2863, 1719, 1684, 1450, 1424, 1366, 1275, 1244, 1165, 1118, 
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1018, 905, 758, 728.  
MS (EI, 70 eV): m/z (%) = 292 (3), 278 (5), 252 (6), 251 (26), 250 (6), 222 (31), 203 (5), 132 (3), 
57 (11).  
HR-MS (EI, 70 eV): [C19H26FNO4], calcd.: 351.1846; found: 351.1831. 
 
Ethyl 2-((1R,2S)-2-((tert-butyldimethylsilyl)oxy)cyclohexyl)-3-fluorobenzoate (76h) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to tert-butyl((2-
iodocyclohexyl)oxy)dimethylsilane (340 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, 
the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography on silica using hexane:ethyl acetate (99:1) as an eluent to afford 76h as a 
colorless oil (68%, 259 mg, 0.68 mmol, d.r. 99:1 (trans:cis)). 
1H-NMR (300 MHz, CDCl3, ppm): δ  = 7.39 (d, J = 7.7 Hz, 1H), 7.22 – 7.05 (m, 2H), 4.36 (q, J = 
7.1 Hz, 2H), 4.03 – 4.12 (m, 1H), 3.21 – 3.31 (m, 1H), 1.86 – 2.01 (m, 3H), 1.70 – 1.82 (m, 2H), 
1.27 – 1.42 (m, 6H), 0.61 (s, 9H), -0.10 (s, 3H), -0.42 (s, 3H). 
 
Ethyl 2-((1R,2S)-2-((tert-butyldimethylsilyl)oxy)cyclopentyl)-3-fluorobenzoate (76i) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to tert-butyl((2-
iodocyclopentyl)oxy)dimethylsilane (326 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, 
the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography on silica using hexane:ethyl acetate (98:2) as an eluent to afford 76i as a 
colorless oil (69%, 253 mg, 0.69 mmol, d.r. 99:1 (trans:cis)). 
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1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.43 (d, J = 7.6 Hz, 1 H), 7.21 (td, J = 7.9, 5.3 Hz, 1 H), 
7.09 - 7.17 (m, 1 H), 4.42 - 4.50 (m, 1 H), 4.34 (qdd, J = 13.1, 8.4, 4.8 Hz, 2 H), 3.51 - 3.66 (m, 1 
H), 2.10 - 2.21 (m, 1 H), 2.04 (dq, J = 12.8, 6.4 Hz, 1 H), 1.75 - 1.96 (m, 3 H), 1.58 - 1.70 (m, 1 
H), 1.38 (t, J = 7.1 Hz, 3 H), 0.74 (s, 9 H) -0.20 (s, 3 H), -0.31 (s, 3 H).  
13C-NMR (100 MHz, CDCl3, ppm): δ  = 167.9 (d, J = 4.4 Hz), 161.9 (d, J = 246.5 Hz), 135.1 (d, 
J = 6.6 Hz), 131.58 (d, J = 13.2 Hz), 127.0 (d, J = 9.5 Hz), 124.9 (d, J = 2.9 Hz), 118.5 (d, J = 
23.5 Hz), 79.0 (d, J = 5.1 Hz), 61.3, 48.4 (d, J = 2.2 Hz), 36.0, 30.3 (d, J = 3.7 Hz), 25.7, 22.9, 
17.9, 14.2, -5.25, -5.34.  
FT-IR (ATR, cm-1): ! = 2956, 2930, 2857, 1724, 1472, 1454, 1283, 1250, 1181, 1128, 1112, 
1084, 1061, 1025, 1007, 937, 892, 866, 835, 813, 774, 758, 668.  
MS (EI, 70 eV): m/z (%) = 351 (1), 321 (6), 311 (5), 310 (17), 309 (71), 265 (7), 264 (23), 263 
(100), 245 (9), 235 (15), 221 (10), 189 (28), 171 (27), 75 (26), 73 (23).  
HR-MS (EI, 70 eV): [C20H31FO328Si], calc.: 351.1792; found: 351.1785 [M+-CH3]. 
 
Ethyl-2-((3S,4R)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl)-3-fluorobenzoate 
(76j) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to ethyl 3-fluorobenzoate 
(235 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t., stirred for 8 h and was then added dropwise according to TP7 to tert-butyl((4-
iodotetrahydrofuran-3-yl)oxy)dimethylsilane (328 mg, 1.0 mmol) in THF (1.0 mL). After standard 
work-up, the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography on silica using hexane:ethyl acetate (95:5) as an eluent to afford 76j as a 
colorless oil (55%, 202 mg, 0.55 mmol, d.r. 99:1 (trans:cis)). 
1H-NMR (300 MHz, CDCl3, ppm): δ  = 7.84 (dd, J = 8.7, 6.1 Hz, 1H), 7.08 (dd, J = 10.5, 2.6 Hz, 
1H), 6.95 (dd, J = 8.7, 7.7 Hz, 1H), 4.40 – 4.28 (m, 4H), 4.23 – 4.19 (m, 1H), 4.12 – 4.01 (m, 
1H), 3.86 (dd, J = 8.7, 3.9 Hz, 1H), 3.75 – 3.65 (m, 1H), 1.44 – 1.33 (m, 3H), 0.84 (d, J = 0.6 Hz, 
9H), -0.01 – -0.08 (m, 6H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 166.7, 165.1 (d, J = 252.4 Hz), 146.1 (d, J = 8.1 Hz), 
132.6 (d, J = 9.3 Hz), 126.8 (d, J=3.3 Hz), 114.5 (d, J=23.1 Hz), 113.4 (d, J=21.6 Hz), 79.8, 
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75.1, 73.6, 61.1, 50.7, 25.7, 17.9, 14.2, -4.9.  
FT-IR (ATR, cm-1): ! = 2930, 2857, 1719, 1608, 1585, 1472, 1272, 1248, 1112, 1084, 1009, 
906, 835, 777, 729.  
MS (EI, 70 eV): m/z (%) = 311 (64), 237 (8), 235 (7), 191 (18), 163 (18), 149 (7), 117 (8), 75 
(12). 
HR-MS (EI, 70 eV): [C15H20FO4Si], calcd.: 311.1115; found: 311.1088 [M+-t-Bu]. 
 
2-Fluoro-6-iso-propylbenzonitrile (77b) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to 2-fluorobenzonitrile (170 
mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6.  The reaction mixture was stirred at r.t. 
for 12 h and was then added dropwise according to TP7 to 2-iodopropane (170 mg, 1.0 mmol) 
in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on silica using hexane:ethyl acetate (15:1) as 
an eluent to afford 77a as a colorless oil (81%, 132 mg, 0.81 mmol). 
1H NMR (400 MHz, CDCl3, ppm): δ = 7.49 - 7.57 (m, 1 H) 7.42 - 7.48 (m, 1 H) 7.20 (t, J=7.7 Hz, 
1 H) 3.28 (spt, 1 H) 1.28 (d, J = 7.1 Hz, 6 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 160.9 (d, J = 256.8 Hz), 136.7 (d, J = 13.2 Hz), 132.5 (d, 
J = 6.6 Hz), 130.7, 124.7 (d, J = 3.7 Hz), 114.4 (d, J = 1.5 Hz), 101.2 (d, J = 16.9 Hz), 27.1, 
22.3. 
FT-IR (ATR, cm-1): ! = 2970, 2936, 2237, 1612, 1462, 1455, 1388, 1367, 1348, 1292, 1245, 
1221, 1201, 1175, 1100, 1049, 1036, 843, 821, 794, 739, 656.  
MS (EI, 70 eV): m/z (%) = 163 (25), 149 (9), 148 (100), 147 (4), 128 (15), 122 (7), 121 (7), 101 
(4), 69 (8), 57 (5), 43 (8).  
HR-MS (EI, 70 eV): [C10H10FN], calc.: 163.0797; found: 163.0790. 
2-Cyclohexyl-3-fluorobenzonitrile (77b): 
F
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TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to 3-fluorobenzonitrile (170 
mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was stirred at r.t. 
for 12 h and was then added dropwise according to TP7 to iodocyclohexane (210 mg, 1.0 mmol) 
in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on silica using hexane:ethyl acetate (20:1) as 
an eluent to afford 77b as a white solid (84%, 171 mg, 0.84 mmol). 
m.p.: 73-74 °C  
1H NMR (400 MHz, CDCl3, ppm): δ = 7.40 - 7.47 (m, 1 H), 7.21 - 7.31 (m, 2 H), 3.02 - 3.17 (m, 
1 H), 1.84 - 2.04 (m, 4 H), 1.80 (m, 3 H), 1.23 - 1.54 (m, 3 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 161.3 (d, J = 248.7 Hz), 137.8 (d, J = 16.9 Hz), 129.4 (d, 
J = 3.7 Hz), 128.0 (d, J = 9.5 Hz), 121.0 (d, J = 24.2 Hz), 117.7 (d, J = 3.7 Hz), 113.5 (d, J = 
8.8 Hz), 30.8, 30.7, 26.7, 25.7.  
FT-IR (ATR, cm-1): ! = 2935, 2854, 2232, 1572, 1462, 1449, 1248, 1240, 1223, 1193, 1160, 
1135, 1002, 948, 890, 860, 795, 733.  
MS (EI, 70 eV): m/z (%) = 204 (5), 203 (33), 202 (19), 188 (12), 186 (7), 175 (17), 174 (31), 162 
(34), 161 (21), 160 (14), 149 (22), 148 (43), 147 (100), 146 (10), 135 (17), 134 (38), 133 (13), 
120 (10), 107 (9).  
HR-MS (EI, 70 eV): [C13H14FN], calc.: 203.1110; found: 203.1107. 
 
2-(4-((tert-butyldimethylsilyl)oxy)pentan-2-yl)-3-fluorobenzonitrile (77c) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to 3-fluorobenzonitrile (170 
mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was stirred at r.t. 
for 12 h and was then added dropwise according to TP7 to tert-butyl((4-iodopentan-2-
yl)oxy)dimethylsilane (328 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent 
was evaporated in vacuo. The crude product was purified by column chromatography on silica 
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using hexane:ethyl acetate (9:1) as an eluent to afford 77c as a colorless oil (63%, 202 mg, 
0.63 mmol, d.r. 52:48). 
Signals of both diastereomers are given: 
1H-NMR (300 MHz, CDCl3, ppm): δ  = 7.43 – 7.19 (m, 6H), 3.86 – 3.58 (m, 3H), 3.53 – 3.21 (m, 
3H), 2.13 – 1.57 (m, 6H), 1.41 – 1.32 (m, 3H), 1.23 (dd, J = 7.0, 2.7 Hz, 3H), 1.19 – 1.09 (m, 
8H), 0.90 – 0.79 (m, 18H), 0.07 – -0.12 (m, 12H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 162.8, 161.9, 161.6, 159.5, 158.6, 158.3, 141.0, 140.8, 
140.5, 140.3, 138.3, 138.1, 137.8, 129.4, 129.3, 129.3, 129.2, 129.2, 128.2, 128.2, 128.1, 128.0, 
128.0, 127.9, 121.0, 120.6, 119.3, 119.3, 119.0, 118.9, 117.8, 117.8, 117.5, 117.5, 117.4, 117.3, 
113.7, 113.6, 110.9, 110.9, 110.8, 110.7, 68.1, 67.9, 67.4, 66.6, 66.4, 66.1, 65.3, 47.8, 46.5, 
46.0, 45.0, 44.9, 30.0, 29.3, 25.9, 25.8, 25.8, 24.1, 24.0, 23.7, 21.9, 20.6, 20.2, 19.2, 18.0, 18.0, 
-4.1, -4.2, -4.3, -4.4, -4.8, -4.8, -4.9, -5.0.  
FT-IR (ATR, cm-1): ! = 2958, 2857, 1462, 1362, 1252, 1091, 1050, 1038, 906, 834, 774, 797, 
730. 
MS (EI, 70 eV): m/z (%) = 264 (17), 222 (26), 208 (12), 130 (13), 77 (6), 75 (22), 73 (8), 57 (5), 
43 (6).  
HR-MS (EI, 70 eV): [C14H19FNOSi], calcd.: 264.1220; found: 264.1259. 
 
3-Fluoro-2-(4,4,4-trifluorobutyl)benzonitrile (77d) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to 3-fluorobenzonitrile (170 
mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was stirred at r.t. 
for 12 h and was then added dropwise according to TP7 to iodocyclohexane (210 mg, 1.0 mmol) 
in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on silica using hexane:ethyl acetate (20:1) as 
an eluent to afford 77d as a yellow oil (52%, 120 mg, 0.52 mmol). 
1H NMR (400 MHz, CDCl3, ppm): δ = 7.44 - 7.51 (m, 1 H), 7.28 - 7.40 (m, 2 H)  2.97 (t, J = 7.70 
Hz, 2 H), 2.09 - 2.29 (m, 2 H), 1.85 - 2.02 (m, 2 H).  
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13C NMR (100 MHz, CDCl3, ppm): δ = 160.8 (d, J = 248.7 Hz), 132.0 (d, J = 19.1 Hz), 129.0 (d, 
J = 5.1 Hz), 128.9, 126.8 (q, J = 276.1 Hz), 120.5 (d, J = 22.7 Hz), 116.7 (d, J = 4.40 Hz), 114.5 
(d, J = 5.9 Hz) 33.3 (q, J = 29.1 Hz), 26.9 (d, J = 2.2 Hz), 22.3 - 22.2 (m).  
FT-IR (ATR, cm-1): ! = 2950, 2232, 1578, 1465, 1441, 1392, 1339, 1316, 1279, 1251, 1208, 
1131, 1112, 1021, 970, 936, 793, 733, 681, 658.  
MS (EI, 70 eV): m/z (%) = 231 (13), 148 (3), 147 (3), 135 (8), 134 (100), 107 (11), 97 (5), 83 (6), 
71 (6), 69 (13), 57 (11), 55 (7), 44 (34), 43 (12).  
HR-MS (EI, 70 eV): [C11H9F4N], calc.: 231.0671; found: 231.0665. 
 
2-Cyclohexylbenzofuran (77e) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to benzofuran (165 mg, 1.4 
mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed to warm to 
r.t., stirred for 12 h and was then added dropwise according to TP7 to iodocyclohexane (210 
mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. 
The crude product was purified by column chromatography on silica using hexane as an eluent 
to afford 77e as a colorless oil (71%, 142 mg, 0.70 mmol). 
m.p.: 35-37 °C  
1H NMR (400 MHz, CDCl3, ppm): δ =  7.47 - 7.56 (m, 1 H), 7.43 (d, J = 7.3 Hz, 1 H), 7.13 - 7.25 
(m, 2 H), 6.36 (s, 1 H), 2.78 (tt, J = 11.1, 3.4 Hz, 1 H), 2.07 - 2.23 (m, 2 H), 1.86 (ddd, J = 12.5, 
3.1, 2.9 Hz, 2 H), 1.71 - 1.81 (m, 1 H), 1.22 - 1.59 (m, 5 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 164.1, 154.3, 128.9, 123.0, 122.3, 120.2, 110.7, 99.7, 
37.6, 31.3, 26.1, 25.9. 
FT-IR (ATR, cm-1): ! = 3048, 2932, 2925, 2854, 2847, 1599, 1592, 1584, 1471, 1453, 1421, 
1299, 1256, 1248, 1220, 1183, 1162, 1149, 1124, 1104, 1007, 946, 922, 890, 883, 856, 830, 
797, 786, 749, 736, 728, 690, 685.  
MS (EI, 70 eV): m/z (%) = 201 (10), 200 (72), 199 (3), 171 (10), 158 (14), 157 (100), 145 (10), 
144 (41), 132 (13), 131 (31), 128 (11), 115 (20).  
HR-MS (EI, 70 eV): [C14H16O], calc.: 200.1201; found: 200.1191. 
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2-iso-Propylbenzofuran (77f) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to benzofuran (165 mg, 1.4 
mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed to warm to 
r.t., stirred for 12 h and was then added dropwise according to TP7 to 2-iodopropane (170 mg, 
1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography on silica using hexane as an eluent to 
afford 77f as a colorless oil (61%, 98 mg, 0.61 mmol). 
1H NMR (400 MHz, CDCl3, ppm): δ = 7.47 - 7.53 (m, 1 H), 7.43 (d, J = 7.8 Hz, 1 H), 7.13 - 7.26 
(m, 2 H), 6.38 (s, 1 H), 3.09 (spt, J = 6.9 Hz, 1 H), 1.36 (d, J = 6.9 Hz, 6 H). 
13C NMR (100 MHz, CDCl3, ppm): δ = 164.9, 154.5, 128.8, 123.0, 122.3, 120.3, 110.7, 99.7, 
28.2, 20.9.  
FT-IR (ATR, cm-1): ! = 2967, 2929, 2874, 1586, 1467, 1454, 1385, 1301, 1253, 1236, 1182, 
1167, 1127, 1105, 1067, 1045, 1009, 942, 926, 884, 795, 750, 738, 684.  
MS (EI, 70 eV): m/z (%) = 160 (15), 146 (11), 145 (74), 125 (16), 115 (21), 113 (17), 111 (18), 
97 (30), 95 (12), 85 (28), 57 (100), 83 (22), 82 (11), 81 (25), 71 (53), 70 (22), 69 (41), 67 (17), 
56 (28), 55 (40), 43 (86), 43 (17), 41 (58).  
HR-MS (EI, 70 eV): [C11H12O], calc.: 160.0888; found: 160.0887. 
 
2-Butylbenzofuran (77g) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to benzofuran (165 mg, 1.4 
mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed to warm to 
r.t., stirred for 12 h and was then added dropwise according to TP7 to 1-iodobutane (184 mg, 
1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The 
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crude product was purified by column chromatography on silica using hexane:ethyl acetate 
(95:5) as an eluent to afford 77g as a colorless oil (63%, 110 mg, 0.63 mmol). 
1H NMR (400 MHz, CDCl3, ppm): δ = 7.56 – 7.41 (m, 2H), 7.28 – 7.14 (m, 2H), 6.40 (s 1H), 
2.85 – 2.72 (t, J = 7.4 Hz, 2H), 1.85 – 1.67 (m, 2H), 1.55 – 1.35 (m, 2H), 0.99 (t, J = 7.3 Hz, 3H). 
13C NMR (100 MHz, CDCl3, ppm): δ = 159.7, 154.6, 129.0, 123.0, 122.3, 120.1, 110.6, 101.7, 
29.8, 28.1, 22.3, 13.8. 
FT-IR (ATR, cm-1): ! = 2957, 2930, 1601, 1587, 1454, 1252, 1168, 945, 905, 795, 749, 738. 
MS (EI, 70 eV): m/z (%) = 174 (12), 133 (1), 132 (13), 131 (54), 115 (21), 103 (16), 77 (31). 
HR-MS (EI, 70 eV): [C12H14O], calc.: 174.1045; found: 174.1054. 
 
 
2-Cyclohexylbenzothiophene (77h) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to thiobenzofuran (188 mg, 
1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed to warm 
to r.t., stirred for 12 h and was then added dropwise according to TP7 to iodocyclohexane 
(210 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was evaporated in 
vacuo. The crude product was purified by column chromatography on silica using hexane as an 
eluent to afford 77h as a white solid (72%, 156 mg, 0.72 mmol). 
m.p.: 60-62 °C  
1H NMR (400 MHz, CDCl3, ppm): δ =  7.78 (d, J = 8.1 Hz, 1 H), 7.68 (d, J = 7.8 Hz, 1 H), 7.31 
(t, J = 7.5 Hz, 1 H), 7.21 - 7.28 (m, 1 H), 7.02 (s, 1 H), 2.89 (tt, J = 11.3, 3.4 Hz, 1 H), 2.04 - 2.19 
(m, 2 H), 1.87 (dt, J = 12.7, 3.1 Hz, 2 H), 1.71 - 1.81 (m, 1 H), 1.37 - 1.60 (m, 4 H), 1.20 - 1.36 
(m, 1 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 153.0, 140.0, 138.6, 123.9, 123.3, 122.7, 122.2, 118.1, 
40.0, 35.0, 26.4, 26.0. 
FT-IR (ATR, cm-1): ! = 3056, 2938, 2922, 2853, 2844, 1534, 1456, 1446, 1436, 1295, 1264, 
1234, 1194, 1172, 1128, 1067, 1016, 987, 930, 892, 861, 846, 819, 798, 736, 725, 706, 658. 
MS (EI, 70 eV): m/z (%) = 217 (12), 216 (67), 187 (7), 175 (6), 174 (17), 173 (100), 171 (5), 161 
S
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(19), 160 (27), 148 (21), 147 (36), 134 (22), 129 (10), 128 (9), 115 (17), 45 (10).  
HR-MS (EI, 70 eV): [C14H16S], calc.: 216.0973; found: 216.0966. 
 
4-iso-Propyl-3,6-dimethoxypyridazine (77i) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to 3,6-dimethoxypyridazine 
(196 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
to warm to r.t. for 4 h and was added dropwise according to TP7 to 2-iodopropane (170 mg, 1.0 
mmol) in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography on silica using hexane:ethyl acetate (9:1) as an 
eluent to afford 77i as a colorless oil (69%, 126 mg, 0.69 mmol). 
1H NMR (400 MHz, CDCl3, ppm): δ = 6.75 (s, 1 H), 4.06 (s, 3 H), 4.02 (s, 3 H), 3.07 (spt, J = 
6.9 Hz, 1 H), 1.20 (d, J = 6.9 Hz, 6 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 162.6, 160.5, 142.0, 116.2, 54.5, 54.3, 27.0, 21.1. 
FT-IR (ATR, cm-1): ! = 2951, 2875, 1617, 1462, 1390, 1381, 1367, 1330, 1231, 1202, 1183, 
1139, 1122, 1094, 1081, 1054, 1026, 1012, 927, 892, 771, 724, 666. 
MS (EI, 70 eV): m/z (%) = 182 (100), 181 (87), 167 (91), 154 (23), 153 (16), 151 (14), 137 (21), 
96 (12), 86 (12), 84 (19), 83 (15), 74 (12), 71 (13), 69 (34), 67 (25), 59 (19), 57 (23), 56 (14), 55 
(24), 53 (27), 45 (90), 45 (17), 44 (33).  
HR-MS (EI, 70 eV): [C9H14N2O2], calc.: 182.1055; found: 182.1052. 
 
4-Cyclohexyl-3,6-dimethoxypyridazine (77j) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to 3,6-dimethoxypyridazine 
(196 mg, 1.4 mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was allowed 
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to warm to r.t. for 4 h and was added dropwise according to TP7 to iodocyclohexane (210 mg, 
1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The 
crude product was purified by column chromatography on silica using hexane:ethyl acetate (8:2) 
as an eluent to afford 77j as a colorless oil (61%, 135 mg, 0.61 mmol). 
1H-NMR (300 MHz, CDCl3, ppm): δ = 6.64 (d, J = 0.9 Hz, 1H), 3.98 (s, 3H), 3.95 (s, 3H), 2.73 – 
2.48 (m, 1H), 1.86 – 1.64 (m, 5H), 1.45 – 1.06 (m, 5H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 162.5, 160.4, 140.9, 116.5, 54.4, 54.2, 36.6, 31.6, 26.3, 
25.9. 
FT-IR (ATR, cm-1): ! = 2929, 2854, 1617, 1465, 1389, 1370, 1247, 1227, 1150, 1038, 1013, 
1006, 906, 879, 750, 726.  
MS (EI, 70 eV): m/z (%) = 222 (64), 221 (62), 193 (26), 191 (38), 167 (15), 163 (13), 154 (10), 
40 (14).  
HR-MS (EI, 70 eV): [C12H18N2O2], calcd.: 222.1368; found: 222.1366. 
 
4-(2-Oxo-2H-chromen-3-yl)butanenitrile (77k) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to coumarin (204 mg, 1.4 
mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was stirred for 1 h at r.t. 
and was then added dropwise according to TP7 to 4-iodobutanenitril (195 mg, 1.0 mmol) in THF 
(1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude product was 
purified by column chromatography on silica using hexane:ethyl acetate (9:1) as an eluent to 
afford 77k as a yellowish solid (76%, 162 mg, 0.76 mmol). 
m.p.: 102-104 °C  
1H NMR (400 MHz, CDCl3, ppm): δ = 7.61 (s, 1 H) 7.44 - 7.55 (m, 2 H) 7.25 - 7.36 (m, 2 H) 2.76 
(t, J = 7.5 Hz, 2 H) 2.44 (t, J = 7.0 Hz, 2 H) 2.06 (qd, J = 7.3, 7.1 Hz, 2 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 161.4, 153.3, 140.2, 131.2, 127.4, 127.2, 124.5, 119.2, 
119.1, 116.5, 30.2, 23.6, 16.7.  
FT-IR (ATR, cm-1): ! = 2923, 2360, 2244, 1716, 1634, 1620, 1605, 1455, 1421, 1284, 1175, 
1069, 1016, 922, 772, 763, 742, 712.  
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MS (EI, 70 eV): m/z (%) = 234 (5), 214 (13), 213 (56), 212 (7), 174 (12), 173 (100), 172 (8), 161 
(11), 160 (92), 259 (61), 144 (10), 132 (15), 131 (42), 128 (7), 126 (8), 115 (42), 102 (8), 77 
(17), 63 (7).  
HR-MS (EI, 70 eV): [C13H11NO2], calc.: 213.0790; found: 213.0790. 
 
3-Cyclohexyl-2H-chromen-2-one (77l) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to coumarin (204 mg, 1.4 
mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was stirred for 1 h at r.t. 
and was then added dropwise according to TP7 to iodocyclohexane (210 mg, 1.0 mmol) in THF 
(1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude product was 
purified by column chromatography on silica using hexane:ethyl acetate (95:5) as an eluent to 
afford 77l as a white solid (66%, 151 mg, 0.66 mmol). 
m.p.: 93-95 °C 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.47 – 7.36 (m, 3H), 7.29 – 7.17 (m, 2H), 2.82 – 2.68 (m, 
1H), 2.00 – 1.66 (m, 5H), 1.50 – 1.15 (m, 5H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 161.5, 152.7, 136.3, 134.8, 130.4, 127.3, 124.10, 119.6, 
116.2, 38.2, 32.1, 26.5, 26.1.  
FT-IR (ATR, cm-1): ! = 1706, 1609, 1456, 988, 904, 755, 726.  
MS (EI, 70 eV): m/z (%) = 228 (46), 227 (9), 171 (34), 146 (13), 128 (9), 115 (24), 43 (19). 
HR-MS (EI, 70 eV): [C15H16O2], calcd.: 228.1150; found: 228.1145. 
 
3-(4-((tert-Butyldimethylsilyl)oxy)pentan-2-yl)-2H-chromen-2-one (77) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to coumarin (204 mg, 1.4 
mmol) in THF (1.0 mL) at 0 °C according to TP6. The reaction mixture was stirred for 1 h at r.t. 
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and was then added dropwise according to TP7 to tert-butyl((4-iodopentan-2-
yl)oxy)dimethylsilane (328 mg, 1.0 mmol) in THF (1.0 mL). After standard work-up, the solvent 
was evaporated in vacuo. The crude product was purified by column chromatography on silica 
using hexane:ethyl acetate (9:1) as an eluent to afford 77m as a colorless oil (88%, 305 mg, 
0.88 mmol, d.r. 62:38). 
Signals of both diastereomers are given: 
1H NMR (400 MHz, CDCl3, ppm): δ = 7.42 - 7.51 (m, 6 H), 7.32 (d, J = 8.3 Hz, 2 H), 7.23 - 7.29 
(m, 2 H), 3.76 - 3.95 (m, 2 H), 3.02 - 3.18 (m, 2 H), 1.83 - 1.95 (m, 2 H), 1.59 - 1.71 (m, 2 H), 
1.26 (m, 6 H), 1.19 (d, J = 6.1 Hz, 6 H), 0.89 (d, J = 2.5 Hz, 9 H), -0.08 - 0.12 (m, 12 H).  
13C NMR (100 MHz, CDCl3, ppm): δ = 161.1 (2 C), 152.9, 137.1, 136.9, 134.9, 1345, 130.5 (2 
C), 127.2 (2 C), 124.2 (2 C), 119.5 (2 C), 116.3, 67.0, 66.4, 45.2, 45.0, 31.8, 31.2, 25.9 (2 C), 
24.1, 23.9, 20.4, 19.8, 18.1, -4.2 (2 C), -4.7 (2 C).  
FT-IR (ATR, cm-1): ! = 2958, 2928, 2856, 1722, 1610, 1456, 1373, 1254, 1177, 1142, 1132, 
1121, 1094, 1051, 1030, 1006, 989, 972, 922, 834, 807, 773, 753, 735, 721. 
MS (EI, 70 eV): m/z (%) = 331 (2), 291 (7), 290 (23), 289 (100), 216 (7), 215 (35), 179 (20), 173 
(8), 157 (5), 115 (12), 75 (27), 73 (15), 57 (5), 41 (9).  
HR-MS (EI, 70 eV): [C20H30O328Si], calc.: 331.1729; found: 331.1720 [M+-CH3]. 
 
2-(sec-Butyl)-4H-thiochromen-4-one (77n) 
 
TMP2Zn·2MgCl2·2LiCl (73, 0.84 mmol, 0.44 M, 1.91 mL) was added to thiochromone (227 mg, 
1.4 mmol) in THF (1.0 mL) at -40 °C according to TP6. The reaction mixture was stirred for 1 h 
and was then added dropwise according to TP7 to 2-iodobutane (184 mg, 1.0 mmol) in THF 
(1.0 mL). After standard work-up, the solvent was evaporated in vacuo. The crude product was 
purified by column chromatography on silica using hexane:ethyl acetate (8:2) as an eluent to 
afford 77n as a colorless oil (51%, 111 mg, 0.51 mmol). 
1H-NMR (300 MHz, CDCl3, ppm): δ  = 8.46 (d, J = 7.8 Hz, 1H), 7.58 – 7.50 (m, 2H), 7.45 – 7.42  
(m, 1H), 6.86 (s, 1H), 2.76 – 2.43 (m, 1H), 1.79 – 1.56 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H), 0.90 (t, 
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J = 7.4 Hz, 3H).  
13C-NMR (75 MHz, CDCl3, ppm): δ = 180.7, 161.9, 137.6, 131.2, 128.4, 127.4, 126.4, 122.7, 
44.1, 30.0, 21.0, 11.9. 
FT-IR (ATR, cm-1): !  = 1617, 1591, 1439, 1326, 1100, 904, 778, 723, 689, 668. 
MS (EI, 70 eV): m/z (%) = 218 (77), 190 (92), 176 (62), 161 (51), 136 (41), 128 (19), 69 (7).  
HR-MS (EI, 70 eV): [C13H14OS], calc.: 218.0767; found: 218.0765. 
 
6. Mild Cobalt-Catalyzed Negishi Cross-Couplings of (Hetero)Arylzinc 
Reagents with (Hetero)Aryl Halides 
6.1. Synthesis of Starting Materials  
The following starting materials were prepared according to literature procedures with only little 
deviation. The spectral data of known compounds are in full agreement with the literature. 
2-Bromoquinoline-3-carbonitrile (78q)98 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.51 (s, 1H), 8.12 – 8.09 (m, 1H), 7.95 – 7.87 (m, 2H), 
7.72 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H). 
 
Ethyl 2-bromoquinoline-4-carboxylate (78r) 
 
                                                
98 N. Boudet, J. R. Lachs, P. Knochel Org. Lett. 2007, 9, 5525. 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 8.66 (s, 1H), 8.25 (d, J = 8.5 Hz, 1H), 7.93 (d, J = 8.1 Hz, 
1H), 7.88 (ddd, J = 8.5, 7.0, 1.4 Hz, 1H), 7.68 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 4.49 (q, J = 7.2 Hz, 
2H), 1.47 (t, J = 7.1 Hz, 3H). 
 
2-Bromo-4-(4-chlorophenyl)pyrimidine (78t)99 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.58 (d, J = 5.2 Hz, 1H), 8.04 (m, 2H), 7.65 (d, J = 5.2 Hz, 
1H), 7.52 – 7.43 (m, 2H). 
 
6.2 Preparation of Organometallic Reagents 
Preparation of zinc reagents (79a-d, f, h-n): 
LiCl (1.1 equiv) was dried under high vacuum and allowed to cool to room temperature, then Mg 
turnings (1.2 equiv), ZnCl2 solution (1 M in THF, 1.1 equiv) and THF (1 M solution relating to the 
aryl bromide) were added. The reaction mixture was cooled to 0 °C and the corresponding aryl 
bromide (1.0 equiv) was added dropwise. The reaction was stirred until iodolysis of a reaction 
aliquot indicated full consumption of the starting material. 
Preparation of zinc reagents (79e, g): 
The corresponding aryl bromide (1.0 equiv) was dissolved in THF (1 M solution relating to the 
aryl bromide) and the reaction mixture was cooled to -30 °C. Then i-PrMgCl.LiCl was added 
dropwise and the reaction was stirred at this temperature until reaction aliquots quenched with 
iodine showed full consumption of the starting material. Transmetalation with ZnCl2 solution (1 M 
in THF, 1.1 equiv) at 0 °C (1 h) provided the corresponding zinc reagent.  
 
                                                
99 M. Mosrin, M. Petrera, P. Knochel Synthesis 2008, 22, 3697.	
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6.3. Cobalt-Catalyzed Cross-Coupling of (Hetero)Arylzinc Reagents with Alkyl 
Iodides and Bromides 
 
 
Typical procedure 8 (TP8) for the cobalt-catalyzed cross-coupling of organozinc 
reagents: 
A dry and argon-flushed 10 mL Schlenk-tube, equipped with a stirring bar and a septum, was 
charged with a solution of CoCl2·2LiCl (1 M in THF) (0.05 mmol, 50 mL, 5 mol%) and dry THF 
(1.0 mL). The respective aryl halide (1.0 mmol, 1.0 equiv) and HCO2Na (0.5 mmol, 34 mg, 50 
mol%) were added at room temperature. Then, a solution of the appropriate zinc reagent (1.2 
mmol, 1.2 equiv) was added dropwise over 15 min via syringe. The reaction was stirred and 
monitored by GC-analysis (C11H24 was used as an internal standard). Upon consumption of the 
starting material, saturated aqueous NH4Cl solution (5 mL) and ethyl acetate (5 mL) were 
added, the phases were separated and the aqueous phase was extracted with ethyl acetate (3 x 
50 mL). The combined organic layers were dried over Na2SO4. The solvents were evaporated 
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and the residue was subjected to column chromatography on silica yielding the respective title 
compound. 
 
2-(4-Methoxyphenyl)quinoline (80a) 
 
Isolated yield: 207 mg, 0.88 mmol, 88% yield; colorless crystals  
Purification: i-hexane/EtOAc 7:3  
m.p.: 123.7 – 124.5 °C.  
1H-NMR (300 MHz, CDCl3, ppm): δ  = 8.20 – 8.09 (m, 4H), 7.84 – 7.76 (m, 2H), 7.71 (ddd, J = 
8.4, 6.9, 1.5 Hz, 1H), 7.49 (ddd, J = 8.1, 6.9, 1.1 Hz, 1H), 7.08 – 6.99 (m, 2H), 3.87 (s, 3H). 
13C-NMR (75 MHz, CDCl3, ppm): δ = 160.8, 156.9, 148.3, 136.6, 132.3, 129.6, 129.5, 128.9, 
127.5, 126.9, 125.91, 118.5, 114.2, 55.4. 
FT-IR (ATR, cm-1): ! = 2960, 2920, 1594, 1495, 1467, 1430, 1289, 1247, 1174, 1156, 1028, 
975, 948, 811, 789, 748, 726. 
MS (EI, 70 eV): m/z (%) = 237 (2), 236 (16), 235 (100), 234 (3), 220 (21), 192 (23), 191 (24), 
190 (6). 
HR-MS (EI, 70 eV): [C16H13ON], calcd.: 235.0997; found: 235.0998. 
 
2-(4-Methoxyphenyl)pyridine (80b) 
 
Isolated yield: 161 mg, 0.87 mmol, 87% yield; white solid  
Purification: i-hexane/EtOAc 4:1  
m.p.: 53.2 – 54.1 °C.  
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.65 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.99 – 7.91 (m, 2H), 
7.75 – 7.62 (m, 2H), 7.17 (ddd, J = 7.1, 4.8, 1.5 Hz, 1H), 7.05 – 6.94 (m, 2H), 3.86 (s, 3H). 
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13C-NMR (100 MHz, CDCl3, ppm): δ = 160.5, 157.1, 149.5, 136.7, 132.0, 128.2, 121.4, 119.8, 
114.1, 55.4.  
FT-IR (ATR, cm-1): ! = 2997, 2836, 1603, 1586, 1512, 1460, 1432, 1272, 1243, 1175, 1151, 
1112, 1036, 1021, 1005, 838, 776, 736, 717.  
MS (EI, 70 eV): m/z (%) = 186 (12), 185 (100), 170 (22), 142 (29), 141 (15), 61 (9). 
HR-MS (EI, 70 eV): [C12H11NO], calcd.: 185.0841; found: 185.0836. 
 
1-(4'-Methoxy-3',5'-dimethyl-[1,1'-biphenyl]-2-yl)ethan-1-one (81a,b) 
 
Isolated yield: 165 mg, 0.65 mmol, 65% yield for X = Cl (81a) colorless oil 
             188 mg, 0.74 mmol, 74% yield for X = Br (81b)  
Purification: i-hexane/EtOAc 9:1  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.51 (dd, J = 7.5, 1.0 Hz, 1H), 7.47 (td, J = 7.5, 1.5 Hz, 
1H), 7.40 – 7.33 (m, 2H), 6.98 (s, 2H), 3.76 (s, 3H), 2.32 (s, 6H), 2.02 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 205.2, 156.9, 140.8, 140.3, 136.1, 131.2, 130.6, 130.1, 
129.3, 127.7, 127.1, 59.8, 30.4, 16.1.  
FT-IR (ATR, cm-1): ! = 2932, 1684, 1471, 1443, 1419, 1353, 1276, 1235, 1194, 1165, 1116, 
1088, 1007, 966, 889, 871, 761, 741, 700.  
MS (EI, 70 eV): m/z (%) = 255 (12), 254 (67), 253 (10), 240 (12), 239 (73), 224 (14), 196 (10), 
165 (10), 70 (12), 61 (17), 45 (15), 43 (100).  
HR-MS (EI, 70 eV): [C17H18O2], calcd.: 254.1307; found: 254.1301. 
 
1-(3'-Fluoro-[1,1':4',1''-terphenyl]-2-yl)ethan-1-one (81c) 
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Isolated yield: 194 mg, 0.67 mmol, 67% yield; white solid 
Purification: i-hexane/EtOAc 98:2 to 90:10 
m.p.: 85.1 – 87.2 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.65 – 7.56 (m, 3H), 7.59 – 7.50 (m, 1H), 7.53 – 7.35 (m, 
6H), 7.22 – 7.16 (m, 1H), 7.17 (s, 1H), 2.19 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 204.1, 159.6 (d, J = 249.5 Hz), 141.8 (d, J = 8.1 Hz), 
140.6, 138.9 (d, J = 1.8 Hz), 135.2 (d, J = 1.4 Hz), 130.9, 130.8 , 130.3, 129.0 (d, J = 3.0 Hz), 
128.5, 128.49, 128.3, 128.1, 127.9 (d, J = 6.4 Hz), 125.0 (d, J = 3.4 Hz), 116.4 (d, J = 23.7 Hz), 
30.5. 
19F (376 MHz, CDCl3, ppm): δ = -117.39. 
FT-IR (ATR, cm-1): ! = 3060, 1686, 1474, 1404, 1354, 1274, 1235, 1183, 893, 834, 759, 746, 
722, 696, 682. 
MS (EI, 70 eV): m/z (%) = 292 (6), 291 (33), 290 (73), 289 (16), 276 (23), 275 (100), 273 (10), 
255 (13), 246 (22), 225 (22), 141 (14), 139 (49), 111 (15). 
HR-MS (EI, 70 eV): [C20H15FO], calcd.: 290.1107; found: 290.1103. 
 
(4'-(Dimethylamino)-[1,1'-biphenyl]-2-yl)(phenyl)methanone (81d) 
 
Isolated yield: 219 mg, 0.73 mmol, 73% yield; yellowish crystals 
Purification: i-hexane/EtOAc 9:1  
m.p.: 114.2 – 116.2 °C.  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.67 – 7.61 (m, 2H), 7.49 (td, J = 7.5, 1.5 Hz, 1H), 7.45 – 
7.40 (m, 2H), 7.40 – 7.31 (m, 2H), 7.25 – 7.21 (m, 2H), 7.13 – 7.07 (m, 2H), 6.56 – 6.48 (m, 2H), 
2.83 (s, 6H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 199.3, 149.7, 141.2, 138.6, 137.5, 132.7, 130.2, 130.0, 
129.8, 129.7, 128.7, 128.1, 128.1, 126.0, 112.2, 40.4.  
FT-IR (ATR, cm-1): ! = 1664, 1613, 1594, 1526, 1479, 1448, 1350, 1315, 1281, 1247, 1222, 
1204, 1169, 1161, 1149, 932, 922, 824, 776, 766, 720, 704, 690, 676. 
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MS (EI, 70 eV): m/z (%) = 303 (3), 302 (25), 301 (100), 300 (38), 224 (9), 180 (5), 152 (7), 105 
(7). 
HR-MS (EI, 70 eV): [C21H19NO], calcd.:  301.1467; found: 301.1462. 
 
2'-Benzoyl-3-fluoro-[1,1'-biphenyl]-4-carbonitrile (81e) 
 
 
Isolated yield: 295 mg, 0.98 mmol, 98% yield; colorless oil 
Purification: i-hexane/EtOAc 8:2  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.70 – 7.64 (m, 2H), 7.65 – 7.60 (m, 1H), 7.58 – 7.41 (m, 
5H), 7.39 – 7.32 (m, 2H), 7.18 – 7.10 (m, 2H).  
13C-NMR (100 MHz, CDCl3, ppm): δ = 197.5, 162.7 (d, J = 259.7 Hz), 147.9 (d, J = 8.2 Hz), 
138.8, 138.4 (d, J = 1.9 Hz), 137.0, 133.5, 133.2, 130.9, 129.9, 129.9, 129.4, 128.6, 128.5, 
125.5 (d, J = 3.4 Hz), 116.9 (d, J = 20.2 Hz), 113.8, 100.1 (d, J = 15.5 Hz). 
19F (376 MHz, CDCl3, ppm): δ = -106.19 – -106.31 (m).  
FT-IR (ATR, cm-1): ! = 3061, 1660, 1619, 1448, 1412, 1279, 1260, 928, 902, 832, 762, 737, 
724, 703, 689, 680.  
MS (EI, 70 eV): m/z (%) = 302 (19), 301 (88), 300 (19), 273 (8), 272 (16), 225 (11), 224 (77), 
196 (19), 195 (21), 105 (100), 76 (43).  
HR-MS (EI, 70 eV): [C20H12FNO], calcd.:  301.0903; found: 301.0897. 
 
Cyclopentyl(4'-methoxy-[1,1'-biphenyl]-2-yl)methanone (81f) 
 
Isolated yield: 213 mg, 0.76 mmol, 76% yield; white solid 
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Purification: i-hexane/EtOAc 95:5 
m.p.: 99.4 – 101.2 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.51 – 7.42 (m, 1H), 7.44 – 7.33 (m, 3H), 7.30 – 7.22 (m, 
2H), 6.98 – 6.91 (m, 2H), 3.85 (s, 3H), 2.79 – 2.65 (m, 1H), 1.74 – 1.53 (m, 4H), 1.51 – 1.29 (m, 
4H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 212.2, 159.3, 141.4, 139.3, 132.9, 130.0, 130.0, 129.9, 
127.7, 126.9, 114.1, 55.3, 51.1, 30.3, 26.2. 
FT-IR (ATR, cm-1): ! = 2941, 1673, 1609, 1518, 1463, 1439, 1307, 1256, 1211, 1186, 1180, 
1039, 998, 834, 822, 781, 766, 727. 
MS (EI, 70 eV): m/z (%) = 281 (4), 280 (21), 212 (19), 211 (100), 168 (14), 139 (9), 61 (9), 43 
(53). 
HR-MS (EI, 70 eV): [C19H20O2], calcd.:  280.1463; found: 280.1458. 
 
1-(3'-((tert-Butyldimethylsilyl)oxy)-5-fluoro-[1,1'-biphenyl]-2-yl)ethan-1-one (81g) 
 
Isolated yield: 224 mg, 0.68 mmol, 68% yield; colorless oil 
Purification: i-hexane/EtOAc 95:5 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.57 (dd, J = 8.5, 5.8 Hz, 1H), 7.29 (t, J = 7.9 Hz, 1H), 
7.13 – 7.03 (m, 2H), 6.92 – 6.86 (m, 2H), 6.81 (t, J = 2.0 Hz, 1H), 1.99 (s, 3H), 0.99 (s, 9H), 0.21 
(s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 203.3, 163.6 (d, J = 252.0 Hz), 156.0, 143.1 (d, J = 8.5 
Hz), 141.1 (d, J = 1.7 Hz), 137.0 (d, J = 3.1 Hz), 130.5 (d, J = 9.2 Hz), 129.9, 121.9, 120.4, 
120.3, 116.9 (d, J = 22.0 Hz), 114.5 (d, J = 21.5 Hz), 30.4, 25.7, 18.2, -4.4. 
FT-IR (ATR, cm-1): ! = 2930, 2859, 1688, 1600, 1572, 1473, 1307, 1279, 1260, 1241, 1216, 
1174, 968, 872, 838, 823, 810, 780, 706, 694. 
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MS (EI, 70 eV): m/z (%) = 344 (15), 288 (18), 287 (73), 272 (26), 271 (54), 269 (32), 253 (28), 
213 (24), 75 (15), 70 (11), 61 (15), 45 (12), 43 (100). 
HR-MS (EI, 70 eV): [C20H25FO2Si], calcd.:  344.1608; found: 344.1603. 
 
(5-Chloro-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)(phenyl)methanone (81h) 
 
Isolated yield: 321 mg, 0.89 mmol, 89% yield; white solid 
Purification: i-hexane/EtOAc 9:1 
m.p.: 79.5 – 81.2 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.68 – 7.61 (m, 2H), 7.52 – 7.45 (m, 6H), 7.39 – 7.29 (m, 
4H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 197.0, 142.5, 141.7, 137.2, 137.0, 136.6, 133.4, 130.5, 
130.1, 129.8, 129.9 (q, J = 32.4 Hz), 129.2, 128.4, 127.9, 125.4 (q, J = 3.8 Hz), 123.9 (q, J = 
272.1 Hz). 
FT-IR (ATR, cm-1): ! = 1666, 1591, 1581, 1321, 1278, 1247, 1166, 1152, 1109, 1096, 1066, 
1031, 1014, 928, 896, 844, 828, 815, 800, 767, 704, 686, 675. 
MS (EI, 70 eV): m/z (%) = 362 (13), 361 (16), 360 (42), 359 (23), 325 (20), 284 (18), 282 (53), 
220 (24), 105 (47), 77 (20), 70 (14), 61 (18), 45 (14), 43 (100). 
HR-MS (EI, 70 eV): [C20H12ClF3O], calcd.:  360.0529; found: 360.0522. 
(4-Chloro-2-(1-methyl-1H-indol-6-yl)phenyl)(phenyl)methanone (81i) 
 
Isolated yield: 210 mg, 0.61 mmol, 61% yield; yellow oil 
Purification: i-hexane/EtOAc 8:2 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 7.61 – 7.55 (m, 2H), 7.52 – 7.47 (m, 2H), 7.43 (tdd, J = 
4.4, 1.4, 0.7 Hz, 2H), 7.36 (ddd, J = 7.6, 6.2, 2.2 Hz, 1H), 7.07 – 7.04 (m, 2H), 6.92 (d, J = 3.1 
Hz, 1H), 6.81 – 6.75 (m, 2H), 6.32 (dd, J = 3.1, 0.7 Hz, 1H), 3.65 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 197.9, 166.5, 163.9, 142.1, 138.9, 136.0, 132.4, 132.3, 
131.4, 130.5, 130.3, 128.5, 126.4, 122.9, 121.5, 115.1, 114.9, 109.0, 101.2, 32.8. 
FT-IR (ATR, cm-1): ! = 2943, 2252, 1662, 1586, 1470, 1448, 1280, 1245, 1091, 905, 727. 
MS (EI, 70 eV): m/z (%) = 347 (11), 346 (10), 345 (28), 344 (15), 267 (6), 104 (4), 76 (40< 58 
(4), 42 (11). 
HR-MS (EI, 70 eV): [C22H16ClNO], calcd.:  345.0920; found: 345.0919. 
 
(4-Fluorophenyl)(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methanone (81j) 
 
Isolated yield: 251 mg, 0.73 mmol, 73% yield; white solid 
Purification: i-hexane/EtOAc 95:5 
m.p.: 97.8 – 99.0 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.65 – 7.58 (m, 2H), 7.55 (ddd, J = 7.6, 5.4, 3.5 Hz, 1H), 
7.48 – 7.38 (m, 5H), 7.33 – 7.27 (m, 2H), 6.96 – 6.88 (m, 2H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 196.6, 166.9, 164.4, 143.7, 139.7, 138.7, 133.7, 132.6 
(d, J = 9.4 Hz), 130.2, 129.7, 129.4 (q, J = 283 Hz), 129.2, 128.8, 125.3 (q, J = 4.3 Hz), 122.3, 
115.6 (d, J = 24.1 Hz). 
FT-IR (ATR, cm-1): ! = 3061, 1660, 1617, 1596, 1504, 1407, 1325, 1304, 1259, 1225, 1160, 
1113, 1104, 1067, 926, 843, 838, 765, 745, 733, 673. 
MS (EI, 70 eV): m/z (%) = 345 (12), 344 (53), 343 (23), 275 (15), 249 (38), 201 (15), 152 (10), 
123 (54), 95 (20), 85 (10), 83 (16). 
HR-MS (EI, 70 eV): [C20H12F4O], calcd.:  344.0824; found: 344.0818. 
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(4-Fluorophenyl)(2-(1-methyl-1H-indol-6-yl)phenyl)methanone (81k) 
 
Isolated yield: 204 mg, 0.62 mmol, 62% yield; orange oil 
Purification: i-hexane/EtOAc 8:2 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.59 – 7.54 (m, 2H), 7.48 (dd, J = 2.0, 0.5 Hz, 1H), 7.44 
(dd, J = 1.7, 0.8 Hz, 1H), 7.38 – 7.25 (m, 3H), 7.17 – 7.12 (m, 2H), 7.08 – 7.00 (m, 2H), 6.92 (d, 
J = 3.1 Hz, 1H), 6.32 (dd, J = 3.2, 0.8 Hz, 1H), 3.64 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 198.2, 144.2, 137.5, 137.2, 136.2, 135.9, 132.8, 130.4, 
130.2, 130.0, 129.8, 129.5, 128.5, 128.0, 126.3, 122.7, 121.5, 109.1, 101.4, 32.8. 
FT-IR (ATR, cm-1): ! = 2943, 2250, 1661, 1597, 1503, 1473, 1303, 1284, 1240 , 1148, 931, 
907, 756, 729. 
MS (EI, 70 eV): m/z (%) = 330 (20), 329 (87), 328 (43), 300 (17), 234 (16), 165 (10), 164 (11), 
95 (7), 58 (7), 42 (17). 
HR-MS (EI, 70 eV): [C22H16FNO], calcd.:  329.1216; found: 329.1214. 
 
Ethyl 2-(4-methoxyphenyl)nicotinate (80c) 
 
Isolated yield: 180 mg, 0.70 mmol, 70% yield; colorless oil 
Purification: i-hexane/EtOAc 95:5 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.64 (dd, J = 4.8, 1.8 Hz, 1H), 7.96 (dd, J = 7.8, 1.8 Hz, 
1H), 7.47 – 7.36 (m, 2H), 7.18 (dd, J = 7.8, 4.8 Hz, 1H), 6.95 – 6.78 (m, 2H), 4.11 (q, J = 7.1 Hz, 
2H), 3.75 (s, 3H), 1.04 (t, J = 7.1 Hz, 3H). 
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13C-NMR (100 MHz, CDCl3, ppm): δ = 168.4, 160.2, 158.2, 151.0, 137.7, 132.5, 130.0, 127.1, 
121.0, 113.6, 61.5, 55.2, 13.8. 
FT-IR (ATR, cm-1): !  = 2982, 1714, 1608, 1582, 1515, 1428, 1298, 1280, 1250, 1175, 
1130,1095, 1054, 1024, 838, 780. 
MS (EI, 70 eV): m/z (%) = 257 (13), 229 (13), 228 (100), 212 (11), 185 (18), 169 (12), 142 (13), 
141 (19), 114 (14). 
HR-MS (EI, 70 eV): [C15H15NO3], calcd.:  257.1052; found: 257.1053. 
 
Methyl 2-(3-(benzyloxy)phenyl)nicotinate (80d) 
 
Isolated yield: 226 mg, 0.71 mmol, 71% yield; yellow oil 
Purification: i-hexane/EtOAc 7:3 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.71 (dd, J = 4.8, 1.8 Hz, 1H), 8.01 (dd, J = 7.8, 1.8 Hz, 
1H), 7.40 – 7.25 (m, 7H), 7.18 – 7.17 (m, 1H), 7.04 – 6.96 (m, 2H), 5.05 (s, 2H), 3.62 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 168.5, 158.8, 158.5, 151.2, , 141.4, 137.8, 136.9, 129.2, 
128.6, 127.9, 127.6, 127.2, 121.6, 121.3, 115.7, 114.6, 70.0, 52.4. 
FT-IR (ATR, cm-1): ! = 2960, 2254, 1635, 1587, 1560, 1483, 1403, 1313, 1190, 1078, 968, 952, 
902, 722. 
MS (EI, 70 eV): m/z (%) = 319 (28), 161 (8), 91 (8), 90 (103), 83 (5), 58 (6), 43 (11). 
HR-MS (EI, 70 eV): [C20H17NO3], calcd.:  319.1208; found: 319.1203. 
 
Methyl 2-(4-(dimethylamino)phenyl)nicotinate (80e) 
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Isolated yield: 232 mg, 0.91 mmol, 91% yield; yellow oil 
Purification: i-hexane/EtOAc 9:1 to 2:1 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.71 (dd, J = 4.8, 1.8 Hz, 1H), 7.98 (dd, J = 7.7, 1.8 Hz, 
1H), 7.54 – 7.45 (m, 2H), 7.20 (dd, J = 7.8, 4.8 Hz, 1H), 6.81 – 6.70 (m, 2H), 3.76 (s, 3H), 3.01 
(s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 169.7, 158.4, 151.1, 150.9, 137.7, 129.7, 127.4, 126.1, 
120.1, 111.8, 52.4, 40.4. 
FT-IR (ATR, cm-1): ! = 1717, 1607, 1579, 1565, 1525, 1422, 1356, 1313, 1282, 1216, 1193, 
1169, 1122, 1094, 1053, 945, 824, 777, 751. 
MS (EI, 70 eV): m/z (%) = 257 (17), 256 (100), 255 (53), 241 (43), 225 (14), 98 (12), 44 (15). 
HR-MS (EI, 70 eV): [C15H16N2O2], calcd.:  256.1212; found: 256.1208. 
 
2-(4-(Methoxymethoxy)phenyl)nicotinonitrile (80f) 
 
Isolated yield: 145 mg, 0.60 mmol, 60% yield; white solid 
Purification: i-hexane/EtOAc 2:1 
m.p.: 83.7 – 85.1 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.84 (dd, J = 4.8, 1.8 Hz, 1H), 8.04 (dd, J = 7.9, 1.8 Hz, 
1H), 7.95 – 7.87 (m, 2H), 7.32 (dd, J = 7.9, 4.8 Hz, 1H), 7.20 – 7.12 (m, 2H), 5.25 (s, 2H), 3.50 
(s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 160.5, 159.0, 152.6, 141.9, 130.7, 130.4, 121.1, 118.0, 
116.3, 106.8, 94.2, 56.2. 
FT-IR (ATR, cm-1): ! = 2225, 1607, 1581, 1574, 1552, 1517, 1432, 1410, 1306, 1256, 1248, 
1209, 1178, 1155, 1108, 1038, 982, 948, 934, 851, 828, 812, 803, 771, 719. 
MS (EI, 70 eV): m/z (%) = 241 (4), 240 (27), 210 (24), 179 (5), 167 (5), 45 (100), 43 (23). 
HR-MS (EI, 70 eV): [C14H12N2O2], calcd.:  240.0899; found: 240.08942. 
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Ethyl 6-(4-methoxyphenyl)nicotinate (80g) 
 
Isolated yield: 230 mg, 0.89 mmol, 89% yield; white solid 
Purification: i-hexane/EtOAc 4:1 
m.p.: 81.5 – 82.1 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 9.24 (dd, J = 2.2, 0.8 Hz, 1H), 8.30 (dd, J = 8.3, 2.2 Hz, 
1H), 8.08 – 7.99 (m, 2H), 7.74 (dd, J = 8.4, 0.9 Hz, 1H), 7.06 – 6.96 (m, 2H), 4.42 (q, J = 7.1 Hz, 
2H), 3.88 (s, 3H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 165.5, 161.2, 160.4, 150.9, 137.7, 130.9, 128.8, 123.7, 
118.9, 114.3, 61.3, 55.4, 14.3. 
FT-IR (ATR, cm-1): ! = 2839, 1706, 1592, 1583, 1561, 1475, 1461, 1379, 1366, 1285, 1247, 
1182, 1144, 1131, 1112, 1033. 
MS (EI, 70 eV): m/z (%) = 259 (17), 257 (100), 256 (3), 231 (30), 215 (9), 214 (10), 213 (51), 
186 (10), 184 (9), 157 (15). 
HR-MS (EI, 70 eV): [C15H15NO3], calcd.:  257.1052; found: 257.1048. 
 
Ethyl 6-(2-fluoro-[1,1'-biphenyl]-4-yl)nicotinate (80h) 
 
Isolated yield: 283 mg, 0.88 mmol, 88% yield; white solid 
Purification: i-hexane/EtOAc 9:1 
m.p.: 111.7 – 112.1 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 9.30 (dd, J = 2.2, 0.9 Hz, 1H), 8.37 (dd, J = 8.3, 2.2 Hz, 
1H), 7.97 – 7.90 (m, 1H), 7.91 (t, J = 0.9 Hz, 1H), 7.83 (dd, J = 8.3, 0.9 Hz, 1H), 7.65 – 7.54 (m, 
3H), 7.52 – 7.44 (m, 2H), 7.44 – 7.37 (m, 1H), 4.45 (q, J = 7.1 Hz, 2H), 1.44 (t, J = 7.1 Hz, 3H). 
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13C-NMR (100 MHz, CDCl3, ppm): δ = 165.2, 161.4, 159.0 (d, J = 2.5 Hz), 158.9, 151.1, 139.3 
(d, J = 7.9 Hz), 138.0, 135.2 (d, J = 1.4 Hz), 131.1 (d, J = 3.8 Hz), 130.5 (d, J = 13.7 Hz), 129.0 
(d, J = 3.1 Hz), 128.6, 128.1, 127.9, 125.0, 123.0 (d, J = 3.3 Hz), 119.7, 115.0 (d, J = 24.9 Hz). 
19F-NMR (375 MHz, CDCl, ppm): δ = -117.20. 
FT-IR (ATR, cm-1): ! = 1712, 1593, 1470, 1417, 1380, 1287, 1274, 1261, 1155, 1124, 1024, 
1011, 897, 851, 829, 780, 761, 740, 728, 718, 694. 
MS (EI, 70 eV): m/z (%) = 322 (19), 321 (100), 293 (35), 277 (11), 276 (57), 248 (14), 221 (21), 
220 (18), 170 (13), 44 (10), 43 (24). 
HR-MS (EI, 70 eV): [C20H16FNO2], calcd.:  321.1165; found: 321.1158. 
 
2-(4-Methoxy-3,5-dimethylphenyl)-5-(trifluoromethyl)pyridine (80i) 
 
Isolated yield: 242 mg, 0.86 mmol, 86% yield; colorless oil 
Purification: i-hexane/EtOAc 4:1 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.90 (dt, J = 2.5, 0.9 Hz, 1H), 7.93 (ddd, J = 8.3, 2.4, 0.7 
Hz, 1H), 7.82 – 7.75 (m, 1H), 7.69 (2H), 3.77 (s, 3H), 2.37 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 160.5 (d, J = 1.5 Hz), 158.9, 146.4 (q, J = 4.1 Hz), 133.8 
(q, J = 3.5 Hz), 133.4, 131.5, 127.9, 124.3 (q, J = 33.0 Hz), 123.9 (q, J = 272.8 Hz), 119.6, 59.7, 
16.3. 
FT-IR (ATR, cm-1): ! = 2929, 1606, 1567, 1476, 1326, 1199, 1164, 1125, 1075, 1012, 839, 718. 
MS (EI, 70 eV): m/z (%) = 282 (16), 281 (100), 280 (3), 267 (16), 266 (79), 238 (34), 222 (15), 
61 (12). 
HR-MS (EI, 70 eV): [C15H14ClF3NO], calcd.:  281.1027; found: 281.1020. 
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2-(3-Methoxyphenyl)-5-(trifluoromethyl)pyridine (80j) 
 
Isolated yield: 185 mg, 0.73 mmol, 73% yield; colorless crystals 
Purification: i-hexane/Et2O 10:1 
m.p.: 53.4 – 55.2 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.95 – 8.93 (m, 1H), 7.98 (ddd, J = 8.3, 2.4, 0.8 Hz, 1H), 
7.84 (d, J = 8.4 Hz, 1H), 7.63 (dd, J = 2.6, 1.6 Hz, 1H), 7.58 (ddd, J = 7.7, 1.7, 1.0 Hz, 1H), 7.42 
(t, J = 8.0 Hz, 1H), 7.03 (ddd, J = 8.3, 2.7, 1.0 Hz, 1H), 3.91 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 160.4 (d, J = 1.4 Hz), 160.2, 146.5 (q, J = 4.1 Hz), 139.4, 
133.9 (q, J = 3.5 Hz), 130.0, 124.9 (td, J = 31.4 Hz), 123.8 (q, J = 273.9 Hz), 120.1, 119.6, 
116.1, 112.4, 55.4. 
FT-IR (ATR, cm-1): ! = 2956, 2838, 1608, 1589, 1566, 1476, 1328, 1304, 1296, 1242, 1220, 
1180, 1166, 1124, 1082, 1052, 1033, 1014, 945, 881, 853, 843, 793, 782, 764, 717, 691. 
MS (EI, 70 eV): m/z (%) = 254 (12), 253 (100), 252 (95), 224 (51), 223 (54), 222 (54), 154 (20), 
141 (21), 44 (23), 43 (64). 
HR-MS (EI, 70 eV): [C13H10F3NO], calcd.:  253.0714; found: 253.0716. 
 
6-(3-((tert-Butyldimethylsilyl)oxy)phenyl)nicotinonitrile (80k) 
 
Isolated yield: 261 mg, 0.84 mmol, 84% yield; white solid 
Purification: i-hexane/EtOAc 95:5 
m.p.: 69.4 – 70.7 °C. 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 8.93 (dd, J = 2.2, 0.9 Hz, 1H), 7.99 (dd, J = 8.3, 2.2 Hz, 
1H), 7.81 (dd, J = 8.4, 0.9 Hz, 1H), 7.61 (ddd, J = 7.8, 1.7, 1.0 Hz, 1H), 7.54 (t, J = 2.1 Hz, 1H), 
7.37 (t, J = 7.9 Hz, 1H), 6.97 (ddd, J = 8.1, 2.5, 1.0 Hz, 1H), 1.01 (s, 9H), 0.24 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 160.3, 156.4, 152.4, 139.8, 138.8, 130.1, 122.3, 120.3, 
120.1, 119.1, 117.1, 107.9, 25.7, 18.2, -4.3. 
FT-IR (ATR, cm-1): ! = 2928, 2857, 2229, 1594, 1582, 1553, 1464, 1432, 1373, 1310, 1288, 
1259, 1252, 1236, 1217, 1206, 936, 892, 830, 799, 779, 760, 739, 690, 681, 662. 
MS (EI, 70 eV): m/z (%) = 311 (2), 310 (6), 295 (2), 254 (19), 253 (100), 43 (11). 
HR-MS (EI, 70 eV): [C18H22N2OSi], calcd.:  310.1501; found: 310.1499. 
 
6-(4-Methoxyphenyl)nicotinonitrile (80l) 
 
Isolated yield: 176 mg, 0.84 mmol, 84% yield; white solid 
Purification: i-hexane/EtOAc 9:1 
m.p.: 104.3 – 106.3 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.88 (dd, J = 2.2, 0.9 Hz, 1H), 8.03 – 7.99 (m, 2H), 7.96 – 
7.90 (m, 1H), 7.78 – 7.73 (m, 1H), 7.03 – 6.99 (m, 2H), 3.87 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 161.8, 160.0, 152.4, 139.6, 129.8, 128.86, 118.9, 117.2, 
114.4, 106.8, 55.4. 
FT-IR (ATR, cm-1): ! = 3053, 2841, 2220, 1607, 1587, 1515, 1474, 1442, 1378, 1303, 1245, 
1169, 1113, 1042, 1017, 817, 757. 
MS (EI, 70 eV): m/z (%) = 210 (22), 196 (1), 195 (5), 179 (1), 168 (1), 167 (9), 166 (4), 141 (1), 
140 (2), 86 (3), 84 (5) 
HR-MS (EI, 70 eV): [C13H10N2O], calcd.: 210.0793 found: 210.0788. 
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2-(3-((tert-Butyldimethylsilyl)oxy)phenyl)quinoline-3-carbonitrile (80m) 
 
Isolated yield: 328 mg, 0.92 mmol, 92% yield; yellow oil 
Purification: i-hexane/EtOAc 8:2 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.59 (d, J = 0.8 Hz, 1H), 8.14 (dq, J = 8.2, 1.0 Hz, 1H), 
7.86 - 7.80 (m, 2H), 7.60 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.52 (ddd, J = 7.7, 1.7, 1.0 Hz, 1H), 
7.42 - 7.32 (m, 2H), 6.95 (ddd, J =8.1, 2.5, 1.0 Hz, 1H), 0.95 (s, 9H), 0.20 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 157.7, 155.9, 148.6, 144.2, 139.0, 132.9, 130.0, 129.8, 
128.0, 127.7, 125.1, 122.1, 121.9, 120.8, 117.9, 105.6, 25.7, 18.2, -4.3. 
FT-IR (ATR, cm-1): ! = 3064, 2856, 2225, 1715, 1619, 1582, 1557, 1460, 1440, 1287, 1250, 
1220, 944, 900, 831, 774, 730. 
MS (EI, 70 eV): m/z (%) = 305 (17), 304 (71), 303 (237), 287 (23), 274 (14), 273 (35), 144 (14). 
HR-MS (EI, 70 eV): [C22H24N2OSi], calcd.:  360.1658; found: 360.1657. 
 
ethyl 2-(4-Methoxyphenyl)quinoline-4-carboxylate (80n) 
 
Isolated yield: 199 mg, 0.65 mmol, 65% yield; white solid 
Purification: i-hexane/EtOAc 9:1 
m.p.: 80.1 – 82.3 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.66 (dd, J = 8.6, 0.7 Hz, 1H), 8.30 (s, 1H), 8.17 – 8.08 
(m, 3H), 7.70 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.54 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.04 – 6.94 (m, 
2H), 4.50 (q, J = 7.1 Hz, 2H), 3.85 (s, 3H), 1.46 (t, J = 7.1 Hz, 3H). 
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13C-NMR (100 MHz, CDCl3, ppm): δ = 166.6, 161.1, 156.3, 149.2, 136.0, 131.4, 130.1, 129.8, 
128.9, 127.3, 125.4, 123.7, 119.8, 114.3, 61.9, 55.4, 14.4. 
FT-IR (ATR, cm-1): ! = 2981, 1714, 1504, 1271, 1244, 1232, 1194, 1178, 1151, 1136, 1113, 
1023, 835, 797, 780, 736, 678. 
MS (EI, 70 eV): m/z (%) = 309 (2), 308 (24), 307 (100), 236 (12), 235 (57), 234 (12), 191 (23), 
190 (10). 
HR-MS (EI, 70 eV): [C19H17NO3], calcd.:  307.1208; found: 307.1203. 
 
2-(3-((tert-Butyldimethylsilyl)oxy)phenyl)pyrimidine (80o) 
 
Isolated yield: 264 mg, 0.92 mmol, 92% yield; colorless oil 
Purification: i-hexane/EtOAc 9:1 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.80 (d, J = 4.8 Hz, 2H), 8.04 (ddd, J = 7.8, 1.6, 1.0 Hz, 
1H), 7.94 (dd, J = 2.5, 1.6 Hz, 1H), 7.35 (t, J = 7.9 Hz, 1H), 7.18 (t, J = 4.8 Hz, 1H), 6.97 (ddd, J 
= 8.1, 2.6, 1.0 Hz, 1H), 1.01 (s, 9H), 0.24 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 164.6, 157.2, 156.1, 139.1, 129.5, 122.6, 121.2, 119.8, 
119.1, 25.7, 18.2, -4.4. 
FT-IR (ATR, cm-1): ! = 2931, 2858, 1713, 1553, 1450, 1422, 1409, 1281, 1250, 1225, 1177, 
1150, 939, 834, 816, 796, 779, 690. 
MS (EI, 70 eV): m/z (%) = 287 (3), 286 (12), 230 (6), 229 (20), 288 (100), 213 (5), 167 (5). 
HR-MS (EI, 70 eV): [C16H22N2OSi], calcd.:  286.1501; found: 286.1496. 
 
4-(4-Chlorophenyl)-2-(3,5-dimethoxyphenyl)pyrimidine (80p) 
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Isolated yield: 281 mg, 0.89 mmol, 86% yield; white solid 
Purification: i-hexane/EtOAc 4:1 
m.p.: 113.3 – 113.8 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.84 (dd, J = 5.3, 0.9 Hz, 1H), 8.21 – 8.11 (m, 2H), 7.76 
(d, J = 2.4 Hz, 2H), 7.57 (dd, J = 5.3, 1.1 Hz, 1H), 7.55 – 7.46 (m, 2H), 6.63 (t, J = 2.4 Hz, 1H), 
3.92 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 164.3, 162.6, 161.0, 157.9, 139.8, 137.3, 135.3, 129.2, 
128.5, 114.5, 106.1, 103.5, 55.6. 
FT-IR (ATR, cm-1): ! = 3019, 2840, 1604, 1595, 1568, 1543, 1493, 1471, 1435, 1421, 1405, 
1380, 1291, 1208, 1158, 1088, 1068, 1045, 1011, 930, 869, 828, 810, 791, 774, 702, 689, 663. 
MS (EI, 70 eV): m/z (%) = 329 (7), 328 (36), 327 (38), 326 (100), 325 (64), 298 (8), 297 (19), 
296 (17), 295 (10), 163 (11). 
HR-MS (EI, 70 eV): [C18H15ClN2O2], calcd.:  326.0822; found: 326.0814. 
 
2-(2-Fluoro-[1,1'-biphenyl]-4-yl)-4-methylpyrimidine (80q) 
 
Isolated yield: 200 mg, 0.76 mmol, 76% yield; white solid 
Purification: i-hexane/EtOAc 9:1 
m.p.: 93.7 – 94.6 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.66 (d, J = 5.1 Hz, 1H), 8.34 – 8.23 (m, 2H), 7.67 – 7.60 
(m, 2H), 7.57 (t, J = 8.0 Hz, 1H), 7.51 – 7.44 (m, 2H), 7.43 – 7.36 (m, 1H), 7.08 (d, J = 5.0 Hz, 
1H), 2.61 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 167.4, 163.0 (d, J = 2.9 Hz), 160.0 (d, J = 247.2 Hz), 
156.9, 139.1 (d, J = 8.1 Hz), 135.5 (d, J = 1.5 Hz), 131.0 (d, J = 13.7 Hz), 130.8 (d, J = 3.7 Hz), 
129.0 (d, J = 3.1 Hz), 128.5, 128.0, 124.0 (d, J = 3.3 Hz), 119.0, 115.8 (d, J = 25.1 Hz), 24.4. 
FT-IR (ATR, cm-1): ! = 2252, 1578, 1557, 1436, 1416, 1390, 904, 832, 828, 797, 768, 723, 697. 
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MS (EI, 70 eV): m/z (%) = 266 (1), 265 (20), 264 (100), 263 (4), 249 (11), 198 (6), 197 (27), 196 
(6), 170 (6).  
HR-MS (EI, 70 eV): [C17H13FN2], calcd.:  264.1063; found: 264.1056. 
 
2-(3,5-Dimethoxyphenyl)-4,6-dimethylpyrimidine (80r) 
 
Isolated yield: 158 mg, 0.65 mmol, 65% yield; white solid 
Purification: i-hexane/EtOAc 4:1 
m.p.: 127.7 – 128.4 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.63 (d, J = 2.4 Hz, 2H), 6.93 (s, 1H), 6.58 (t, J = 2.4 Hz, 
1H), 3.89 (s, 6H), 2.53 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 166.7, 163.8, 160.9, 140.3, 118.2, 105.9, 103.3, 55.5, 
24.2. 
FT-IR (ATR, cm-1): ! = 2926, 2834, 1610, 1584, 1540, 1465, 1450, 1440, 1427, 1384, 1360, 
1318, 1284, 1240, 1203, 1170, 1154, 1096, 1057, 1002, 985, 941, 926, 877, 867, 835, 812, 794, 
754, 690. 
MS (EI, 70 eV): m/z (%) = 245 (4), 244 (25), 243 (23), 215 (6), 214 (7), 191 (8),  88 (5), 70 (10). 
HR-MS (EI, 70 eV): [C14H16N2O2], calcd.:  244.1212; found: 244.1204. 
 
tert-Butyl (3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) carbonate (80s) 
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Isolated yield: 260 mg, 0.61 mmol, 61% yield; white solid 
Purification: i-hexane/EtOAc 4:1 
m.p.: 182.3 – 183.0 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.81 – 8.73 (m, 4H), 8.67 (dt, J = 7.8, 1.3 Hz, 1H), 8.56 
(dd, J = 2.5, 1.6 Hz, 1H), 7.67 – 7.54 (m, 7H), 7.46 (ddd, J = 8.1, 2.5, 1.1 Hz, 1H), 1.62 (s, 9H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 171.7, 170.8, 151.8, 151.5, 138.0, 136.1, 132.6, 129.6, 
129.0, 128.7, 126.3, 125.5, 121.7, 83.9, 27.8. 
FT-IR (ATR, cm-1): ! = 2982, 1757, 1519, 1447, 1363, 1253, 1218, 1147, 909, 770, 732, 689. 
MS (EI, 70 eV): m/z (%) = 426 (1), 326 (21), 325 (100), 104 (18), 103 (21), 57 (33). 
HR-MS (EI, 70 eV): [C26H23N3O3+H+], calcd.:  426.1812; found: 426.1811. 
 
4,6-Bis(4-methoxyphenyl)pyrimidine (83) 
 
Isolated yield: 225 mg, 0.77 mmol, 77% yield; white solid 
Purification: i-hexane/EtOAc 7:1 
m.p.: 146.8 – 148.3 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 9.14 (d, J = 1.3 Hz, 1H), 8.09 – 8.01 (m, 4H), 7.91 (d, J = 
1.3 Hz, 1H), 7.03 – 6.93 (m, 4H), 3.83 (s, 6H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 163.9, 161.9, 159.0, 129.6, 128.7, 114.4, 111.0, 55.5. 
FT-IR (ATR, cm-1): ! = 3009, 1602, 1583, 1506, 1457, 1443, 1379, 1298, 1255, 1231, 1170, 
1112, 1021, 825, 804, 780. 
MS (EI, 70 eV): m/z (%) = 293 (20), 292 (100), 277 (19), 41 (9), 249 (6), 234 (5), 146 (8). 
HR-MS (EI, 70 eV): [C18H16N2O2], calcd.:  292.1212; found: : 292.1205. 
 
N
N
OMe
OMe
EXPERIMENTAL PART 
____________________________________________________________________________ 
 183 
1-Methyl-6-(pyrimidin-2-yl)-1H-indole (84a) 
 
Isolated yield: 144 mg, 0.69 mmol, 69% yield; white solid 
Purification: i-hexane/EtOAc 7:3 
m.p.: 122.6 – 124.1 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.75 – 8.67 (m, 3H), 8.29 (dd, J = 8.7, 1.7 Hz, 1H), 7.34 
(dt, J = 8.8, 0.8 Hz, 1H), 7.09 – 6.99 (m, 2H), 6.53 (dd, J = 3.1, 0.9 Hz, 1H), 3.77 (s, 3H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 166.0, 157.1, 138.4, 129.7, 129.1, 128.7, 121.9, 121.8, 
118.1, 109.2, 102.5, 33.0. 
FT-IR (ATR, cm-1): ! = 3098, 1612, 1563, 1552, 1433, 1404, 1339, 1277, 1240, 1148, 919, 790, 
769, 728, 698. 
MS (EI, 70 eV): m/z (%) = 209 (100), 208 (24), 156 (24), 155 (12), 104 (10), 85 (20), 83 (30). 
HR-MS (EI, 70 eV): [C13H11N3], calcd.:  209.0953; found: 209.0950. 
 
2-(Thiophen-3-yl)pyrimidine (84b) 
 
Isolated yield: 99 mg, 0.61 mmol, 61% yield; white solid 
Purification: i-hexane/EtOAc 8:2 
m.p.: 96.8 – 98.8 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.67 (d, J = 4.9 Hz, 2H), 8.23 (dd, J = 3.1, 1.2 Hz, 1H), 
7.83 (dd, J = 5.1, 1.2 Hz, 1H), 7.32 (dd, J = 5.1, 3.1 Hz, 1H), 7.06 (t, J = 4.9 Hz, 1H). 
13C-NMR (100 MHz, CDCl3, ppm): δ = 161.9, 157.2, 141.5, 127.9, 127.3, 126.1, 118.6. 
FT-IR (ATR, cm-1): ! = 3117, 2925, 2360, 1566, 1557, 1530, 1435, 1376, 866, 804, 773, 698. 
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MS (EI, 70 eV): m/z (%) = 244 (11), 163 (15), 162 (19), 161 (42), 135 (12), 110 (12), 109 (78), 
58 (41), 57 (12), 49 (11), 42 (9). 
HR-MS (EI, 70 eV): [C8H6N2S], calcd.:  162.0252; found: 162.0243.  
 
7. A Robust and Broadly Applicable Cobalt-Catalyzed Cross-Coupling 
of Functionalized Bench-Stable Organozinc Pivalates with 
Unsaturated Halides 
 
7.1 Preparation of Organometallic Reagents 
Typical procedure 9 (TP9) for the preparation of organozinc pivalates (3a-c, e-f): 
A dry and argon flushed Schlenk-tube equipped with a magnetic stirring bar and a septum was 
charged with magnesium turnings (1.1 equiv), dry LiCl (1.1 equiv) and dry THF (1 M solution 
relating to the aryl halide). The aromatic halide (1.0 equiv) was added. If necessary the Schlenk-
tube was placed in a water bath for cooling during the initial heat evolution of the insertion 
reaction. The progress of the insertion reaction was monitored by GC-analysis of reaction 
aliquots quenched with I2. Upon completion of the insertion, solid Zn(OPiv)2 (1.0 equiv) was 
added in one portion and stirred at ambient temperature for 15 min. Solvent removal affords the 
solid organozinc pivalates. 
 
Typical procedure 10 (TP10) for the preparation of organozinc pivalates (3d)100: 
The iodobenzoic acid (1.6 mmol) was placed in a dry and argon-flushed Schlenk-tube equipped 
with a magnetic stirring bar and a septum. Then, a solution of LiCl in THF (0.50 M, 3.2 mL, 1.6 
mmol) was added and after stirring for 5 min at rt, the resulting solution was cooled to –20 °C 
and MeMgCl (2.83 M in THF; 0.85 mL, 1.6 mmol) was added dropwise. After completion of the 
addition, the mixture was stirred at –20 °C for further 20 min. Then i-PrMgCl·LiCl (1.15 M in 
THF; 1.53 mL, 1.76 mmol) was added slowly and the resulting mixture was allowed to warm up 
to room temperature. The progress of the halogen-magnesium exchange was monitored by GC-
                                                
100 F. Kopp, S. Wunderlich, P.Knochel, Chem. Commun. 2007, 2075. 
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analysis of reaction aliquots quenched with I2 and found to be completed within 45 min. Solid 
Zn(OPiv)2 (2.0 equiv) was added at 0 °C in one portion and the mixture was allowed to slowly 
warm up to 25 °C.  
7.2. Optimization of the Reaction Conditions 
Additional Co-catalyzed cross-couplings using heteroarylzinc pivalates: 
 
 
Temperature screening: 
 
 
 
 
Solvent screening: 
(Het)Ar Hal (Het)Ar ZnOPiv+ (Het)Ar Ar(Het)
5% CoCl2
THF, 40 °C, 16 h
(1.5 equiv)
N
N
65% yield (Hal = Br)
N
CN
19% yield (Hal = I)
S
N
N N
70% yield (Hal = Br)
Me
NC
5% CoCl2
Br
THF, temp, 16 h
85a (1.0 equiv)
OMe
ZnOPiv
F
OMe
CN
F
86a
entry
yield of 86a [a]
(%)
1 310
3 8540
2 5925
temp
(oC)
4 6960
[a] GC yield. Undecane was used as an internal standard.
87a (1.5 equiv)
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Catalyst screening: 
 
 
 
NC
5% CoCl2
Br
solvent, 40 °C, 16 h
85a (1.0 equiv)
OMe
ZnOPiv
F
OMe
CN
F
87a (1.5 equiv)
86a
entry
yield of 86a [a]
(%)
1 85THF
3 17DMPU
2 42NMP
solvent
5 421,4-Dioxane
4 47DME
7 56EtOAc
6 61tBuOMe
8 71THFtec
[a] GC yield. Undecane was used as an internal standard.
9 70toluene
NC
X% CoCl2
Br
THF, 40 oC, 16 h
85a (1.0 equiv)
OMe
ZnOPiv
F
OMe
CN
F
86a
entry
yield of 86a [a]
(%)
1 772.5
3 8110
2 855
CoCl2
(mol%)
4 8120
[a] GC yield. Undecane was used as an internal standard.
87a (1.5 equiv)
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7.3. A Robust and Broadly Applicable Cobalt-Catalyzed Cross-Coupling of 
Functionalized Bench-Stable Organozinc Pivalates with Unsaturated Halides 
Typical procedure 11 (TP11) for the cobalt-catalyzed cross-coupling of organozinc 
pivalates: 
A dry and argon-flushed 10 mL Schlenk-tube, equipped with a stirring bar and a septum, was 
charged with dry CoCl2 (6.5 mg, 0.05 mmol, 5 mol%) and dry THF (2.0 mL). The respective aryl 
halide (1.0 mmol, 1.0 equiv) was added at room temperature. Then, a solution of the appropriate 
(hetero)aryl zinc pivalate (1.5 mmol, 1.5 equiv) was added dropwise over 5 min via syringe. The 
reaction was stirred at 40 °C and monitored by GC-analysis (C11H24 was used as an internal 
standard). Upon consumption of the starting material, saturated aqueous NH4Cl solution (5 mL) 
and ethyl acetate (5 mL) were added, the phases were separated and the aqueous phase was 
extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed with 
aqueous NaOH solution (2 M, 50 mL) and dried over Na2SO4. The solvents were evaporated 
and the residue was subjected to column chromatography purification on silica yielding the 
respective title compound. 
 
3-Fluoro-4'-methoxy-[1,1'-biphenyl]-4-carbonitrile (86a) 
 
Following TP11 4-bromo-2-fluorobenzonitrile (85a, 200 mg, 1 mmol, 1.0 equiv, in 2 mL of THF) 
reacts with (4-methoxyphenyl)zinc pivalate, (87a, 1.5 mmol, 1.5 equiv) prepared according to 
TP9, at 40 °C. The solution was stirred at this temperature for 16 h and was worked-up as 
usual. The crude product was purified by column chromatography on silica using i-hexane:ethyl 
acetate (9:1) as an eluent to afford 86a as a white solid (80%, 181 mg, 0.80 mmol). 
m.p.: 150.9 – 152.7 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.64 (dd, J = 8.1, 6.7 Hz, 1H), 7.56 – 7.49 (m, 2H), 7.43 
(dd, J = 8.1, 1.7 Hz, 1H), 7.38 (dd, J = 10.5, 1.6 Hz, 1H), 7.04 – 6.97 (m, 2H), 3.87 (s, 3H). 
F
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13C-NMR (101 MHz, CDCl3, ppm): δ = 163.7 (d, J = 258.1 Hz), 160.8, 148.3 (d, J = 8.2 Hz), 
133.8 (d, J = 1.1 Hz), 130.4 (d, J = 2.1 Hz), 128.5, 122.9 (d, J = 3.1 Hz), 114.8, 114.4, 114.2 (d, 
J = 20.2 Hz), 99.1 (d, J = 15.6 Hz), 55.6. 
FT-IR (ATR, cm-1): ! = 2941, 2839, 2224, 1618, 1608, 1582, 1560, 1524, 1493, 1467, 1436, 
1407, 1315, 1298, 1276, 1250, 1223, 1210, 1180, 1120, 1040, 1026, 900, 881, 844, 813, 795, 
736, 562. 
MS (EI, 70 eV): m/z (%) = 228 (15), 227 (100), 121 (17), 184 (47), 158 (25). 
HR-MS (EI, 70 eV): [C14H10FNO], calcd.: 227.0746; found: 227.0741.  
 
4'-Methoxy-[1,1'-biphenyl]-2-carbonitrile (86b) 
 
Following TP11 2-iodobenzonitrile (85b, 229 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
(4-methoxyphenyl)zinc pivalate (87a, 1.5 mmol, 1.5 equiv) prepared according to TP9,  at 40 °C. 
The solution was stirred at this temperature for 36 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (9:1) as 
an eluent to afford 86b as a white solid (71%, 148 mg, 0.71 mmol). 
m.p.: 85.0 – 85.9 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.74 (ddd, J = 7.8, 1.4, 0.5 Hz, 1H), 7.62 (td, J = 7.7, 1.4 
Hz, 1H), 7.54 – 7.47 (m, 3H), 7.40 (td, J = 7.6, 1.2 Hz, 1H), 7.05 – 6.99 (m, 2H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 160.2, 145.3, 133.9, 132.9, 130.7, 130.1, 130.0, 127.2, 
119.1, 114.3, 111.2, 55.5. 
FT-IR (ATR, cm-1): ! = 2937, 2224, 1610, 1580, 1517, 1479, 1465, 1443, 1306, 1294, 1269, 
1247, 1180, 1048, 1035, 1018, 1001, 907, 834, 811, 764, 729, 649, 600. 
MS (EI, 70 eV): m/z (%) = 210 (16), 209 (100), 194 (8), 166 (39), 140 (14), 139 (7), 43 (22). 
HR-MS (EI, 70 eV): [C14H11NO], calcd.: 209.0841; found: 209.0837.  
 
4'-Methoxy-[1,1'-biphenyl]-3-carbonitrile (86c) 
MeO CN
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Following TP11 3-iodobenzonitrile (85c, 229 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
(4-methoxyphenyl)zinc pivalate (87a, 1.5 mmol, 1.5 equiv) prepared according to TP9,  at 40 °C. 
The solution was stirred at this temperature for 36 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (9:1) as 
an eluent to afford 86c as a slightly yellow oil (72%, 150 mg, 0.72 mmol). The remaining 
impurity was deducted from the final yield. The spectral data of this known compound was in full 
agreement with the literature.101 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.81 – 7.78 (m, 1H), 7.77 – 7.73 (m, 1H), 7.56 (dt, J = 
7.7, 1.4 Hz, 1H), 7.52 – 7.45 (m, 3H), 7.03 – 6.96 (m, 2H), 3.85 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 160.1, 142.2, 131.4, 131.1, 130.3, 130.2, 129.7, 128.3, 
119.1, 114.7, 113.0, 55.5. 
FT-IR (ATR, cm-1): ! = 2959, 2230, 1610, 1516, 1479, 1442, 1434, 1296, 1269, 1247, 1182, 
1114, 1049, 1029, 908, 832, 796, 731, 690. 
MS (EI, 70 eV): m/z (%) = 210 (15), 209 (100), 194 (22), 166 (32), 140 (17), 44 (9), 43 (28). 
HR-MS (EI, 70 eV): [C14H11NO], calcd.: 209.0841; found 209.0833.   
 
4'-Methoxy-[1,1'-biphenyl]-4-carbonitrile (86d) 
 
Following TP11 4-iodobenzonitrile (85d, 229 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
(4-methoxyphenyl)zinc pivalate (87a, 1.5 mmol, 1.5 equiv) prepared according to TP9,  at 40 °C. 
The solution was stirred at this temperature for 36 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (9:1) as 
an eluent to afford 86d as a white solid (75%, 156 mg, 0.75 mmol). 
m.p.: 99.4 – 101.4 °C. 
                                                
101 I. Stibingerov, S. Voltrova, S.Kocova, M. Lindale, J. Srogl, Org. Lett. 2016, 18, 312. 
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1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.71 – 7.61 (m, 4H), 7.57 – 7.51 (m, 2H), 7.04 – 6.98 (m, 
2H), 3.86 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 160.3, 145.3, 132.7, 131.6, 128.5, 127.2, 119.2, 114.7, 
110.2, 55.5. 
FT-IR (ATR, cm-1): ! = 2964, 2840, 2225, 1605, 1580, 1515, 1494, 1468, 1446, 1398, 1313, 
1306, 1294, 1267, 1247, 1179, 1112, 1038, 1021, 1016, 1001, 907, 854, 823, 770, 728, 649, 
639, 628, 564. 
MS (EI, 70 eV): m/z (%) = 210 (15), 209 (100), 194 (20), 166 (32), 140 (14). 
HR-MS (EI, 70 eV): [C14H11NO], calcd.: 209.0841; found: 209.0831.  
4-(Benzo[d][1,3]dioxol-5-yl)benzonitrile (86e) 
 
Following TP11 4-iodobenzonitrile (85d, 229 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
benzo[d][1,3]dioxol-5-ylzinc pivalate (87b, 1.5 mmol, 1.5 equiv) prepared according to TP9,  at 
40 °C. The solution was stirred at this temperature for 16 h and was worked-up as usual. The 
crude product was purified by column chromatography on silica using i-hexane:ethyl acetate 
(9:1) as an eluent to afford 86e as a white solid (72%, 161 mg, 0.72 mmol). 
m.p.: 125.6 – 126.7°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.74 – 7.57 (m, 4H), 7.10 – 7.04 (m, 2H), 6.91 (dd, J = 
7.9, 0.6 Hz, 1H), 6.03 (s, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 148.6, 148.4, 145.4, 133.5, 132.7, 127.5, 121.3, 119.1, 
110.6, 109.0, 107.6, 101.6. 
FT-IR (ATR, cm-1): ! = 2898, 2227, 1604, 1501, 1480, 1442, 1412, 1341, 1306, 1294, 1275, 
1252, 1228, 1181, 1108, 1038, 1011, 932, 906, 871, 841, 808, 729. 
MS (EI, 70 eV): m/z (%) = 224 (14), 223 (100), 222 (47), 164 (25), 112 (6), 111 (6). 
HR-MS (EI, 70 eV): [C14H9NO2], calcd.: 223,0633; found: 223,0629.  
 
2-Fluoro-4-(1-methyl-1H-indol-5-yl)benzonitrile (86f) 
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Following TP11 4-bromo-2-fluorobenzonitrile (85a, 200 mg, 1 mmol, 1.0 equiv, in 2 mL THF) 
reacts with (1-methyl-1H-indol-5-yl)zinc pivalate (87c, 1.5 mmol, 1.5 equiv) prepared according 
to TP9,  at 40 °C. The solution was stirred at this temperature for 36 h and was worked-up as 
usual. The crude product was purified by column chromatography on silica using i-hexane:ethyl 
acetate (8.5:1.5) as an eluent to afford 86f as a white solid (65%, 162 mg, 0.65 mmol). 
m.p.: 139.8 – 141.6°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.85 (dd, J = 1.7, 0.8 Hz, 1H), 7.64 (dd, J = 8.1, 6.7 Hz, 
1H), 7.53 (dd, J = 8.1, 1.7 Hz, 1H), 7.49 – 7.39 (m, 3H), 7.13 (d, J = 3.1 Hz, 1H), 6.57 (dd, J = 
3.1, 0.8 Hz, 1H), 3.85 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 163.6 (d, J = 257.6 Hz), 150.3 (d, J = 8.5 Hz), 137.3, 
133.6 (d, J = 1.4 Hz), 130.4, 129.6 (d, J = 2.3 Hz), 129.2, 123.4 (d, J = 3.3 Hz), 120.9, 120.1, 
114.7 (d, J = 20.2 Hz), 114.6, 110.1, 102.0, 98.5 (d, J = 15.8 Hz), 33.2. 
FT-IR (ATR, cm-1): ! = 2946, 2230, 1609, 1574, 1557, 1514, 1483, 1449, 1425, 1362, 1337, 
1311, 1281, 1260, 1247, 1212, 1160, 1119, 1105, 1081, 908, 871, 833, 800, 762, 746, 729. 
MS (EI, 70 eV): m/z (%) = 252 (1), 251 (20), 250 (100), 249 (29), 208 (9), 125 (8), 42 (7). 
HR-MS (EI, 70 eV): [C14H9NO2], calcd.: 250,0906 ; found 250,0899:   
4'-Cyano-3'-fluoro-[1,1'-biphenyl]-4-carboxylic acid (86g) 
 
Following TP11 4-bromo-2-fluorobenzonitrile (85a, 200 mg, 1 mmol, 1.0 equiv, in 2 mL THF) 
reacts with the bis-zinc pivalate 87d (1.6 mmol, 1.6 equiv) prepared according to TP9, at 40 °C. 
The solution was stirred at this temperature for 16 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (6:4) with 
1% acetic acid as an eluent to afford 86g as a white solid (70%, 168 mg, 0.70 mmol). 
m.p.: 246 – 248°C. 
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1H-NMR (400 MHz, DMSO–d6, ppm): δ  = 13.11 (s, 1H), 8.07 – 8.01 (m, 3H), 7.98 – 7.89 (m, 
3H), 7.81 (dd, J = 8.2, 1.6 Hz, 1H). 
13C-NMR (101 MHz, DMSO–d6, ppm): δ = 166.8, 162.9 (d, J = 255.1 Hz), 146.5 (d, J = 8.5 Hz), 
140.9 (d, J = 2.1 Hz), 134.4, 131.4, 130.0, 127.5, 123.9 (d, J = 3.1 Hz), 114.8 (d, J = 20.7 Hz), 
114.0, 99.4 (d, J = 15.2 Hz). 
FT-IR (ATR, cm-1): ! = 3074, 2671, 2236, 1723, 1689, 1620, 1609, 1578, 1559, 1493, 1432, 
1423, 1400, 1321, 1314, 1292, 1268, 1236, 1206, 1196, 1184, 1121, 1111, 904, 881, 858, 828, 
808, 785, 772, 737, 721, 702, 684. 
MS (ESI–): 240 [M–H] 
HR-MS (ESI–): [C14H17FNO2–], calcd.: 240.0466; found: 240.0466. 
4'-(1,3-dioxolan-2-yl)-3-fluoro-[1,1'-biphenyl]-4-carbonitrile (86h) 
 
Following TP11 4-bromo-2-fluorobenzonitrile (85a, 200 mg, 1 mmol, 1.0 equiv, in 2 mL THF) 
reacts with (4-(1,3-dioxolan-2-yl)phenyl)zinc pivalate (87e, 1.5 mmol, 1.5 equiv) prepared 
according to TP9, at 40 °C. The solution was stirred at this temperature for 36 h and was 
worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (7:3) as an eluent to afford 86h as a white solid (75%, 202 mg, 
0.75 mmol). 
m.p.: 132 – 133.3°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.68 (dd, J = 8.1, 6.6 Hz, 1H), 7.64 – 7.56 (m, 4H), 7.47 
(dd, J = 8.1, 1.6 Hz, 1H), 7.42 (dd, J = 10.2, 1.6 Hz, 1H), 5.87 (s, 1H), 4.19 – 4.03 (m, 4H).  
13C-NMR (101 MHz, CDCl3, ppm): δ = 163.6 (d, J = 258.8 Hz), 148.2 (d, J = 8.1 Hz), 139.3, 
139.0 (d, J = 2.1 Hz), 133.9 (d, J = 1.0 Hz), 127.4 (d, J = 13.4 Hz), 123.6 (d, J = 3.3 Hz), 115. 1, 
114.9, 114.1, 103.3, 100.2 (d, J = 15.7 Hz), 65.6.  
FT-IR (ATR, cm-1): ! = 2961, 2893, 2234, 1618, 1558, 1493, 1434, 1400, 1311, 1265, 1224, 
1207, 1194, 1184, 1122, 1084, 1029, 1020, 974, 945, 903, 891, 842, 810, 734, 684. 
MS (EI, 70 eV): m/z (%) = 270 (9), 269 (46), 268 (100), 224 (28), 210 (11), 108 (26), 198 (13), 
197 (74), 196 (16), 195 (20), 73 (15). 
HR-MS (EI, 70 eV): [C16H11FNO2], calcd.: 269.0852; found: 269.0757. 
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3',4',5'-Trimethoxy-3-(trifluoromethyl)-[1,1'-biphenyl]-4-carbonitrile (86i) 
 
Following TP11 4-iodo-2-(trifluoromethyl)benzonitrile (85e, 297 mg, 1 mmol, 1.0 equiv, in 2 mL 
THF) reacts with (3,4,5-trimethoxyphenyl)zinc pivalate (87f, 1.5 mmol, 1.5 equiv) prepared 
according to TP9, at 40 °C. The solution was stirred at this temperature for 36 h and was 
worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (7:3) as an eluent to afford 86i as a white solid (72%, 241 mg, 
0.72 mmol). 
m.p.: 137.7 – 138.6°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.94 – 7.87 (m, 2H), 7.84 – 7.83 (m, 1H), 6.76 (s, 2H), 
3.95 (s, 6H), 3.91 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 154.1, 146.4, 139.6, 135.3, 133.7, 133.4 (q, J = 32.5 Hz), 
130.5, 125.3 (q, J = 4.7 Hz), 122.5 (q, J = 274.0 Hz), 115.7, 108.4 (q, J = 2.1 Hz), 104.9, 61.2, 
56.5.  
FT-IR (ATR, cm-1): ! = 2940, 2839, 2231, 1611, 1588, 1562, 1516, 1494, 1463, 1429, 1403, 
1349, 1313, 1274, 1247, 1218, 1179, 1128, 1082, 1054, 1003, 907, 828, 768, 730, 686. 
MS (EI, 70 eV): m/z (%) = 339 (2), 338 (15), 337 (100), 322 (45), 294 (24), 264 (24), 208 (22). 
HR-MS (EI, 70 eV): [C17H14F3NO3], calcd.: 337.0926; found: 337.0926. 
 
Ethyl 3-fluoro-2',4',6'-trimethyl-[1,1'-biphenyl]-4-carboxylate (86j) 
 
Following TP11 ethyl 4-bromo-2-fluorobenzoate (85f, 247 mg, 1 mmol, 1.0 equiv, in 2 mL THF) 
reacts with mesitylzinc pivalate (87g, 1.5 mmol, 1.5 equiv) prepared according to TP9, at 40 °C. 
The solution was stirred at this temperature for 16 h and was worked-up as usual. The crude 
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product was purified by column chromatography on silica using i-hexane:diethylether (100:3) as 
an eluent to afford 86j as a colorless oil (71%, 202 mg, 0.71 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.99 (t, J = 7.8 Hz, 1H), 7.00 (dd, J = 8.0, 1.5 Hz, 1H), 
6.97 – 6.93 (m, 3H), 4.43 (q, J = 7.1 Hz, 2H), 2.33 (s, 3H), 2.00 (s, 6H), 1.43 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 164.6 (d, J = 3.7 Hz), 162.1 (d, J = 260.6 Hz), 148.5 (d, J 
= 8.7 Hz), 137.6, 136.9 (d, J = 1.5 Hz), 135.5, 132.2 (d, J = 1.6 Hz), 128.4, 125.4 (d, J = 3.5 Hz), 
118.1 (d, J = 21.9 Hz), 117.4 (d, J = 9.9 Hz), 61.4, 21.2, 20.7, 14.5. 
FT-IR (ATR, cm-1): ! = 2980, 2921, 1729, 1715, 1619, 1561, 1508, 1476, 1465, 1445, 1410, 
1380, 1366, 1284, 1259, 1247, 1240, 1193, 1172, 1157, 1136, 1092, 1035, 1018, 897, 876, 868, 
850, 780, 743, 710, 696. 
MS (EI, 70 eV): m/z (%) = 288 (2), 287 (19), 286 (100), 242 (15), 241 (88), 213 (12), 198 (10), 
197 (12), 183 (17). 
HR-MS (EI, 70 eV): [C18H19FO], calcd.: 286.1369; found: 286.1362. 
 
Ethyl 4'-methoxy-[1,1'-biphenyl]-4-carboxylate (86k) 
 
Following TP11 ethyl 4-iodobenzoate (85g, 276 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
(4-methoxyphenyl)zinc pivalate (87a, 1.5 mmol, 1.5 equiv) prepared according to TP9, at 40 °C. 
The solution was stirred at this temperature for 16 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (100:4) 
as an eluent to afford 86k as a colorless crystals (61%, 155 mg, 0.71 mmol). 
m.p.: 104.7 – 105.7°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 8.12 – 8.06 (m, 2H), 7.65 – 7.55 (m, 4H), 7.02 – 6.97 (m, 
2H), 4.40 (q, J = 7.1 Hz, 2H), 3.86 (s, 3H), 1.41 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.7, 160.0, 145.2, 132.6, 130.2, 128.8, 128.5, 126.6, 
114.5, 61.0, 55.5, 14.5. 
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FT-IR (ATR, cm-1): ! = 2963, 1706, 1604, 1582, 1564, 1529, 1497, 1465, 1445, 1426, 1401, 
1369, 1312, 1286, 1278, 1252, 1198, 1186, 1110, 1035, 1014, 1001, 907, 861, 828, 807, 772, 
730, 699, 650. 
MS (EI, 70 eV): m/z (%) = 258 (2), 257 (20), 256 (100), 228 (20), 212 (11), 211 (61), 168 (13), 
140 (12), 139 (22), 43 (11). 
HR-MS (EI, 70 eV): [C16H16O3], calcd.: 256.1099; found: 256.1080. 
 
 
 
4'-(Ethoxycarbonyl)-[1,1'-biphenyl]-4-carboxylic acid (86l) 
 
Following TP11 ethyl 4-iodobenzoate (85g, 276 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
the bis-zinc pivalate 87d (1.6 mmol, 1.6 equiv) prepared according to TP9, at 40 °C. The 
solution was stirred at this temperature for 16 h and was worked-up as usual. The crude product 
was purified by column chromatography on silica using i-hexane:ethyl acetate (6:4) with 1% 
acetic acid as an eluent to afford 86l as a white solid (65%, 177 mg, 0.65 mmol). 
m.p.: 238 – 240°C. 
1H-NMR (400 MHz, DMSO–d6, ppm): δ  = 13.03 (s, 1H), 8.07 – 8.04 (m, 4H), 7.92 – 7.82 (m, 
4H), 4.34 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, DMSO–d6, ppm): δ = 167.0, 165.4, 143.4, 142.9, 130.5, 130.0, 129.8, 
129.4, 127.2, 127.1, 60.8, 14.2. 
FT-IR (ATR, cm-1): ! = 2980, 2928, 2847, 2671, 2546, 1707, 1672, 1606, 1579, 1560, 1430, 
1401, 1371, 1324, 1314, 1270, 1191, 1176, 1099, 1028, 1007, 932, 878, 845, 783, 754, 708, 
697, 672. 
MS (ESI–): 269 [M–H] 
MS (ESI+): 288 [M+NH4] 
HR-MS (ESI–): [C16H13O4–], calcd.: 269,0819 found: 269,0818. 
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Ethyl 5-(4-methoxy-3,5-dimethylphenyl)furan-2-carboxylate (86m) 
 
Following TP11 ethyl 5-bromofuran-2-carboxylate (85h, 219 mg, 1 mmol, 1.0 equiv, in 2 mL 
THF) reacts with (4-methoxy-3,5-dimethylphenyl)zinc pivalate (87h, 1.5 mmol, 1.5 equiv) 
prepared according to TP9, at 40 °C. The solution was stirred at this temperature for 16 h and 
was worked-up as usual. The crude product was purified by column chromatography on silica 
using i-hexane:ethyl acetate (95:5) as an eluent to afford 86m as a slightly yellow solid (65%, 
177 mg, 0.65 mmol). 
m.p.: 97.9 – 99.0°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.47 – 7.40 (m, 2H), 7.21 (d, J = 3.6 Hz, 1H), 6.62 (d, J = 
3.6 Hz, 1H), 4.38 (q, J = 7.1 Hz, 2H), 3.74 (s, 3H), 2.32 (t, J = 0.7 Hz, 6H), 1.39 (t, J = 7.1 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 159.1, 157.9, 157.8, 143.6, 131.6, 125.6, 125.3, 120.0, 
106.2, 60.9, 59.9, 16.3, 14.6. 
FT-IR (ATR, cm-1): ! = 2963, 1605, 1515, 1466, 1309, 1254, 1204, 1175, 1106, 1028, 971, 903, 
838, 810, 729. 
MS (EI, 70 eV): m/z (%) = 275 (21), 274 (100), 260 (16), 259 (89), 227 (43), 115 (11), 107 (11), 
43 (36). 
HR-MS (EI, 70 eV): [C16H18O4], calcd.: 274.1205; found: 274.1198. 
 
 (4-Fluorophenyl)(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methanone (86n) 
 
Following TP11 (2-chlorophenyl)(4-fluorophenyl)methanone (85i, 235 mg, 1 mmol, 1.0 equiv, in 
2 mL THF) reacts with (4-trifluormethylphenyl)zinc pivalate (87i, 1.5 mmol, 1.5 equiv) prepared 
according to TP1 at 40 °C. The solution was stirred at this temperature for 16 h and was 
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worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (95:5) as an eluent to afford 86n as a white solid (80%, 276 mg, 
0.80 mmol). 
m.p.: 97.8 – 99.0 °C.  
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.73 – 7.65 (m, 2H), 7.61 (ddd, J = 7.6, 6.3, 2.7 Hz, 1H), 
7.55 – 7.45 (m, 5H), 7.41 – 7.35 (m, 2H), 7.01 – 6.93 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 196.6, 165.8 (d, J = 255.8 Hz), 143.9 (q, J = 1.4 Hz), 
139.8, 138.8, 133.8 (d, J = 2.9 Hz), 132.63 (d, J = 9.4 Hz), 130.8, 130.3, 129.6 (q, J = 32.6 Hz), 
129.4, 128.9, 128.0, 125.4 (q, J = 3.8 Hz), 124.1 (q, J = 272.1 Hz), 115.6 (d, J = 22.0 Hz). 
FT-IR (ATR, cm-1): ! = 3061, 1660, 1617, 1596, 1504, 1407, 1325, 1304, 1259, 1225, 1160, 
1113, 1104, 1067, 926, 843, 838, 765, 745, 733, 673. 
MS (EI, 70 eV): m/z (%) = 345 (12), 344 (53), 343 (23), 275 (15), 249 (38), 201 (15), 152 (10), 
123 (54), 95 (20), 85 (10), 83 (16).  
HR-MS (EI, 70 eV): [C20H12F4O], calcd.:  344.0824; found: 344.0818. 
 
(4-(Benzo[d][1,3]dioxol-5-yl)phenyl)(phenyl)methanone (86o) 
 
Following TP11 (4-bromophenyl)(phenyl)methanone (87j, 261 mg, 1 mmol, 1.0 equiv, in 2 mL 
THF) reacts with benzo[d][1,3]dioxol-5-ylzinc pivalate (85b, 1.5 mmol, 1.5 equiv) prepared 
according to TP9, at 40 °C. The solution was stirred at this temperature for 16 h and was 
worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (9:1) as an eluent to afford 86o as a white solid (81%, 244 mg, 
0.81 mmol). 
m.p.: 111.6 – 112.7°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.89 – 7.80 (m, 4H), 7.65 – 7.56 (m, 3H), 7.53 – 7.47 (m, 
2H), 7.14 (d, J = 7.4 Hz, 2H), 6.94 – 6.88 (m, 1H), 6.03 (s, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 196.4, 148.5, 148.0, 145.0, 137.9, 136.0, 134.4, 132.4, 
130.9, 130.1, 128.4, 126.7, 121.2, 108.9, 107.8, 101.5. 
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FT-IR (ATR, cm-1): ! = 2894, 2253, 1652, 1601, 1502, 1481, 1441, 1313, 1276, 1250, 1226, 
1039, 938, 905, 849, 813, 792, 755, 726, 701, 682. 
MS (EI, 70 eV): m/z (%) = 303 (27), 302 (100), 225 (56), 139 (28), 105 (15), 77 (18), 43 (36). 
HR-MS (EI, 70 eV): [C20H14O3], calcd.: 302.0943; found: 302.0953. 
 
3-(4-Methoxyphenyl)quinoline (86p) 
 
Following TP11 3-bromoquinoline (85k, 208 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with (4-
methoxyphenyl)zinc pivalate (87a, 1.5 mmol, 1.5 equiv) prepared according to TP9, at 40 °C. 
The solution was stirred at this temperature for 16 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate (6:4) as 
an eluent to afford 86p as a yellow solid (74%, 173 mg, 0.74 mmol). 
m.p.: 99.4 – 101.4°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 9.16 (d, J = 2.3 Hz, 1H), 8.22 – 8.21 (m, 1H), 8.14 – 8.11 
(m, 1H), 7.86 – 7.80 (m, 1H), 7.69 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.66 – 7.62 (m, 2H), 7.55 
(ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 7.08 – 7.01 (m, 2H), 3.86 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 159.9, 149.9, 147.1, 133.5, 132.4, 130.4, 129.3, 129.1, 
128.6, 128.2, 128.0, 127.0, 114.8, 55.5. 
FT-IR (ATR, cm-1): ! = 2957, 2934, 1609, 1516, 1492, 1462, 1431, 1440, 1341, 1285, 1250, 
1180, 1045, 1029, 954, 906, 829, 785, 751, 727. 
MS (EI, 70 eV): m/z (%) = 237 (2), 236 (21), 235 (100), 221 (8), 220 (31), 192 (13), 191 (8), 191 
(8), 190 (9), 165 (8), 163 (6), 117 (8). 
HR-MS (EI, 70 eV): [C16H13ON], calcd.: 235.0997; found: 235.0994. 
 
4-(4-Methoxyphenyl)-2-(trifluoromethyl)quinoline (86q) 
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Following TP11 4-chloro-2-(trifluoromethyl)quinoline (85l, 232 mg, 1 mmol, 1.0 equiv, in 2 mL 
THF) reacts with (4-methoxyphenyl)zinc pivalate (87a, 1.5 mmol, 1.5 equiv) prepared according 
to TP9, at 40 °C. The solution was stirred at this temperature for 16 h and was worked-up as 
usual. The crude product was purified by column chromatography on silica using i-hexane:ethyl 
acetate (9:1) as an eluent to afford 86q as a slightly yellow oil (72%, 217 mg, 0.72 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 8.31 – 8.26 (m, 1H), 8.05 – 8.03 (m, 1H), 7.82 (ddd, J = 
8.4, 6.8, 1.4 Hz, 1H), 7.66 (s, 1H), 7.62 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.52 – 7.45 (m, 2H), 7.12 
– 7.06 (m, 2H), 3.92 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 160.5, 150.8, 148.0, 147.7 (q, J = 34.3 Hz), 131.0, 130.7, 
130.6, 129.6, 128.6, 127.7, 126.1, 121.8 (q, J = 275.5 Hz), 117.0 (q, J = 2.1 Hz), 114.5, 55.6. 
FT-IR (ATR, cm-1): ! = 2933, 1610, 1518, 1506, 1466, 1384, 1342, 1296, 1268, 1250, 1188, 
1168, 1138, 1094, 1033, 908, 876, 836, 769, 732. 
MS (EI, 70 eV): m/z (%) = 304 (19), 303 (100), 190 (16), 44 (14), 43 (44). 
HR-MS (EI, 70 eV): [C11H15O3N2], calcd.: 303.0871; found: 303.0864. 
 
2-(3-(Methylthio)phenyl)pyrazine (86r) 
 
Following TP11 2-chloropyrazine (85m, 115 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with (3-
(methylthio)phenyl)zinc pivalate (87j, 1.5 mmol, 1.5 equiv) prepared according to TP9, at 40 °C. 
The solution was stirred at this temperature for 16 h and was worked-up as usual. The crude 
product was purified by column chromatography on silica using i-hexane:ethyl acetate 
(9:1 to 7:3) as an eluent to afford 86r as a colorless oil (89%, 179 mg, 0.89 mmol; or 85% on a 
10 mmol scale). 
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1H-NMR (400 MHz, CDCl3, ppm): δ  = 9.02 (d, J = 1.5 Hz, 1H), 8.63 (dd, J = 2.5, 1.6 Hz, 1H), 
8.52 (d, J = 2.5 Hz, 1H), 7.95 – 7.91 (m, 1H), 7.75 (ddd, J = 7.6, 1.7, 1.2 Hz, 1H), 7.46 – 7.39 
(m, 1H), 7.36 (ddd, J = 7.8, 2.0, 1.2 Hz, 1H), 2.56 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 152.5, 144.3, 143.3, 142.4, 140.0, 137.1, 129.5, 128.0, 
125.0, 123.6, 15.9. 
FT-IR (ATR, cm-1): ! = 3055, 2923, 2236, 1591, 1580, 1567, 1523, 1470, 1460, 1427, 1411, 
1394, 1380, 1304, 1292, 1147, 1084, 1036, 1015, 968, 907, 848, 819, 786, 729, 700, 691. 
MS (EI, 70 eV): m/z (%) = 204 (5), 203 (17), 202 (100), 201 (20), 169 (24), 157 (11), 148 (14), 
85 (12). 
HR-MS (EI, 70 eV): [C11H10SN2], calcd.: 202.0565; found: 202.0555. 
 
 
1-Methyl-6-(4-methylpyrimidin-2-yl)-1H-indole (88a) 
 
Following TP11 2-bromo-4-methylpyrimidine (78u, 173 mg, 1 mmol, 1.0 equiv, in 2 mL THF) 
reacts with (1-methyl-1H-indol-5-yl)zinc pivalate (87c, 1.5 mmol, 1.5 equiv) prepared according 
to TP9, at 40 °C. The solution was stirred at this temperature for 16 h and was worked-up as 
usual. The crude product was purified by column chromatography on silica using i-hexane: ethyl 
acetate (7:3) as an eluent to afford 86a as a white solid (81%, 180 mg, 0.81 mmol). 
m.p.: 149.5 – 151.4°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  =  8.78 (dd, J = 1.7, 0.7 Hz, 1H), 8.62 (d, J = 5.0 Hz, 1H), 
8.37 (dd, J = 8.7, 1.7 Hz, 1H), 7.39 (dt, J = 8.8, 0.8 Hz, 1H), 7.07 (d, J = 3.1 Hz, 1H), 6.98 (d, J = 
5.0 Hz, 1H), 6.59 (dd, J = 3.1, 0.9 Hz, 1H), 3.82 (s, 3H), 2.59 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 167.1, 165.7, 156.8, 138.5, 129.7, 129.5, 128.8, 122.1, 
121.9, 117.7, 109.2, 102.5, 33.1, 24.6. 
FT-IR (ATR, cm-1): ! = 2927, 1615, 1578, 1565, 1551, 1515, 1450, 1432, 1387, 1370, 1354, 
1344, 1275, 1242, 1148, 1080, 907, 818, 790, 775, 763, 727, 694. 
MS (EI, 70 eV): m/z (%) = 225 (2), 224 (17), 223 (100), 222 (14), 208 (15), 156 (20). 
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HR-MS (EI, 70 eV): [C11H15O3N2], calcd.: 223,1109; found: 223,1079. 
 
1-Methyl-6-(pyrazin-2-yl)-1H-indole (88b) 
 
Following TP11 2-chloropyrazine (85m, 115 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with (1-
methyl-1H-indol-5-yl)zinc pivalate (87c, 1.5 mmol, 1.5 equiv) prepared according to TP9, at 
40 °C. The solution was stirred at this temperature for 16 h and was worked-up as usual. The 
crude product was purified by column chromatography on silica using i-hexane:ethyl acetate 
(7:3) as an eluent to afford 88b as a slightly brown solid (85%, 178 mg, 0.85 mmol). 
m.p.: 108.9 – 110.2°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 9.09 (d, J = 1.5 Hz, 1H), 8.60 (dd, J = 2.5, 1.5 Hz, 1H), 
8.43 (d, J = 2.5 Hz, 1H), 8.31 (dd, J = 1.8, 0.7 Hz, 1H), 7.92 (dd, J = 8.6, 1.8 Hz, 1H), 7.45 –
 7.42 (m, 1H), 7.11 (d, J = 3.1 Hz, 1H), 6.59 (dd, J = 3.1, 0.9 Hz, 1H), 3.83 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 154.3, 144.1, 142.3, 141.8, 137.8, 130.1, 129.1, 127.9, 
120.8, 120.1, 110.0, 102.2, 33.1. 
FT-IR (ATR, cm-1): ! = 2928, 1616, 1575, 1517, 1466, 1448, 1424, 1404, 1340, 1312, 1246, 
1164, 1142, 1107, 1081, 1012, 906, 846, 803, 906, 846, 803, 723. 
MS (EI, 70 eV): m/z (%) = 211 (1), 210 (14), 209 (100), 208 (12), 156 (25). 
HR-MS (EI, 70 eV): [C13H11N3], calcd.: 209.0953; found: 209.0952. 
 
Ethyl (Z)-3-(4-methoxy-3,5-dimethylphenyl)acrylate (90a) 
 
Following TP11 ethyl (Z)-3-iodoacrylate (89a, 226 mg, 1 mmol, 1.0 equiv, E/Z 1:99, in 2 mL 
THF) or ethyl (Z)-3-bromoacrylate (89b, 179 mg, 1 mmol, 1.0 equiv, E/Z 1:99, in 2 mL THF) 
reacts with (4-methoxy-3,5-dimethylphenyl)zinc pivalate (87h, 1.5 mmol, 1.5 equiv) prepared 
according to TP9, at 40 °C. The solution was stirred at this temperature for 16 h and was 
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worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (95:5) as an eluent to afford 90a as a slightly yellow oil (starting with 89a: 
98%, 230 mg, 0.98 mmol, E/Z 1:99; starting with 89b: 94%, 220 mg, 0.94 mmol, E/Z 1:99; ). 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.31 (q, J = 0.7 Hz, 2H), 6.81 (dt, J = 12.7, 0.7 Hz, 1H), 
5.85 (d, J = 12.7 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.73 (s, 3H), 2.28 (s, 6H), 1.27 (t, J = 7.1 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.6, 157.9, 142.8, 130.9, 130.5, 130.5, 118.7, 60.3, 
59.8, 16.2, 14.3. 
FT-IR (ATR, cm-1): ! = 2982, 2939, 1714, 1627, 1600, 1485, 1445, 1388, 1286, 1228, 1174, 
1136, 1096, 1033, 1014, 907, 826, 767, 729. 
MS (EI, 70 eV): m/z (%) = 235 (17), 234 (100), 219 (10), 191 (16), 189 (59), 162 (19), 147 (10), 
91 (12). 
HR-MS (EI, 70 eV): [C14H18O3], calcd.: 234.1256; found: 234.1251. 
 
Ethyl (Z)-3-(4-(trifluoromethyl)phenyl)acrylate (90b) 
 
Following TP11 ethyl (Z)-3-iodoacrylate (89a, 226 mg, 1 mmol, 1.0 equiv, E/Z 1:99,  in 2 mL 
THF) reacts with (4-trifluormethylphenyl)zinc pivalate (87i, 1.5 mmol, 1.5 equiv) prepared 
according to TP9, at 40 °C. The solution was stirred at this temperature for 16 h and was 
worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (97:3) as an eluent to afford 90b as a colorless oil (80%, 195 mg, 
0.80 mmol, E/Z 3:97). 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.62 (d, J = 6.7 Hz, 4H), 6.98 (d, J = 12.6 Hz, 1H), 6.06 
(d, J = 12.6 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 165.7, 141.5, 138.5 (d, J = 1.7 Hz), 130.5 (q, J = 32.6 
Hz), 129.7, 124.9 (q, J = 3.9 Hz), 124.0 (q, J = 272.1 Hz), 12.1, 60.6, 14.1. 
FT-IR (ATR, cm-1): ! = 2986, 2362, 2349, 2256, 1721, 1637, 1617, 1407, 1324, 1200, 1185, 
1166, 1127, 1114, 1068, 1019, 909, 858, 732. 
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MS (EI, 70 eV): m/z (%) = 244 (27), 225 (6), 216 (25), 215 (10), 200 (6), 199 (100), 172 (13), 
171 (32), 151 (36), 147 (7), 145 (7), 109 (7), 102 (12), 97 (10), 83 (14). 
HR-MS (EI, 70 eV): [C12H11F3O2], calcd.: 244.0711; found: 244.0700. 
 
(E)-1-Methoxy-4-(4-(trifluoromethoxy)styryl)benzene (90c) 
 
Following TP11 (E)-1-(2-bromovinyl)-4-methoxybenzene (89c, 213 mg, 1 mmol, 1.0 equiv, E/Z 
99:1, in 2 mL THF) reacts with (4-(trifluoromethoxy)phenyl)zinc pivalate (87k, 1.5 mmol, 
1.5 equiv) prepared according to TP9, at 40 °C. The solution was stirred at this temperature for 
16 h and was worked-up as usual. The crude product was purified by column chromatography 
on silica using i-hexane:ethyl acetate (95:5) as an eluent to afford 90c as a white solid (97%, 
285 mg, 0.97 mmol, E/Z 99:1). 
m.p.: 149.2 – 151.1°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.52 – 7.42 (m, 4H), 7.21 – 7.17 (m, 2H), 7.07 – 6.89 (m, 
4H), 3.84 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 159.7, 148.3 (d, J = 1.9 Hz), 136.6, 129.9, 129.4, 128.0, 
127.5, 125.1, 121.3 (d, J = 1.1 Hz), 120.7 (q, J = 257.0 Hz), 114.3, 55.5. 
FT-IR (ATR, cm-1): ! = 2963, 1605, 1515, 1309, 1254, 1204, 1175, 1106, 1028, 971, 903,838, 
810, 729. 
MS (EI, 70 eV): m/z (%) = 295 (20), 294 (100), 279 (23), 251 (5), 166 (9), 165 (28), 153 (5), 152 
(6). 
HR-MS (EI, 70 eV): [C16H13F3O2], calcd.: 294.0868; found: 294.0862. 
 
2-(3,4,5-Trimethoxyphenyl)-1H-indene (90d) 
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Following TP11 2-bromo-1H-indene (89d, 195 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts with 
(3,4,5-trimethoxyphenyl)zinc pivalate (87f, 1.5 mmol, 1.5 equiv) prepared according to TP9, at 
40 °C. The solution was stirred at this temperature for 16 h and was worked-up as usual. The 
crude product was purified by column chromatography on silica using i-hexane:ethyl acetate 
(85:15) as an eluent to afford 90d as a white solid (83%, 234 mg, 0.83 mmol). 
m.p.: 115.6 – 117.8°C. 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.49 – 7.46 (m, 1H), 7.42 – 7.38 (m, 1H), 7.29 (td, J = 
7.5, 1.1 Hz, 1H), 7.23 – 7.15 (m, 2H), 3.94 (s, 6H), 3.90 (s, 3H), 3.78 – 3.77 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 153.4, 146.4, 145.4, 143.0, 138.0, 131.9, 126.7, 126.4, 
124.8, 123.7, 121.0, 102.9, 61.1, 56.2, 39.3. 
FT-IR (ATR, cm-1): ! = 2938, 2250, 1581, 1562, 1504, 1460, 1431, 1415, 1395, 1354, 1340, 
1297, 1240, 1203, 1187, 1162, 1125, 1058, 1030, 1004, 906, 820, 752, 727, 717. 
MS (EI, 70 eV): m/z (%) = 283 (20), 282 (100), 268 (14), 267 (67), 165 (12), 153 (13), 152 (14), 
141 (15), 43 (11). 
HR-MS (EI, 70 eV): [C18H18O3], calcd.: 282.1256; found: 282.1253. 
((4-Methoxyphenyl)ethynyl)trimethylsilane (92a) 
 
Following TP11 (bromoethynyl)trimethylsilane (91a, 177 mg, 1 mmol, 1.0 equiv, in 2 mL THF) 
reacts with (4-methoxyphenyl)zinc pivalate (87a, 1.7 mmol, 1.7 equiv) prepared according to 
TP9, at – 40 °C. The solution was allowed to warm to room temperature over 16 h and was 
worked-up as usual. The crude product was purified by column chromatography on silica using 
i-hexane:ethyl acetate (9:1) as an eluent to afford 92a as a yellow oil (61%, 124 mg, 0.61 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.36 – 7.30 (m, 2H), 6.79 – 6.70 (m, 2H), 3.73 (s, 3H), 
0.17 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 159.6, 133.4, 115.2, 113.7, 105.1, 92.4, 55.2, 0.0. 
FT-IR (ATR, cm-1): ! = 2959, 2936, 2901, 2838, 2361, 2156, 1606, 1572, 1508, 1465, 1442, 
1293, 1249, 1231, 1180, 1172, 1107, 1034, 909, 864, 834, 756, 734, 700. 
MS (EI, 70 eV): m/z (%) = 206 (3), 205 (11), 294 (65), 190 (33), 189 (100), 173 (11), 146 (9), 94 
(9). 
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HR-MS (EI, 70 eV): [C12H16O2Si], calcd.: 204.0970; found: 204.0960. 
 
Ethyl 3-(4-methoxyphenyl)propiolate (92b) 
 
Following TP11 ethyl 3-bromopropiolate (91b, 177 mg, 1 mmol, 1.0 equiv, in 2 mL THF) reacts 
with (4-methoxyphenyl)zinc pivalate (87a, 1.7 mmol, 1.7 equiv) prepared according to TP9, at –
 40 °C. The solution was allowed to warm to room temperature over 16 h and was worked-up as 
usual. The crude product was purified by column chromatography on silica using i-hexane:ethyl 
acetate (9:1) as an eluent to afford 92b as a yellow oil (71%, 144 mg, 0.71 mmol). 
1H-NMR (400 MHz, CDCl3, ppm): δ  = 7.58 – 7.49 (m, 2H), 6.92 – 6.83 (m, 2H), 4.28 (q, J = 7.1 
Hz, 2H), 3.83 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 161.6, 154.5, 135.0, 114.4, 111.6, 87.0, 80.3, 62.0, 55.5, 
14.3. 
FT-IR (ATR, cm-1): ! = 2982, 2236, 2205, 1703, 1604, 1510, 1463, 1443, 1367, 1287, 1253, 
1194,  1163, 1025, 834, 748. 
MS (EI, 70 eV): m/z (%) = 205 (4), 204 (29), 160 (8), 159 (73), 144 (9), 133 (11), 132 (100), 117 
(8), 116 (9), 88 (9). 
HR-MS (EI, 70 eV): [C12H12O3], calcd.: 204.0786; found: 204.0780.  
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